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ABSTRACT 
 
The fumonisin mycotoxins are known to be the causative principle for several animal 
diseases and are associated with the development of liver and oesophagus cancer 
and neural tube defects in humans. The thesis focuses mainly on the 
characterisation of the compounds from maize cultures of the fungus Fusarium 
verticillioides, isolated from maize, the toxicological effects in animals, mechanism 
involved in hepato- and nephrocarcinogenicity and discussing the major differences 
and contradictions in the literature together with their impact on setting relevant risk 
assessment parameters to safeguard human health. Controversies include the 
importance of non-genotoxicity vs genotoxicity in the development of cancer, the role 
of threshold effects in carcinogenesis and the establishment of realistic risk 
assessment parameters that will also be applicable in developing countries. Recent 
approaches suggest that thresholds should also apply for genotoxic carcinogens as 
interaction with the DNA is only one event in the multi-step process of cancer 
development and therefore could not be taken as the basis for applying a no-effect 
threshold for genotoxins. It would appear that a carcinogen such as fumonisin, 
whether it is labeled genotoxic or non-genotoxic per se, exhibits some degree of risk 
at any level due to additive or synergistic interactions with other xenobiotics and/or 
dietary constituents. The underlying mechanisms of fumonisin-induced 
carcinogenicity includes the disruption of sphingolipid, phospholipids and fatty acid 
metabolism, which plays a major role in the modulation of apoptotic and cell 
proliferative pathways related to cancer development. Interactive responses between 
arachidonic acid and ceramide affect downstream cell signal transduction pathways 
and depending on the cell type the disruption of these pathways could either 
stimulate or inhibit cell proliferation which eventually will determine the induction of 
apoptosis and hence affect cell survival. The modulating roles of dietary constituents 
such as vitamins, protein and the South African herbal teas are also highlighted as 
they affected the outcome of toxicological assays, thus determining thresholds of the 
adverse effects in specific target organs that will impact risk assessment parameters. 
Regulation of the fumonisins in food and the associated risk are debated from many 
perspectives. In developing countries there is a lack of quality control implying that 
maize highly contaminated with mycotoxins may directly enter the food chain of 
adults and children as control of mycotoxins is difficult or in some cases totally 
absent. The interaction of politics, economy and technology will eventually determine 
the impact on health as the regulation of fumonisin in food differs between countries. 
Knowledge about the biological effects of the fumonisins is currently playing an 
important role in the development of simple and inexpensive methods to reduce the 
levels of the fumonisin in maize by targeting specific populations at risk. 
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OPSOMMING 
 
Die fumonisien mikotoksiene veroorsaak verskeie siektes by diere en is 
geassosieerd met die ontwikkeling van lewer en slukderm kanker en geboorte 
defekte by mense. Die tesis handel oor die karakterisering van die fumonisiene in 
mielie kulture van die swam Fusarium verticillioides oorspronklik geisoleer uit mielies, 
die toksikologiese effekte in diere, die onderliggende meganismes betrokke in die 
kankerontwikkeling in die lewer en niere en ’n bespreking van die verskille en 
teenstrydighede in die literatuur rakende die toksikolgiese effekte asook hoe dit die 
risiko bepaling in mense en regulering in voedsel kan beinvloed. Sekere van die 
kontroversiele aspekte sluit in die rol wat verbindings wat met genetiese materiaal 
(DNA) bind en beskadig (genotoksies) teenoor die wat kanker induseer volgens 
ander meganismes (nie-genotoksies) en die rol in die bepaling van drumpelwaardes 
wat belangrik is in die vastelling van risikoparameters in ontwikkelde en 
ontwikkelende lande. Onlangse benaderings dui daarop dat vanwee die 
kompleksieteit van kankerontwikkeling, karsinogene wat nie DNA beskadig nie ook ’n 
drumpelwaarde besit soos in die geval met genotoksiese karsinogene en behoort 
dus tot dieselfde mate gereguleer word. Dit blyk dat ’n karsinogeen soos fumonisien, 
of dit nou genotoksies of nie-genotoksies beskou word, n mate van risiko by enige 
vlak inhou as gevolg van additiewe en sinergistiese interaksies met verskeie ander 
toksiene en voedselkomponente wat die drumpelwaarde en dus regulering in voedsel 
kan beinvloed. Studies rakende die meganismes van kanker-induksie handel 
ondermeer oor die effek van die fumonisiene op fosfolipied-, sfingolipied- en 
vetsuurmetabolisme. Hierdie veranderings speel ’n belangrike rol in selgroei en 
geprogrammeerde seldood, twee belangrike aspekte wat die oorlewing van selle 
bepaal en onderliggend is aan die ontwikkeling van kanker. ’n Interaksie tussen 
arachidoonsuur en seramied, twee belangrike molekules in die vetsuur en 
sfingolipied metaboliese paaie, word selektief deur die fumonisiene geaffekteer en 
speel dus ‘n belangrike rol in sein transduksie paaie geassosieer met sel groei en 
geprogrameerde seldood. Die modulering van die karsinogene effekte van die 
fumonisiene deur verskeie voedselkomponente soos vitamienes, protein en Suid 
Afrikaanse kruietees word ook bespreek in die lig van moontlike intervensies van die 
toksikologiese effekte in mense. Die finale gedeeltes van die tesis handel oor die 
regulering van die fumoniene in voedsel en die verskille wat bestaan tussen 
ontwikkelende en ontwikkelde lande. Hierdie verskille kan nadelige effekte hê in 
ontwikkelende lande waar regulering nie streng toegepas word nie en die toksien in 
die voedselketting van volwassenes en kinders kan beland. Die interaksie tussen die 
politiek, ekonomie en tegnologie sal uiteindelik die impak op gesondheid bepaal deur 
die vastelling van spesifieke vlakke in voedsel. Kennis oor die biologiese effekte van 
die fumonisiene speel huidiglik ’n belangrike rol in die ontwikkeling van eenvoudinge 
en goedkoop metodes om die vlakke in stapelvoedsel van hoë-risiko populasies te 
verlaag.  
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….Where were you when I laid the earth’s foundation? 
…  have you ever give orders to the morning, 
     or show the dawn its place?          
…  Do you give the horse his strength 
     or clothe his neck with a flowing mane? 
…  Does the hawk take flight by your wisdom?     
…  Does the eagle soar at your command?    Job 38 to 39 
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INTRODUCTION 
 
Mycotoxins are mainly produced by species of the fungal genera Aspergillus, 
Penicillium and Fusarium on a wide range of food commodities worldwide (Marasas 
et al., 2008). It is estimated that mycotoxins affect a quarter of the world’s food crops 
resulting in economical losses amounting to approximately $1.4 billion in the United 
States annually (Wu, 2004). Crop losses associated with aflatoxin contamination of 
maize in the United States was estimated $75 to $100 million in 1985 (Henry et al., 
1999). Stringent mycotoxin regulations resulted in the trade of the best quality foods 
whilst contaminated foods are marketed and consumed locally with increased the risk 
of mycotoxin exposure. The high regulatory standards adversely affect the economy 
of developing countries due to the rejection of certain food products, resulting in 
losses of over $600 million when considering the regulation of aflatoxin. Apart from 
severe crop losses due to mycotoxin contamination it impacts on a large array of 
chronic health risks including cancer, digestive, blood and nerve disorders in humans 
and/or animals (Shephard et al., 2006). The health impact of mycotoxins in 
developing countries is far more severe due to the chronic exposure to high levels of 
malnourished populations. The reduction of mycotoxin intake is therefore of major 
importance, especially in developing countries where exposure is extremely high due 
to malpractices regarding farming, storing and the utilisation of grains as the sole 
dietary staple. 
 
Since the discovery of Fusarium verticillioides (previously known as F. moniliforme or 
Oospora verticillioides) isolated from moldy maize, it has been associated with 
disease development in animals and humans as it is the most prevalent fungus 
associated with maize intended for human and animal consumption (Marasas, 1985; 
2001). The first remarkable disease induced by the fungus in animals was 
leukoencephalomalacia (LEM) in equines when either using naturally contaminated 
maize or maize fungal cultures (Wilson and Maronpot, 1971; Marasas et al., 1976). 
Numerous studies in experimental animals showed that the fungus caused diverse 
toxic lesions with the main target organ that differs depending on the animal species. 
One of the most prominent findings was the induction of liver cancer in rats by 
chronic exposure to fungal culture material suggesting that carcinogenic principles 
are produced by the fungus (Marasas et al., 1984). The first indication that the fungus 
is associated with a human disease was derived from studies conducted in the 
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Transkei region of the Eastern Cape Province, South Africa during the late 1970 and 
early 1980, showing that the fungus was correlated with the incidence of human 
oesophageal cancer (OC) (Marasas et al., 1979, 1981, 1982). Similar findings were 
also noted in China in five counties with high OC incidence rates (Zhang, et al., 
1997). None of the known Fusarium mycotoxins, such as the trichothecenes, 
zearalenone and moniliformin is produced by F. verticillioides, although some 
conflicting reports have been published. Therefore for two decades the toxic and 
carcinogenic principles of the fungus remained unknown despite continued attempts 
to characterise the active metabolites. 
 
The present dissertation commenced with studies related to the carcinogenicity of the 
potent mutagen, fusarin C, produced by the fungus F. verticillioides (Chapter II). 
There were strong indications that fusarin C could be responsible for the 
carcinogenic properties of the fungus but the heat instability and prominent 
deactivation by drug metabolizing enzymes in the liver were contra indicators. The 
ground-breaking paper regarding the characterisation of the newly discovered 
fumonisin B (FB) mycotoxins was the finding that culture material of the fungus 
promoted the formation of preneoplastic lesions in the liver of rats utilising a cancer 
initiation/promotion model with diethylnitrosamine (DEN) as the cancer initiator 
(Gelderblom et al., 1988). Details regarding this finding and the subsequent isolation, 
purification, characterisation and radiolabelling are described in Chapter II. Studies in 
experimental animals, presented in Chapter III, showed that FB1 is the causative 
principle of both LEM in horses and the hepatotoxic and hepatocarcinogenic effects 
in both male BD IX and Fischer 344 rats. Different dietary constituents, including iron, 
high protein diet and tea antioxidants modulate the carcinogenic properties of FB1. A 
synergistic interaction with aflatoxin B1 was also demonstrated in a liver cancer 
model. These dietary constituents are likely to alter the biological response and site 
specific sensitivity of FB1–induced effects in different animal species.  
 
The mechanism of cancer induction of the fumonisins in the liver is presented in 
Chapter IV. Two controversial aspects of FB1-induced hepatocarcinogenesis are 
addressed which include (i) the cancer initiating properties of this apparent non-
genotoxin which should impact on risk assessment in humans and (ii) a unique 
model for cancer promotion involving fatty acids (FA), specifically arachidonic acid 
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(C20:4n-6). This is the first time that such a model is proposed for cancer promotion 
by a chemical carcinogen in the liver. The proposed mechanism for cancer promotion 
is critically debated with respect to known models that exist for cancer promotion in 
the liver. Cancer promotion by FB1 is also discussed in relation to the biological 
effects obtained in vitro utilising primary hepatocyte cultures and in vivo in rat 
liver.The interactive mechanism that seems to exist between the FA, phospholipids 
and sphingolipid metabolism is presented in detail with discussions extending into 
Chapter V.   
 
Aspects regarding parameters determining the risk assessment of the fumonisins 
and some controversies that exists are addressed in Chapter V. These include the 
role of thresholds in fumonisin-induced toxic and carcinogenic effects and the 
adoption of non-linear dose response extrapolations with respect to genotoxic and 
nongenotoxic carcinogens. A critical assessment of the current risk paradigm for the 
fumonisins and the interaction of health, economy, technology and politics are 
debated with specific reference to the potential impact on human populations in 
developing countries. These aspects are further developed in the short Summary and 
Discussion of the thesis, presented in Chapter VI. 
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TOXICITY, MUTAGENICITY AND CARCINOGENICITY OF FUSARIUM 
VERTICILLIOIDES 
 
1.1 Studies using maize culture material. 
 
1.1.1  Studies in rats 
 Initial studies on the toxicological effects of F verticillioides in male BD IX rats fed a 
commercial rat mash were performed by Kriek et al. (1981a). The culture material of 
21 isolates of the fungus from Transkeian maize was incorporated at dietary levels of 
8, 16 and 32 %. The two high dosage levels (32% and 16%) of the different isolates, 
including strain MRC 826, were toxic and all the rats died after 49 and 78 days, 
respectively, while surviving rats receiving the lower dosage level were killed after 78 
days. Lesions were mainly restricted to the heart and liver. These include cirrhosis 
and development of hyperplastic nodules in the liver and prominent heart lesions in 
the left ventricular endocardium including acute and proliferative endocardial lesions 
and concurrent intraventricular thrombosis. Changes in the other organs were less 
common but endothelial proliferation of pulmonary arteries and low-grade toxic 
nephrosis were of interest. It was suggested that with respect to the cardiotoxicity the 
target cells appear to be the endothelial cells. The cardiotoxicity induced by cultures 
of F verticillioides also differed from that induced by moniliformin, a mycotoxin 
produced by F. subglutinans, which mainly affects the myocardium (Kriek et al., 
1977).   
 
Two separate studies were performed regarding the long-term toxicological effects of 
maize cultures of verticillioides MRC 826 in male BD IX rats (Marasas et al., 1984; 
Jaskiewicz et al., 1987a). The fungal strain used in both studies was isolated from 
maize cultivated in a high incidence area of OC in the Transkei region on the Eastern 
Cape Province, South Africa. The first experiment was carried out over a period of 
763 days using commercial rat feed containing mouldy maize meal at a level of 8% 
and 4 % for 286 days followed by 2 % for the remainder of the experiment (Marasas 
et al., 1984). Both freeze-dried and oven-dried (45-50 °C) materials were used to 
obtain some information about the heat stability of the active compound(s). The 
maintenance diet was screened on a regular basis for the presence aflatoxin during 
the course of the experiment and found to be negative. None of the rats survived the 
8 % dietary treatment and were terminated between 50 and 75 days following the 
onset of the experiment with pathological liver lesions including cirrhosis, nodular 
hyperplasia, bile duct hyperplasia and adenofibrosis. Other pathological changes 
include endothelial hyperplasia of the ventricular endocardium and/or intraventricular 
 7 
thrombosis with oesophageal basal cell hyperplasia in about 50% of the rats that 
received the freeze-dried culture material. The most remarkable pathological features 
developed in the livers of the rats that received the lower dosage levels of both the 
freeze- and oven-dried culture material. In 80% of the rats the culture material 
caused hepatocellular carcinoma while 63% of the rats developed ductular 
carcinoma. These cancers invariably developed in severely cirrhotic livers showing 
nodular hyperplasia as well as a range of altered cell populations including clear cell, 
acidophilic and basophilic cell foci and areas. Pulmonary metastases developed in 
three rats of each treatment. Adenofibrosis also developed consistently in all the 
animals and they progressed into large expansile neoplastic lesions referred to as 
cholangiocarcinoma that were observed macroscopically to extend above the surface 
of the liver. Hyperplasia of the oesophageal basal cells was also detected commonly 
in the treated rats, with a higher incidence in those receiving the freeze-dried culture 
material. It was concluded that some of the causative principles, especially those 
responsible for the basal cell hyperplasia, are heat sensitive. The major finding, 
however, was that culture material of the fungus induced two types of liver cancer 
suggesting that the fungus, commonly occurring in maize which is a major human 
dietary staple, has the ability to produce a carcinogenic metabolite(s), some of which 
may be heat labile.   
 
In a follow-up long-term study the same freeze dried culture material of F. 
verticillioides MRC 826 was fed to male BD IX rats at a low (0.5%) dietary level using 
a semi-synthetic diet marginally deficient in certain vitamins and minerals (Jaskiewicz 
et al., 1987a). Culture material of another non-toxigenic fungal strain designated F. 
verticillioides MRC 1069 that lacks any detectable toxic effects in rats, although it 
produces the mutagen fusarin C, was included at a dietary level of 5% for 
comparative purposes. Following a feeding period of 23 to 27 months, 2 out of 21 
rats fed culture material of strain MRC 826 developed hepatocellular carcinoma with 
lung metastases and 8 out of 21 animals developed cholangiocarcinoma. The livers 
of the rats also contained numerous hepatocyte nodules while adenofibrosis, ductular 
cell (“oval cell”) hyperplasia and gamma glutamyltranspeptidase (GGT) positive foci 
were common features. Basal cell hyperplasia was prominent in the oesophageal 
epithelium of the rats, myocardial disseminated fibrosis occurred frequently while 
endocardial and subcardial fibrosis also occurred in 3 rats. Rats fed the non-toxic 
strain MRC 1069, containing high levels of fusarin C, developed very few lesions in 
the liver, including mild ductular hyperplasia and a hepatocyte nodule in one rat. The 
low outcome of liver tumours in this study was ascribed to the low to marginal 
hepatotoxic effects. As the non-toxic strain MRC 1069 failed to induce any 
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carcinogenic changes in the liver of the rats implies that the hepatotoxicity was 
closely associated with the carcinogenic effects of strain MRC 826. 
 
1.1.2 A study in vervet monkeys 
Studies with F. verticillioides strain MRC 826 amongst others, in nonhuman primates 
commenced during the 1980’s. Initial studies were conducted in baboons using F 
verticillioides strain MRC 602 with acute congestive heart failure and liver cirrhosis as 
the major pathological lesions (Kriek et al., 1981b). Subsequent studies were 
conducted with the more toxic strain of the fungus F verticillioides MRC 826, shown 
to effect equine leukoencaphalomalacia, lung edema in pigs, acute nephrosis and 
hepatosis in sheep and cirrhosis, nephrosis and congested heart failure in rats. 
Based on this information long-term studies with strain MRC 826 were performed in 
rats, described above, and vervet monkeys that extended over a period of 13.5 
years. Jaskiewicz et al. (1987b) and Fincham et al., (1991) published findings 
regarding the hepatoxic and arthrogenic effects of the fungal culture material, 
respectively. The time course of the study spans the pre- and post-fumonisin period, 
resulting in a retrospective evaluation of exposure after fumonisin analyses of the 
different cultured batches used (Gelderblom et al., 2001). Dose selection, consisting 
of an initial low (0.1% culture material) and a high dose (0.25% culture material) was 
based on blood clinical chemical analyses associated with liver and kidney function. 
Three different maize culture batches of the fungus were used and feed and FB 
intake profiles were determined. Changes in the serum liver parameters were 
confirmed histopathologically by liver biopsies and were characteristic of a chronic 
toxic hepatosis. Threshold levels for liver and kidney damage were similar and 
ranged between 0.1 to 0.18 mg FB/kg bw/day and 0.18 to 0.2 mg FB/kg bw/day, 
respectively. Based on these data a no-observed-effect-level (NOEL) was estimated 
between 0.11 to 0.18 mg FB/kg bw/day representing maize contamination levels of 
8.21 to 13.25 mg FB/kg. Changes in the sphinganine and sphinganine/-sphingosine 
ratio, possible biomarkers of exposure were detected at an intake of 0.29 to 0.64 mg 
FB/kg bw/day that represented a contamination level of 21.7 to 47.9 mg FB/kg, 
respectively.  
 
1.2 A study using naturally contaminated maize.   
A study conducted in the USA pursued the evidence provided by the toxicological 
studies with strain MRC 826 in experimental animal that differences exist with respect 
to the target organ affected in various animals species (Wilson et al., 1985). 
Following a natural outbreak of equine leukoencaphalomalacia (ELEM) on a farm in 
southeastern Pennsylvania, a maize sample which was fed during the epizootic of 
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ELEM, was recovered and fed to male Fisher 344 rats over a period of 5-6 months. 
Despite the many limitations regarding the short duration of the study due to the lack 
of sufficient material as well as the lack of controls for the nutritionally deficient 
maize-only diet, the lesions induced were remarkably similar to those reported by 
Marasas et al. (1984a) and Jaskiewicz et al. (1987a) with culture material of MRC 
826 in BD IX rats. These included multiple hepatic nodules, large areas of 
adenofibrosis and cholangiocarcinomas that distorted the lobular structure of the 
liver. The role of the dietary deficiencies, especially those related to methionine and 
choline, were discussed in detail and their importance in the acceleration and/or 
promoting the formation of these lesions was recognised. However, the fact that 
culture material of MRC 826 induced similar lesions using a balanced diet as well as 
a diet marginally deficient in vitamins and minerals further supported the hypothesis 
developed by Kriek et al. (1981a) and Marasas et al. (1984b) that F. verticillioides 
produces toxic principles that are responsible for both ELEM in horses and different 
toxicological effects in male BD IX rats and, by inference, also in male Fisher 344 
rats. 
 
Retrospective analyses of the unique naturally contaminated maize sample used in 
the Wilson rat study (Wilson et al., 1985) study indicated that it contains a total FB 
level of 33.1 mg/kg and only trace amounts of aflatoxin B1 and B2 (Gelderblom et al., 
2004). The same sample was previously reported to contain moniliformin and fusarin 
C, but none of the major trichothecene mycotoxins T2-toxin and diacetoxyscirpinol 
(Thiel et al., 1986). The role of moniliformin and fusarin C in the toxicological effects 
of the fungus has been debated (Thiel et al, 1986; Jaskiewics et al, 1987a). 
Moniliformin is apparently not involved in either of the syndromes induced in horses 
and rats, as MRC 826, which is known to cause both mycotoxicoses, does not 
produce it. The role of the mutagenic fusarin C has also be questioned in the 
hepatocarcinogenicity of the fungus (Jaskiewicz et al., 1987a) although very little is 
known about the synergistic interactions between different mycotoxins and certain 
dietary deficiencies. 
 
1.3 Short-term hepatocarcinogenesis studies related to cancer initiation and 
promotion. 
 
1.3.1 Carcinogenicity of fusarin C 
The mutagen fusarin C was purified from culture material of F. verticillioides MRC 
826 and shown to occur naturally in maize (Gelderblom et al., 1983, 1984a, b; Cheng 
et al, 1985). As fusarin C, a type II substrate for cytochrome P450 (Gelderblom et al., 
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1988a), exhibited comparable mutagenic activities to aflatoxin B1 in the presence of 
metabolic activation a possible role in the carcinogenicity of the fungus was 
suggested (Gelderblom et al., 1984b). However, short-term carcinogenesis studies 
utilizing two stage cancer initiation/promotion models in mouse skin and rat liver 
failed to indicate any cancer initiating properties for fusarin C. As fusarin C is heat 
labile and rapidly conjugated to glutathione, either chemically and ensymatically via 
the glutathione-S-transferase (Gelderblom et al., 1988b) and by a microsomal 
esterase (Gelderblom et al., 1988c), a possible role in the carcinogenicity of the 
fungus has been abandoned. This notion was further strengthened by the fact that 
long-term studies using F verticilloides strain MRC1069, containing high levels of 
fusarin C as compared to the carcinogenic strain MRC 826, failed to induce 
hepatocarcinogenesis (Jaskiewicz et al., 1987). 
 
1.3.2 Cancer promotion by F. verticillioides 
The cancer promoting activity of culture material of F. verticillioides strain MRC 826 in 
a short-term cancer initiation/promotion liver model in male BD IX rats indicated that 
both initiation and promotion could be effected (Gelderblom et al., 1988a; 1988b). 
Subsequent studies showed that other strains of the fungus (MRC 4315, 4319 and 
4321) also exhibited cancer promotion activity that, as discussed above for cancer 
induction, was also associated with a hepatotoxic effect. One of the major findings 
during these early stages of the characterisation of the active cancer promoters was 
that several strains of F. verticillioides isolated from maize intended for human 
consumption exhibited this property. In addition F. verticillioides strain MRC 826 
effected cancer promotion in the absence of DEN initiation suggesting that the 
carcinogenic principle may effect both phases of cancer induction. This implied that 
these carcinogenic principles, occurring naturally in maize infected by the fungus, 
could pose a health risk to humans. 
 
1.4 Perspectives 
 
The role of fungal contamination of maize in human and animal diseases has been 
described since the turn of the 20th century. The toxicological effects of the fungus F. 
verticillioides became of interest following reports of the induction of ELEM in horse 
and donkeys experimentally with maize cultures of the fungus during the 1970’s 
(Wislon, 1971; Kellerman et al., 1972; Marasas et al., 1976). Subsequent studies 
provided evidence regarding the diversity of toxicological lesions induced in different 
animals, which include the induction of pulmonary edema in pigs. As F verticillioides 
is a natural contaminant on maize and plays a role in several animal diseases raise 
some concerns about a possible role in human diseases. Interest in the possible role 
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in human disease was pioneered with the finding that the presence of the fungus on 
maize, a major dietary staple, was correlated with the high incidence rates of OC in 
rural areas of the former Transkei region of the Eastern Cape Province. These 
concerns were further strengthened by the finding that the fungus produced 
mutagenic and carcinogenic principles, which stimulated research to characterise 
these unknown fungal metabolites. Studies on the mutagenic properties, resulting in 
the purification and identification of fusarin C, failed to clarify the carcinogenic 
properties of the fungus. Renewed attempts focused on the characterisation of the 
hepatotoxic principles in rats by developing a suitable biological model to screen 
different fractions of the maize cultures of the fungus. During the studies evaluating 
the carcinogenic effects of fusarin C a cancer initiating/promotion model was 
established in the liver using diethylnitrosamine (DEN) as cancer initiator. This model 
adressed both the hepatoxic and hepatocarcinogenic properties of the fungus in rats 
and eventually led to the characterization of the major toxic and carcinogenic 
principles of the fungus, ie the fumonisins.      
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Toxicologic studies with culture material of
Fusarium verticillioides (= F. moniliforme)
grown on corn have been performed in a vari-
ety of experimental animals, including pigs,
sheep, horses, baboons, and rats (1). The sci-
entific importance of this fungal species, how-
ever, was first recognized with the finding
that contamination of feedstuff, particularly
corn, with F. verticillioides was responsible for
natural outbreaks of the mycotoxicosis equine
leukoencephalomalacia (ELEM) (2,3). This
implied that the causative principle(s)
occur(s) under natural conditions and could
affect the health of livestock and also humans.
The latter was of particular interest because
many human populations in southern Africa
consume corn as the major dietary staple (4).
Efforts were launched in South Africa and
elsewhere to develop sensitive screening
methods to aid in the chemical isolation of
the active compound(s). A duckling toxicity
assay was designed whereby numerous isolates
of the F. verticillioides were screened for the
presence of toxic secondary metabolites pro-
duced by the fungus (5). Several isolates with
different degrees of duckling toxicity were
identified and formed the basis of further tox-
icologic studies in various animal species.
One of these, designated F. verticillioides strain
MRC 826, was identified as one of the most
toxic isolates from corn. This strain caused
many toxic effects in experimental animals,
such as ELEM in horses, pulmonary edema in
pigs, acute nephrosis and hepatosis in sheep,
and cirrhosis, intraventricular cardiac throm-
bosis, and nephrosis in rats (1). A less toxic
strain, F. verticillioides MRC 602, also induced
acute congested heart failure in baboons. A
remarkable finding of these early experiments
was that the main target organ differed in each
animal species although certain organs, includ-
ing the liver and kidneys, were consistently
affected. It was suggested that rats provided the
best screening system able to mimic biologic
effects of the fungus in the various mammalian
species (5). Toxicologic studies in rats eventu-
ally formed the basis for evaluating the car-
cinogenic effects of the potent mutagen fusarin
C and subsequently for isolating the fumonisin
(F)B mycotoxins from culture material of
F. verticillioides MRC 826 (6,7). 
Studies in nonhuman primates were
initially performed with baboons (1). A
prominent lesion was acute congestive heart
failure, and liver cirrhosis was observed as a
principal lesion in another baboon. The latter
study was performed between 5 months and
2 years at varying dietary levels of the culture
material of F. verticillioides strain MRC 602.
Subsequent studies were conducted in rats to
evaluate the long-term toxicologic effects of
different isolates of F. verticillioides including
strain MRC 826 (8,9). At the same time, a
long-term toxicity study was initiated at the
Programme on Mycotoxins and Experimental
Carcinogenesis (PROMEC), Medical
Research Council (MRC), Tygerberg, South
Africa, in vervet monkeys (10,11) by feeding
different dietary levels of F. verticillioides
strain MRC 826. In this article we describe
the clinical and biochemical data and
dose–response effects in relation to the FB
exposure levels during the course of the
experiment (approximately 13.5 years).
Materials and Methods
Animals and Diets
Twelve vervet monkeys (Cercopithecus
aethiops), consisting of eight females and four
males weighing between 1 and 2 kg, were
selected from the breeding colony of the
MRC Primate Unit of the Experimental
Biology Programme of the Medical Research
Council, Tygerberg, South Africa. They were
caged singly in a closed environment (26 ±
1°C) with a 12-hr photoperiod, 50% humid-
ity, and 20 air changes/hr. The vervet mon-
keys were divided into three groups consisting
of six animals (four females and two males) in
the high-dose group, four animals (two males
and two females) in the low-dose group, and
two animals (females) in the control group.
The diet consisted of 57 g of commercial pre-
cooked corn meal, 1 g of an in-house vitamin
mixture, and 10 g of a protein–vitamin–
mineral supplement (PVM Product, Pretoria,
South Africa). Culture material of F. verticil-
lioides MRC 826 was incorporated at different
We conducted a chronic feeding study in vervet monkeys (Cercopithecus aethiops) over 13.5 years.
The experimental design consisted of two dietary treatment groups, each including males and
females, fed varying levels of culture material of Fusarium verticillioides (Sacc.) Nirenberg (= F.
moniliforme Sheldon) strain MRC 826 mixed into their daily food ration. Two females were included
as treatment controls. We conducted blood chemical analyses bimonthly and recorded all clinical
signs during the course of the experiment. We took liver biopsies at various stages during the initial
phase of the experiment. Several monkeys were terminated in extremis during the experiment.
Detailed feed intake profiles were determined 5 years after the experiment began, and the
fumonisin B (FB) mycotoxin content of the feed was determined during the final stages of the
experiment. The apparent FB consumption patterns were related to changes observed in the
biochemical parameters in the blood and urine, including the liver function enzymes and creatinine
clearance as well as differential blood counts and sphingolipid levels in the serum and urine. An
apparent no-effect threshold for kidney and liver damage is estimated to be between 0.11 and 0.18
mg FB/kg body weight (bw)/day, which corresponds to a feed contamination level of between 8.21
and 13.25 mg FB/kg bw diet. Apart from the effects on the liver and kidney, a wide variety of
parameters, including cholesterol and creatine kinase, were also adversely affected. Several blood
parameters, including white and red blood cells, also significantly decreased in the treated animals.
The serum sphinganine level and the sphingosine/sphinganine ratio, monitored toward the end of
the experiment, significantly increased in both the low-dose and high-dose animals. The present
study provides important information about the diversity of lesions induced by culture material of F.
verticillioides in vervet monkeys and the dosage levels of fumonisins to be used in long-term
studies in nonhuman primates. Key words: culture material, fumonisins, Fusarium verticillioides,
hepatotoxicity, nonhuman primates. — Environ Health Perspect 109(suppl 2):267–276 (2001).
http://ehpnet1.niehs.nih.gov/docs/2001/suppl-2/267-276gelderblom/abstract.html
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concentrations during a pilot experiment to
avoid excessive toxicity (Table 1). The control
diet contained 0.5% autoclaved corn meal.
All diets were prepared in bulk (approxi-
mately 9.5 kg) and stored at 4°C and from
1992 they were routinely analyzed for aflatox-
ins and FB mycotoxins. The mixed diet was
prepared as a porridge after which vitamins
D3 (200 I.U.) and C (40 mg) were added
before feeding. The estimated energy and
nutrients supplied per vervet monkey per day
have been calculated and published in detail
elsewhere (11). The diet has been used to sus-
tain successful in-house breeding over several
generations with satisfactory development of
the offspring (12). The diet was supple-
mented further with 35.4 ± 4.1 g of whole-
wheat brown bread and a slice of apple (70.5
± 6.6 g) in the afternoon. Feed wastage was
monitored starting 4 years after the experi-
ment began. This was accomplished by first
weighing the dry and wet food as well as the
wet wastage collected from underneath the
cage. The dry wastage was extrapolated from
the wet:dry ratio of the food. Housing the
vervet monkeys in pairs after 5 years circum-
vented abnormal social behavior caused by
solitary confinement. They also had access to
large exercise cages for 24 hr/week. 
One vervet monkey (female 681) of
Group 1 was used in a pilot study (approxi-
mately 3 months) to evaluate early signs of
toxicity from ingestion of culture material. As
the experiment progressed, the level of the
culture material incorporated in the diet was
altered accordingly (Table 1) to avoid exces-
sive toxicity. At that stage (1984/1985) the
FB mycotoxins had not been characterized,
and detailed chemical analyses of the diet and
culture material became possible only about
8 years after the experiment began (1991/
1992). Subsamples of the different fungal cul-
ture batches used during the course of the
experiment were retained and subsequently
analyzed for fumonisins in order to calculate
exposure levels. The different culture batches
were prepared according to standardized pro-
cedures using autoclaved yellow corn kernels
inoculated with single-conidial isolates of
F. verticillioides strain MRC 826 and were
incubated at 25°C for 2 weeks and then for 2
weeks at 15°C (8). Three different culture
batches designated batch B (BB), batch 55
(B55), and batch 57 (B57) were used during
the experiment. Batch BB was freeze dried;
B55 and B57 were oven-dried at 45–50°C.
The dry fungal cultures were ground to a fine
meal and stored in airtight containers at 4°C. 
Clinical Monitoring
Appetite and habitus were observed daily;
body weights, heart rates, and respiration
rates were recorded at monthly intervals.
Blood samples for measurement of clinical
biochemical parameters were collected every 2
months throughout the experiment. These
parameters included aspartate transaminase
(AST), alanine transaminase (ALT), lactate
dehydrogenase (LDH), gamma glutamyl-
transferase (GGT), alkaline phosphatase
(ALP), conjugated, unconjugated, and total
bilirubin, glucose, urea, creatinine, sodium,
potassium, chloride, calcium, phosphorous,
and magnesium. These parameters reflect
liver, kidney, muscle, respiratory, intestinal,
and bone functions. Full and differential
counts of venous blood, collected in potas-
sium EDTA tubes, were obtained with a
Technicon H 6010 C cytochemical flow
through cell counter (Beckman/Coulter,
Cape Town, South Africa). Plasma lipids and
lipoproteins were analyzed at the time the
final liver biopsies were taken and when the
animals were sacrificed. 
Urinary creatinine clearance was moni-
tored when increased serum urea and creati-
nine became evident. A 24-hr urine sample of
each vervet was collected into a plastic con-
tainer with the aid of a stainless steel funnel
(13). The funnels drained the entire cage
floor and a strainer prevented contamination
with feces. Clearance of creatinine from the
serum was expressed as milliliters per
kilogram of body weight per minute. 
Disruption of Sphingolipid Metabolism 
It has been demonstrated in a variety of ani-
mal species that exposure to fumonisin
mycotoxins altered sphingolipid metabolism
and that FB1 and FB2 inhibit the enzyme
ceramide synthase in the sphingolipid
biosynthetic pathway (14). At the cellular
level this leads to an accumulation of sphin-
ganine, which is then manifested in changes
in the circulating levels of this base. During
the course of the experiment, serum levels of
the sphingoid bases sphingosine and sphin-
ganine (and hence their ratio) were moni-
tored over 60 weeks from January 1994 to
March 1995 (15). By this time, the experi-
mental groups (controls, low-dose and high-
dose groups) consisted of two females each.
Serum samples were drawn at regular inter-
vals during this period to yield 10 sets of
results. In addition, 24-hr urine samples
were collected at the same time as the last
two blood samples.
Table 1. Summary of the duration, dietary level, and daily intake profiles of different F. verticillioides MRC 826 culture batches used during the chronic feeding study in vervet
monkeys.a
Feeding regimens
No. of FCMb Commenced Termination Duration FMC intake
Group vervet (sex) (MRC 826) (%) (dd/mm/yy) (dd/mm/yy) (days) (mg/kg bw/day) Terminated
Group 1 681(F) BB 5 13/12/84 03/01/85 21 705.8 30/06/87
High dose BB 1 04/01/85 18/01/85 14 141.2
(trial) BB 0.25 19/01/85 29/01/86 375 35.3
B55 0.50 30/01/86 31/03/87 425 70.6
Group 1 688 (F) BB 1 14/03/85 23/04/85 40 141.40 03/11/92
High dose 702 (M) BB 0.25 24/04/85 29/01/86 280 35.30 30/08/89
705 (M) BB 0.50 30/01/86 31/03/87 425 70.60 24/07/92
709 (F) B55 0.50 01/04/87 24/10/88 572 70.60 14/09/95
712 (F) B57 0.50 25/10/88 05/06/91 953 72.8 ± 17.9c 11/11/98
B57 1 06/09/91 11/11/98 2623 151.0 ± 36.8c
Group 2 696 (M) BB 0.25 14/03/85 23/04/85 40 34.0 14/01/94
Low dose 700 (M) BB 0.1 24/04/85 29/01/86 280 14.0 30/10/92
710 (F) BB 0.25 30/01/86 31/03/87 425 34.0 30/07/97
711 (F) B55 0.25 01/04/87 24/10/88 572 34.0 11/11/98
B57 0.25 25/10/88 05/06/91 953 35.2 ± 8.2c
B57 0.5 06/09/91 11/11/98 2623 73.6 ± 17.4c
Group 3 707 (F) Corn meal 0.5% 14/03/85 11/11/98 4993 84.5 ± 15.7c 11/11/98
Control 708 (F) Corn meal 0.5% 14/03/85 11/11/98 4993 84.5 ± 15.7c 11/11/98
aValues are means ± SD of at least 20 determinations per group of the surviving vervets. bTotal fumonisin concentration: MRC 826 BB = 5.31 mg FB/kg, MRC 826 B55 = 2.61 mg FB/kg, and MRC 826 B57 =
3.43 mg FB/kg. cCalculated from feed intake data monitored 3–6 times per year from 1989.
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Biopsy and Necropsy Procedures
The toxic effects of the different feeding regi-
mens were evaluated in liver biopsies taken at
different time intervals during the course of
the experiment. Subsequent investigations
regarding histopathologic changes in the liver
and kidneys of the animals terminated during
the experiment and those sacrificed at the end
of the experiment are currently in progress
and will be reported elsewhere. Initial biopsies
were taken on alternative monkeys of each
group on days 2 and 6 of the experiment, and
all individuals were subjected to biopsies at
180, 300, 520, 890, and 1,631 days after
commencement. Wedge liver biopsies were
taken by laparotomy under halothane general
anesthesia. For the histopathologic evaluation
of these biopsies, we used different staining
procedures, including orcin stain to detect bile
acids, cholesterol, and copper in hepatocytes;
standard hematoxylyn and eosin; periodic
acid–Schiff; and reticulin stains (10,11). 
Necropsy procedures in monkeys that
were terminated in extremis and at the end of
the experiment were performed after perfu-
sion fixation under surgical anesthesia. For
this fixation, 4% buffered formalin (pH 7.2)
was perfused into the left ventricle at physio-
logic pressure (100 mm Hg) and flow. Before
the perfusion, blood samples and fresh biop-
sies were collected from the liver and kidneys
for electron microscopy and biochemical
analyses. Cutting the femoral and jugular
veins as well as cutting deeply into the kid-
neys and liver ensured free flow of fixative.
Immersion of the organs in the buffered for-
malin, at which time the organ weights were
recorded, completed fixation. 
Data Analysis
All statistical analyses and graphical summaries
were performed with the Number Cruncher
Statistical System (NCSS 2000), Statistical
System for Windows (16). The correlation
coefficients reported are the partial coeffi-
cients—the correlation between two variables,
with the effect of other possible confounders
excluded. The p values reported are the partial
values obtained from the multiple regression
analyses—the relationship between the depen-
dent and the independent variables after the
effect of the other independent variables has
been taken into account. The plots used the
spline smoother of the scatterplot option of the
program to draw the curves.
Results
Clinical Observations, Biopsies,
Necropsies, and Termination
The biopsies, which were taken at stipulated
time points, resulted in the death of one
female. The histopathologic evaluations of
these biopsies have been reported elsewhere
and suggested an active chronic toxic hepati-
tis (10) at a very early stage, whereas mild
portal-to-portal fibrosis was reported in some
animals of the high-dose and low-dose groups
(11). Clinical observations indicated that the
females were in better condition than the
males. A number of vervet monkeys of the
low-dose and high-dose groups were termi-
nated during the course of the experiment
because of general poor health (Table 2).
These conditions of cachexia include ataxia,
poor food consumption, and weight loss. The
experiment was terminated 4,990 days after
commencement. At that stage the two con-
trols (females 707 and 708) and only one
each of the low-dose (female 711) and high-
dose (female 712) groups survived. The livers
of all the animals killed during treatment and
at termination showed signs of chronic toxic
hepatosis. Some animals (females 711 and
712) showed patchy atheromatous plaques in
the aorta. One animal (male 702) died from
brain hemorrhages with lesions in the cerebel-
lum, midbrain, and the right cortex. The kid-
neys were also affected, although some
animals, such as male 702, showed no specific
lesions. In one of the animals (male 705) ter-
minated after 2,689 days of treatment, only
microscopic cytoplasmic vacuolization of
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Table 2. Clinical symptoms and lesions observed at different times during the experiment as well as the major macroscopic changes noticed at termination.a
Dosage Days after
Number Sex group commencement Symptoms and/or lesions Necropsy (macroscopic observations)
681 F H 929 Hemorrhage in abdomen (terminated) Pale liver with irregular surface
688 F H 2,791 Alopecia on trunk and thighs Fibrotic, atrophic liver (chronic toxic hepatosis)
702 M H 1,630 Cachexic, ataxic, difficulty in handling Hemorrhages of about 1 cm in grey matter of midbrain; most recent and largest 
and eating food lesions found in the cerebellum, midbrain, and right cortex of the midbrain
705 M H 2,689 Focal hemorrhages in the skin Necrosis of the distal and proximal rectum; fibrotic liver (chronic toxic hepatosis); 
hard kidneys with streaks of blood from the corticomedullary junction
709 F H 2,497 Weight loss, yellow discoloration of Fibrotic, atrophic liver (chronic toxic hepatosis)
the periorbital skin, blood in feces
3,836 Yellow discoloration of the skin
712 F H 4,990 Termination of experiment Liver atrophic accentuated lobulation (chronic toxic hepatosis); multifocal to 
confluent atheromatous plaques throughout the aorta
696 M L 2,414 Torsion of the colon Small, fibrotic liver (chronic toxic hepatosis); colon and stomach contained 
3,228 Torsion of the colon hemorrhagic ulcers
700 M L 896 Mild subcutaneous hemorrhage in the Fibrotic liver (chronic toxic hepatosis); hemorrhagic diasthesis; mild icterus
groin area
1,762 Erythema on right thigh and left abdomen
2,723 Mild alopecia on left arm, blood in feces
2,747 Vomition, reluctant to move
710 F L 2,650 Starring coat Hard fibrotic liver (chronic toxic hepatosis); kidneys showed petechial hemor-
2,738 Blood in feces rhages in cortex; enlarged lymph nodes and inflamed mesenteries
2,812 Yellowish discoloration of skin
4,521 Cachexia, vomition
711 F L 896 Focal hemorrhages in the skin of abdomen Atrophic liver with nodular appearance and accentuated lobulation and cobble-
and left leg (disappeared after 30 days) stone effect; chronic toxic hepatosis; a few patchy atheromatous plaques in 
the aorta
3,707 Consistently poor feed consumption
4,990 Terminated experiment
707 F Controls 4,990 Termination of experiment No clinical signs
708 F Controls 4,990 Termination of experiment No clinical signs
aAll cases were terminated in extremis except females 707, 708, 711, and 712.
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epithelial cells of convoluted tubules was
present. The other cases that were terminated
demonstrated mild to severe cortical nephro-
sis manifested as toxic atrophy of the epithelia
of the convoluted tubules and probably the
glomeruli. No acute or chronic inflammation
was present. Final body and organ weights
(Table 3) indicated that the relative liver
weights of the high-dose group appeared to
be slightly lower than that of the low-dose
group, but the low number of animals and
differences in sex meant that statistical analy-
ses could not be performed. However, despite
the toxic effects encountered in the liver and
kidneys, multiple regression analyses showed
a positive correlation (r = 0.47; p < 0.0001) of
fungal culture material (FCM) intake and
body weight. It should be noted that the
higher dose levels were administered from
1992 onward during the stage of the experi-
ment where the vervets had established their
adult weight. The loss in body weight in
those vervet monkeys sacrificed in extremis
was encountered only a few months before
termination. Therefore the dietary levels of
FCM used apparently did not affect the nor-
mal body weight gain of the vervet monkeys
with age.
Feed and Fumonisin Intake Parameters
Feed intake profiles were conducted in detail
about 4 years after commencement of the
experiment. Discovery of the fumonisins (7)
and the development of the relevant analytic
methodology (17) resulted in routine analyses
of the maintenance diet for the fumonisins,
including retrospective analyses of the differ-
ent culture batches used. Given these data,
the FB intake during the earlier part of the
experiment could be estimated fairly accu-
rately (Table 4). However, several variables
complicate the calculation of accurate expo-
sure data, expressed as mean intake per kilo-
gram body weight per day for the duration of
the experiment. These variables included the
varying levels of the fungal material in the
diet as well as the use of different culture
batches (Table 1) containing different levels
of total FB (FB1, FB2, and FB3), namely
MRC 826 BB (5.38 mg FB/kg), MRC 826
B55 (2.61 mg/FB/kg), and MRC BB57 (3.73
mg FB/kg). During the last 8 years only one
culture batch (BB57) was used, although the
dietary level of the culture material was raised
from 0.25 to 0.5% in the low-dose group and
from 0.5 to 1% in the high-dose group. The
mean total FB intake of the vervet monkeys
in the different groups, as a function of the
various cultures and dietary levels used during
the experimental period, is illustrated in
Figure 1. 
Clinical Pathology
For the purpose of this article, the parameters
used to assess liver function are presented sep-
arately from those associated with kidney
function.
Serum enzymes associated with liver func-
tion. General patterns. Multiple regression
analyses of the serum enzyme indicators asso-
ciated with hepatocellular damage (AST,
ALT, LDH, and GGT) indicated that males
Table 3. Comparison of body and organ weights of the vervet monkeys fed high and low doses of F. verticillioides culture material for different time periods.
Terminated Body weight
Vervet (dd/mm/yy) (kg) Liver (g) % Left kidney (g) % Right kidney (g) % Total kidney (g) % Heart (g) % Brain (g) %
High dose
681 (F) 30/06/87 3.67 55 1.50 7.564 0.21 7.352 0.20 14.92 0.41 20.5 0.56 71 1.93
702 (M) 30/08/89 4.29 64.4 1.50 6.84 0.16 7.45 0.17 14.29 0.33 24.7 0.58 69.82 1.63
705 (M) 24/07/92 4.79 69.2 1.44 8.35 0.17 8.31 0.17 16.66 0.35 36 0.75 63.9 1.33
688 (F) 03/11/92 2.70 53.5 1.98 8.885 0.33 9.884 0.37 18.77 0.70 16.9 0.63 62 2.30
709 (F) 14/09/95 3.38 43.62 1.29 8.91 0.26 9.7 0.29 18.61 0.55 21.59 0.64 63.3 1.87
712 (F) 11/11/98 5.71 79.49 1.39 8.94 0.16 8.11 0.14 17.05 0.30 49.23 0.86 71.96 1.26
Low dose
700 (M) 30/10/92 4.94 69.5 1.41 10.2 0.21 9.9 0.20 20.10 0.41 28.2 0.57 65.5 1.33
696 (M) 14/01/94 5.71 86.96 1.52 10.66 0.19 14.95 0.26 25.61 0.45 39.78 0.70 66.4 1.16
710 (F) 30/07/97 3.24 82.1 2.53 7.66 0.24 7.37 0.23 15.03 0.46 22 0.68 68 2.10
711 (F) 11/11/98 4.48 75.78 1.69 9.32 0.21 9.28 0.21 18.60 0.42 31.7 0.71 70.54 1.57
Controls
707 (F) 11/11/98 3.23 70.1 2.17 ND ND ND ND 59.88 1.85
708 (F) 11/11/98 3.69 66.56 1.80 8.43 0.23 8.79 0.24 17.22 0.47 23.9 0.65 57.57 1.56
ND, not determined.
Table 4. Summary of the body weight in relation to the average feed, F. verticillioides culture material, and the calculated and estimated fumonisin intake during the experiment. 
Body weight (kg) Average Total 
Duration Maximum Final feed intake Mean FCM/ FB/kg bw/day (mg) FB (mg)
Vervet (days) Initial (dd/mm/yy) (dd/mm/yy) (g/kg bw/day) kg bw/day (mg) Estimateda Calculatedb estimated
High dose
681 (F) 929 2.57 – 3.07 (30/06/87) 14.12 ± 2.14 80.03 ± 44.59 0.38 ± 0.27c – 330.4
688 (F) 2,791 2.42 4.05 (24/07/91) 2.70 (03/11/92) 15.45 ± 1.79 90.4 ± 40.9 0.39 ± 0.22 861.2
702 (M) 1,630 1.75 4.45 (14/02/89) 4.29 (30/08/89) 14.12 ± 2.14 77.6 ± 38.7 0.36 ± 0.24 – 431.6
705 (M) 2,689 1.76 5.20 (15/03/91) 4.79 (24/07/92) 15.45 ± 1.79 89.5 ± 44.7 0.39 ± 0.22 – 832.7
709 (F) 3,836 1.50 – 3.38 (14/09/95) 16.10 ± 1.55 98.5 ± 55.5 0.42 ± 0.25 – 1714.6
712 (F) 4,990 1.50 3.92 (27/04/95) 3.70 (11/11/98) 16.11 ± 1.50 80.1 ± 35.56 0.35 ± 0.21 0.49 ± 0.20 2147.2
Low dose
696 (M) 3,228 2.09 6.03 (26/08/93) 5.71 (14/01/94) 14.91 ± 1.21 36.89 ± 18.69 0.15 ± 0.07 – 1304.08
700 (M) 2,747 2.25 6.03 (15/01/91) 4.94 (30/10/92) 14.23 ± 1.46 36.89 ± 18.69 0.15 ± 0.07 – 1022.98
710 (F) 4,527 1.61 3.65 (24/07/91) 3.24 (30/07/97) 15.1 ± 1.08 37.78 ± 20.68 0.16 ± 0.08 – 1846.20
711 (F) 4,990 1.62 – 4.48 (11/11/98) 15.1 ± 1.08 37.78 ± 20.68 0.16 ± 0.08 0.17 ± 0.09 2037.97
Control
707 (F) 4,990 1.58 3.38 (25/06/96) 3.23 (10/11/98) 17.74 ± 1.67 88.72 ± 8.34 0.01 ± 0.006 –
708 (F) 4,990 1.45 3.80 (05/08/98) 3.69 (10/11/98) 17.74 ± 1.67 88.72 ± 8.34 0.01 ± 0.006 0.01 ± 0.01 48.94
aEstimated from the feed intake profiles. Levels that were estimated before 1989 were based on the feed intake profiles that were measured during 1989. bDosage was calculated from routine analyses of
the stock feed samples since 1992. cExposure of female 681 to 5% for 40 days was not included in calculating the average fumonisin intake profile. The average intake during that period was 3.79 mg
FB/kg/day. 
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showed higher levels of LDH and GGT and
females had higher levels of ALT; there was no
difference between them with respect to AST
serum levels (Table 5; Figure 2). AST and
GGT increased significantly as a function of
time, whereas ALT and LDH decreased.
Females exhibited a higher cholesterol level;
males had higher levels of total bilirubin.
Overall, the total bilirubin increased as a func-
tion of time, but cholesterol was not affected.
All the markers mentioned above were signifi-
cantly (p < 0.0001) positively correlated with
the levels of the FCM and hence the levels of
total FB. Glucose and ALP, serum markers
not necessarily associated with liver function,
showed a negative (r = –0.48; p < 0.0001) and
a positive (r = 0.40; p < 0.0001) correlation,
respectively, with FCM (Table 5; Figure 2).
Glucose tended to increase with time, but
there were no differences between males and
females. ALP decreased significantly with age,
with males exhibiting higher levels than
females. Creatine kinase, measured only from
1991 onward, increased with time and was
also positively correlated (r = 0.57; p <
0.0001) with FCM (Table 5). 
Dose–response effects. When considering
the above results, two critical time periods
exist (Figure 1): when the FB intake was
reduced as a result of the use of different cul-
ture batches between 1986 and 1990; and
when the FB intake profiles were increased
due to a doubling of the dietary level of the
culture material between 1991 and 1992. 
During 1987 a different culture batch of
the fungus (B55) replaced the original batch
(BB), decreasing the FB intake profile. Both
culture batches were included at a dietary
level of 0.5% (high dose) and 0.25% (low
dose). The total FB concentrations were 5.38
mg/kg and 2.61 mg/kg culture material for
BB and B55, respectively. The FB intake pro-
files decreased from 0.18 to 0.11 mg/kg
bw/day in the low-dose group and from 0.38
to 0.18 mg/kg bw/day in the high-dose
group. Toward the end of 1988 another cul-
ture batch, B57 (3.73 mg FB/kg), was intro-
duced into the experiment and slightly
increased the FB intake profiles to 0.13 ±
0.03 and 0.29 ± 0.04 mg/kg bw/day during
1989 and 1990 for the low-dose and high-
dose groups, respectively (Figure 1). 
A downward trend occurred in the liver
function enzymes, AST and ALT, during the
1986–1988/1989 period in the high-dose
group (Figure 2). In the low-dose group, the
activities of the enzymes were very similar to
those of the control females. No differences
were observed between the dosage groups
with respect to the total bilirubin and blood
glucose levels. However, serum cholesterol
levels showed a downward trend in the high-
dose group similar to that mentioned for AST
and ALT. The levels of ALP tended to
decrease with time in the controls and the
low-dose group, but this decrease was
markedly delayed in the high-dose group.
When the dietary level of the culture material
(B57) was increased 2-fold during the end of
1991, AST, ALT, and cholesterol levels
increased markedly during 1992 in both the
high-dose and low-dose groups compared to
the control group. There were no clear differ-
ences between the low-dose and high-dose
groups toward the end of the experiment,
although a higher trend was observed initially
in AST and cholesterol levels (Figure 2). The
same holds for total serum bilirubin and
blood glucose, which, respectively, increased
and decreased markedly in the high-dose
group. The low-dose group also showed mar-
ginal effects with levels just above those of the
control females. Creatine kinase, monitored
from 1991 onward, also showed a marked
dose–response effect with no clear-cut differ-
ence between the high-dose and low-dose
groups (data not shown).
Serum enzymes associated with kidney
function. General patterns. Serum urea (r =
0.41; p < 0.0001) and creatinine (r = 0.74;
p < 0.0001) were positively correlated with
the dietary levels of FCM and increased sig-
nificantly compared to the controls (Table
4). In both cases males exhibited higher lev-
els than females; urea decreased and creati-
nine increased as a function of time.
Multiple regression analyses indicated that
FCM was negatively correlated (r = –0.47;
p < 0.0001) with a decrease in creatinine
clearance. The latter also tended to decrease
as a function of time; males had lower
clearance values than females. 
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Figure 1. Daily fumonisin intake data of the low-dose (dotted line) and high-dose (solid line) groups of vervet mon-
keys as a function of the different culture batches of Fusarium verticillioides strain MRC 826 (BB, B55, B57) used dur-
ing the course of the experiment. 
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Table 5. Partial correlation coefficients from multiple regression analyses of different serum parameters associated
with liver and kidney function. The correlation factor for FCM was corrected for age and sex.
Sex Age FCM
Dependent ra p Levelb r p Levelb r p Levelb R 2
Serum
Urea (log) –0.11 0.0035 –0.27 < 0.0001 0.41 < 0.0001 0.2191
Creatinine (log) –0.40 < 0.0001 0.28 < 0.0001 0.56 < 0.0001 0.3629
Glucose (log) 0.08 0.0744 0.21 < 0.0001 –0.48 < 0.0001 0.2624
Cholesterol (log) 0.17 < 0.0001 –0.05 0.1177 0.40 < 0.0001 0.1856
Total bilirubin (log) –0.20 < 0.0001 0.27 < 0.0001 0.37 < 0.0001 0.2599
AST (log) 0.00 0.9597 –0.13 0.0001 0.67 < 0.0001 0.4545
ALT (log) 0.24 < 0.0001 –0.19 < 0.0001 0.42 < 0.0001 0.2067
LDH (log) 0.02 0.6535 –0.28 < 0.0001 0.47 < 0.0001 0.2366
GGT (log) –0.13 0.0002 0.10 0.0055 0.53 < 0.0001 0.3296
ALP (log) 0.14 < 0.0001 –0.72 < 0.0001 0.40 < 0.0001 0.5207
Creatinine kinase (log) 0.00 0.9742 0.29 < 0.0001 0.57 < 0.0001 0.3536
Urine
Serum creatinine (log)c –0.0125 0.0691 –0.15 0.0371 0.74 < 0.0001 0.5443
Creatinine clearance –0.0109 0.0308 –0.22 0.0018 –0.47 < 0.0001 0.2541
Urine (log) –0.0332 0.8618 0.02 0.7994 0.07 0.3917 0.0056
aA positive correlation indicates females higher than males. bSignificance level (on multiple regression analysis). cCreatinine clear-
ance was measured from 1991.
109S2.Part 2  04/16/01  5:30 PM  Page 271    (Black plate)
Gelderblom et al. 
272 VOLUME 109 | SUPPLEMENT 2 | May 2001 • Environmental Health Perspectives
Dose–response effects. As discussed for
the liver function enzymes, two time points
were selected: between 1986 and 1988 and
between 1991 and 1993 time periods. From
1986 to 1988, no decreases in the serum urea
and creatinine levels were noticed in either of
the treated groups (Figure 3). During the
1991–1993 dose increase, the serum urea
level of the high dose slowly increased until
1995, after which there was a clear distinction
between the high-dose and the low-dose and
control groups. Creatinine clearance was
assessed only from 1992 on, and both the
high-dose and low-dose groups showed a
reduced capacity (Figure 3). However, the
low-dose group tended to revert to control
values after about 4 years. The high-dose ani-
mals showed a consistently lower creatinine
clearance compared to the control females,
and the reduced creatinine clearance capacity
relates well with the increased urea and creati-
nine levels in the serum.
Differential blood counts. Differential
blood counts were performed from 1991
onward. The white blood cell (WBC) counts
were negatively correlated (r = –0.49;
p < 0.0001) with the FCM levels in the diet
Figure 2. Multiple regression analyses of selected serum parameters associated with liver function and other important serum components during the experimental period. Hi,
high dose; Lo, low dose; Ctl, control; Tot_Bilirubin, total bilirubin. 
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(Table 6). In general WBC counts tended to
decrease with time, although females exhibited
higher WBCs. With respect to the relative
contribution to the WBC count, eosinophils,
monocytes, and basophils increased as a result
of the FCM dietary treatment; the lymphosites
decreased. These parameters were also age
dependent; neutrophils and eosinophils tended
to decrease and monoscytes increased as a
function of time. Except for the monocytes,
which were higher in males, there were no sex
differences in the other WBC components.
From the spline smooth (Figure 4), both the
low-dose and high-dose groups showed a
marked decrease in the WBC count, which
tended to approximate values of the controls
toward the end of the experiment. 
The red blood cell (RBC) count was
lower in females (r = –0.48; p < 0.0001),
increased with age (r = 0.11; p < 0.04), and
was negatively correlated (r = –0.45;
p < 0.0001) with FCM dietary levels (Table
6). A similar effect was noticed for hemoglo-
bin (Hb) and the hematocrit (HCT), except
that both parameters also increased with age.
The red cell distribution width (RDW) posi-
tively correlated (r = 0.18; p < 0.0001) with
FCM treatment despite the fact that it gener-
ally decreased with age. The graphical plots
(spline smooth) indicated that these parame-
ters were affected in both the high-dose and
low-dose groups, whereas the low-dose group
tended to approximate the control values
toward the end of the experiment (Figure 4).
The mean corpuscular volume (MCV), the
mean corpuscular hemoglobin (MCH), and
the mean corpuscular hemoglobin concentra-
tion (MCHC) were not affected by FCM,
whereas the MCV and MCHC were higher
in males and tended to increase with age.
Blood platelet (PL) counts and the mean
platelet volume (MPV) significantly
(p < 0.0001) decreased as a result of FCM
treatment despite the fact that PL decreased
and MPV increased, respectively, as a function
of age. Females had higher platelet counts than
males, whereas the MPV tended to be lower in
females. The spline smooth graphical plot
showed some lowering effects on PL by both
the low-dose and high-dose groups throughout
the experiment (Figure 4). The MPV clearly
showed a decrease in the high-dose group; the
low-dose group tended to exhibit similar values
toward the end of the experiment.
Two males, one of the high-dose group
(male 705) and one of the low-dose group
(male 700), were terminated during the sec-
ond year after the dose increase, followed by
the last male (low-dose; male 696) during the
third year. One high-dose female (female 688)
died within 2 years of the dosage increase. 
Alteration of Sphingolipid Metabolism
During the monitoring period for sphin-
golipid basis, mean sphingosine levels were
not significantly different between any of the
experimental groups, whereas sphinganine
levels were significantly (p < 0.05) elevated in
both the low-dose and high-dose groups con-
suming the FCM (15) as compared to the
controls. However, although the high-dose
group had a numerically higher sphinganine
concentration, the individual variability
observed both between and within vervet
monkeys in each group caused the 95% con-
fidence limits to be wide. Consequently, this
difference between the low-dose and high-
dose groups was not statistically significant
(p > 0.05). During this period, the sphinga-
nine/sphingosine (Sa/So) ratio in the serum
increased from 0.43 in the controls to 1.72 in
the low-dose and 2.57 in the high-dose
groups, with the latter two means signifi-
cantly elevated over the control (p < 0.05) but
not significantly different from each other. 
During the monitoring period, only a few
samples of urine were analyzed. The sphin-
golipid base levels in urine have been linked
to its cellular content because of the presence
of exfoliated cells (18); hence, the levels of the
individual bases will vary accordingly, making
the ratio potentially a more reliable measure
of disruption in sphingolipid metabolism.
Although the results indicated a numeric
increase in the Sa/So ratio for the two experi-
mental groups, once again there was consider-
able variation and the values were not
statistically significantly different.
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Figure 3. Graphical illustration of the effect of the low and high dose of FCM on clinical parameters associated with
kidney function. Hi, high dose; Lo, low dose; Ctl, control; Ser_Creatinine, serum creatinine; Creat_Clear, creatinine
clearance. Creatinine clearance was measured only from 1992 and onward. Serum creatinine measurements were
performed during the course of the experiment as well as during the creatinine clearance determinations.
Table 6. Partial correlation coefficients from multiple regression analyses of blood parameters measured as a func-
tion of sex, year, and FCM. The correlation factor for FCM was corrected for age and sex.
Sex Age FCM
Dependent ra p Levelb r p Levelb r p Levelb R 2
Blood parameters
WBC (log) 0.28 < 0.0001 –0.23 < 0.0001 –0.49 < 0.0001 0.2878
Lymphocytes –0.03 0.5937 0.06 0.2857 –0.11 0.0435 0.0200
Neutrophils (log) 0.08 0.1941 –0.17 0.0036 –0.08 0.1593 0.0333
Eosinophils (log) –0.02 0.7484 –0.14 0.0243 0.14 0.0229 0.0469
Basophils (log) –0.10 0.1213 –0.06 0.3057 0.28 < 0.0001 0.0874
Monocytes –0.14 0.0216 0.38 < 0.0001 0.44 < 0.0001 0.2725
RBC –0.48 < 0.0001 0.11 0.0446 –0.45 < 0.0001 0.3603
Hemoglobin –0.61 < 0.0001 0.20 0.0003 –0.45 < 0.0001 0.4616
RDW (log) –0.02 0.6688 –0.43 < 0.0001 0.18 < 0.0001 0.2443
MCV (log) –0.20 0.0003 0.13 0.0232 0.08 0.1606 0.0497
MCH –0.22 < 0.0001 0.13 0.0216 0.09 0.1224 0.0569
MCHC –0.05 0.3295 0.02 0.6751 0.04 0.5027 0.0045
PL (log) 0.53 < 0.0001 –0.40 < 0.0001 –0.33 < 0.0001 0.3584
MPV –0.13 0.0234 0.17 0.0029 –0.35 < 0.0001 0.1631
aA positive correlation indicates females higher than males. bSignificance level (on multiple regression analysis). 
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Histopathology
The liver biopsies, taken at regular intervals
up to the middle of 1990, revealed lesions
that are characteristic of a chronic toxic
hepatosis and that varied from subacute to
acute effects in the vervet monkeys receiving
the high dose of the culture material (10,11).
These changes included perilobular fibrosis,
nodular hyperplasia, apoptosis, distortion of
reticulin staining pattern, and mild to scant
bile duct proliferation, which distorted the
normal architecture of the liver. Hepatocyte
nodules were uneven in size and showed
increased mitosis, uneven nuclear size, and
single-cell necrosis (apoptosis). Bi-nucleated
cells, fatty changes, and in some cases (female
681) influx of inflammatory cells were
noticed randomly throughout the liver.
Similar changes were observed in the livers of
the vervet monkeys terminated during the
experiment. The livers of terminated animals
were markedly smaller, with portal-to-portal
fibrosis and nodular hyperplasia as constant
features (Table 5). In the low-dose group no
specific changes were apparent except in
female 710, where disseminated foci of hepa-
tocellular necrosis and inflammatory response
occurred with a scant distortion of the reticu-
lar pattern. One of the control females (708)
also presented with focally disseminated,
mild, eosinophilic hepatitis, with no specific
toxic lesions of distortion of the lobular struc-
ture except in the areas with hepatitis. This
lesion was similar to that observed in the low-
dose female 710 and, to some extent, in the
high-dose female 688 and was ascribed to
chronic parasitic hepatitis.
Discussion
Previous reports on the effects of culture
material of F. verticillioides MRC 826 on
vervet monkeys used in the same long-term
experiment (10,11) indicated that the liver is
an important target organ. The levels of major
serum enzymes used as markers for liver dam-
age (ALT, AST, GGT, and LDH) were ele-
vated in the high-dose and low-dose groups
depending on the dietary level of FCM.
Jaskiewicz et al. (10) reported increased levels
of AST, ALT, and LDH in vervet monkeys
within the first few days in a pilot trial with
culture material of MRC 826. The high-dose
group that received 1% showed a marked
increase within 14 days and a decrease within
2–3 weeks after the dose was lowered to
0.25%. The increase in hepatocellular enzyme
activity in the low-dose group was far slower
and first appeared 6–7 weeks after the treat-
ment commenced. Increases in total bilirubin
and cholesterol paralleled these early changes
in liver enzyme activities. These findings were
confirmed with multiple regression analysis of
all the data as a function of the FCM dietary
levels used for the duration of the experiment.
The dose–response effects previously
described by Jaskiewicz et al. (10) were also
clearly illustrated over the period of decreased
FCM intake (1986–1988) and the period of
increased FCM intake (1991–1993).
However, detailed dose–response effects and
statistical evaluation of the data with respect
to the biochemical parameters measured are
complicated by the fact that low numbers of
animals were used in each group, both males
and females were used, and some of the vervet
monkeys from each group were terminated in
extremis during the course of the experiment.
Despite these complications and that fact that
some interindividual variations seem to exist
among vervet monkeys, the low-dose groups
exhibited levels of AST, ALT, LDH, and
GGT similar to those of the controls during
1988. During this treatment period, the total
FB level was at a minimum and it would
appear that at this exposure level (0.10 mg
FB/kg bw/day) very few changes are induced
in liver function enzymes. The same is true for
serum cholesterol, total bilirubin, glucose, and
ALP values, although some individual varia-
tion appears to occur. Some animals in the
high-dose group showed a marked decrease in
the levels of the serum enzymes and closely
resembled those of the controls. The mini-
mum dosage level of the high-dose group,
reached during 1988, was on the order of 0.18
mg FB/kg bw/day. 
Changes in the serum parameters, associ-
ated with an increase in the FCM level in the
diet, were monitored during 1991–1993. All
liver function serum enzymes showed a
marked increase from the 1991 background
level in the high-dose animals. The increased
dietary level of FCM represents an FB expo-
sure level from approximately 0.38 mg/kg
bw/day in 1991 to 0.64 mg/kg bw/day in
1992. Serum enzyme levels also increased in
the low-dose animals after an increase of the
FB intake from approximately 0.18 to 0.28
mg/kg bw/day. In some of the low-dose ani-
mals the serum enzyme levels equaled those of
the high-dose group. A threshold for liver
damage in vervet monkeys ranged between
Figure 4. Dose–response effects of FCM on selected blood parameters from 1991 to 1989. Hi, high dose; Lo, low
dose; Ctl, control. 
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0.10 mg FB/kg bw/day (low dose 1988) and
0.18 mg FB/kg bw/day (low dose 1991),
where most of the vervets exhibited baseline
values compared to the control females. In
general, it appears that males were more sensi-
tive than females because three males were ter-
minated within 2–3 years after the dietary level
of the culture material was doubled. Only one
high-dose female died during this period.
Histopathologic changes associated with
changes in liver enzyme activities have been
described in detail. These changes suggest a
chronic toxic hepatosis that simulates acute
viral hepatitis, with some similarities to the
effects induced by aflatoxins. Mild portal-to-
portal fibrosis was also described by Fincham et
al. (11) in biopsy specimens of both the high-
dose and low-dose groups collected up to 1,631
days (middle 1989) after the experiment began.
These biopsies also indicated that consumption
of culture material of the fungus (high dose)
caused atherogenic plasma lipid profiles to
develop. These changes entailed elevations of
plasma low-density lipoprotein (LDL)-C and
apoprotein B strongly associated with acceler-
ated atherosclerosis in vervet monkeys. It was
suggested (11) that increased plasma cholesterol
could be related to changes at the hepatocyte
membrane leading to a reduced or impaired
internalization of LDL into the hepatocytes,
and hence the reduced clearance from the
plasma. The reduced receptor activity might be
caused by cytotoxicity induced by the FCM, an
aspect that was clearly indicated by the serum
enzyme profiles related to liver function. It was
suggested that the synthesis of cholesterol was
not affected, although in rats cholesterol accu-
mulates both in the plasma and the liver (19).
Plaque formation in the aorta of some of the
animals sacrificed (Table 3) is therefore of
interest in this regard. Additional studies must
be conducted to evaluate the role of FB on cho-
lesterol metabolism because it can effect
changes in lipid metabolism in rat liver at
different levels (19).
We also monitored the effects of the
1986–1988 and 1991–1992 changes in
dietary levels of FCM on renal function. The
low-dose group did not show any marked
changes in serum urea or creatinine during the
1986–1988 culture batch dietary change.
However, most of the high-dose animals
showed elevated levels and therefore did not
reflect the decrease in FB levels from 0.35 mg
FB/kg bw/day in 1986 to 0.18 mg/kg bw/day
in 1988. The 1991–1992 dosage increase
markedly increased the serum creatinine levels
in all high-dose vervet monkeys and in most
of the animals of the low-dose group. The
results of these two time points suggest that a
threshold for changes in these two renal para-
meters exists in the region of 0.18–0.2 mg
FB/kg bw/day as discussed for liver function.
Creatinine clearance was monitored only
1 year after the dosage increase and showed
markedly lower values during 1992 compared
to the controls. All females (both high-dose
and low-dose groups) showed a remarkable
recovery phase over the first 3 years, where-
after creatinine clearance decreased to values
similar to those of the control females.
Although creatinine clearance is widely inter-
preted as a measure of glomerular filtration
rate (GFR) and therefore renal function, the
serum creatinine levels can be affected by
many variables apart from glomerular filtra-
tion (20). These variables include the reab-
sorption and secretion of creatinine by renal
tubules, which could over- or underestimate
the GFR. In the present study, some nephro-
toxic effects were noticed in the proximal
tubular epithelium that could have decreased
the tubular excretion of creatinine and there-
fore reduced the urinary levels of creatinine
and indirectly affected the measured GFR. 
Of interest were changes in the level of
creatine kinase, which were markedly
increased in all the high-dose animals in a
dose-dependent manner. Monitoring total
creatine kinase activity, measurement nor-
mally reflects the muscle isoenzyme because
the heart and brain isoenzymes occur at far
lower levels (21). As discussed for creatine
kinase, care must be taken when interpreting
the various clinical biochemical serum para-
meters. Some of the parameters, such as LDH
and ALP, consist of many isoenzymes, each
associated with specific tissue compartments,
and electrophoretic enzyme characterization is
required for identification (20). Bone origin of
ALP elevations is quite easy to distinguish
from hepatobiliary conditions in the absence
of increased levels of AST, ALT, and GGT.
AST and ALT have no specific isoenzymes,
but AST is quite widely distributed in skeletal
and cardiac muscle, liver, and erythrocytes.
GGT occurs mainly in the liver and kidneys,
but clinically it is confined to liver conditions;
in small animals it roughly parallels ALT.
Increases in bilirubin can also result from
many abnormal physiologic conditions,
including liver failure and obstructive biliary
disease. Although Jaskiewicz et al. (10)
reported cholestasis in the high-dose group,
this could not be confirmed in subsequently
biopsied animals that received decreased
dosage levels of the culture material. It would
appear that chronic liver injury was responsi-
ble for increased levels of total plasma biliru-
bin. As discussed for bilirubin, an increase in
plasma cholesterol could be related to a
number of causes, including diabetes mellitus,
liver or biliary disease, or a fatty meal (21). It
was suggested that in the absence of cholesta-
sis, a reduced uptake of LDL cholesterol,
caused by changes to the hepatocyte mem-
branes, could be an important reason for the
increased serum cholesterol (11). Of interest is
the finding of Fincham et al. (11) that culture
material caused atherogenic effects in the
high-dose vervet monkeys in this experiment.
This study provides interesting exposure
parameters to be considered regarding
dose–response effects of FB contaminated
feeds and/or foods. The no-observed-effect
level, with respect to the total fumonisin levels
in the corn culture material, for liver and kid-
ney damage in vervet monkeys can be esti-
mated at between 0.11 and 0.18 mg FB/kg
bw/day. This level is slightly below the values
proposed to effect natural outbreaks of ELEM
(0.6–2.1 mg/kg bw/day) (22). The probable
daily intake (PDI) calculated for humans con-
suming corn as the staple diet, such as in the
Transkei region of the Eastern Cape Province
of South Africa, is 0.36 and 0.047 mg FB/kg
bw/day when consuming “moldy” and
“healthy” corn, respectively (23). These PDI
values decreased considerably when calculated
for people consuming corn exported from
South Africa (0.002 mg FB/kg bw/day) or
from the United States (0.007 mg FB/kg
bw/day). Based on the FB-intake profiles of
the vervet monkeys of 0.11 to 0.18 mg FB/kg
bw/day and an average feed intake profile of
16.0 ± 1.6 mg/kg bw/day, fumonisin contam-
ination levels of corn between 8.21 and 13.25
mg FB/kg diet can be calculated. These values
appear not to affect liver and kidney function
in the vervet monkey but were suggested to be
dangerous to horses, and 10-fold higher values
could induce pulmonary edema syndrome in
pigs (21). Changes in sphingolipid metabo-
lism, specifically in the sphinganine concen-
tration and the Sa/So ratio, were effected in
the serum and also to some extent in the urine
of the vervet monkeys at dietary levels of
0.29–0.64 mg FB/kg bw/day. These intake
levels represent, as calculated above, contami-
nation levels in corn of 21.7–47.8 mg FB/kg.
The vervet monkey appears to be a promising
model to study the use of the Sa/So ratio as a
biomarker to determine fumonisin exposure
in human populations. 
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ISOLATION, CHARACTERISATION AND NATURAL OCCURRENCE  
OF THE FUMONISINS 
 
2.1 Fumonisin purification 
The two-stage cancer initiating promoting model in rat liver, using 
diethylnitrosamine (DEN) as cancer initiator, was successfully used as a 
bioassay to purify the cancer promoting compounds, the fumonisins B (FB) 
mycotoxins from maize culture material of F.verticillioides strain MRC 826 
(Gelderblom et al., 1988a). The bulk of the fumonisins was recovered in a 
75% MeOH/water extract after extraction with ethyl acetate and subsequent 
partitioning of the aqueous methanol extract with chloroform. The fumonisins 
eluted from a reversed phase Amberlite XAD-2 column in MeOH and further 
fractionated on silica gel using CHCl3/MeOH/CH3COOH (6:3:1) as the 
developing solvent. Final purification of the two major compounds FB1 and 
FB2 were achieved on reversed phase C18 column using MeOH/H2O as 
eluting solvents. The major FB containing fractions and the purified FB1 
significantly increased the mean number of liver foci in the DEN-initiated rats 
during a feeding period of 4 weeks, similarly to the F. verticillioides maize 
culture material. The subacute pathological changes of FB1, characteristic of a 
toxic hepatitis, were similar to that described for the fungus and in agreement 
with the finding that cancer promotion was associated with a hepatotoxic 
effect. Similar to the fungal culture material (Gelderblom et al., 1988b), FB1 
induces preneoplastic lesions in the absence of DEN-initiation, suggesting 
that FB1 is a complete carcinogen.  
 
The preparative-scale isolation of the fumonisins was undertaken during 
which two minor constituents, FB3 and FB4 were purified (Cawood et al., 
1991). Two structural n-acetyl analogues of FB1 and FB2, FA1 and FA2, 
respectively were also purified for the first time. Structural analogues that 
resulted as artifacts from the isolation process, the mono- and dimethyl ester 
derivatives of FB1 and FB2 were purified for studies on structural activity. The 
formation of these analogues, however, decreased the final yield to 
approximately 40 % for both FB1 and FB2. The quantitative method developed 
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was applied for the bulk purification of FB1 and FB2 to a purity of >90% which 
was used for biological studies. 
 
2.2 Structural elucidation and structural analoques 
Chemical structures of the fumonisins and the structural analogues were 
elucidated by mass spectrometry and 1H and 13C nmr spectroscopy 
(Bezuidenhout et al., 1988). FB1 and FB2 are di-esters, at C-14 and C15 
hydroxy positions, of propane-1, 2, 3-tricarboxylic acid (TCA) and 2-amino-12, 
16-dimethyl-3, 5, 10, 14, 15 pentahydroxyicosane. FB2 is the C-10 deoxy 
analoque of FB1, while FA1 and FA2 are the n-acetyl derivatives of FB1 and 
FB1 respectively. Recently, FB3 and FB4 were found to exist as structural 
epimers, which should be considered during the quantification of FB3 
(Gelderblom et al., 2007).  
 
2.3 Natural occurrence 
The natural occurrence of mycotoxins in basic dietary staples is of concern, as 
it is known to adversely effect many aspects of human health. The ubiquitous 
nature of the fungus, specifically on maize, and the involvement in many 
natural outbreaks of F. verticillioides-associated diseases in animals predicted 
that the toxic principles could occur naturally. The sample selected to 
investigate the natural occurrence of FB1, was obtained from a rural area in 
the former Transkei region, shown to be contaminated with other Fusarium 
mycotoxins, including moniliformin, zearalenone, deoxynivalenol and the 
mutagen fusarin C (Thiel et al., 1982, 1986; Gelderblom et al., 1984a). Two 
independent HPLC methods utilizing maleyl anhydride and fluorescamine 
derivitisation of the free amino group and subsequent confirmation with GS-
MS provides conclusive evidence of the natural occurrence of FB1. Apparent 
level of FB1 was considerably higher in the “moldy” and Fusarium infected 
kernels as compared to the “healthy” maize (Sydenham et al., 1990). The 
study provides proof, not only for the natural occurrence of FB1, but for the co-
occurrence with other Fusarium mycotoxins and the mutagen fusarin C, and 
evidence that humans may well be exposed. The first report that FB1 and FB2 
also occur in maize samples associated with leukoencephalomalacia (LEM) in 
horses suggested that these mycotoxins could be involved in the development 
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of this syndrome (Voss et al., 1989). Feeding studies utilizing the same 
material of F. verticillioides in rats demonstrated hepato- and nephrotoxicity 
that, together with the known toxic effects by FB1 in rats (Gelderblom et al., 
1988a) further provides evidence that the fumonisins could be the causative 
principles for LEM. 
 
2.4 Fumonisin production and heat stability in maize cultures  
Studies on the toxicological effects of F. verticillioides strain MRC 826 were 
complicated by the variation of the toxigenic properties of different cultured 
batches. Prior to the discovery of the fumonisins, toxicity was determined by 
the duckling test (Leslie et al., 1996), while clinical chemical analyses for liver 
function enzymes were utilised during chronic feeding studies to assess the 
extent of toxicity in a specific animal species. Variation in the toxicity is likely 
to be determined by toxin production that is affected by different parameters 
including temperature, aeration, water activity, growth kinetics and the 
composition of the growth medium. To ascertain optimal fumonisin production 
for bulk purification these different parameters had to be optimized and to 
screen other Fusarium spp for their ability to produce these mycotoxins. 
 
A study by Thiel et al. (1991) screened 27 taxa in 9 of the sections of 
Fusarium. Maize cultures of the different species were prepared in glass fruit 
jars (see below) and analysed by HPLC using o-phthaldialdehyde 
derivatisation with fluorescence detection. Fumonisin production was 
restricted to F. verticillioides (F. moniliforme) and F. proliferatum with F. 
verticillioides strain MRC 826 found to be the highest producer. Only one 
other species, F. nygamai, isolated from soil was also found to produce FB1 
and FB2. Subsequent studies on fumonisin production therefore utilised F. 
verticillioides strain MRC 826  
 
Two different experiments utilizing a) whole yellow maize kernels in 2-liter 
glass fruit jars (Alberts et al., 1990) and finely ground yellow maize kernels in 
100 by 18 mm glass petri dishes (Alberts et al., 1993) were conducted. In the 
first study, using whole maize kernels, the initial growth rate was higher at 25 
C than 20 °C reaching the stationary phase after 4 to 6 weeks. FB production 
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commenced after 2 weeks during the active growth phase and started to 
decrease after 13 weeks. Although the overall maximal yield, ranging from 
17.9 to 16.5 g FB1/kg dry weight, respectively, did not differ between the 2 
temperatures, the average yield was significantly higher at 25 °C (9.5g vs 
8.7g). Incubation of the cultures at 30 °C provided very low yields of 0.6g 
FB1/kg dry weight. In order to increase the surface area and aeration a 
subsequent experiment was conducted using ground yellow maize kernels in 
the form of a patty contained in a glass petri dish. Maximum FB1 production 
(11.6 g/kg dry weight) was achieved after 2 weeks with an apparent maximum 
yield (P>0.05) of 14.8 g FB1/kg dry weight after 3.5 weeks (Alberts et al., 
1993). The production of FB2, which was approximately 50% lower, followed 
similar trends. Compared to the first study, FB1 production in the glass petri 
dish patty method provides a more convenient procedure for the production of 
high yields in a short time that facilitates the bulk purification thereof. 
  
The ground maize petri dish patty model was subsequently developed to 
produce [14C] isotope labeled FB1 using L-[methyl-14C] methionine (Alberts et 
al., 1993). Optimum incorporation of [14C] that occurs at C-21 and C-22 of the 
molecule was achieved after 9 days in the presence of unlabeled methionine, 
yielding a specific radio activity of 36 µCi/mmol. Despite the controlled 
conditions, variation the labeling of FB1 occurred which was ascribed to 
differences in the viability of the inocula and variations in the composition of 
the yellow maize used. A study using liquid cultures was conducted as the 
composition is less complex, but the FB1 production was extremely low as 
compared to the maize patty cultures, making the labeling of FB1 with a higher 
specific activity problematic (Alberts et al., 1994). 
 
The stability of the fumonisins was addressed to evaluate the effect of 
cooking, as maize porridge is the traditional way of preparing maize to be 
consumed in Africa. Boiling of freeze dried maize culture material in H2O (1:1 
w/v) for 30 min did not reduce the FB1 concentration (Alberts et al., 1990). The 
cancer promoting properties of the boiled culture material were also not 
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reduced when considering the induction of GGT positive foci in DEN-initiated 
rats. 
 
2.5 Perspectives 
The characterization of the fumonisins was mainly hampered by the lack of a 
suitable model that represents the diverse toxicological effects of the fungus in 
different animal species. It was not known whether a toxic hepatic lesion in 
rats represents the action of a toxin(s) that is responsible for LEM in horses 
and pulmonary edema in pigs. The characterization of the fumonisin 
mycotoxins, therefore, has been an important breakthrough and can be 
regarded as a turning point that clarified many of the toxicological effects of F. 
verticillioides in animals since the first report that the fungus is a causative 
agent for ELEM.  
 
The stepwise elucidation of the carcinogenic principles produced by the 
fungus following the findings of the hepatocarcinogenic effects resulting in the 
characterization of a potent mutagen fusarin C, were the major initial events in 
the characterization of the fumonisins. Despite the findings that fusarin C is 
not the major carcinogenic principle produced by the fungus, the isolation of 
this mutagen led the way to elucidate the cancer promoting potency of the 
fungus resulting in the development a short-term cancer initiating/promoting 
cancer model in the liver. An important aspect for developing the model was 
the notion that all carcinogens are not mutagens and, that a bioassay based 
on genotoxicity, such as the Salmonella mutagenicity test, would not 
necessarily identify the actual carcinogen. The finding that the different 
cultures of the fungus exhibiting cancer promoting activity in rat liver was 
associated with a toxic effect, provided the first evidence that the toxic 
principle(s) is also likely to exhibit cancer promoting activity. This was based 
on the findings that the heptocarcinogenic effects of the fungal culture material 
were associated with a chronic toxic hepatitis with development of hepatocyte 
nodules, early markers for cancer development in the liver. These events and 
knowledge that accumulated since the first report on the carcinogenicity of the 
fungus in 1981 resulted in the development of the liver bioassay and the 
purification of the fumonisins in a matter of a few months. 
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Following the discovery of the fumonisins, emphasis was placed on the 
development of suitable analytical techniques to determine its natural 
occurrence and studies regarding the production profiles in maize in order to 
supply ample fumonisin standard stock material for analytical purposes and 
biological investigations. Optimisation of fumonisin production in maize by 
developing the maize patty culture technique, using F. verticillioides strain 
MRC 826, led to the bulk purification of large amounts. The maize patty model 
was also successfully utilized for the production of radio-labeled fumonisins to 
be utilized in biological investigations. The setting of an international “gold” 
standard for fumonisins and the infrastructure to produce stock preparations 
of high purity created the basis for the detailed elucidation of the toxicological 
effects in different animal species and subsequent investigation of the 
underlying mechanisms involved.  
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The kinetics of the production of fumonisin B1 (FB1) by Fusarium moniliforme MRC 826 in corn cultures was
investigated as a function of fungal growth at various incubation temperatures. The growth rate of F.
monilformne, as measured by ergosterol concentration, was higher at 25°C than at 20°C, reaching a stationary
phase after 4 to 6 weeks in both cases. FB, production commenced after 2 weeks during the active growth
phase, continued to increase during the stationary phase, and decreased after 13 weeks. The overall maximal
yield of FB1 (17.9 g/kg, dry weight) was obtained in corn cultures incubated at 20°C for 13 weeks, but it was
not significantly (P > 0.05) higher than the maximum yield (16.5 g/kg, dry weight) obtained at 25°C after 11
weeks. However, a significantly (P < 0.05) higher mean yield was detected at 25°C (9.5 g/kg, dry weight) than
at 20°C (8.7 g/kg, dry weight). Production reached a plateau after 7 weeks of incubation at 25°C or 9 weeks of
incubation at 20°C. The maximal production of FBI at 30°C was very low (0.6 g/kg, dry weight). FB1 was also
found to be heat stable, as there was no reduction in the FB1 concentration after boiling culture material of F.
moniliforme MRC 826.
Fusarium moniliforme Sheldon is one of the most preva-
lent fungi associated with basic human and animal dietary
staples such as corn (10, 13-15). Culture material of F.
moniliforme MRC 826, isolated from corn intended for
human consumption in Transkei, southern Africa, proved to
be highly toxic to a variety of experimental animals (6, 8, 9),
has been shown to cause leukoencephalomalacia in horses
(8) and to be hepatocarcinogenic in rats (7, 12), and has
cancer-promoting activity in a short-term cancer initiation-
promotion model in rats (3, 4). The latter bioassay was used
in the isolation and purification of two new mycotoxins,
fumonisins B1 (FB1) and B2 (FB2), from culture material of
F. moniliforme MRC 826 (2). The structures of FB1 and FB2
have recently been elucidated (1), and FB1 has been shown
to have cancer-promoting activity in rats (2) and to cause
leukoencephalomalacia in a horse (11).
The fumonisins may be of major importance in the etiol-
ogy of several animal and human diseases. However, for a
proper evaluation of the toxicological effects of these my-
cotoxins, sufficient amounts have to be purified for a variety
of biological studies. At present, no information is available
on experimental conditions for the optimal production of the
fumonisins in culture. This paper reports the chemical de-
termination of FB1 in corn cultures ofF. moniliforme and the
influence of temperature and incubation period on the pro-
duction of FB1 in these cultures. In addition, the relationship
between fungal growth and FB1 production as well as the
heat stability of this mycotoxin were also investigated.
MATERIALS AND METHODS
Fungal cultures. The strain of F. moniliforme used in all
experiments was originally isolated from corn in Transkei,
southern Africa, during 1975 and deposited in the culture
collection of the South African Medical Research Council
* Corresponding author.
(MRC) as F. moniliforme MRC 826 (14). Lyophilized conidia
were used to inoculate autoclaved (1 h at 121°C and 120 kPa
on each oftwo consecutive days) corn (400 g of whole yellow
corn kernels and 400 ml of water in 2-liter wide-mouthed
glass fruit jars with a diameter of 11 cm and a cotton cover),
and cultures (surface/volume ratio, approximately 2:5) were
incubated in the dark at 20, 25, and 30°C. Triplicate jars were
harvested weekly; their contents were weighed, lyophilized,
and ground; and the concentration of FB1 was determined as
described below.
Chemical analyses. (i) Fumonisin B1 standard. FB1 was
isolated and purified as described previously (2). For use as
an analytical standard, FB1 was further subjected to two
successive column separations on silica gel and reverse
phase (C18) columns, using CHCl3-CH30H-CH3COOH (6:
3:1) and CH3OH-H20 (3:1) as eluants, respectively. The
purity of FB1 was verified by nuclear magnetic resonance
spectroscopy.
(ii) Extraction and HPLC quantification. Culture extracts
were prepared and partially purified by the maleyl derivati-
zation method described previously (20). Briefly, culture
material (5 g) was extracted with CH30H-H20 (3:1; 50 ml).
A sample (25 ml) was evaporated to dryness, taken up in an
equal volume ofCH3OH-H20 (1:3), and extracted twice with
CHC13 (50 ml). Final purification of the aqueous phase was
accomplished by using a Sep-pak C18 cartridge, eluting FB1
in CH30H-H20 (3:1; 10 ml). Purified extracts were treated
with maleic anhydride and analyzed by high-performance
liquid chromatography (HPLC) by the method of Siler and
Gilchrist (18). HPLC analyses were performed on a Waters
liquid chromatograph (Waters Associates, Milford, Mass.),
using a reverse-phase cartridge (C18; 10 ,um) in a radial
compression module (model RCM-100) and 0.05 M KH2PO4-
CH30H (3:7; pH 3.5) as the mobile phase. The eluate was
monitored at 230 nm. To determine whether the HPLC
technique is quantitative at both low and high FB1 concen-
trations, a standard curve was composed by analyzing
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different amounts (1, 2, 3, 4, and 5 ,ug) of pure FB1 standard
after maleylation. For determination of the percent recov-
ery, control corn (5 g) was spiked in triplicate with 1.5 mg of
pure FB1 standard'and analyzed as described above.
(iii) Ergosterol analyses. Ergosterol determinations were
performed in duplicate on corn cultures of F. moniliforme
MRC 826 incubated for 0, 2, 4, 6, 8, 10, 13, 15, and 17 weeks
at 20, 25, and 30°C. The method of Seitz et al. (17) was used,
with minor modifications. Samples (5 g) were extracted with
methanol, the methanol extract was saponified for 30 min,
and the mixture was extracted with petroleum ether (bp 60 to
80'C). After evaporation of the aqueous phase, the residue
was dissolved in 2.5 ml of CH2Cl2-isopropanol (98:2) and a
100-fold dilution was used for HPLC analysis on a Waters
liquid chromatograph, using a silica gel (Microsil) column
(5.0 mm by 30 cm; 7 ,um) and CH2Cl2-isopropanol (98:2) as
the mobile phase. The eluate was monitored at 280 nm.
Stability to heat. Lyophilized culture material of F. monil-
iforme MRC 826 (500 g) was boiled in 500 ml of water for 30
min, after which it was oven dried at 60°C for 24 h. Both
boiled and untreated materials were incorporated in rat mash
(Epol Ltd., Johannesburg, South Africa) at a dietary level of
5% and fed to diethylnitrosamine-initiated male BD IX rats
over a period of 4 weeks (3). Noninitiated rats receiving the
untreated (nonheated)' culture material (5%) served as the
controls. The induction of gamma-glutamyl-transpeptidase-
positive foci, a common marker for preneoplastic lesions (5),
was used as endpoint for the assay. In addition, the boiled
and untreated materials were analyzed for FE1 by HPLC as
described above.
Statistical analyses. All analyses were performed by using
the general linear model analysis of variance procedure of
the Statistical Analysis System program package. The Stu-
dent-Newman-Keuls multiple comparison method was used
to test for significant differences between main-effect means.
Significance tests for differences between the yields at 20 and
250C for the separate weeks were performed by using a
significance level adjusted for the number of tests per-
formed. The method used was Bonferroni inequality; i.e., an
observed difference is deemed significant if its'P value is less
than P' = 1 - (1 - P)l/n, where P is desired overall
significance level and n is the number of weeks for which
observations were taken.
RESULTS AND DISCUSSION
The analytical technique used for the quantification of FB1
in culture material of F. moniliforme MRC 826 had a
recovery of approximately 85%. The detection limit of the
method was in the order of 10 ,ug/g, as reported by Syden-
ham et al. (20). HPLC chromatograms demonstrating the
eluting position of FB1 standard and a purified extract of a F.
moniliforme MRC 826 corn culture are illustrated in Fig. 1.
The standard curve indicated that, for the concentration
range used, a linear relationship (r = 0.9955) exists between
the recorder response and the amount of FB1 analyzed. The
method described is suitable for the determination of FB1 in
extracts of corn cultures of F. moniliforme MRC 826 as a
result of the high quantities found to be produced by this
strain in culture.
The fumonisins have recently been found to occur natu-
rally in corn in South Africa (20) and the United States (21).
These findings emphasize the importance of screening hu-
man and animal foodstuffs for the presence of these myco-
toxins. However, to assess human exposure, the heat sta-
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FIG. 1. HPLC-eluting chromatograms of FB1 standard (Std) and
a purified extract of culture material of F. moniliforme MRC 826.
bility of the fumonisins is of major importance. In the
present study, no difference in the FB1 concentration of
boiled and untreated culture materials could be detected by
HPLC (Table 1). In addition, culture material also retained
its cancer-promoting (gamma-glutamyl-transpeptidase-posi-
tive) activity in diethylnitrosamine-initiated rats (Table 1).
The data indicate that FB1 is not destroyed by cooking and
could -therefore enter the human food chain.
The optimum incubation temperature for growth of Fusar-
ium spp. in culture has been reported to be alternating at
25°C day/20°C night, although they also grow well at con-
stant temperatures between 20 and 25°C (16). As incubation
of fungal cultures at alternating temperatures is impractical,
we investigated the production of FB1 at constant tempera-
tures of 20, 25, and 30°C. The ergosterol content of the
fungal cultures was used as an indication of fungal growth,
since it is a useful indicator of fungal invasion of grains (17),
measuring both viable and nonviable fungal biomass.
Kinetics of the growth of F. moniliforme MRC 826 in coM
TABLE 1. Effect of heat treatment on FB1 concentration
and cancer-promoting activity of corn culture material
of F. moniliforme MRC 826 in diethylnitrosamine
(DEN)-initiated rats
MRC 826 FB1 concn DEN Mean GGT activity
sample (g/kg, dry wt)a initiationb (foci/cm2)c
Untreated 2.3 ± 0.6 - ND
Untreated 2.3 ± 0.6 + 4.85 ± 0.92
Boiledd 2.5 ± 0.2 + 3.45 ± 0.71
a Values represent means ± standard deviations of triplicate determina-
tions.
b Indicates whether or not the rats to be tested for cancer-promoting
gamma-glutamyl-transpeptidase activity had been initiated with DEN (200
mg/kg). The promoting treatment commenced 1 week after initiation. Boiled
and untreated culture material was incorporated in rat mash at a dietary level
of 5% for a period of 4 weeks, five rats per treatment.
c Values represent means ± standard deviations of five rats. GGT, Gamma-
glutamyl-transpeptidase; ND, none detected.
d Boiled in water for 30 min and dried at 60'C for 24 h.
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FIG. 2. Time course of growth as measured by ergosterol concentration of F. moniliforme MRC 826 in corn cultures at 20, 25, and 30°C.
*Cultures not further analyzed during the remainder of the experiment.
cultures at 20, 25, and 30°C are presented in Fig. 2. During
the first .2 weeks of incubation, cultures at 30°C grew
significantly better than those at 200C (P < 0.01) and 25°C (P
< 0.05), while after 4 weeks the cultures incubated at 20 and
25°C had higher ergosterol concentrations than those incu-
bated at 30°C; only that obtained at 25°C, however, was
significant (P < 0.05). After 6 weeks, significantly (P < 0.05)
higher levels of ergosterol were detected in cultures incu-
bated at 20 and 250C than at 30°C, and no further increase
occurred in the cultures incubated at 30°C. Although the
initial growth rate was higher at 25°C than at 200C, the
maximum growth rates were similar, reaching a stationary
phase at 4 to 6 weeks. In this experiment, the optimum
conditions for growth of F. moniliforme MRC 826 prevailed
in cultures incubated at 20 and 25°C.
As our culture vessels and incubation conditions allowed
evaporation, changes in the moisture content of cultures
durlng incubation almost certainly influenced both growth
and FB1 production. This is evident from the data concern-
ing the weight loss (Fig. 3) of the cultures incubated at the
different temperatures. From 2 weeks onward, the cultures
at 30°C had lost significantly more weight than those at 250C
(P < 0.05) and 200C (P < 0.01). The weight loss between
cultures incubated at 20 and 250C also differed significantly
(P < 0.01) from 2 weeks onward. This difference increased
markedly with time, and the weight loss after 4 weeks at
350 - 25uG
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FIG. 3. Time course of weight loss of corn cultures of F. moniliforme MRC 826 at 20, 25, and 30°C. *, Cultures not further analyzed during
the remainder of the experiment.
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TABLE 2. Time course of FB, production by F. moniliforme
MRC 826 in corn cultures at 20 and 25°C
FB1 concn (g/kg, dry wt)a
Wk
200C 25°C pb
0 ND ND NS
1 ND ND NS
2 0.4 +0.25 a 1.2 + 0.38 a NS
3 3.5 ± 0.91 ab 6.7 t 1.10 b <0.05
4 6.1 ± 0.62 bc 9.3 ± 3.26 bc <0.01
5 5.4 ± 1.08 bc 11.6 ± 1.00 cd <0.01
6 7.4 ± 3.78 c 10.3 ± 1.28 c <0.05
7 8.9 ± 0.79 cd 14.6 ± 3.21 de <0.01
8 11.2 ± 2.10 d 11.7 ± 1.18 cd NS
9 15.3 ± 0.85 e 11.5 ± 1.55 cd <0.01
10 15.2 ± 1.59 e 12.7 ± 0.33 cd NS
11 16.2 ± 0.62 e 16.5 ± 2.36 e NS
13 17.9 ± 1.84 e 15.4 ± 1.47 de NS
15 14.3 ± 1.40 e 12.3 ± 0.76 cd NS
17 8.1 ± 3.27 cd 9.1 ± 0.71 bc NS
Mean 8.7 9.5 <0.05
a Values represent means + standard deviations of triplicate determina-
tions. Means in a column followed by the same letter do not differ significantly
(P > 0.05). ND, Not detected.
b Denotes significance of differences between means in rows (20 and 25°C).
NS, Not significant.
25°C was identical to that of the cultures at 20°C after 8
weeks. The weight loss observed in these cultures cannot be
ascribed solely to a loss in moisture content as fungal growth
did occur (Fig. 2) and some carbon dioxide must have been
produced. However, the weight loss in the cultures at 30°C
between 4 and 6 weeks of the incubation treatment can only
be ascribed to evaporation as no fungal growth occurred
during this period (Fig. 2).
As the moisture content undoubtedly limited both fungal
growth and FB1 production at 30°C, data for FB1 production
at 30°C were not included in the statistical evaluation of the
growth-dependent production at different temperatures.
Production of FB1 at 20 and 25°C commenced at 2 weeks
and continued to increase during the stationary phase,
confirming the inverse relationship reported previously (19)
between the rate of mycelial growth and the biosynthesis of
many secondary metabolites of fungi. The concentration of
FB1 started to decrease at both temperatures after 13 weeks.
Since FB1 is heat stable, the decrease in the FB1 concentra-
tion after incubation periods longer than 13 weeks probably
stems from enzymatic cleavage of the molecule or a conver-
sion to other related compounds or both.
The initial rate of FB1 production was faster at 25°C than
at 20°C (Table 2), with FB1 production significantly (P < 0.01
to 0.05) higher at 25°C than at 20°C between weeks 3 and 7.
An apparent maximum FB1 yield (17.9 g/kg, dry weight) was
obtained at 13 weeks at 20°C (Table 2), but this was not
significantly (P > 0.05) higher than the maximum yield
obtained after 11 weeks at 25°C (16.5 g/kg, dry weight).
However, the mean FB1 yield over the total incubation
period was significantly (P < 0.05) higher at 25°C than at
20°C, with production reaching a plateau after 7 weeks of
incubation at 25°C in contrast to 9 weeks at 20°C.
It can be concluded that, under the conditions of the
present experiment, the optimal incubation regimen for FB,
production by F. moniliforme MRC 826 in cultures on corn,
in terms of cost effectiveness, is 7 weeks at 25°C. However,
the effect of various moisture levels, at different incubation
temperatures, on the production of FB1 and other fumoni-
sins needs to be investigated.
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Kinetics of growth and fumonisin production by Fusarium moniliforme MRC 826 in corn "patty" cultures
were investigated, and a technique was developed for the production of ["4C]fumonisin B1 ([14C]FB,) by using
L-[methyl-'4CJmethionine as the precursor. A significant (P < 0.01) correlation exists between fungal growth
and FB1 (r = 0.89) and FB2 (r = 0.87) production in corn patties, beginning after 2 days and reaching the
stationary phase after 14 days of incubation. [14C]FB, was produced by adding L-[methyl-14CJmethionine daily
to cultures during the logarithmic phase of production. Incorporation of the isotope occurred at C-21 and C-22
of the fumonisin molecule and was enhanced in the presence of unlabeled L-methionine. Although the
concentration of exogenous unlabeled methionine is critical for incorporation of the 14C label, optimum
incorporation was achieved by adding 50 mg of unlabeled L-methionine and 200 ,uCi of L-[methyl-14Cjmethio-
nine to a corn patty (30 g) over a period of 9 days, yielding [14CJFB1 with a specific activity of 36 ,uCi/mmol.
The fumonisin B mycotoxins are a group of structurally
related metabolites (Fig. 1) produced by Fusarium monili-
forme Sheldon (6), one of the most prevalent fungi associ-
ated with corn (Zea mays L.), which is used as basic human
food and animal feed (18). Fumonisin B1 (FB1), the major
fumonisin produced both in culture (2) and under natural
conditions (26), is responsible for several toxicological ef-
fects in animals. These effects include the neurotoxic syn-
drome, leukoencephalomalacia in horses (15), pulmonary
edema in pigs (13), and hepatocarcinogenic and hepatotoxic
effects in rats on chronic feeding over an extended period
(9). Apart from two reports on the excretion and tissue
distribution of FB1 in rats (23, 24), little work has been done
on the metabolism of the fumonisins in affected animals.
As a result of its high sensitivity, isotopic labeling has
greatly facilitated investigations into the metabolism in ani-
mals of several mycotoxins such as [14Cjzearalenone in
chickens (8, 19) and mice (3) and [3H]T-2 toxin in chickens
(7) and a lactating cow (27), as well as studies of the
subcellular distribution of [3H]T-2 toxin in perfused rat livers
(20). The availability of isotopically labeled FB1 would
therefore be useful in research to clarify the mechanisms
involved in the above-mentioned toxicological effects of this
mycotoxin.
The biosynthesis of isotopically labeled mycotoxins pro-
duced by Fusarium spp. has been carried out with both solid
(11, 12) and liquid (4, 17) media. Although production of
mycotoxins is much higher in solid media, isotopic labeling
in solid media yields compounds with low specific activities
(12). The production of FB1 in corn cultures (2) begins 14
days after inoculation and reaches a plateau (16.5 g/kg) after
7 weeks, whereas production in a liquid medium begins after
3 days and reaches a maximum (73 ,ug/ml) after 29 days (14).
Since the relatively long period of FB1 production in both
these media would encourage nonspecific incorporation of
isotopically labeled precursors into cell components other
* Corresponding author.
than the fumonisins, these media are not ideal for use in
isotopic labeling of FB1. In the present studywe investigated
the kinetics of growth and fumonisin production by F.
moniliforme MRC 826 in corn "patties" to evaluate the
culture system required for isotopic labeling experiments. In
subsequent experiments attention was directed toward opti-
mizing the conditions for labeling the methyl groups in FRB
by using L-[methyl-14Cjmethionine as the precursor.
MATERIALS AND METHODS
Chemicals. Amberlite XAD-2 and silica gel 60 (Kieselgel
60; diameter, 0.063 to 0.200 mm) were purchased from
Merck SA. The reversed-phase packing material (C18; Bond-
esil; diameter, 40 ,um) was obtained from Analytichem
International, Harbor City, Calif., or prepared from silica gel
60 by the method of Kingston and Gerhardt (16). Analytical-
grade organic solvents were glass distilled prior to use for the
final column purification steps of FB1 on silica gel and RP
C18. The L-[methyl-14Clmethionine (specific activity, 56 mCi/
mmol) was obtained from Amersham.
Fumonisin standards. FB1, FB2, and FB3 standards were
purified as described by Cawood et al. (6) and had a chemical
21 22
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FIG. 1. Chemical structures of FB1, FB2, and FB3.
2673
2674 ALBERTS ET AL.
15
1-%
cm
(_ 10
0
0C)
._
cn
0.
E
0
12
m
0
coC-l)
8 (D
0
6 0
0
0
4
2 gg
1 3 5 7 9 12 16 20 24 28 32 36
Incubation Period (days)
FIG. 2. Time course of growth, as measured by ergosterol concentration (O) and production of FB1 (*) and FB2 (E) by F. moniliforme
MRC 826 in corn patty cultures.
purity of greater than 95% as assessed by thin-layer chro-
matography, high-pressure liquid chromatography (HPLC),
and 1H- and 13C-nuclear magnetic resonance (NMR) spec-
troscopy.
Corn patty cultures. Yellow corn kernels, ground to fine
meal (20 to 30 g) was used to prepare patty media in Pyrex
petri dishes (100 by 18 mm) by the addition of water (20 to 30
ml) and then autoclaving (1 h at 121°C and 120 kPa) on each
of two consecutive days. In all experiments 1 ml of a
suspension of lyophilized conidia of F. monilifonne MRC
826 (2) in 100 ml of sterile distilled water was used to
inoculate media.
Analytical methods. Extraction, purification, and HPLC
quantification of FB1, FB2, and FB3 were performed by the
techniques described by Alberts et al. (1). The ergosterol
concentration in corn cultures was determined by the
method of Sietz et al. (25) with slight modifications (2).
Kinetics of fungal growth versus fumonisin production.
Inoculated corn patty cultures were incubated at 25°C in the
dark, and cultures were harvested daily in triplicate for 10
days and thereafter on every other day for 36 days (Fig. 2).
Cultures were lyophilized and ground, and the fumonisin
concentrations were determined. Ergosterol concentrations
were determined in duplicate in cultures harvested every
other day over the incubation period.
Production of [14CJFB,. Inoculated corn patties (30 g) were
incubated at 25°C in the dark for 12 days. An aliquot (1 ml)
of a solution of L-[methyl-14C]methionine in sterile distilled
water (10 ml) was applied topically in small droplets to each
culture every 24 h from days 3 to 11 (9 days) during
incubation. The cultures were harvested on day 12 and
lyophilized, the fumonisins were quantified as described
above, the FB1 was isolated, and its specific activity (in
microcuries per millimole) was determined. The dilution
factor was obtained from the equation (specific activity of
precursor + specific activity of product) x (number of
labeled sites in product + number of labeled sites in precur-
sor).
(i) Isotopic labeling. Preliminary experiments (Table 1)
were conducted to evaluate L-[methyl-4C]methionine as a
precursor for the labeling of FB1. In the first experiment, 50
,Ci of L-[methyl-14CJmethionine was added to a corn patty
(20 g) as described above. The origin of the methyl groups
present in the FB1 molecule was established by using a
mixture of L-[methyl-14C]methionine and L-[methyl-'3C]me-
thionine (97 atom% of '3C) as a precursor and performing
13C-NMR spectroscopy of the enriched FB1. The effect of
unlabeled L-methionine (100 mg), which was admixed with
the L-[methyl-14C]methionine, on the incorporation of the
14C label was evaluated in a third experiment. The role of
acetate as a precursor was also investigated by monitoring
the incorporation of sodium [1-14C]acetate (125 p,Ci) in the
presence of unlabeled sodium acetate (250 mg) and sodium
[1-13C]acetate (500 mg).
(ii) Effect of unlabeled L-methionine on growth, fumonisin
production, and isotopic labeling. The effect of unlabeled
L-methionine on fungal growth and fumonisin production
was investigated by adding different amounts (0, 50, 100,
150, 200, 250, and 300 mg) of unlabeled L-methionine to
cultures over a period of 9 days as described above (Fig. 3).
TABLE 1. Preliminary results for specific activities obtained by using different isotopes of methionine and sodium acetate
as precursors in corn patty cultures of F. moniliforme MRC 826
Precursor Amt of unlabeled Amt of '3C-labeled Amt of 14C-labeled Amt of corn Sp act Dilutionprecursor (mg) precursor (mg) precursor (pCi) (g) (pLCi/mmol) factor
L-Methionine 0 0 50 20 4.26 > 100
0 50 25 30 6.03 25.0
100 0 100 30 22.07 13.7
Sodium acetate 0 500 125 30 2.274 138.5
250 0 125 30 5.577 113.0
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FIG. 3. Effect of L-methionine treatments on growth, as measured by ergosterol concentration (E) and production of FB, (M) and FB2 (0)
by F. monilifonne MRC 826 in corn patty cultures.
In a subsequent experiment the effect of different amounts of
unlabeled L-methionine (0, 50, 100, 150, 200, 250, and 300
mg) on the incorporation of the '4C label was investigated by
using a fixed amount of L-[methyl-l4C]methionine (25 ,uCi)
(Table 2).
(iii) Isotopic labeling using different concentrations of
L-[methyl-'4C]methionine at constant unlabeled L-methionine
concentrations. In three separate experiments, different lev-
els of L-[methyl-l4C]methionine (50, 100, and 200 ,uCi) were
added during the growth period with fixed amounts (50, 150,
and 300 mg) of unlabeled L-methionine (Table 3) in each
case.
Purification of FB1. Extraction and purification of FB,
were performed essentially as previously described (6).
Culture material (20 g [dry weight]) was extracted twice with
ethyl acetate (100 ml) by blending (Polytron) and filtering
(Whatman no. 4 filter paper). The residue was extracted
three times with CH3OH-H20 (3:1) after the pH had been
adjusted to 3.5 with 10 M HCI prior to blending (1). The
combined extracts were evaporated to dryness under re-
duced pressure at 45°C, reconstituted in 50 ml of CH30H-
H20 (1:3), and extracted three times with 100 ml of CHC13.
The aqueous phase was evaporated to dryness under re-
duced pressure at 45°C. Subsequent purification was per-
formed with Amberlite XAD-2, silica gel 60 and RP C18
columns as previously described (6).
NMR spectroscopy. NMR spectra were recorded for solu-
tions in [ H6]dimethylsulfoxide on a Brucker AC-300 spec-
troscope (7.0 T) operating at 300 MHz for 'H nuclei and 75
MHz for 3C nuclei. Chemical shifts are reported relative to
tetramethylsilane at 8 0.00.
Liquid scintillation counting. The liquid scintillation cock-
tail for aqueous samples (Ready Value) was obtained from
Beckman, Fullerton, Calif. The purified [14C]FB, samples (1
mg) were analyzed by liquid scintillation counting for 10 min
in a Packard Tri-carb 460CD instrument. Quenching was
corrected by using external standardization for calculations
of disintegrations per minute.
Statistical analyses. An analysis of variance was carried
out and the coefficients of variation were determined on the
original data for the experiments relating to (i) fumonisin
production and fungal growth and (ii) the influence of methi-
onine on fumonisin production and fungal growth. Tukey's
Studentized range Q test (28) was then used to determine
whether the means for the incubation period and the methi-
onine treatment were significantly different. In addition,
correlation coefficients were determined for (i) fungal growth
and fumonisin production and (ii) methionine treatment
versus growth and fumonisin production.
RESULTS AND DISCUSSION
Biosynthetic isotopic labeling of several mycotoxins pro-
duced by Fusanium spp. has been achieved by addition of
isotopically labeled precursors to fungal cultures during the
logarithmic growth phase (5, 11). The optimum period for the
addition of labeled precursors was determined by the rate of
fumonisin production as a function of fungal growth in corn
patty cultures ofF. moniliforme MRC 826 over a period of 36
days. Production of FB, and FB2 in corn patty cultures
began 3 days after inoculation (Fig. 2) and increased rapidly
between days 4 and 14, whereafter a plateau was reached.
An apparent maximum yield of FB, (14.8 g/kg [dry weight])
and FB2 (6.4 g/kg [dry weight]) was observed after 26 and 16
days, respectively, but was not significantly (P > 0.05)
higher than the maximum yield of FB, (11.2 g/kg [dry
weight]) and FB2 (5.0 g/kg [dry weight]) obtained after 14
days of incubation.
A significant (P < 0.01) correlation was observed between
TABLE 2. Specific activities of FB, obtained following addition
of 25 ,uCi of L-[methyl-14C]methionine and different
concentrations of unlabeled L-methionine to corn
patty cultures of F. monilifonne MRC 826
Amt of Amt of Amt of L-[methyl-'4C] Sp act Dilution
L-methionine cor methionine (,uCi) (ACi/mmol) factor(mg) (g)
0 30 25 0.90 >100
50 30 25 3.34 45.2
100 30 25 2.64 28.6
150 30 25 2.86 17.6
200 30 25 2.18 17.3
250 30 25 2.14 14.1
300 30 25 2.40 10.5
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TABLE 3. Specific activities of pure FB1 obtained following the addition of unlabeled L-methionine and different concentrations of
L-[methyl-14C]methionine to corn patty cultures of F. moniliforme MRC 826
Amt of Amt of Amt of Fumonisin concn (g/kg [dry wt]) Sp act Dilution
L-[methyonine corn L-methionine act factonmethionine (g) (mg) FBI FB2 FB3 (~CWmmol) ctor
50 30 50 13.09 5.03 1.28 1.82 165.8
100 30 50 7.08 2.98 1.14 11.90 50.8
200 30 50 6.71 2.80 0.81 36.00 33.6
50 30 150 13.70 2.62 0.68 5.71 17.7
100 30 150 16.11 2.38 0.61 10.71 18.8
200 30 150 15.17 3.62 0.87 18.57 21.7
50 30 300 3.24 2.22 0.87 4.75 10.6
100 30 300 3.18 2.10 0.64 6.48 15.5
200 30 300 2.75 1.90 0.64 10.26 19.6
fungal growth (as measured by ergosterol concentration) (2)
and FB1 (r = 0.89) and FB2 (r = 0.87) production in the corn
patty cultures. Although growth and fumonisin production in
corn patty cultures are accomplished in a shorter period
(stationary phase after 14 days) than in corn jars (stationary
phase after 7 weeks) (2), the incorporation of isotopically
labeled precursors in cell components other than the fumo-
nisins would also be minimized. The higher growth rate and
fumonisin production in corn patty cultures can be attributed
to the greater accessibility of nutrients in ground corn as well
as the greater availability of oxygen as reflected by the
surface/volume ratio of corn patty cultures (1:1) and corn
kernels in jars (2:5) (2). Therefore the corn patty cultures
were likely to be more suitable than jar cultures for isotopic
labeling experiments.
To circumvent any adverse effects of the high levels of
added precursor on fungal growth and metabolite production
(21), we carried out experiments by the pulsed addition of
precursors every 24 h during the active production phase
(days 3 to 14) of the fumonisins. In preliminary experiments
with unlabeled, 1-13C-labeled, and 1-14C-labeled sodium
acetate, FB1 was produced with a specific activity of 2.27
and 5.58 uCi/mmol (Table 1). It would appear that with
increasing concentrations of acetate, a decrease in the incor-
poration of 14C, probably as a result of a dilution effect, was
obtained since no enhancement of signals was observed in
the '3C-NMR spectrum of the purified FB1. It would appear
that, when using corn pat% cultures, sodium acetate is not
an ideal precursor for the 4C labeling of FB1.
In the first experiment with L-[methyl-14C]methionine (50
,uCi) as precursor, FB1 was produced with a specific activity
of 4.26 ,uCi/mmol (Table 1). The location of the isotope label
in the FB1 structure was successfully determined in a
subsequent experiment with a mixture of L-[methyl-14C]me-
thionine (25 pCi) and L-[methyl-13C]methionine (50 mg, 97
atom% of 13C) as precursors. In the 13C-NMR spectrum,
enhancements were observed for the resonances at Bc 15.47
(enrichment factor, 5.2) and 20.16 (enrichment factor, 4.5),
which have been assigned to C-21 and C-22, respectively (4).
This result is in agreement with the labeling pattern of FB1 in
liquid cultures with L-[methyl-2H3]methionine as the precur-
sor (22): deuterium was present only in the C-12 and C-16
methyl groups.
Addition of L-[methyl-13C]methionine (50 mg) in the sec-
ond experiment yielded FB1 with a higher specific activity
(6.03 ,uCi/mmol) than in the first experiment, even though
only half the amount of L-[methyl-14Cjmethionine was used
(Table 1). A similar effect was noted in the third experiment:
the admixture of 100 mg of unlabeled L-methionine with
twice the amount of L-[methyl-14Cjmethionine (100 ,uCi)
used in the first experiment gave FB1 with ca. 5 times the
specific activity (22.07 ,Ci/mmol). Although incorporation
of the 14C label occurs only if the chemical concentration of
the methionine exceeds the Km for the relevant transport
system, we investigated the effect of added L-methionine on
fungal growth and fumonisin production of FB1 and FB2.
Although added L-methionine had no significant (P > 0.05)
effect either on fungal growth or on FB2 production, there
was a marked effect on FB1 production (Fig. 3). A significant
(P < 0.05) increase in FB1 production was observed up to
the level of 150 mg of added L-methionine. At higher levels
the added L-methionine had an inhibitory effect and produc-
tion of FB1 decreased. This phenomenon was confirmed in a
later study, in which the effect of different concentrations of
L-[methyl-'4C]methionine at a constant amount of unlabeled
L-methionine was investigated (Table 3). These data are in
agreement with the finding of Plattner and Shackelford (22)
that the overall yield of FR1 in liquid cultures of F. monili-
fonne is increased in the presence of L-methionine.
The stimulating effect of added unlabeled L-methionine on
incorporation of the 14C label was confirmed by subsequent
labeling experiments (Table 2): a low specific activity (0.90
p,Ci/mmol) was obtained when unlabeled L-methionine was
omitted. It is likely that the small amount of added L-[meth-
yl-14Cjmethionine is diluted with endogenous L-methionine
in the cell and is consequently utilized mainly for the normal
metabolic processes instead of incorporated into FB1. In
contrast, at higher levels of added (exogenous) L-methio-
nine, less is directed to metabolic purposes and conse-
quently more of the added material is incorporated into FB1.
In general, the dilution values obtained (Tables 2 and 3) are
determined by the ratio of the added 14C label to the total
amount of unlabeled methionine present (exogenous and
endogenous) during FR1 synthesis. Therefore, above a cer-
tain level of unlabeled methionine the specific activity of the
FB1 will decrease with increasing methionine concentrations
and the amount of the added L-[methyl-14C]methionine in-
corporated will become progressively smaller. From these
studies it can be concluded that the optimum level of
exogenous methionine is ca. 50 mg, since this leads to an
optimum dilution value of ca. 30 and the highest specific
activities (Tables 2 and 3). It should be kept in mind that the
natural L-methionine content of the medium is critical in
determining the optimum amount of L-methionine to be
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added during labeling experiments. Since the L-methionine
content of yellow corn is on the order of 1.67 mg/g (10),
L-methionine additions to other media containing higher or
lower concentrations should be compensated for.
In subsequent experiments the specific activity of the
[14C]FB1 was enhanced by increasing the amount of L-[meth-
yl-'4C]methionine (50, 100, and 200 ,uCi) but keeping the
amount of added unlabeled L-methionine constant at either
50, 150, or 300 mg per patty (Table 3). The results again
revealed the same trend in that the highest specific activity
was achieved in the presence of 50 mg of unlabeled L-me-
thionine and 200 ,uCi of L-[methyl-14C]methionine and de-
creased with increasing L-methionine concentrations. The
[14CJFB1 with the highest specific activities obtained in the
present study (22 to 36 uCi/mmol) has been used effectively
in metabolic studies with experimental animals (24).
Variation in the growth and fumonisin production profiles
(Fig. 2) will occur between different runs, depending on the
composition of the corn and the viability of the inoculum,
which could have a profound effect on the radiolabeling of
the fumonisins. Although production of most Fusarium
mycotoxins is much lower in liquid media than in solid media
(12, 14, 22), the nutritional composition of liquid media is
less complex, can be controlled more accurately, and usually
results in higher specific activities of labeled toxins than
when solid media are used. Future studies will be directed
toward obtaining a suitable liquid medium which supports
optimum fumonisin production for the isotopic labeling of
the fumonisins.
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Structure Elucidation of the Fumonisins, Mycotoxins from Fusarium moniliforme 
S. Catherine Bezuidenhout,a Wentzel C. A. Gelderblom,b Charles P. Gorst-Allman,a R. Marthinus Horak,a 
Walter F. 0. Marasas,b Gerhard Spiteller,c and Robert Vleggaar*a 
a National Chemical Research Laboratory, CSIR, P.O. Box 395, Pretoria 0001, Republic of South Africa 
b Research Institute for Nutritional Diseases, Medical Research Council, P. 0. Box 70, Tygerberg 7505, Republic of 
South Africa 
c laboratorium fur organische Chemie, Universitat Ba yreuth, Universitatstrasse 30, 0-8580 Ba yreuth, Federal 
Republic of Germany 
The structures of the fumonisins, a family of structurally related mycotoxins isolated from cultures of Fusarium 
moniliforme, were elucidated by mass spectrometry and 1H and 13C n.m.r. spectroscopy as the diester of 
propane-lr2,3-tricarboxylic acid and either 2-acetylamino- or 2-amino-1 2,16-dimethyl-3,5,10,14,15-penta- 
hydroxyicosane as well as in each case the C-10 deoxy analogue; in all cases both the C-14 and C-15 hydroxy 
groups are involved in ester formation with the terminal carboxy group of propane-I ,2,3-tricarboxylic acid. 
The fungus Fusarium moniliforme Sheldon occurs world-wide 
on a variety of plant hosts and is one of the most important ear 
rot pathogens of maize (Zea mays L.).1 An isolate of F. 
moniliforme (strain MRC 826) obtained from maize in an area 
of the Transkei with a high oesaphageal cancer rate2 was 
found to be not only highly toxic to experimental animals and 
able to induce leukoencephalomalacia in horses,3 but also 
hepatocarcinogenic to rats,4 and mutagenic to Salmonella 
typhimurium.5 Although F. moniliforme (strain MRC 826) 
produces the mutagen fusarin C,6 this compound is apparently 
not involved in the carcinogenicity of the fungus. In continu- 
ation of our efforts towards solving this important problem, 
we now report on the isolation and structure elucidation 
of a family of related mycotoxins, the fumonisins, from 
F. moniliforme. 
Extraction of cultures of F. moniliforme (strain MRC826) 
grown on sterilized maize with aqueous methanol gave an 
extract which was active in rat liver histopathological and 
cancer initiationlpromotion bioassays.7 Subsequently, exten- 
sive fractionation of this extract, using macroreticular poly- 
styrene resin (XAD-2), Sephadex LH-20 and reversed phase 
silica gel chromatography, and guided by the assays men- 
tioned, resulted in the isolation of a mixture of fumonisin Al 
(1) and A2 (2), as well as fumonisin B1 (3) and B2 (4). 
Treatment of the mixture of fumonisin Al and A2 with an 
excess of diazomethane, followed by chromatography on silica 
gel (chloroform-methanol, 92 : 8 v/v) gave colourless oils of 
the tetramethyl ester derivatives ( 5 )  and (6), respectively. 
Liquid secondary ion mass spectrometry (1.s.i.-m.s.) of 
tetramethylfumonisin Al (5 ) ,  Y,. (CHC13) 1730 (ester CO) 
and 1650 (amide CO) cm-1, gave the protonated molecular 
ion as mlz 820 ( M  + H)+*, supported by an ion at mlz 842 ( M  
744 J .  CHEM. SOC., CHEM. COMMUN., 1988 
+ Na)+*. The multiplicities of the different resonances in the 
13C n.m.r. spectrum of (5) were determined by generating the 
proton-decoupled CH, CH2, and CH3 subspectra using the 
DEPT pulse sequence.* These data (see Table 1) suggested 
the empirical formula CaH6gNol6 for (5)  which is consistent 
with the accurate mass measurement of the ion of highest mass 
in the electron impact ( e i )  mass spectrum at m/z 770.4321 
(C39H64N014) [ M  -(H20 + CH30')]+. The presence of three 
hydroxy groups in (5) was indicated by the formation of a 
tris(trimethylsily1) derivative (M+ 1035 , C49H93N016Si3) on 
treatment with N-methyl-N-trimethylsilyl trifluoroacetamide 
and a triacetate ( M +  945, C46H75N019) on acetylation. Basic 
hydrolysis with 0.05 M methanolic potassium hydroxide for 
16 h at room temperature gave a neutral product (7), 
G4H49N06, and a salt which on acidification and methylation 
with an excess of diazomethane was converted into a product 
identical (g.c.-m.s.) to trimethy1propane-l72,3-tricarboxy- 
late. 
The proton-proton connectivity pattern of tetramethyl 
fumonisin Al (5)  was determined by two-dimensional (2D) 
(1H, 1H) correlation spectroscopy using the COSY-45 pulse 
sequence,g and defined two distinct structural units, i. e .  
C-1-C-5 and C-10-C-17. The involvement of both the C-14 
and C-15 oxygen atoms in ester linkages with the terminal 
21 
y 3  
22 
y 3  
(1) R' = COCH2CH(C02H)CH2CO,H, R2 = OH, R3 = C230C24H3 
(2) R' = COCH2CH(C02H)CH2C02H, R2 = H, R3 = COCH3 
(3) R' = COCH2CH(C02H)CH2C02H, R2 = OH, R3 = H 
(4) R' = COCH2CH(C02H)CH2C02H, R2 = R3 = H 
(5) R1 = COCHzCH(CO2CH3)CH2CO,CH3, R2 = OH, R3 = COCH3 
(6) R' = COCH2CH(C02CH3)CH2CO2CH3, R2 = H, R3 = COCH3 
(7) R1 = H, R2 = OH, R3 = COCH3 
Table 1. N.m.r. data for tetramethylfumonisin Al (5).a 
Carbon 
atom 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
6Cb 
18.03 Q 
49.72 D 
71.49 D 
40.22 T 
68.83 D 
38.55 Td 
25.63 Te 
25.48 Te 
37.22 Td 
68.78 D 
43.08 T 
25.17 D 
35.39 T 
71.24 D 
77.79 D 
33.64 D 
31.84 T 
28.48 T 
22.73 T 
13.92 Q 
15.36 Q 
20.36 Q 
170.48 S 
23.32 Q 
6,c.j 
1.139 d 
3.902 m 
3.79 m 
1.56 
1.43 
3.82 
3.56 
1.37 
0.96 
1.75 
1.64 
1.28 
5.137 ddd 
4.867 dd 
1.58 
1.31 
0.98 
1.23 
1.08 
0.829 t 
0.872 d 
0.912 d 
1.949 s 
-1.2 
- 
J(  HH)/Hz 
6.8 
11.3,3.3,2.3 
8.8,3.3 
Carbon 
atom 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
7.1 
6.8 37 
6.6 38 
39 
40 
C- 15 ester: R1 = C250C26H2C27H( C3002C31H3) C28HzC2902C32H3 
6Cb 
170.88 S 
35.27 Th 
37.28 Df 
35.10 Th 
173.41 S 
171.69 S g  
52.31 Qi 
51.82 Qi 
6 , C  J( HH)/Hz 
- 
2.780 ddh 16.7,6.7 
2.603 dd 16.8,6.4 
3.22 m 
2.732 ddh 16.6,7.1 
2.583 dd 16.7,6.5 
- 
- 
3.664 si 
3.645 si 
C-14 ester: R* = C330C34H2C35H(C3802C39H3)C36H2C3702CaH3 
171.42 S 
35.10 Th 
37.19 Df 
34.93 Th 
173.93 S 
171.66 Sg 
52.15 Qi 
51.80 Qi 
- 
2.672 dd 16.8,S.l 
2.400 dd 16.8,5.9 
3.22 m 
2.647 ddh 16.7,6.5 
2.583 dd 16.7,6.5 
- 
- 
3.645 si 
3.634 si 
a Recorded on a Bruker WM-500 spectrometer. b Relative to CDCI3 at aC 77.00. Chemical shifts of the proton-bearing carbon atoms were 
correlated with specific proton resonances.9.11 c Relative to CDC13 at tjH 7.24. d-i May be interchanged. j The NH proton appears as 
a doublet at 8, 6.071 [J(NH, 2-H) 8.7 Hz]. 
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Figure 1. Fragmentation pattern observed in the e.i. mass spectrum of 
(5 ) .  
carboxy groups of the two propane-l,2,3-tricarboxylate 
moieties (as indicated by the 1H and 13C n.m.r. data)lO and 
the location of the methyl groups in ( 5 )  followed from the 
two- and three-bond (13C, 1H) connectivity pattern (Table 2) 
determined in a chemical shift correlation experiment adjus- 
ted to detect correlations via long-range ( W ,  1H) couplings 
The fragmentation pattern for compound ( 5 )  (see Figure 1) 
in the electron impact mass spectrum was of vital importance 
in determining the linkage of the C-1-C-5 and C-10-C-17 
structural fragments by a C4Hs group and placing a C6HI3 
substituent at C-15. The base peak in the mass spectrum 
occurs at rnlz 187 (CsHI1OS) and is associated with the 
cleavage of the ester moiety as indicated. The loss of 204 mass 
units from a number of fragment ions throughout the spectrum 
is due to the loss of a dimethyl propane-172,3-tricarboxylate 
group. The location of the hydroxy groups in ( 5 )  as indicated 
by the n.m.r. data is consistent with the fragment ions at mlz 
671, 603, 228, and 142 and was confirmed by the fragmenta- 
tion pattern of the tris(trimethylsily1) derivative. 
Tetramethylfumonisin A2 (6 ) ,  C40H69N015, contains one 
oxygen atom less than tetramethylfumonisin Al (5 ) .  The 
protonated molecular ion of (6) appears at rnlz 804 (M + H)+* 
in the 1.s.i. mass spectrum and the fragment ion which arises 
from the molecular ion in the e.i. spectrum through loss of 
(H20  + CH30’) appears at rnlz 754 (C39H64N013). A 
comparison of the fragmentation patterns of compounds (6)  
and ( 5 )  shows that it is the C-10 hydroxy group of ( 5 )  which is 
replaced by a hydrogen atom in (6) as the bond cleavage which 
generates the fragment ions mlz 603 -+ 399 -+ 195 in the 
spectrum of ( 5 )  does not occur. In addition a number of bond 
cleavages common to both compounds generate fragment ions 
of 16 mass units less for tetramethylfumonisin A2 (6) .  
L.s.i. mass spectrometry of fumonisin Bl (3) (C34Hs9N015) 
gave the protonated molecular ion as rnlz 722 whereas that of 
fumonisin B2 (4) (C34H59N014) appears at rnlz 706. In each 
case ions are also present at rnlz values corresponding to ( M  + 
Na)+*. A comparison of the 13C n.m.r. data of these two 
compoundst indicates that once again it is the C-10 hydroxy 
group of fumonisin B1 (3) (6, 67.17) which is replaced by a 
hydrogen atom in fumonisin B2 (4). In addition, the 1H and 
(“J 5 Hz).97” 
t (3): 6c (CD3SOCD3) 175.91S, 175.60S, 174.31S, 173.97S, 171.45s 
(C-25), 171.39s (C-33), 76.48D (C-15), 70.35D (C-14), 68.42D 
(C-13), 67.17D (C-lo), 66.01D (C-5), 51.69D (C-2), 43.28T (C-ll), 
(C-26), 36.54T (C-28), 36.38T (C-34), 35.72T (C-36), 32.96D (C-16), 
30.96T (C-17), 28.08T (C-18), 25.43T, 25.28T, 25.20D (C-12), 22.22T 
(C-19), 20.19Q (C-22), 15.570 (C-1), 15.510 (C-21), 13.86Q (C-20). 
40.72T (C-4), 38.17D (C-27 and C-35), 38.19T, 38.07 (2 x T), 37.80T 
Table 2. Two- and three-bond (1H, 13C) connectivity pattern for 
tetramethylfumonisin A, (5). 
6 H  
0.829 (20-H) 
0.872 (21-H) 
0.912 (22-H) 
1.139(1-H) 
1.949 (24-H) 
4.867 (15-H) 
5.137 (14-H) 
Correlation signals Gc/p.p.m. 
22.73 T (C-19), 28.48 T (C-18) 
31.84T(C-17),33.64D (C-16) 
77.79 D (C-15) 
25.17 D (C-12), 35.39T (C-13) 
49.72D (C-2),71.49D (C-3) 
33.64D(C-16),71.24D (C-14), 
77.79 D (C-15), 171.42 S (C-33) 
170.48 S (C-23) 
170.88 S (C-25) 
13C resonances of the atoms of the N-acetyl group present in 
the fumonisin A metabolites, e.g. (5 ) :  1.949; 6, 170.48, 
and 23.32, are absent from the spectra of the fumonisin B 
compounds. 
It is of interest to note that a related mono-ester of 
propane-l,2,3-tricarboxylic acid and l-amino-ll,15-dimethyl- 
2,4,5,13,14-pentahydroxyheptadecane is a host-specific 
phytotoxin produced by Alternuria alternatu (Fr.) Keissler f. 
sp. lycopersici, the causal agent of stem canker disease of 
tomato.10J2 
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Cultures on corn of Fusarium moniliforme MRC 826 are known to cause leukoencephalomalacia in horses
and to be toxic and hepatocarcinogenic in rats. Culture material of this F. moniliforme isolate has also been
shown to exhibit cancer-promoting activity in a short-term cancer initiation-promotion bioassay with
diethylnitrosamine-initiated rats and the induction of gamma-glutamyl-transpeptidase-positive (GGT+) foci as
an endpoint after 4 weeks of promotion. This bioassay was used as a monitoring system to isolate
cancer-promoting compounds from cultures of F. moniliforme MRC 826. Culture material was successively
extracted with ethyl acetate and CH30H-H20 (3:1). Most of the cancer-promoting activity was recovered in the
CH30H-H20 extract and remained in the aqueous phase following partitioning of this extract between
CH30H-H20 (1:3) and CHCl3. The CH30H-H20 fraction was chromatographed on an Amberlite XAD-2
column, and the active fraction was eluted with CH30H. This fraction was chromatographed on a silica gel
column with CHCl3-CH30H-CH3COOH (6:3:1) as eluent and further purified on a C18 reverse-phase column.
Two pure compounds were isolated, and these have been chemically characterized and given the trivial names
fumonisin B1 and B2. At least 2 g of the major compound fumonisin B1 was purified from 1 kg of culture
material. Fumonisin BI in the diet (0.1%) significantly (P < 0.001) induced the formation of GGT+ foci in the
livers of initiated as well as noninitiated rats. The cancer-promoting effect of fumonisin B1 in rats was
associated with a toxic effect, as evidenced by a significant (P < 0.0005) reduction in weight gain during the
4-week promoting treatment. The principal pathological change in rats treated with fumonisin B1 was an
insidious and progressive toxic hepatitis similar to that induced by toxic culture material of F. moniliforme
MRC 826.
The toxicological effects of Fusarium moniliforme Shel-
don in animals have been studied extensively (11). This
fungus is known to cause leukoencephalomalacia (LEM) in
horses (9) and to be highly toxic to a variety of experimental
animals (5, 7, 8) and hepatocarcinogenic in rats (6, 10).
Recently, corn samples naturally infected by F. moniliforme
and implicated in field outbreaks of LEM in the United
States have been reported to be hepatocarcinogenic in rats
(14). These findings not only suggest that the LEM toxin and
the hepatocarcinogen produced by F. moniliforme may be
the samne metabolite, but also imply that this compound(s)
occurs naturally in F. moniliforme-infected corn. The toxic
and/or carcinogenic principle(s) has, however, not been
identified to date.
Culture material of F. moniliforme MRC 826, isolated
from corn intended for human consumption in Transkei,
southern Africa, has been shown to cause LEM in horses (7)
and to be carcinogenic in rats (6, 10). Attempts to identify
the carcinogen(s) produced by this strain have resulted in the
isolation (3) and chemical characterization (1) of the potent
mutagen fusarin C. However, this compound is apparently
not involved in the hepatocarcinogenic activity of the fungus
(2, 6). A recent study (2) indicated that culture material of F.
moniliforme MRC 826, known to be hepatocarcinogenic in
rats (6, 10), exhibited cancer-promoting activity in a cancer
initiation-promotion model with diethylnitrosamine (DEN)-
initiated rats and the induction of gamma-glutamyl-transpep-
tidase-positive (GGT+) foci as an endpoint. Based on these
* Corresponding author.
results, a short-term cancer initiation-promotion bioassay
was established to screen different toxic strains of F. moni-
liforme for their cancer-promoting activity (W. C. A. Gel-
derblom, W. F. 0. Marasas, K. Jaskiewicz, S. Combrinck,
and D. J. van Schalkwyk, Carcinogenesis, in press). Rats fed
diets containing 5% culture material of each strain during the
4-week promotion period revealed a highly significant corre-
lation between the toxicity and cancer-promoting activity of
the different strains. This finding strongly suggests that the
same metabolite is responsible for the toxic (7, 8) and
carcinogenic (6, 10) effects of F. moniliforme MRC 826
culture material in rats.
This paper reports on the isolation of cancer-promoting
compounds produced by F. moniliforme MRC 826 with a
short-term cancer initiation-promotion bioassay in rats as a
monitoring system. Preliminary data on the toxic effects of
one of these pure compounds in rats are also presented.
MATERIALS AND METHODS
Chemicals. DEN was obtained from Sigma Chemical Co.,
St. Louis, Mo. Sephadex LH-20 was obtained from Pharma-
cia Fine Chemicals, Uppsala, Sweden, and Amberlite
XAD-2 was purchased from Merck SA. The reverse-phase
packing material (C,8; Sepralyte, 40 p.m) was obtained from
Analytichem International, Harbor City, Calif. All the or-
ganic solvents were analytical grade.
Fungus cultures. Corn cultures of F. moniliforme strain
MRC 826 were prepared as described previously (8) and
incubated in the dark at 25°C for 2 weeks, followed by 2
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TABLE 1. Cancer-promoting activity of F. moniliforme MRC 826
culture material and fractions obtained during
the solvent partitioning step
Rat Culture DEN Mean GOT
treatment Frac- .. activity
group Sample material tion.(g) initia- (foci/CM2)(n=5) (g) tion ±_SD
1 Culture material 200 + 9.82 + 4.00
2 Culture material 200 - N.D."
3 Rat mash + N.D.
(control)
4 Ethyl acetateb 1,000 99.4 + 0.18 ± 0.30
5 CH3OH-H20 1,000 144.0c + 34.76 ± 13.46
(3:1)b
6 Residueb 1,000 736.0 + 0.56 ± 0.57
a N.D., None detected.
b Samples obtained after successive extraction of 1 kg of culture material.
c After the first week of promotion, the diet was diluted 1:2 with rat mash.
weeks at 15°C. Cultures were then lyophilized and stored in
air-tight containers at 4°C prior to extraction.
Animals. Male BD IX rats (ca. 150 g) were caged individ-
ually in an animal house with a controlled environment at
25°C and 50% humidity with a 12-h artificial-light cycle. They
were fed rat mash prepared from rat cubes (Epol Ltd.,
Johannesburg) and had free access to drinking water.
Cancer initiation-promotion bioassay. Rats were random-
ized into treatment groups of five each. The standard proto-
col to demonstrate the cancer-promoting activity of F.
moniliforme MRC 826 culture material consisted of an
initiation treatment (200 mg of DEN per kg, intraperitone-
ally), followed by the 4-week promoting treatment com-
mencing 1 week later. The latter was effected by incorporat-
ing lyophilized culture material of strain MRC 826 at a level
of 5% into the diet. Two control groups, one initiated with
DEN and fed rat mash and another receiving the promoting
treatment without initiation (dimethyl sulfoxide [DMSO]
instead; 0.1 ml/100 g of body weight), were included. At least
4 kg of rat mash was prepared per group for the 4-week
promotion treatment.
Fractions isolated from culture material were screened for
cancer-promoting activity by incorporating them in the rat
mash (4 kg) and feeding them to DEN-initiated rats as
described above. The amounts incorporated in 4 kg of feed
are indicated in Tables 1 and 2. DEN-initiated rats receiving
only rat mash were included as a control in each assay during
the isolation procedure. All rats were weighed twice weekly
and killed after the 4-week promotion treatment, and their
livers were subjected to histochemical analyses for GGT.
Histochemical analyses. Cryostat sections (5 ,um) were
prepared from rat livers at -25°C and stained for GGT by the
method of Rutenburg et al. (12). At least 2 cm2 of tissue was
scanned, and only foci containing 10 or more cells were
counted.
Extraction and purification. (i) Extraction. Culture material
(1 kg) was successively extracted once with 1 liter of ethyl
acetate and three times with 1 liter of CH30H-H20 (3:1) by
blending and filtering. Both the ethyl acetate and the aque-
ous methanol extracts as well as the remaining residue were
tested for cancer-promoting activity as described above.
(ii) Solvent partitioning and Amberlite XAD-2 column chro-
matography. The CH30H-H20 (3:1) extract obtained as
described above was evaporated to dryness and partitioned
between CH30H-H20 (1:3; 200 ml) and CHCl3 (three por-
tions, 100 ml each). The aqueous phase was divided equally,
and one part (ca. 65 g) chromatographed on an Amberlite
TABLE 2. Cancer-promoting activity of fractions obtained by
solvent partitioning and Amberlite XAD-2 column
fractionation of the CH30H-H20 (3:1) extract of F. moniliforme
MRC 826 culture material
Rat Ma G
treatment Fractiona Elution vol Fraction activitY (foci/group (liters) wt (g) c2)_ SD(n = 5)
1 CHCl3 extract 12.5 NDb
First XAD-2
fractionation
2 CH30H-H20 (1:3) 4.0 55.3 ND
3 CH30H-H20 (1:1) 2.0 3.0 ND
4 CH30H 1.0 14.0 50.90 ± 3.44
Second XAD-2
fractionation
5 CH30H-H20 (3:1) 2.3 (fractions 8.75c 9.0 ± 3.24
1-23)
6 CH30H-H20 (3:1) 2.1 (fractions 0.42c ND
24-45)
7 CH30H 0.4 (fractions 1.32c ND
46-49)
8 CH30H 1.0 (fractions 2.91c ND
50-60)
a XAD-2 fractionations: the first was done after the solvent partitioning
step, and one-half (65 g) of the CH3OH-H20 (1:3) fraction was fractionated;
after the second half of the CH30H-H20 (1:3) solvent-partitioning fraction
was fractionated, the CH30H fraction (15.3 g) was subjected to the second
XAD-2 column fractionation.
b ND, None detected.
c One-half of the fraction was incorporated in the diet during the 4 weeks of
promotion.
XAD-2 column (sample-resin, 1:15). The column was suc-
cessively eluted with H20 (1 liter), CH30H-H20 (1:3; 4
liters), CH30H-H20 (1:1; 2 liters), and finally CH30H (1
liter). The fractions from the XAD-2 column together with
the combined CHCl3 fractions were evaporated onto rat
mash and tested for cancer-promoting activity.
After similar fractionation of the remaining CH30H-H20
(1:3) solvent partitioning fraction (ca. 65 g) on Amberlite
XAD-2, the CH30H eluate was further purified on Amberlite
XAD-2. The column was successively eluted with CH30H-
H20 (3:1; 5 liters) and CH30H (2 liters), collecting 100-ml
fractions. Four pooled fractions were prepared (Table 2) and
divided into equal portions, and one part was tested for
cancer promoting activity.
(iii) Sephadex LH-20 column fractionation. The active
fraction (4.89 g) eluted from the second Amberlite XAD-2
column with CH30H-H20 (3:1) was fractionated on a Seph-
adex LH-20 column (150 g; 5 by 70 cm) with CH30H-H20 (3:
1) as the mobile phase, collecting 100-ml fractions. Fractions
were analyzed by reverse-phase thin-layer chromatography
(RP-TLC) with CH30H-H20 (3:1) as the developing solvent,
spraying with 0.5% p-anisaldehyde solution in CH30H-
H2S04-CH3COOH (85:5:10) and heating at 120°C. Those
fractions containing compounds with similar Rf values were
combined, and the samples designated A, B, and C (Table 3)
were screened for cancer-promoting activity.
(iv) RP (C18) column chromatography. Sample B (2 g) was
further purified on a Sepralyte C18 RP column (200 g; 2.5 by
60 cm), maintaining the flow rate at 1 ml/min. The column
was successively eluted with CH30H-H20 (1:1; 200 ml),
CH30H-H20 (3:1; 200 ml), and CH30H (200 ml). Fractions
(50 ml) were collected and analyzed by RP-TLC as described
above. One major and two minor compounds eluted with
CH30H-H20 (3:1), comprising at least 85% of the weight of
sample B. The compounds eluting first and last, given the
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TABLE 3. Cancer-promoting activity of fractions obtained during
Sephadex LH-20 column chromatography
Rat
treatment a Fraction Mean GGT activity
group Fraction wt (g) Rf (foci/cm2) ± SD
(n = 5)
1 A 0.28 0.75-0.88 NDb
2 B 4.10 0.22-0.44 30.22 ± 3.45
3 C 0.45 0.62-0.80 0.33 ± 0.54
a See Materials and Methods for explanation.
b ND, None detected.
trivial names fumonisin B1 and fumonisin B2, respectively,
were obtained in pure form and were chemically character-
ized by nuclear magnetic resonance and mass spectroscopy
(S. C. Bezuidenhout, W. C. A. Gelderblom, C. P. Gorst-
Allman, R. M. Horak, W. F. 0. Marasas, G. Spiteller, and
R. Vleggaar, J. Chem. Soc. Chem. Commun., in press). The
chemical structures of fumonisins B1 and B2 are illustrated in
Fig. 1. The structure of the compound eluting between these
two has yet to be determined.
(v) Bulk purification of fumonisin Bl. Culture material (2
samples of 1 kg each) was extracted and fractionated as
described above, omitting the second XAD-2 and the Seph-
adex LH-20 chromatographic steps. Instead, a silica gel
column (5 by 80 cm) with CHCl3-CH30H-CH3COOH (6:3:1)
as the eluent was included after the first XAD-2 column
fractionation. The sample-silica ratio used was 1:80.
HPLC analyses of fumonisin Bl. A maleyl derivative of
fumonisin B1 was prepared by the method of Siler and
Gilchrist (13) with a 10-fold molar excess of a 1 M maleic
anhydride solution in dioxane. After the solvents were
evaporated, the residue was dissolved in the high-pressure
liquid chromatography (HPLC) mobile phase, CH30H-po-
tassium phosphate buffer, 0.1 M, pH 3.8 (7:3). HPLC
analyses were performed with a liquid chromatograph (Wa-
ters Associates, Milford, Mass.) and an RP cartridge (C18, 10
l,m) in a radial compression module (model RCM-100). The
column eluate was monitored at 250 nm at a flow rate of 1 ml/
min. The purity of fumonisin B1 used as the analytical
standard was verified by NMR and TLC on both RP and
silica gel plates.
Cancer-promoting activity and toxicity of fumonisin B1 in
rats. The cancer-promoting activity was monitored as for
culture material of F. moniliforme MRC 826 except that
fumonisin B1 was incorporated in the diet at a concentration
of 0.1% during the 4-week promotion treatment. The toxicity
was tested over a period of 21 days in eight male BD IX rats
(ca. 100 g each), with four rats per treatment group. Rats
were dosed per os (0.25 ml per rat) on a daily basis with
DMSO as the solvent control. Three of four rats died within
3 days after being dosed with a solution containing 0.95 g of
fumonisin B1 per 10 ml of DMSO. In a separate experiment,
rats were dosed with 0.19 g of fumonisin B1 per 10 ml of
DMSO for 12 days, followed by 0.28 g of fumonisin B1 per 10
ml of DMSO for the remaining 9 days of the experiment.
All organs were fixed in 10% buffered Formalin, processed
in the conventional way, stained with hematoxylin and eosin
and examined by light microscopy. Organs of the noninitia-
ted rats receiving only fumonisin B1 (0.1% in the diet) during
the 4-week promotion treatment were treated in a similar
way.
RESULTS
Isolation of fumonisin B1 and B2. The cancer-promoting
activity of culture material of F. moniliforme MRC 826 in
rats is shown in Table 1. Exposure to diets containing 5% of
culture material for 4 weeks significantly (P < 0.0001)
induced the formation of GGT+ foci in DEN-initiated rats
(group 1). No GGT+ foci were observed in the control
groups that received either culture material without DEN
initiation (group 2) or DEN without culture material (group
3). After extraction, the bulk of the cancer-promoting activ-
ity was recovered in the CH3OH-H20 (3:1) extract (group 5).
After partitioning of the dried CH3OH-H20 extract be-
tween CH3OH-H20 (1:3) and CHCl3, all of the cancer-
promoting activity was associated with the aqueous phase
and none with the CHCl3 phase (Table 2). While the majority
of compounds eluted from the first Amberlite XAD-2 column
with CH3OH-H20 (1:3) as the eluent, the cancer-promoting
principle(s) was eluted with CH30H (group 4). However, as
indicated by the second fractionation on Amberlite XAD-2,
these compounds could be recovered when eluting with
CH3OH-H20 (3:1) (group 5). Further purification on Sepha-
dex LH-20 indicated that compounds having Rf values
between 0.22 and 0.44 (sample B) on an RP-TLC plate with
CH3OH-H20 (3:1) as the developing solvent comprised the
bulk of the sample as well as the bulk of the cancer-
promoting activity applied to the column (Table 3).
Subsequent fractionation of this fraction on an RP (C18)
column yielded two pure amorphous solid compounds.
When analyzed by RP-TLC, these compounds visualized as
dark purple spots after spraying with p-anisaldehyde and
heating. Fumonisin B1, eluting first, was the major com-
pound, while less of the later-eluting fumonisin B2 was
21 22
CH3 CH3
20 15 14 10 5 3 2
CH3-[CH2]-CH -CH -CH -CH2-CH -CH2- CH -[CH2]4- CH-CH2-CH-CH-CH3CH-C2316 12 ]4
0 0 L OH OH NH2
O=c c=O
O CH2 CH2 0
11 11
OH-C-CH CH-C-OH
OH-C-CH2 CH2-C-OH
11 11
O 0 [1] R = OH
[2] R = H
FIG. 1. Chemical structures of fumonisins B1 [1] and B2 [2].
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TABLE 4. Cancer-promoting activity of fumonisin B1 in rats
treat No. of DEN Promotiona Mean GGT activityeament
rats initiation r ' (foci/cm') ± SDgroup
1 5 + - NDb
2 5 - - ND
3 4 - + 20.00+8.34c
4 4 + + 54.80 + 10.30c
Fumonisin B1 at 0.1% in the diet.
b ND, None detected.
c Means significantly different (P < 0.005).
obtained. During the large-scale extraction, approximately 2
g of fumonisin B1 was purified from 1 kg of the cultured corn,
while 10 times less fumonisin B2 was obtained. The purity of
the fumonisin B1 preparation, as determined by HPLC, was
found to be 92%.
Cancer-promoting activity of fumonisin B1 in rats. A di-
etary level of 0.1% fumonisin B1 markedly induced the
formation of GGT+ foci in both DEN-initiated and control
(DMSO-treated) rats (Table 4). The induction of GGT+ foci
was, however, significantly higher (P < 0.0005) in the
DEN-initiated (group 4) than the noninitiated (group 3) rats.
In both of these groups of rats treated with fumonisin B1, a
marked reduction in weight gain occurred from the first week
of promotion treatment (Fig. 2). At the end of the promotion
period, the mean body weights of the rats treated with
fumonisin B1 (groups 3 and 4) were significantly (P < 0.0001)
lower than those of the nontreated rats (groups 1 and 2).
Pathological changes in rats caused by fumonisin B1. In the
rats that died after 3 days of dosing with fumonisin B1, there
was toxic hepatitis, characterized by scattered single-cell
necrosis accompanied by mild fatty changes, hydropic de-
generation, and hyaline droplet degeneration (Fig. 3).
V
0
FIG. 3. Histopathological changes in the liver of a rat receiving
0.25 ml of fumonisin B1 solution (0.95 g in 10 ml of DMSO) per day
for 3 days. Note the single-cell necrosis, hyaline droplets, and fatty
changes. Magnification, x25.
Kupffer cells were increased and enlarged. The necrotic cells
occurred indiscriminately throughout the lobules, while the
degenerative changes were periacinar. Hepatocellular nuclei
varied in size; few of them were markedly enlarged. Lesions
of a lesser degree occurred in some of the other organs.
Fatty changes and scant necrosis were present in the prox-
imal convoluted tubules of the kidney. Prominent lymphoid
Days of promotion
FIG. 2. Mean body weights of rats over the 4-week promotion period. Rats were weighed twice weekly.
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FIG. 4. Histopathological changes in the liver of a rat fed fumo-
nisin B1 in the diet (0.1%) for 33 days. Note the fibrosis, bile duct
hyperplasia, and anisonucleosis at the edge of a hyperplastic nodule.
Magnification, x250.
necrosis in the Peyer's patches and scattered focal superfi-
cial and midzonal epithelial necrosis occurred in the mucosa
of the stomach. Severe, disseminated acute myocardial
necrosis and severe pulmonary edema were observed in two
of the rats.
In the rats that were killed after 21 and 33 days, chronic
toxic hepatitis was present that was further advanced in the
latter group.
In the livers of the rats killed after 21 days of dosing with
fumonisin B1, there was marked hydropic degeneration,
single-cell necrosis, and a few hyaline droplets. Early bile
duct proliferation and fibrosis radiated out from the portal
tract or developed focally within the midzonal area of the
hepatic lobules. A few hepatocellular nuclei were markedly
enlarged and contained a fine granular chromatin pattern;
some had a lobed nucleus.
In the rats that were killed after 33 days on a diet
containing 0.1% fumonisin B1, the changes were similar but
more advanced. The proliferation of bile ducts and fibrosis
caused distortion of the lobular structure of the liver that,
together with the development of hyperplastic nodules (Fig.
4), gave the liver a distinctly nodular appearance. Many
more enlarged nuclei, similar to those observed in the rats
killed after 21 days, were seen in this group. The hepatocytes
in the hyperplastic nodules had large vesicular nuclei and a
voluminous foamy cytoplasm. Numerous mitotic figures,
some of which were abnormal, were also present. The
lesions in the kidney were similar but less severe than those
seen in the rats that died within 3 days. No lesions occurred
in any of the other organs.
No comparable lesions were observed in the livers or the
kidneys of the rats in the control groups.
DISCUSSION
The induction of GGT+ foci has been used widely as a
marker of preneoplastic hepatic lesions during chemical
carcinogenesis (4). In a short-term cancer initiation-promo-
tion bioassay with DEN-initiated rats, hepatocarcinogenic
culture material of F. moniliforme MRC 826 induced GGT+
foci within 4 weeks of promoting treatment (Gelderblom et
al., in press). This short-term bioassay was used for the
isolation of cancer-promoting principles from culture mate-
rial of F. moniliforme MRC 826. A group of related com-
pounds, the fumonisins, were isolated in this way, and some
of them have been chemically characterized (Bezuidenhout
et al., in press).
The fumonisins were extracted from the culture material
in CH3OH-H20 (3:1) and are polar compounds, since no
cancer-promoting activity could be recovered in the ethyl
acetate fraction and they preferred an aqueous environment
after solvent partitioning with CHCI3. Solvent partitioning
removed most of the lipophilic compounds that are likely to
interfere during the Amberlite XAD-2 chromatographic frac-
tionation. During this fractionation, the fumonisins exhibited
a relatively nonpolar character because they could not be
eluted by 50% aqueous CH30H (Table 2) but eluted in
CH3OH-H20 (3:1). This resulted in excellent separation, as
indicated by the 80% purification obtained during this frac-
tionation step. In contrast, Sephadex LH-20 was far less
efficient and resulted in a purification of only 20%. During
later bulk purification of the fumonisins, both the second
XAD-2 and the Sephadex LH-20 fractionation steps were
omitted and replaced by a single chromatographic separation
on silica gel. The inclusion of this step resulted in the
isolation of pure fumonisins B1 and B2 by means of only
three chromatographic separations.
The induction of GGT+ foci by fumonisin B1 in DEN-
initiated as well as noninitiated rats agrees well with the
previous finding that culture material of F. moniliforme
MRC 826 exhibits cancer-promoting activity in the absence
of DEN initiation (2). In the present experiment, however, a
different batch of lyophilized culture material of this fungus
did not induce GGT+ foci in noninitiated rats. A possible
explanation is that the second batch of culture material
contained lower levels of fumonisin B1 and related com-
pounds than the previous one. These results imply that
fumonisin B1 is a complete carcinogen and, together with the
other two related compounds, might be responsible for the
hepatocarcinogenicity of F. moniliforme MRC 826.
The cancer-promoting activity of fumonisin B1 was also
associated with a toxic effect, as evidenced by the significant
reduction in weight gain of treated compared with control
rats. This again is in agreement with the previous finding that
a highly significant correlation exists between the cancer-
promoting activity and toxicity of different strains of F.
moniliforme (Gelderblom et al., in press). Fumonisin B1
proved to be acutely toxic to rats, and high doses caused
death within 3 days. The subacute pathological changes in
the livers of rats caused by fumonisin B1 were also similar to
those caused by culture material of F. moniliforme MRC 826
and some other strains of this fungus (7, 8). Thus, it appears
that fumonisin B1 is also responsible for the toxicity of F.
moniliforme MRC 826 in rats.
Experiments are in progress to investigate the carcinoge-
nicity of fumonisin B1 and related compounds in rats and to
determine whether the fumonisins are also responsible for
LEM in horses.
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Structure and Natural Occurrence of Stereoisomers of the
Fumonisin B Series Mycotoxins
WENTZEL C. A. GELDERBLOM,†,‡ VIKASH SEWRAM,† GORDON S. SHEPHARD,†
PETRA W. SNIJMAN,† KENNY TENZA,§ LIANA VAN DER WESTHUIZEN,† AND
ROBERT VLEGGAAR*,§
Programme on Mycotoxins and Experimental Carcinogenesis, Medical Research Council, P.O. Box
19070, Tygerberg 7505, Department of Biochemistry, University of Stellenbosch, Stellenbosch 7600,
and Department of Chemistry, University of Pretoria, Pretoria 0002, South Africa
1H and 13C NMR spectroscopy of both fumonisin B3 and B4, as well as high-performance liquid
chromatography (HPLC) analysis of samples of fumonisin B3 used as standards, showed in each
case the presence of two stereoisomers, which could not be separated by preparative chromatography.
The 2,3-anti relative configuration for the two minor stereoisomers of fumonisin B3 and B4 was deduced
from the NMR data, and their 2S,3R absolute configurations were established by application of
Mosher’s method using the fumonisin B3 sample. Samples of fumonisin B3 and B4 can contain between
10 and 40% of fumonisin B compounds of the 3-epi series. The 3-epi-FB3, determined by HPLC with
fluorescence detection of the o-phthaldialdehyde derivative and confirmed by liquid chromatography-
tandem mass spectrometry, was found to occur naturally in a range of maize samples at levels much
lower than FB3 (<20%). The identification of members of the 3-epi-fumonisin B series provides insight
into the order and selectivity of steps in fumonisin biosynthesis.
KEYWORDS: Fumonisins; corn; NMR; LC-MS; biosynthesis
INTRODUCTION
The fumonisins of the B series, for example, B1-4 (1-4) (see
Figure 1), are a family of structurally related mycotoxins first
isolated from cultures of Fusarium Verticillioides (strain MRC
826) (1, 2). These secondary metabolites are common contami-
nants of corn throughout the world (3) and the causative agents
of equine leucoencephalomalacia (4) and porcine pulmonary
edema (5). The carcinogenic nature of these mycotoxins in
rodent studies (6, 7), their association with human esophageal
cancer (8), and the recent demonstration of their possible role
in neural tube defects (9, 10) have heightened international
concern over their natural occurrence. The International Agency
for Research on Cancer has recently declared FB1, the most
abundant of the fumonisins, to be a group 2B carcinogen (i.e.,
possibly carcinogenic to humans) (11). Since the initial discov-
ery of FB1 (1) and FB2 (2) in 1988, the number of known
fumonisin analogues has greatly increased and a recent review
of this family of compounds listed 28 members (12). The
fumonisins are generally divided into the A, B, C, and P series.
The significance of many of these analogues as natural contam-
inants of food is uncertain, and reports of fumonisin analysis
are frequently restricted to FB1 (1) and FB2 (2), although some
reports include FB3 (3). The necessity for including FB3 in total
fumonisin analysis has recently been highlighted by the inclusion
* To whom correspondence should be addressed. Tel: +27 12 420-
3095. Fax: +27 12 362-5297. E-mail: robert.vleggaar@up.ac.za.
† Medical Research Council.
‡ University of Stellenbosch.
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Figure 1. Chemical structures of the fumonisins.
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of all three analogues in the setting of Food and Drug
Administration guidelines for industry in the United States (13)
as well as in the provisional maximum tolerable daily intake
determined in the recent risk assessment of fumonisins con-
ducted by the Joint FAO/WHO Expert Committee on Food
Additives (14).
Analytical standards of FB1 (1), FB2 (2), and FB3 (3)
have been prepared by scientists at the MRC, Tygerberg,
South Africa, on a commercial basis since the early 1990s.
Analysis of fumonisin B3 samples obtained from different
batches of F. Verticillioides (MRC 826) has recently shown the
presence of 10-40% of a stereoisomer of FB3 that elutes
immediately prior to FB3 in the analytical reversed-phase high-
performance liquid chromatography (HPLC) chromatogram of
the o-phthaldialdehyde (OPA)-derivatized standards. In this
paper, we report on the identification and absolute configuration
of the stereoisomers 3-epi-FB3 (5) and 3-epi-FB4 (6) (Figure
1) present in samples of FB3 and FB4, respectively, and the
natural occurrence of 3-epi-FB3 (5).
MATERIALS AND METHODS
HPLC-Tandem Mass Spectrometry (MS-MS) Analyses of Fu-
monisin Standards. The fumonisin standards (FB1, FB2, FB3, and FB4)
were isolated from corn cultures of F. Verticillioides as described by
the method of Cawood et al. (2). The isolated FB3 standard and the
dried residues of corn sample extracts, prepared as described below
for determination by fluorescence detection, were dissolved in aceto-
nitrile-water-formic acid (10:90:0.1). The two stereoisomers of FB3
were separated by binary gradient reversed-phase HPLC on a Luna
C18 column (Phenomenex, Torrance, CA). The individual elution
solvents were mixtures of water-acetonitrile-formic acid in the ratios
(90:10:0.1; solvent A) and (10:90:0.1; solvent B), respectively. The
mobile phase was pumped at a flow rate of 0.7 mL/min. The initial
composition of 80% solvent A was adjusted linearly to 75% solvent A
over 35 min. The fumonisins were detected by mass spectrometry using
a Finnigan MAT (San Jose, CA) LCQ ion trap instrument with positive
ion electrospray (ES) ionization. The HPLC eluate was passed directly
into the MS at a source voltage of 4.5 kV and a capillary voltage of 40
V. The heated capillary temperature was maintained at 220 °C, and
the sheath to auxiliary gas ratio was set at 4:1. Fumonisins were
Figure 2. Chemical structures of FB3 and 3-epi-FB3 tetramethyl esters and their MTPA derivatives.
Figure 3. Chemical structures of natural products with the terminal 2-amino-3-hydroxy motif.
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monitored by full-scan MS-MS between m/z 330 and m/z 730. A
collision energy of 32% was used to fragment the molecular ions, and
the resultant product ions were monitored as diagnostic indicators for
the presence of the toxins.
NMR Analysis. NMR spectra were recorded on a Bruker Avance-
500DRX spectrometer operating at 500 MHz for 1H and 125 MHz for
13C nuclei using standard Bruker pulse sequences. Spectra acquired
for DMSO-d6 solutions were referenced to the signals at äH 2.49 and
äC 39.50 and for spectra in CDCl3 to the signals at äH 7.24 and äC
77.00.
Determination of Fumonisin Analoques by HPLC with Fluores-
cence Detection. Determination of fumonisin analogues in corn was
conducted by the method of Sydenham et al. (15). Briefly, corn samples
were homogenized in methanol-water (3:1), centrifuged, and filtered.
An aliquot of the clear extract was applied to a strong anion exchange
solid-phase extraction cartridge (Varian, Harbor City, CA) and washed
with methanol, and the fumonisins were eluted with 1% acetic acid in
methanol. The purified extracts were dried down under nitrogen at
60 °C. Immediately prior to analysis, the residues were redissolved in
methanol and an aliquot was derivatized with OPA. The fumonisin
analogues were separated and detected by reversed-phase HPLC
(Ultracarb 5 ODS column; Phenomenex) with fluorescence detection
(Figure 4). The mobile phase was pumped at 1 mL/min and consisted
of methanol-sodium dihydrogen phosphate (0.1 M, pH 3.3) (77:23)
as generally used for fumonisin determination.
Preparation of the FB3 Derivatives. Fumonisin B3 Tetramethyl
Ester. A solution of FB3 standard (549 mg) containing a mixture of
FB3 (3) and 3-epi-FB3 (5) was treated with an excess of a diethyl ether
solution of diazomethane (prepared from 4.28 g of Diazald). After 10
min, the excess diazomethane was evaporated in a stream of nitrogen
and the residue was dried in vacuo to give the tetramethyl esters 7 and
8 (590 mg, 99%) (Figure 2).
Preparation of the Mosher Amide DeriVatiVes. Oxalyl chloride (220
mg. 1.74 mmol) was added to a solution of (R)-(-)-MTPA (e.e. g99%,
82 mg, 0.35 mmol) and dimethyl formamide (DMF) (25.4 mg, 0.35
mmol) in hexane (5 mL) at room temperature. A white precipitate
formed immediately. After 60 min, the mixture was passed through a
small cotton plug to filter off the formed DMF-Cl. The filtrate was
concentrated under reduced pressure to yield the (S)-MTPA chloride.
A solution of the tetramethyl esters 7 and 8 (265 mg, 0.35 mmol),
Et3N (352 mg, 3.48 mmol), and DMAP (5 mg) in CH2Cl2 (5 mL) was
added to a solution of the (S)-MTPA chloride in CH2Cl2 (2 mL)
solution. The mixture was stirred for 30 min and then quenched by
addition of water (2 mL). The organic solution was washed with 0.5
M HCl, followed by saturated NaHCO3 solution and water. The CH2-
Cl2 solution was dried (Na2SO4), filtered, and evaporated. The product
was purified by column chromatography on silica gel with EtOAc-
hexane (3:2) as the eluent to give the (R)-Mosher amide derivative
(180 mg, 59%), an oil, as a mixture of two diastereomers (9a and 10a)
(d.r. 82:18); Rf 0.34.
The same protocol was followed but using (S)-(+)-MTPA (e.e.
g99%), to convert a sample of the tetramethyl esters 7 and 8 (265 mg,
0.34 mmol) to a mixture of the two diastereomeric (S)-Mosher amide
derivatives (9b and 10b) (214 mg, 63%) (d.r. 82:18) (Figure 2).
RESULTS AND DISCUSSION
The terminal 2-amino-3-hydroxy motif of the fumonisin C20
backbone is also present in a number of marine natural products
(see Figure 3). In 1989, Gulavita and Scheuer (16) isolated two
epimeric aliphatic amino alcohols from a Papua New Guinea
sponge, Xestospongia sp., and proposed their structures as
(2S,3S,5E,7E)- and (2S,3R,5E,7E)-2-aminotetradeca-5,7-dien-
3-ol, ent-(11) and ent-(12), respectively. The relative stereo-
chemistry followed from nuclear Overhauser effect studies on
the oxazolidinone derivative and the absolute configuration at
C(2) by degradation of the diacetyl derivatives to alanine and
HPLC analysis of the derivative formed with 1-fluoro-2,4-
dinitrophen-5-yl-(2S)-alanine amide. Mori and Matsuda (17)
reported the total synthesis of both enantiomers of 11 and 12
and assigned the enantiomeric stereochemistry to the natural
products isolated by Gulavita and Scheuer (16), since the 2R
stereoisomers showed the same sign of optical rotation as the
natural products. The stereochemistry of the xestoaminols A
(13), B (14), and C (15) isolated by Jime´nez and Crews (18)
from two different sponges of the genus Xestospongia was
determined by Garrido et al. (19) in their study on the
obscuraminols, for example, obscuraminol C (16) obtained from
the tunicate Pseudodistoma obscurum. Sata and Fusetani (20)
isolated two new cytotoxic stereoisomeric 2,3-amino alcohols,
amaminol A (17) and B (18), from an unidentified tunicate of
the family Polyclinidae. The stereochemical relationship between
these two compounds, as in the case of the amino alcohols 11
and 12 isolated by Gulavita and Scheuer (16), is of particular
Table 1. NMR Data for the Normal and 3-epi Series of Fumonisin B3
and B4a
FB3 (3) 3-epi-FB3 (5)
atom äC äH äC äH
1 15.61 Q 1.113 d (J 6.7) 12.01 Q 1.054 d (J 6.7)
2 51.36 D 2.956 qd (J 6.7, 6.8) 50.63 D 3.125 qd (J 6.8, 3.1)
3 71.08 D 3.336 m 69.65 D 3.568 m
4 32.90 T 32.46 T
FB4 (4) 3-epi-FB4 (6)
atom äC äH äC äH
1 15.42 Q 1.120 d (J 6.6) 11.93 Q 1.060 d (J 6.7)
2 51.23 D 2.957 qd (J 6.7, 6.7) 50.56 D 3.120 qd (J 6.8, 3.1)
3 70.96 D 3.33 m 69.57 D 3.58 m
4 32.75 T 32.37 T
a Solvent DMSO-d6. NMR analyses were performed on mixtures of stereoisomers
of FB3 and FB4.
Table 2. 1H NMR Data for the MTPA Amides (ä, CDCL3)
compound atom (S)-MTPA (b) (R)-MTPA (a) ¢ä (äS − äR)
9 H(1) 1.110 1.179 −0.069
H(3)a 3.49 3.47 +0.02
10 H(1) 1.025 1.095 −0.070
H(3)a 3.60 3.54 +0.06
a Chemical shift values obtained from COSY and HETCOR data.
Table 3. Fumonisin Levels in Samples of Corn and Commercial Corn
Meal
fumonisin levels íg/kg)a
sample FB1 FB2 FB3 epi-FB3 total % epi/FB3
commercial corn meal 380 100 30 2 512 6.7
625 215 60 5 905 8.3
240 70 15 2 327 13
265 80 25 4 374 16
Brazilian corn 1960 720 370 45 3095 12
4515 255 665 95 5530 14
3635 900 320 60 4915 19
2405 1985 400 75 4865 19
Transkei home-grown, 2350 540 200 35 3125 18
good corn 1370 465 120 20 1975 17
2980 780 215 45 4020 21
Transkei home-grown, 26240 10070 2490 200 39000 8.1
moldy corn 2665 830 165 25 3685 15
12480 6860 1740 285 21365 16
5035 2050 495 75 7655 15
5365 2025 445 30 7865 6.7
a FB4 was not detected.
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significance to the structure elucidation of the minor metabolites
of the fumonisins. A detailed analysis of the 1H NMR spectra
of 17 and 18 disclosed that the relative stereochemistry of the
C(2) and C(3) stereogenic centers differed as indicated by the
coupling constant between H(2) and H(3) [J2,3 3.1 Hz for (17)
vs 7.3 Hz for (18)]. The Mosher ester analysis (21-23) indicated
that the two compounds had the same 3S absolute configuration
and were epimeric at C(2). This is in direct contrast to the results
obtained by Gulavita and Scheuer (16) on the amino alcohols
11 and 12, which are C(3) epimers. The absolute configuration
of the crucigasterins 19-21, isolated by Jarez et al. (24) from
a Mediterranean tunicate Pseudodistoma crucigaster, was as-
signed by chemical degradation to (3S,4R)-3-hydroxy-4-ami-
nopentanoic acid. The anti stereochemistry of the 2-amino-3-
hydroxy group of the crucigasterins is reflected by the 3.0 Hz
coupling constant for the C(2) and C(3) protons. Analysis of
the 13C NMR data reported by Gulavita and Scheuer (16) and
Mori and Matsuda (17) in the work on the amino alcohols 11
and 12 and by Sata and Fusitani (20) on the amaminols 17 and
18 showed characteristic chemical shift values for the methyl
group of the syn- and anti-2,3-amino alcohols. Thus, the methyl
group, C(1), in the diacetyl derivative of 11 appeared at äC 18.49
(syn) whereas in the diacetyl derivative of 12 it appeared at äC
14.93 (anti). The same trend is observed for the amaminols:
äC 16.0 for the syn compound (11) and äC 12.1 for the anti
compound (12). The anti-amino alcohol (22) (25) showed the
methyl groups at äC 12.1 and 11.9, whereas in the syn-amino
alcohols such as fumonisin B3 (3) and B4 (4) the methyl group
appears at äC 15.61 and 15.42. It is thus evident that the 13C
chemical shift values for the methyl group, C(1), define the
relative stereochemistry of the 2,3-amino alcohol moiety in these
compounds.
Fast atom bombardment and ES mass spectrometry of FB3
samples, which exhibited two peaks in the HPLC analysis,
showed the [M + H]+ ion at 706 and established the molecular
formula C34H59NO14 for each of the two compounds. The 1H
and 13C NMR spectra showed in all cases the presence of a
minor component 3-epi-FB3 (5). The use of two-dimensional
correlation spectroscopy (COSY) and heteronuclear correlation
(HETCOR) experiments established that the discernible signals
of the minor component in the 1H and 13C spectra represent the
C(1)-C(4) unit of the backbone. The coupling constant of 6.8
Hz between the C(2) and the C(3) protons of FB3 is character-
istic of the syn-2,3-amino alcohol in these metabolites. The anti
stereochemistry for the 2,3-amino alcohol unit of the minor
metabolite 3-epi-FB3 (5) followed from the 3.1 Hz coupling
observed for the C(2) and C(3) protons (Table 1). The 13C
chemical shifts for the methyl group in fumonisin B3 (äC
15.61Q) and the minor component 3-epi-FB3 (5) (äC 12.01Q)
confirmed the anti-2,3 stereochemistry of the latter.
The 1H and 13C NMR spectra of samples of fumonisin B4
(4) isolated over the years sometimes also showed the presence
of up to 40% of a minor metabolite 3-epi-FB4 (6) with the 2,3-
anti stereochemistry (Table 1). The anti stereochemistry of
3-epi-FB4 (6) followed once again from the coupling constant
of 3.1 Hz for the C(2) and C(3) protons and the 13C chemical
shift value of 11.93 for the methyl group, C(1) (see Table 1).
In contrast, the 1H and 13C NMR spectra of samples of FB1 (1)
and FB2 (2) prepared by us have always lacked the signals for
the corresponding 3-epi stereoisomers with the anti-2,3 stereo-
chemistry.
The absolute configuration of the C(2) and C(3) stereogenic
centers of FB1-4 has been established as (2S,3S) (26-32), and
consequently, the minor metabolites 3-epi-FB3 (5) and 3-epi-
FB4 (6) must either have the (2S,3R) or (2R,3S) configuration.
The C(2) absolute configuration for the FB3 minor metabolite,
3-epi-FB3 (5), was determined using Mosher methodology (21-
23). A sample of FB3 (3) [containing 18% of the minor
metabolite 3-epi-FB3 (5)] was converted to the tetramethyl ester
derivatives 7 and 8 (minor) by treatment with an excess of
diazomethane. The amino group was then converted to the (R)-
and (S)-MTPA amides (7a,b and 8a,b) (minor), respectively,
by reaction with the (S)- and (R)-MTPA chlorides [prepared
from the (R)- and (S)-MTPA acid, respectively, following the
protocol developed by Ward and Rhee (33)]. The ¢ä (äS -
äR) values observed for H(1) (-0.069 ppm) and H(3) (+0.02
Figure 4. HPLC chromatogram with fluorescence detection of the OPA derivatives of the isolated FB3 standard showing the relative areas of the two
stereoisomers.
Figure 5. Biosynthetic formation of the fumonisins and the 3-epi
stereoisomers.
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ppm) of the Mosher amide derivatives (9) (see Table 2) are in
agreement with the 2S absolute configuration of the fumonisins.
The fact that similar values are observed for the corresponding
protons of the Mosher amide derivatives (10) implies that the
minor metabolite 3-epi-FB3 (5) present in samples of FB3 (3)
also has the 2S absolute configuration and therefore on the basis
of its 2,3-anti relative stereochemistry, the 3R absolute config-
uration. As a consequence of this result, the assignment of the
2S,3R absolute configuration to the minor metabolite 3-epi-FB4
(6) present in samples of fumonisin B4 (4) is reasonable.
Biosynthetic studies on the fumonisins using [1-13C]-, [2-13C]-
, and [1,2-13C2]acetate, [methyl-13C]-(2S)-methionine, and [3-13C]-
(2S)-alanine precursors established that C(3)-C(20) are derived
from acetate and C(1), C(2), and the 2-NH2 group are derived
from alanine. The C(12) and C(16) methyl groups are derived
from methionine (34-38). An acetate-derived carbonyl group
is the source of the C(3) hydroxyl group, whereas the C(5),
C(10), C(14), and C(15) hydroxyl groups are likely derived from
molecular oxygen (39). The citric acid cycle is believed to be
the source of the tricarballylic acid moiety (37). Recently, a
15-gene cluster (FUM1-FUM3, FUM6-FUM8, FUM10,
FUM11, and FUM13-FUM19) required for the biosynthesis
of the fumonisins in F. Verticilloides was cloned and character-
ized (40-42). The data obtained from direct studies of these
biosynthetic genes by genetic and biochemical approaches (40-
48) provided the basis for a biosynthetic pathway (46-48). The
biosynthesis starts with the formation of a dimethylated,
saturated C18 polyketide chain catalyzed by the Fum1p polyketide
synthase (see Figure 5) The carbon-carbon bond formation
between the (2S)-alanine and the enzyme-bound C18 polyketide
chain by the pyridoxal-phosphate-dependent aminoacyl trans-
ferase enzyme Fum8p, encoded by the FUM8 gene (42, 43),
involves the loss of CO2 to form the 3-keto intermediate (23)
with overall retention of the C(2) configuration. Stereospecific
reduction of the 3-keto intermediate at the ReS face of the
carbonyl group by ketoreductase Fum13p results in the forma-
tion of the 3S hydroxyl group and the syn-2,3 amino alcohol
motif (24) (43, 45, 47). This reduction is analogous to that of
3-ketosphinganine to sphinganine (43) except that the reduction
of the carbonyl group with 3-ketosphinganine reductase must
occur at the Si face to generate the 3R hydroxyl group and the
anti-2,3 amino alcohol of sphinganine.
The formation of 3-epi-FB3 (5) with its 3R hydroxyl group
and thus the 2,3-anti stereochemistry is postulated to occur by
reduction at the SiS face of the carbonyl group of the 3-keto
intermediate (23) to give the intermediate (25) in the fumonisin
biosynthesis by a 3-ketosphinganine type reductase. The pres-
ence of such a 3-ketosphinganine type reductase has been
proposed to account for the low levels of FB1-4 production in
FUM13 deletion mutants (43).
Evidence has been presented that the reduction of the 3-keto
group is an early step in the biosynthetic pathway, whereas the
introduction of the C(5) hydroxyl group by a 2-ketoglutarate-
dependent dioxygenase Fum3p, encoded by the FUM3 gene, is
the last step (43, 47, 48). On the basis of this proposed
biosynthetic pathway, the presence of 3-epi-FB3 (5) and 3-epi-
FB4 (6) should lead to the formation of the 3-epi stereoisomers
of FB1 and FB2 by the Fum3p enzyme. This is not the case as
these 3-epi stereoisomers of FB1 and FB2 have never been
detected by us. This failure of Fum3p to convert 3-epi-FB3 (5)
and 3-epi-FB4 (6) to 3-epi-FB1 and 3-epi-FB2, respectively,
suggests that the metabolites with the 3R hydroxyl group, that
is, the 2,3-anti stereochemistry, are not recognized by Fum3p
and thus do not serve as substrates.
The newly described 3-epi-FB3 (5) was identified from the
FB3 standard isolated in the PROMEC Unit from various batches
of corn patty culture material prepared from F. Verticillioides
MRC 826. In an attempt to avoid the presence of this analogue
in the analytical standard, a range of other F. Verticillioides
strains, including MRC 8041 that only produces FB3, have been
cultured. The 3-epi-FB3 (5) has been found to occur in all of
these at levels ranging from 21 to 42% of the level of the normal
FB3. In a limited comparison, two strains grown in liquid
medium showed lower levels (around 7-8%) of the epi
stereoisomer. Of greater concern is the potential natural occur-
rence of this new fumonisin analogue. A range of corn samples
from various sources have recently been analyzed by HPLC
with fluorescence detection. 3-epi-FB3 (5) was identified by its
Figure 6. Total ion chromatogram of a Transkeian moldy corn sample and mass spectra of the protonated FB3 and 3-epi-FB3 analogues.
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retention time as a small peak eluting from the HPLC column
immediately prior to normal FB3. Table 3 shows the results of
the analytical determination of FB3 (3) and 3-epi-FB3 (5) for
16 samples of corn and commercial corn meal. The presence
of the stereoisomer was confirmed by LC-MS-MS analysis and
the presence of the characteristic fragmentation pattern for
fumonisins. Figure 6 shows the total ion chromatogram for a
sample of Transkeian corn, as well as a comparison of the mass
spectra for FB3 (3) and for the peak corresponding to 3-epi-
FB3 (5). The similarity of the spectra and the presence of the
fragment ions corresponding to [M + H - H2O]+ (m/z 688),
[M + H - 2H2O]+ (m/z 670), [M + H - TCA]+ (m/z 530),
[M + H - H2O - TCA]+ (m/z 512), [M + H - 2TCA]+ (m/z
354), and [M + H - H2O - 2TCA]+ (m/z 336) provides
unequivocal identification of the compounds. The level of 3-epi-
FB3 (5) in these samples ranged from 6.7 to 21% of the level
of FB3 and contributed only marginally to the total level of
fumonisins. On the basis of these data and the fact that it also
only occurs at lower levels than FB3 in culture, it can be
concluded that, in general, the influence of 3-epi-FB3 on
fumonisin exposure will be small.
The use of an isolated FB3 analytical standard for chromato-
graphic analysis is problematic due to the presence of the two
stereoisomers. Nevertheless, because of their chemical similarity
and similar retention times on a reversed-phase HPLC column,
the assumption of the same chromatographic response factors
for the two isomers would appear to be reasonable and allows
accurate analysis to be performed. The response factor calculated
for the combination of the two isomers in the standard
chromatogram is then applied separately to each isomer peak
in the chromatogram of the sample.
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Fumonisins B1 (FBR) and B2 (FB2), two structurally related mycotoxins with cancer-promoting activity, were
recently isolated from corn cultures of Fusarium moniliforme MRC 826. These toxins have been reported to be
produced also by isolates of F. proliferatum. Contamination of foods and feeds by F. moniliforme has been
associated with human esophageal cancer risk, and FB, has been shown to be the causative agent of the
neurotoxic disease leukoencephalomalacia in horses. Because of the toxicological importance of the fumonisins,
the potential to produce FBI and FB2 was determined in a study of 40 toxic Fusarium isolates representing 27
taxa in 9 of the 12 sections of Fusarium, as well as two recently described species not yet classified into sections.
With the exception of one isolate of F. nygamai, fumonisin production was restricted to isolates of F.
moniliforme and F. proliferatum, in the section Liseola. The F. nygamai isolate produced 605 ,ug of FB1 g1- and
530 ,ug of FB2 g-', and the identity of the toxins was confirmed by capillary gas chromatography-mass
spectrometry. This is the first report of the production of the fumonisins by F. nygamai.
Fusarium moniliforme contamination of feeds has been
associated with several diseases in animals, including leu-
koencephalomalacia (LEM) in horses (12), and the incidence
of F. moniliforme infection of home-grown corn has been
shown to be correlated with the high incidence of human
esophageal cancer in Transkei, southern Africa (9, 10, 16),
and in China (8, 27).
Fumonisins B1 (FB1) and B2 (FB2), structurally related
mycotoxins with cancer-promoting activity, were recently
isolated from corn cultures of F. moniliforme Sheldon strain
MRC 826 (3), and their structures were elucidated (1). FB1
has since been shown to induce LEM in horses after either
intravenous (11) or per os (6) administration and to induce
pulmonary edema in swine after intravenous administration
(5).
Both FB1 and FB2 have been found to occur naturally in
corn and in feeds associated with field outbreaks of LEM in
horses (20, 21, 23, 25, 26). Higher concentrations of both
toxins have been detected in corn samples from areas with a
high esophageal cancer rate in Transkei than in samples from
low-rate areas (22).
At present there is no experimental proof that the fumo-
nisins, which are rat liver cancer promoters, are causative
agents of esophageal cancer in humans. However, the toxi-
cological importance of the fumonisins emphasizes the need
to establish the extent of human and animal exposure to
these toxins. One approach is to screen different fungal
isolates that commonly occur on foods and feeds for their
potential to produce the fumonisins. A recent report (19)
documented the production of FB1 and FB2 by cultures of
both F. moniliforme and F. proliferatum (Matsushima)
Nirenberg isolated from feeds associated with LEM in
horses and pulmonary edema in swine in the United States.
In the present study 40 toxic Fusarium isolates represent-
ing 27 taxa in 9 of the 12 sections of Fusarium as classified by
Nelson et al. (17), as well as two recently described species
not yet classified into sections, were screened for their
potential to produce FB1 and FB2.
* Corresponding author.
MATERIALS AND METHODS
Fusarium isolates. All Fusarium isolates used in this inves-
tigation were obtained from the culture collection of the
Research Institute for Nutritional Diseases, Medical Re-
search Council, Tygerberg, South Africa. Cultures on corn
of all the isolates tested were known to be highly toxic to
ducklings, causing four of four deaths when fed to 1-day-old
Pekin ducklings for 14 days, as previously described (15).
The origin of each isolate, the substrate from which it was
isolated, and the Fusarium taxon to which it belongs are
given in Table 1. The Fusarium taxa are also arranged in
sections as described by Nelson et al. (17), except for the
two recently described species F. nygamai Burgess & Trim-
boli (2) and F. napiforme Marasas, Nelson & Rabie (13),
which have not yet been classified into sections.
Culture techniques. Lyophilized conidia of the different
Fusarium isolates were suspended in sterile water and used
to inoculate moistened yellow corn kernels (400 g of kernels
and 400 ml of water) in 2-liter glass fruit jars previously
autoclaved at 121°C for 1 h on each of 2 consecutive days.
Cultures were incubated in the dark at 25°C for 21 days,
dried overnight at 45°C, ground to a fine meal in a laboratory
mill, and stored at 0°C until analyzed.
Reference standards. FB1 and FB2 standards were isolated
and purified from cultures of F. moniliforme MRC 826 as
previously described (3). The identity and purity of each
standard were assessed by thin-layer chromatography, high-
performance liquid chromatography, and nuclear magnetic
resonance spectroscopy.
Determination of fumonisins. FB1 and FB2 were deter-
mined by a recently developed high-performance liquid
chromatography method (20). Briefly, fumonisins were ex-
tracted from a sample of the culture material with methanol-
water (3:1, vol/vol). The extract was purified on a strong
anion-exchange cartridge, and an aliquot was derivatized
with o-phthaldialdehyde. The derivatized fumonisins were
separated on a reversed-phase column, monitored by fluo-
rescence detection, and quantified by comparison of peak
areas with those obtained with reference standards of FB,
and FB2.
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TABLE 1. Fumonisin production by Fusarium species
Fumonisin concn J.g g-Section, MRCa no., and species Origin Substrate
FB1 FB2
Spicarioides
2801 F. decemcellulare
Sporotrichiella
43 F. sporotrichioides
3424 F. poae
1577 F. tricinctum
Roseum
3302 F. avenaceum
Arthrosporiella
2905 F. semitectum
4815 F. camptoceras
3520 F. camptocerasc
Gibbosum
2330 F. equiseti
4463 F. equiseti
3311 F. acuminatum
4028 F. acuminatumd
3687 F. scirpi
3528 F. longipese
4458 F. longipes
Discolor
3307 F. sambucinum
4666 F. sambucinum
1115 F. graminearum Gr.2
4917 F. graminearum Gr.1
5052 F. graminearum Gr.2
3636 F. reticulatum
1386 F. compactum
Lateritium
1925 F. lateritium
Liseola
826 F. moniliforme
1065 F. moniliforme
4315 F. moniliforme
4317 F. moniliforme
4318 F. moniliforme
4319 F. moniliforme
4321 F. moniliforme
2059 F. proliferatum
2301 F. proliferatum
2302 F. proliferatum
2383 F. proliferatum
1077 F. subglutinans
3823 F. anthophilum
Elegans
1492 F. oxysporum
Newly described species
4003 F. nygamai
4150 F. nygamaif
4134 F. napiforme
South Africa
France
South Africa
United States
South Africa
South Africa
Costa Rica
South Africa
United States
Transkei
South Africa
South Africa
Australia
South Africa
New Guinea
South Africa
South Africa
Transkei
South Africa
South Africa
South Africa
South Africa
Zimbabwe
Transkei
Transkei
Transkei
Transkei
Transkei
Transkei
Transkei
South Africa
United States
United States
Sierra Leone
Transkei
South Africa
South Africa
South Africa
Namibia
Namibia
Avocado
Corn
Barley
Ivy
Medicago
Corn
Cocoa
Soil
Cereal
Soil
Medicago
Soil
Soil
Soil
Soil
Medicago
Potato
Corn
Barley
Wheat
Medicago
Groundnut
Coffee
Corn
Corn
Corn
Corn
Corn
Corn
Corn
Sorghum
Corn
Corn
Corn
Corn
Oats
Groundnut
Soil
Millet
Sorghum
NDb
ND
ND
ND
ND
ND
ND
ND
ND ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND ND
7,100
85
2,645
205
105
180
1,330
20
870
290
660
ND
ND
3,000
10
325
40
ND
40
140
160
450
65
200
ND
ND
ND ND
605
ND
ND
530
ND
ND
a MRC, Medical Research Council.
b ND, Not detected (<1 ,ug g-1).
c Lamprecht et al. (7).
d Rabie et al. (18).
e Van Wyk et al. (24).
f Marasas et al. (14).
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FIG. 1. (a) Total ion chromatogram (TIC) of the acylated hydrolysates of authentic fumonisin standards. (b) Partial mass spectrum of the
amino-tetraol moiety of FB2. (c) Similar mass spectrum of the amino-pentol moiety of FBj.
Confirmation of the presence of FB, and FB2. Corn culture
extracts were prepared and purified on strong anion-ex-
change cartridges and then hydrolyzed with 2 M potassium
hydroxide (25). The hydrolysates were acidified with 1 M
hydrochloric acid and purified further on short Amberlite
XAD-4 columns (25). Aliquots of the purified hydrolysates
were either derivatized with o-phthaldialdehyde and ana-
lyzed by high-performance liquid chromatography or deriva-
tized with trifluoroacetylimidazole and analyzed by capillary
gas chromatography-mass spectrometry. The amino-pentol
moiety of FB1 and the amino-tetraol moiety of FB2 (present
in the hydrolysates) were determined by both chromato-
graphic techniques. The retention times and mass spectra
observed in the culture extracts were compared with those
obtained for the amino-pentol and amino-tetraol present in
similarly hydrolyzed fumonisin standards.
RESULTS AND DISCUSSION
Results of fumonisin analyses of corn cultures of 40 toxic
Fusarium isolates are summarized in Table 1. With the
exception of one isolate of F. nygamai, fumonisin produc-
tion was restricted to section Liseola. All the isolates tested
of two of the Fusarium spp. in section Liseola, F. monili-
forme and F. proliferatum, produced both FB1 and FB2
except for F. moniliforme strain MRC 4318, which produced
only FB1. One isolate of each of two other species in this
section, F. subglutinans (Wollenweber & Reinking) Nelson,
Toussoun & Marasas, and F. anthophilum (A. Braun) Wol-
lenweber, did not produce any chemically detectable FB1 or
FB2.
Six of the seven F. moniliforme isolates from corn from a
high-risk area of human esophageal cancer in the Transkei
(4) produced both FB1 and FB2, whereas the seventh isolate
(MRC 4318) produced only FBI. The highest producer of
both FB1 (7,100 [ig g-') and FB2 (3,000 ,ug g-') was F.
moniliforme MRC 826, the strain from which the fumonisins
were originally isolated and characterized (1, 3). Cultures of
MRC 826 also had the highest cancer promotion activity
compared with those of 10 other isolates of F. moniliforme
from Transkeian corn, in a short-term cancer initiation-
promotion bioassay in rat liver (4). The two other highest
producers of fumonisins (MRC 4315 and MRC 4321, Table 1)
similarly exhibited high cancer promotion activity in the
cancer initiation-promotion bioassay (4). Of the three lowest
producers of fumonisins (MRC 4317, MRC 4318, and MRC
4319; Table 1), two (MRC 4317 and MRC 4318) exhibited no
cancer promotion activity, whereas the third (MRC 4319)
registered the second-highest activity (4). With the exception
of F. moniliforme MRC 4319, the fumonisin production by
all F. moniliforme strains correlated well with the cancer
promotion activity of the cultures.
The observation that all four isolates of F. proliferatum
tested produced both FB1 and FB2 (Table 1) confirms a
previous report (19) on fumonisin production by two isolates
of F. proliferatum from feeds associated with field outbreaks
of equine LEM and porcine pulmonary edema, respectively.
The concentrations reported by Ross et al. (19) were in
excess of 1,600 ,ug g-1 for FB1 and 150 pug g-1 for FB2. In the
present study, four F. proliferatum isolates, either from
sorghum in South Africa or from corn in the United States
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FIG. 2. (a) Total ion chromatogram (TIC) of the acylated hydrolysate of an extract of F. nygamai MRC 4003. (b) Partial mass spectrum
of the peak eluting at 23.45 min. (c) Similar mass spectrum of the peak eluting at 23.68 min.
and Sierra Leone, produced FB1 and FB2 in cultures on
corn, at levels ranging from 20 to 660 1Lg g-1 and 65 to 450 Fag
g-', respectively. One South African isolate of F. prolifer-
atum (MRC 2059) from sorghum differed from all other
fumonisin-producing strains thus far analyzed, in that it
produced more FB2 (160 jig g-') than FB1 (20 ,ug g-
In addition to the two fumonisin-producing Fusarium
species in section Liseola, i.e., F. moniliforme and F.
proliferatum, only one other toxic Fusarium isolate pro-
duced chemically detectable levels of FB1 and FB2; this was
F. nygamai MRC 4003 (Table 1). The identity of the fumo-
nisins produced by this isolate was confirmed by the hydro-
lysis of a sample extract followed by o-phthaldialdehyde
derivatization and high-performance liquid chromatographic
analysis as well as by acylation and analysis by capillary gas
chromatography-mass spectrometry.
Figure la shows the total ion chromatogram of the hydro-
lyzed, acylated products of authentic fumonisin standards.
The two chromatographic peaks eluting at 23.45 and 23.70
min correspond to the amino-tetraol and -pentol moieties of
FB2 and FB1, respectively. Figures lb and c show the partial
mass spectra (90 to 200 mlz) of the peaks.
Figure 2a illustrates the total ion chromatogram of an
extract of F. nygamai MRC 4003, and Fig. 2b and c show the
mass spectra of the two major peaks observed in Fig. 2a. The
excellent agreement between the two sets of retention times
and mass spectra confirmed the production of both FB1 and
FB2 by F. nygamai MRC 4003. The presence of the amino-
pentol moiety of FB1 and the amino-tetraol moiety of FB2 in
the hydrolyzed extracts of a culture of F. nygamai MRC
4003 was also confirmed by HPLC analysis of the o-phthal-
dialdehyde-derivatized hydrolysate.
The recently described species F. nygamai (2) is related to
but excluded from the section Liseola by the production of
chlamydospores but has not yet been assigned to a section.
F. nygamai MRC 4003 was isolated from soil in the Kruger
National Park, South Africa, and is one of the authentic
isolates cited (as M-2368) in the original description (2).
Cultures of F. nygamai MRC 4003 on corn produced 605 ,ug
of FB1 g-1 and 530 ,ug of FB2 g1 (Table 1). This is the first
report of fumonisin production by F. nygamai.
REFERENCES
1. Bezuidenhout, S. C., W. C. A. Gelderblom, C. P. Gorst-Allman,
R. M. Horak, W. F. 0. Marasas, G. Spiteller, and R. Vleggaar.
1988. Structure elucidation of the fumonisins, mycotoxins from
Fusarium moniliforme. J. Chem. Soc. Chem. Commun. 1988:
743-745.
2. Burgess, L. W., and D. Trimboli. 1986. Characterization and
distribution of Fusarium nygamai, sp. nov. Mycologia 78:223-
299.
3. Gelderblom, W. C. A., K. Jaskiewicz, W. F. 0. Marasas, P. G.
Thiel, R. M. Horak, R. Vleggaar, and N. P. J. Kriek. 1988.
Fumonisins-novel mycotoxins with cancer-promoting activity
produced by Fusarium moniliforme. Appl. Environ. Microbiol.
54:1806-1811.
4. Gelderblom, W. C. A., W. F. 0. Marasas, K. Jaskiewicz, S.
Combrink, and D. J. Van Schalkwyk. 1988. Cancer promoting
potential of different strains of Fusarium moniliforme in a
short-term cancer initiation/promotion assay. Carcinogenesis
9:1405-1409.
5. Harrison, L. R., B. M. Colvin, J. T. Greene, L. E. Newman, and
1092 THIEL ET AL.
FUMONISIN PRODUCTION BY FUSARIUM SPECIES 1093
J. R. Cole. 1990. Pulmonary edema and hydrothorax in swine
produced by fumonisin B1, a toxic metabolite of Fusarium
moniliforme. J. Vet. Diagn. Invest. 2:217-221.
6. Kellerman, T. S., W. F. O. Marasas, P. G. Thiel, W. C. A.
Gelderblom, M. Cawood, and J. A. W. Coetzer. 1990. Leukoen-
cephalomalacia in two horses induced by oral dosing of fumo-
nisin B1. Onderstepoort J. Vet. Res. 57:269-275.
7. Lamprecht, S. C., W. F. 0. Marasas, E. W. Sydenham, P. G.
Thiel, P. S. Knox-Davies, and P. S. Van Wyk. 1989. Toxicity to
plants and animals of an undescribed, neosolaniol monoacetate-
producing Fusarium species from soil. Plant Soil 114:75-83.
8. Li, M., S. Lu, C. Ji, Y. Wang, M. Wang, S. Cheng, and G. Tian.
1980. Experimental studies on the carcinogenicity of fungus-
contaminated food from Linxian county, p. 139-148. In H. V.
Gelboin (ed.), Genetic and environmental factors in experimen-
tal and human cancer. Japan Science Society Press, Tokyo.
9. Marasas, W. F. 0. 1982. Mycotoxicological investigations on
corn produced in esophageal cancer areas in Transkei, p. 29-40.
In C. J. Pheiffer (ed.), Cancer of the esophagus. CRC Press,
Inc., Boca Raton, Fla.
10. Marasas, W. F. O., K. Jaskiewicz, F. S. Venter, and D. J. Van
Schalkwyk. 1988. Fusarium moniliforme contamination of maize
in oesophageal cancer areas in Transkei. S. Afr. Med. J.
74:110-114.
11. Marasas, W. F. O., T. S. Kelierman, W. C. A. Gelderblom, J. A.
W. Coetzer, P. G. Thiel, and J. J. Van der Lugt. 1988. Leukoen-
cephalomalacia in a horse induced by fumonisin B1, isolated
from Fusarium moniliforme. Onderstepoort J. Vet. Res. 55:197-
203.
12. Marasas, W. F. O., P. E. Nelson, and T. A. Toussoun. 1984.
Toxigenic Fusarium species: identity and mycotoxicology.
Pennsylvania State University Press, University Park.
13. Marasas, W. F. O., C. J. Rabie, A. Lubben, P. E. Nelson, T. A.
Toussoun, and P. S. Van Wyk. 1987. Fusarium napiforme, a new
species from millet and sorghum in southern Africa. Mycologia
79:910-914.
14. Marasas, W. F. O., C. J. Rabie, A. Lubben, P. E. Nelson, T. A.
Toussoun, and P. S. Van Wyk. 1988. Fusarium nygamai from
millet in southern Africa. Mycologia 80:263-266.
15. Marasas, W. F. O., P. G. Thiel, C. J. Rabie, P. E. Nelson, and
T. A. Toussoun. 1986. Moniliformin production in Fusarium
section Liseola. Mycologia 78:242-247.
16. Marasas, W. F. O., F. C. Wehner, S. J. Van Rensburg, and D. J.
Van Schalkwyk. 1981. Mycoflora of corn produced in human
esophageal cancer areas in Transkei, southern Africa. Phytopa-
thology 71:792-797.
17. Nelson, P. E., T. A. Toussoun, and W. F. 0. Marasas. 1983.
Fusarium species: an illustrated manual for identification. Penn-
sylvania State University Press, University Park.
18. Rabie, C. J., E. W. Sydenham, P. G. Thiel, A. Lubben, and
W. F. 0. Marasas. 1986. T-2 toxin production by Fusarium
acuminatum isolated from oats and barley. Appl. Environ.
Microbiol. 52:594-596.
19. Ross, P. F., P. E. Nelson, J. L. Richard, G. D. Osweiler, L. G.
Rice, R. D. Plattner, and T. M. Wilson. 1990. Production of
fumonisins by Fusarium moniliforme and Fusarium prolifera-
tum isolates associated with equine leukoencephalomalacia and
a pulmonary edema syndrome in swine. Appl. Environ. Micro-
biol. 56:3225-3226.
20. Shephard, G. S., E. W. Sydenham, P. G. Thiel, and W. C. A.
Gelderblom. 1990. Quantitative determination of fumonisins B1
and B2 by high-performance liquid chromatography with fluo-
rescence detection. J. Liq. Chromatogr. 13:2077-2087.
21. Sydenham, E. W., W. C. A. Gelderblom, P. G. Thiel, and
W. F. 0. Marasas. 1990. Evidence for the natural occurrence of
fumonisin B1, a mycotoxin produced by Fusarium moniliforme,
in corn. J. Agric. Food Chem. 38:285-290.
22. Sydenham, E. W., P. G. Thiel, W. F. 0. Marasas, G. S.
Shephard, D. J. Van Schalkwyk, and K. R. Koch. 1990. Natural
occurrence of some Fusarium toxins in corn from low and high
oesophageal cancer prevalence areas of the Transkei. J. Agric.
Food Chem. 38:1900-1903.
23. Thiel, P. G., G. S. Shephard, E. W. Sydenham, W. F. 0.
Marasas, P. E. Nelson, and T. M. Wilson. 1991. Levels of
fumonisins B1 and B2 in feeds associated with confirmed cases
of equine leukoencephalomalacia. J. Agric. Food Chem. 39:
109-111.
24. Van Wyk, P. S., 0. Los, and W. F. 0. Marasas. 1988. Pathoge-
nicity of a new Fusarium sp. from crown rot of wheat in South
Africa. Phytophylactica 20:73-75.
25. Voss, K. A., W. P. Norred, R. D. Plattner, and C. W. Bacon.
1989. Hepatotoxicity and renal toxicity in rats of corn samples
associated with field cases of equine leukoencephalomalacia.
Food Chem. Toxicol. 27:89-96.
26. Wilson, T. M., P. F. Ross, L. G. Rice, G. D. Osweiler, H. A.
Nelson, D. L. Owens, R. D. Plattner, C. Reggiardo, T. H. Noon,
and J. W. Pickrell. 1990. Fumonisin B1 levels associated with an
epizootic of equine leukoencephalomalacia. J. Vet. Diagn. In-
vest. 2:217-221.
27. Yang, C. S. 1980. Research on esophageal cancer in China: a
review. Cancer Res. 40:2633-2644.
VOL. 57, 1991
CHAPTER III 
 
 
TOXICOLOGICAL EFFECTS AND CARCINOGENESIS STUDIES  
OF FUMONISIN B1 
Page No 
 
3.1 Induction of leukoencephalomalacia (LEM) 22 
3.2 Carcinogenesis studies with purified fumonisin B1 22 
3.2.1 Long-term studies in male BD IX rats 22 
3.2.2 Long-term studies in male Fischer rats 24 
3.3 Dietary modulation and synergistic interactions of FB1-induced  
hepatocarcinogenesis 25 
3.3.1 Role of different dietary constituents 25 
3.3.2 Role of dietary iron 26 
3.3.3 Role of tea antioxidants 27 
3.3.4 Role of aflatoxin B1  27 
3.4 Perspectives 28 
 References 35 
 Selected publications 40 
 
 22 
TOXICOLOGICAL EFFECTS AND CARCINOGENESIS STUDIES  
OF FUMONISIN B1  
 
 
3.1 Induction of leukoencephalomalacia (LEM) 
A major toxic syndrome associated with culture material of F. verticillioides is 
the induction of equine LEM that was first induced by naturally fungal 
contaminated maize in 1902 (Butler, 1902). The actual involvement of F 
verticillioides was only   
verified during the 1970’s by Wilson & Maronpot (1971) and Marasas  et al. 
(1976) with pure cultures of the fungus in maize. The first evidence that FB1 is 
the causative principle for LEM resulted from a study following the intravenous 
application of 0.125 mg FB1/kg bw/day for 7 days (Marasas et al., 1988). The 
principal lesions were severe oedema of the brain and early bilaterally 
symmetrical, focal necrosis of the medulla oblongata. In a subsequent 
experiment the characteristic lesion of liquefactive necrosis of the white matter 
in the brain was induced in two horses. The dosages utilized were 1,25 to 4 
mg/kg in one horse and 1 to 4 mg/kg in the other horse yielding an effective 
total dose of 29.7 and 42.1 mg FB1, respectively. Chemical pathological 
changes associated with liver function were carefully monitored as high doses 
could result in hepatosis without inducing the clinical signs of LEM. The 
apparent dose ranges compared well to the levels ranging between 0.6 to 2.1 
mg FB1/kg bw/day associated with a natural outbreak of LEM in horses fed 
maize screenings (Wilson et al., 1990). It was suggested that maize 
contaminated up to a level of 10 mg FB per kg could pose an increased risk 
for horses to develop LEM (Viljoen and Marasas, 2002). This level is slightly 
lower than that proposed by the Joint Evaluating Committee on Food 
Additives (JECFA) which defines a minimum dose between 15-22 mg FB/kg 
of the diet (WHO, 2001). 
 
3.2 Carcinogenesis studies with purified fumonisin B1 
 
3.2.1 Long-term studies in male BD IX rats 
Following the characterisation of the fumonisin B mycotoxins from culture 
material of F. verticillioides MRC 826 a long-term toxicological study was 
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conducted in male BD IX rats at a dietary level of 50 mg FB1/kg (Gelderblom 
et al., 1991). The experimental diet used was very similar to that used by 
Jaskiewicz et al. (1987). The kinetics of the toxic and/or carcinogenic changes 
was followed during the course of the experiment by killing subgroups of rats 
at 6, 12 and 16 months with the remaining rats terminated after 16 to 26 
months depending on their health status. The control diet contained low levels 
of FB1 (0.5 mg/kg) that occurs naturally in the maize while no trace of aflatoxin 
was detected. Changes associated with the development of cirrhosis and 
cholangiofibrosis (adenofibrosis) were already present after 6 months, while at 
12 months the livers of the rats were distorted with a nodular appearance, 
described as a chronic toxic hepatitis progressing to cirrhosis. From 18 
months onwards some of the hepatocyte nodules manifested dysplasia and 
nuclear atypia characteristic of preneoplastic changes, a few of which were 
transformed into hepatocellular carcinoma. Of the 15 rats that were killed 
between 18 and 26 months, 10 developed hepatocellular carcinoma of which 
two metastasised to the lung and heart and one to the kidneys. Another 
prominent lesion that was consistently present from 6 months onwards was 
cholangiofibrosis, which was considered in some rats to develop into 
cholangiocarcinoma towards the end of the experiment. The culture material 
of strain MRC 826, used in the two previous experiments, also induced both 
types of hepatic lesions. Two lesions that were induced by the culture 
material, i.e. mild basal cell hyperplasia in the oesophagus and cardiac 
changes were not reproduced by FB1. Histopathological changes in the kidney 
were not commonly observed, although FB1 tends to cause some chronic 
lesions towards the end of the experiment. No specific lesions were induced in 
the kidneys of the BD IX rats treated with the culture material of strain MRC 
826.  
 
In order to study dose-response effects with respect to FB1-induced 
hepatocarcinogenesis in BD IX rats, a follow-up study using low dietary levels 
of fumonisin B1 (1, 10 and 25 mg FB1/kg diet) was performed using the same 
diet (Gelderblom et al., 1996a). Only mild toxic effects were observed in the 
liver, and apart from the induction of hepatocyte foci and nodules staining 
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positively for the placental form of gluthathione-S-transferase (PGST+) up to 
10 mg FB1/kg diet, no evidence of hepatocellular carcinoma was noticed.  
 
Several observations regarding the long-term studies using either the maize 
culture material or purified FB1 have to be considered: 
• FB1 is responsible for the hepatocarcinogenic effects of F. verticillioides 
and the liver is the major target organ in male BD IX rats. 
• FB1-induced hepatocarcinogenesis was associated with a chronic toxic 
hepatosis, eventually leading to cirrhosis. 
• All the hepatotoxic effects induced by the culture material of strain 
MRC 826 in rats were reproduced by FB1. 
3.2.2 Long-term studies in male Fischer rats 
More recently, a study in male Fischer rats showed that FB1 causes dysplastic 
nodules and bile duct lesions in the liver (Lemmer et al., 2004). Male Fisher 
rats were fed FB1 at different dosage levels over a period of 5 months using 
the AIN 76 diet. The dosage levels used were 250 mg FB1/kg diet for 5 weeks 
followed by 100 mg FB1/kg diet for the remainder of the experiment. The FB1 
dietary treatment was discontinued after 5 months at which time liver biopsies 
were collected from a subpopulation of the rats. The liver biopsies were 
continued on individual rats for a further 6 months and the rats terminated 
after 12 months. In the rats terminated after 12 months, hepatic lesions were 
described and shown to be very similar to those reported in male BD IX rats 
receiving either culture material (Marasas et al., 1984) and/or pure FB1 
(Gelderblom et al., 1991) and in male Fisher rats receiving naturally 
contaminated maize (Wilson et al., 1985). Therefore, irrespective of the diets 
used, very similar hepatotoxic effects were induced in the liver of male BD IX 
and Fisher 344 rats. FB1 induced a variety of preneoplastic and neoplastic 
hepatic lesions, including GSTP positive lesions, dysplastic liver nodules, 
cholangiofibrotic lesions, intraductal cholangiocarcinomas, and one 
unequivocal trabecular/-pseudoglandular hepatocellular carcinoma (Lemmer 
et al., 2004). Proliferating cells with the morphology of oval cells were found 
inside/adjacent to PGST+ lesions, dysplastic nodules, and cholangiofibrotic 
lesions, suggesting that oval cells may be involved in FB1-induced hepato- 
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and cholangiocarcinogenesis in the liver. Furthermore, immunohistochemical 
analysis demonstrated that proliferating oval cells and bile ductules, hepatic 
nodules, cholangiofibrotic lesions, and cystic lesions expressed the OV-6 
antigen, indicating that all of these cells may have a common cell of origin. 
These provocative findings suggested that oval cells (putative liver progenitor 
cells) may be involved in the generation of the dysplastic nodules and 
hepatocellular carcinomas seen in FB1-fed male Fischer rats. It is conceivable 
that both the hepatocellular and bile duct tumours induced by FB1 are derived 
from a common (‘stem’) cell of origin. The short-term dietary exposure (250 
mg FB1/kg for 5 weeks) also developed adenomas and cholangiofibrosis in 
the liver after one year indicating the irreversible nature of these neoplastic 
lesions. 
 
3.3 Dietary modulation and synergistic interactions of FB1-induced 
hepato-carcinogenesis 
 
3.3.1  Role of different dietary constituents 
A critical evaluation of the different diets used in studies, investigating the 
carcinogenic properties of maize culture material of F. verticillioides and FB1, 
has recently been published (Gelderblom et al., 2004). Studies using naturally 
contaminated maize, maize cultures of the fungus and purified FB1 in male 
Fischer 344 or male BD IX rats yield remarkably similar lesions in the liver 
with specific dose response effects. When utilizing a maize only diet (Wilson 
et al, 1985) and the semi purifed diet (Marasas et al, 1984; Jaskiewicz et al, 
1987), the choline and methione content seemed to be adequate considering 
the minimum requirements for rats (Keenan et al., 2000). In the corn-only diet, 
vitamins B12 and D were absent while vitamin E and folate were very low. 
The latter seems not to play a role as intestinal bacteria serve as a source 
although the disruption of the folate receptor by FB1 is likely to alter folate 
metabolism in the cell (Stevens et al., 1997). The low vitamin E levels in the 
corn-only diet could also be important to increase the susceptibility of FB1-
induced hepatotoxic effects. Low calcium and phosphate present as phytate, 
result in a low calcium-to-phosporus molar ratio (<1:3) that could lead to 
nephrocalcinosis that was observed when rats were fed a high dosage of FB1 
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(Gelderblom et al., 2001). Another important dietary constituent is the protein 
content with the corn (9.4%) and semi-purified (10.2%) diets falling well within 
the minimal requirements for rats. A high protein diet was reported to effect 
nephropathy as indicated by the NIH 31 diet used in the long-term FB1 
toxicology study in male Fischer rats that contained approximately twice the 
required protein content with 80 to 90 % of rats developed the syndrome 
(Howard et al., 2001). It is not known at present whether the high protein diet 
played a role in the development of kidney carcinoma induced by FB1 in the 
long-term study. This aspect will be further debatted in section 3.4.  
 
3.3.2  Role of dietary iron 
Dietary iron overload has been identified as a risk factor for the development 
of hepatocellular carcinoma although the underlying mechanisms are poorly 
understood (Mandishona et al., 1998). Several commonalities exist in the 
hepatoxtoxic effects induced by iron and the fumonisins, suggesting a 
possible synergistic interaction regarding the development of liver cancer. 
Both stimulated the induction of membrane lipid peroxidation resulting in 
oxidative cellular damage including DNA leading to the development of liver 
tumors, either directly or indirectly. However, induction of liver cancer was 
associated with the development of chronic persistent cirrhosis with FB1 while 
it was absent in the iron model (Asare et al., 2006). Excessive iron overload (1 
to 2% of carbolylic iron) significantly potentiated lipid peroxidation induced by 
FB1 in the liver over a period of 5 weeks, which was not associated with an 
increased hepatotoxic effect (Lemmer et al., 1999). FB1, however, shifted the 
iron distribution from the hepatocytes to the Kupffer cells, presumably due to 
phagocytosis of the necrotic iron-loaded hepatocytes. Dietary iron significantly 
reduced the number and size of hepatocyte PGST+ foci and nodules, which 
was related to the augmentation of the hepatic regenerative response to the 
FB1-induced hepatoxic effect. The decreased relative liver weight induced by 
FB1 was normalised by iron, suggesting that the associated inhibition of 
hepatocyte proliferation was countered. In this regard the mito-stimulatory 
effect of iron in the liver has been reported (Stal et al., 1995) and therefore 
could counter the FB1-induced selection process related to cancer promotion.  
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3.3.3 Role of tea antioxidants  
The possible role of lipid peroxidation in the hepotocarcinogenic effects of FB1 
initiated a study on the possible role of antioxidants on cancer promotion in rat 
liver utilizing diethylnitrosamine (DEN) as cancer initiator (Marnewick et al., 
2009). Different herbal infusions, unfermented and fermented rooibos 
(Aspalathus linearis) and honeybush (Cyclopia intermedia) herbal teas, and 
green and black teas (Camellia sinensis) were investigated. Unfermented 
rooibos and honeybush enhanced the hepatotoxic effects of FB1 when 
considering certain clinical chemical parameters associated with liver and 
kidney damage, suggesting specific FB1/iron/polyphenolic interactions related 
to pro-oxidant effects. Green tea significantly (P<0.05) enhanced the FB1-
induced reduction of the oxygen radical absorbance capacity, while fermented 
herbal teas and unfermented honeybush tea significantly (P<0.05) decreased 
FB1-induced lipid peroxidation in the liver. The latter was ascribed to the 
known reduced antioxidant potencies of these teas in different in vitro 
antioxidant assays. The teas exhibited varying effects on FB1-induced 
changes in the activities of catalase, glutathione peroxidase (GPx) glutathione 
reductase (GR) as well as the glutathione (GSH) status. All the teas reduced 
the relative amount of the larger foci suggesting an interference with the FB1-
selection process of initiated cells. Unfermented rooibos and honeybush teas 
significantly (P<0.05) to marginally (P<0.1) reduced the total number of foci 
(>10µm), respectively, suggesting an increased removal of initiated cells 
presumably due to apoptosis. Fermentation appeared to reduce the protective 
effect of the herbal teas. Differences in the major polyphenolic components 
and certain FB1/polyphenolic/tissue interactions may explain the varying 
effects of the different teas on the oxidative parameters, hepatotoxic effects 
and cancer promotion by FB1.  
 
3.3.4  Role of aflatoxin B1 
AFB1 is an important carcinogenic mycotoxin reported to co-occur with FB1 on 
dietary staples of humans (Ono et al., 2001). Both AFB1 and FB1 was shown 
to be weak cancer initiators when utilising the resistant hepatocyte liver 
model, which was related to their inhibitory effect on cell proliferation and the 
induction of apoptosis likely to remove initiated cells from the liver 
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(Gelderblom et al, 2002). A sequential model was therefore selected, as the 
simultaneous application of the two carcinogens could have countered the 
cancer initiating potency in the liver as described above. The separate 
treatment of rats with the mycotoxins only resulted in mild hepatotoxic effects 
while the sequential treatment resulted in cirrhotic livers with numerous 
PGST+ regenerative and dysplastic nodules, indicating a strong synergistic 
interaction. The sustained toxic effects of AFB1 rendered the liver more 
susceptible to the initiating potency of FB1, similar to other hepatotoxicants 
such as CCl4 known to effect regenerative cell proliferation (Gelderblom et al., 
2001). The major effect of FB1 in the sequential model, however, could be 
related to the cancer promoting properties which exceeded the properties of 
the 2-AAF/PH promoting stimulus. A more significant interaction was noticed 
between AFB1 vs FB1 as compared to FB1 vs 2-AAF, when considering the 
size of the preneoplastic lesions, which were ascribed to the promotion of the 
different subsets of initiated hepatocytes by FB1. As an apparent threshold for 
cancer initiation and promotion by FB1 exists, the synergistic interaction of the 
two mycotoxins may alter the potential to develop early preneoplastic lesions 
and hence their role in the development of certain phases in cancer 
development. 
 
3.4 Perspectives 
FB1 was shown to be responsible for most of the toxicological effects of F. 
verticillioides culture material in experimental and domestic animals. Two 
studies in horses showed the causative role of FB1 in the development of LEM 
while intravenous dosing in pigs provided evidence for the involvement of 
pulmonary edema (Harrison et al., 1990). A chronic hepatotoxic effect in rats 
was associated with the development of two types of carcinomas, i.e. 
hepatocellular and cholangiocarcinoma in male BD IX rats when fed over a 
period of two years. Subchronic levels significantly reduced the induction of 
hepatocellular and cholangiocarcinoma similar to that obtained with the fungal 
culture material. A discontinued feeding study in male Fischer 344 rats 
showed that a short-term exposure of 250 mg FB1/kg for five weeks and a 
subsequent 100 mg FB1/kg diet for 5 months resulted in the induction of 
hepatoadenomas and cholangiofibromas in these rats after a period on 1 
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year. Rats treated only with the five-week FB1 dietary regimen also developed 
similar lesions, providing evidence of the irreversible nature of the neoplastic 
lesion initiated in the liver. In one rat this lesion developed into a hepatocelluar 
carcinoma. The incidence of cholangiofibromas was increased when FB1 was 
used in combination with a cancer promoting 2-AAF dietary treatment 
(Lemmer et al., 2004). A possible role of oval cells in the development of 
adenomatous lesions has been suggested via the activation of a facultative 
stem cell compartment that could be the source of both the hepatocellular and 
cholangiocellular tumors induced by FB1. Both types of tumours were also 
induced in male Fischer rats by a naturally infected maize sample associated 
with an outbreak of LEM containing an apparent level of 50 mg FB/kg, 
indicating that the fumonisins are responsible for the hepatotoxicity in both rat 
species. The lack of hepatotoxic and carcinogenic effects of a chronic 
exposure of male Fischer rats to FB1 up to a level of 150mg/kg diet is 
somewhat surprising. Instead chronic kidney toxicity was reported with the 
development of kidney tumours in the mid and high dose groups.  Of interest 
was the development of rare anaplastic variants in 50% and 80% of the 
animals that developed tumors (Howard et al., 2001; Hard et al., 2001).  
 
The nephrocarcinogenicity properties of FB1 could be related to specific 
dietary interactions such as a high protein diet selectively sensitising the 
kidneys due the chronic progressive nephropathy (CPN). Recently it was 
reported that many renal tubule proliferative lesions developed in kidneys of 
especially male Fischer and Sprague-Dawley rats when chronically fed a high 
protein diet culminating in advanced CPN in older rats (Hard et al., 2005). One 
of these proliferative lesions includes atypical tubule hyperplasia (ATH) that 
develops into adenomas and is therefore regarded as a precursor lesion for 
kidney carcinogenesis. When considering the toxic and cancer promoting 
properties of the fumonisins, specific FB1/high protein diet interactions are 
likely to prevail whereby ATH could be promoted into adenomas and 
carcinomas. The induction of ATH in rats fed a high protein diet is also age 
related which is of interest as no neoplastic lesions were noticed in the 
kidneys up to six months in any of the FB1-treated rats, while hyperplastic 
tubule, ATH, adenomas and carcinomas were noticed after two years (NTP, 
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2001). This would suggest that renal adenomas and carcinomas develop in 
the presence of advanced CPN, which complicate attempts to mechanistically 
define the role of FB1. The presence of tubule hyperplasia, ATH and 
adenomas was also noticed in the females fed the two highest dose levels, 
although to a far lower extent (NTP, 2001; Hard et al., 2001). This is in 
agreement with the notion that male rats are more sensitive to CPN, which 
coincided with the higher tumor response when compared to females. 
However, it should be noted that lower FB1 dose levels were used in the 
females (Howard et al., 2001). The marginal dose response effect regarding 
the induction of renal tumors by FB1 further suggests a possible interaction 
with advanced CPN. 
 
The interactions between CPN and carcinogens are complex and should be 
treated with caution in order to exclude any confounding effect in relation to 
FB1-induced nephrocarcinogenesis. The use of male Fischer rats receiving a 
high protein diet in chronic nephrotoxicity and nephrocarcinogenicity models 
was questioned due to the formation of ATH and adenomas (Hard et al., 
2004). The NTP study, therefore, is likely to provide additional information on 
FB/dietary interactions and further elaborate on the cancer promoting 
properties of the fumonisins utilising different experimental protocols. This 
must be considered against the background that most of the long-term rat 
studies conducted thusfar provide evidence that the fumonisins are liver 
carcinogens (Sections 1.1 and 3.2). Of interest is that the NIH 31 diet (20.1% 
protein) was recently replaced by the NIH 2000 diet containing 14.5% protein 
to be used in long term toxicity testing (Rao et al., 1996). A similar argument 
could also be used when considering the hepatocarcinogenicity of FB1 in 
B6C3F1 female mice (Howard et al., 2001a). These mice are known to 
spontaneously develop adenoma and carcinomas over a period of two years 
(Haseman et al., 1994) and the dose dependent increase in the number of 
neoplastic lesions can be ascribed to the cancer promoting properties of FB1.   
 
The liver cancer model utilising male BD IX rats, therefore, provides a far 
better model to be utilised in determining risk assessment parameters, as 
more information is available regarding the underlying mechanisms of cancer 
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induction. In a long-term study in BD IX rats, early neoplastic lesions were 
already present after 6 months (Gelderblom et al., 1991) while the cancer 
initiating and promoting properties have been well defined (See details in 
Chapter IV) which provide, beyond any doubt, that the fumonisins are 
hepatocarcinogenic. Except for the myocardial endocardial fibrosis and 
oesophageal basal cell hyperplasia obtained, all the lesions induced by the 
fungal culture material of F. verticillioides in male BD IX rats were reproduced 
by FB1. The association of cardiac lesions with the consumption of culture 
material of F verticillioides is, however, still unresolved but could be related to 
the high dose of the culture material that was sued. The original study by 
Kriek et al. (1981a) with culture material of F. verticillioides reported on acute 
and proliferative endocardial lesions whereas culture material of a 
moniliformin-producing strain F. subglutinans caused myocardial degeneration 
and fibrosis (Kriek et al., 1977). These differences were confirmed by Marasas 
et al. (1984) who reported endothelial hyperplasia of the ventricular 
endocardium in male BD IX rats fed culture material of F verticillioides MRC 
826 that did not produce moniliformin (Kriek et al., 1981b). In contrast 
Jaskiewicz et al. (1987) reported a high incidence of myocardial disseminated 
fibrosis in male BD IX rats using the same culture material of MRC 826 while 
the incidence of endocardial fibrosis was far lower. Myocardial fibrosis was 
associated with moniliformin whilst endocardial damage was linked to an 
unknown compound produced by F. verticillioides. The only difference 
between the two studies was the use of freeze-dried material instead of oven-
dried culture material used by Marasas et al (1984).  
 
Although the culture material of MRC 826 is known to affect different organs in 
different animal species (Kriek et al 1981b), the kidney was not an important 
target organ in male BD IX rats fed culture material of F. verticillioides MRC 
826 (Kriek et al., 1981a, b; Marasas et al., 1984; Jaskiewicz et al., 1987). The 
long-term feeding study using pure FB1 up to a level of 1.6 FB1/kg/day 
showed no carcinogenic effects in the kidney of male BD IX rats (Gelderblom 
et al., 1991). The protein level in the semi-purified diet used in all these 
studies was 10.2% (Gelderblom et al., 2004). Dose response effects were 
noticed in the liver during a chronic feeding study using low dietary levels (1, 
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10 and 25 mg FB1/kg) representing an intake of 0.03, 0.3 and 0.8 mg 
FB1/kg/day over a period of 2 years. Lesions in rats receiving the highest dose 
(0.8 mg FB1/kg/day) were typical of those described previously in rats 
receiving an apparent FB1 dose of 1.6 ug/kg bw/day while only mild changes 
were noticed at an intake of 0.3 mg FB1/kg bw/day (Gelderblom et al., 2001). 
Typical ground glass foci were indcued at the lowest dose of 0.03 mg FB1/kg 
bw/day indicating that cancer initiation was also effected at this dose level. In 
the kidneys typical toxic lesions were noticed in the tubular epithelium, mainly 
the proximal convoluted tubules at an intake of 0.3 mg FB1/kg bw/day.  
 
In a study with purified FB1, fed to male Sprague Dawley rats no hepatotoxic 
changes were observed in the liver of the rats fed a 50 mg FB1/kg diet 
representing an estimated intake of 4.7 mg FB1/kg bw/day over a period of 4 
weeks (Voss et al., 1993, 1995a). Lesions characteristic of those induced by 
fungal culture material were obtained in the liver at a higher dosage (13.6 mg 
FB1/kg bw/day) diet. In the male rats, shown to be more sensitive than female, 
changes were observed at a dose of 14 mg FB1/kg bw/day. Studies in male 
Fisher rats at different locations using different diets indicated that very similar 
toxicological effects were induced in the liver either by incorporating FB1 in the 
diet or by gavage dosing  (Gelderblom et al., 1994, 1996, 2001a). Mild 
changes were observed in the liver at 3.5 mg FB1/kg bw/day dietary level for 
21 days, which is in agreement with the long-term study in BD IX rats 
(Gelderblom et al, 1996b; 2001b). In contrast, no hepatotoxic effects were 
reported in the liver at a dietary intake of up to 5.7 mg FB1/kg bw/day over 90 
days while kidney lesions were noticed at an intake of 0.62 mg FB1/kg bw/day 
with a NOEL of 0.21 mg FB1/kg bw/day (Voss et al., 1995b). The latter study 
is in accordance with the findings of the NTP study where male Fischer rats 
developed renal adenoma and carcinoma while no toxic lesions were obtained 
in liver at an exposure level of 6.6 mg FB1/kg bw/day over a period of two 
years (Howard et al., 2001). A NOEL for kidney tumors in male Fischer rats 
was defined to be between an intake of 0.7 and 2.2 mg FB1/kg bw/day. A 
NOEL for nephrotoxicity was set at 0.2 mg FB1/kg bw/day which was obtained 
during the 90 day and two year chronic feeding NTP studies (Vos et al., 1995; 
Howard et al., 2001). Based on the notion that nephrotoxicity is a prerequisite 
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for renal carcinogenesis the intake level was considered by Joint FAO/WHO 
Expert Committee on Food Additives (JECFA) to obtain the Provisional 
Tolerable Daily Intake (PMTDI) for fumonisins in humans. However, a dose of 
0.7 mg FB1/kg bw/day for 2 years induced kidney lesions without the induction 
of ATH, a precursor lesion of the renal tumors which raised some doubts 
about the cell death/compensatory regenerative model for FB1-induced 
nephrocarcinogensis proposed by Dragan et al, (2001). This is further 
complicated by the induction of proliferative lesion in the kidney due to the 
development of CPN. 
 
The possible role of different dietary constituents on the FB1-induced 
toxicological effects has been addressed recently (Gelderblom et al., 2004). 
However, very few studies regarding the role of diet and FB1 carcinogenicity 
have been conducted. The interaction between FB1 and dietary iron has 
recently being addressed indicating that a protective effect was obtained 
against cancer promotion, presumably due to the mitogenic properties of iron. 
In a subsequent long-term study the role of low levels of dietary iron was re-
evaluated in a discontinued FB1 feeding study (Werner, 2002). A dual role of 
iron on FB1-induced hepatocarcinogenesis was proposed in that (i) iron 
overload enhanced the induction of hepatocyte nodules in the presence of 
FB1 while (ii) after removal of FB1, the continued iron supplementation 
impaired the progression of the hepatic nodules. The exact mechanism 
involved is not known but the differential modulation of FB1 and iron on cell 
proliferation and oxidative damage could be of importance in altering the 
growth of preneoplastic lesions. The interaction between antioxidants and 
FB1-induced hepato- and nephrotoxicity has been investigated by monitoring 
the protective effect of royal jelly, obtained from worker honey bees, in 
Sprague-Dawley rats (El-Nekeety et al., 2007). Co-treatment of the rat with 
the royal jelly significantly reduced the toxic effects of FB1 in the liver and 
kidneys in a dose-dependent manner. The protection was associated with a 
significant increase in the FB1-induced reduction in glutathione peroxidase 
and superoxide dismutase while it also counteracted the increase in lipid 
peroxidation, presumably related to the free oxygen radical scavenging and 
antioxidant properties of the royal jelly.  Garlic and cabbage extracts have 
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been shown to protect against FB-induced developmental toxicity in Sprague-
Dawley rats (Abdel-Wahhab et al., 2004). The extracts siginificantly reduced 
the number of skeletal malformations, presumably due to the presence of 
dially sulphide known to protect against oxidative damage (Horie et al., 1989). 
These studies provide further evidence that different dietary constituents may 
interfere with fumonisin-induced toxic effects which could be used in 
developing chemopreventative initiatives. 
 
The synergistic interactions between FB1 and other toxins and/or different 
dietary components, although complex, are of importance when considering 
the toxic and carcinogenic properties. The combined hepatotoxic effects of 
AFB1 and FB1 in growing barrows also exceed that of the individual 
mycotoxins (Harvey et al., 1995). A similar finding was recorded using 
growing barrows regarding the combined effects of FB1 and deoxynivalenol 
while the hematological and immunological parameters showed increased 
responses as a result of the combined treatment (Harvey et al., 1996). Co-
administration of FB1 increased the mortality caused by AFB1 in rats in an 
additive manner (Mckean et al., 2006). In New Zealand white rabbits co-
administration of AFB1 and FB1 showed synergistic liver and kidney 
toxicological effects when considering the clinical chemical data and histology 
analyses (Orsi et al., 2007). FB1 also significantly enhanced the development 
of tumours in AFB1 treated rainbow trout (Carlson et al., 2001). Several 
studies utilising different cell culture systems reported on the synergistic 
and/or additive effects of FB1 in combination with different toxins. A synergistic 
cytotoxic effect was noticed between FB1 and ochratoxin A when monitoring 
cytototixity in rat brain gliomal cells, human intestinal Caco cells and green 
monkey kidney Vero cells (Creppy et al., 2004). Additive effects regarding the 
increase in TBARS and decrease in GSH levels by FB1, ochratoxin A, and 
beauvericin were reported in porcine kidney epithelial cells (Klarić et al., 
2006). However, depending on the time of exposure and dose utilised 
synergistic and/or antagonistic effects were obtained. In human 
lymphoblastoid cells (Jurkat T) FB1 increased cell proliferation while it 
enhanced the inhibitory effects of alpha-zearalenol (Luongo et al., 2006). In 
hepatoma cells (HepG2), FB1 exhibited an antagonistic effect against AFB1-
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induced cytotoxic effects while an additive effect was noticed in human 
bronchial epithelial cells (Mckean et al., 2006). These interactive models 
should to impact on setting realistic risk assessment parameters, not only for 
the fumonisins, but also other naturally occurring mycotoxins. 
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Abstract
The toxicity of low dietary levels of fumonisin B1 (FB1), i.e. 1, 10 and 25 mg FB1:kg diet, were monitored in rats
over a period of 24 months. No effects on the body weight gain and feed intake profiles were noticed, while the
relative liver weight was significantly (PB0.05) reduced in the FB1-treated rats. Mild toxic effects, including single
cell necrosis (apoptosis), proliferation of bile duct epithelial cells (DEC), and early signs of fibrosis, bile duct
hyperplasia and in one case, adenofibrosis, were noticed in the liver of the rats fed the highest (25 mg:FB1:kg diet)
dietary level. A significant (PB0.05) increase in the level of oxidative damage was also noticed in the liver of the rats
of high dosage dietary group. The toxic effects were less severe in the 10 mg FB1:kg dietary group, whilst only a few
ground glass foci were observed in the 1 mg FB1:kg dietary group. Hepatocyte nodules, staining positively for
glutathione-S-transferase (placental form, PGST), were observed macroscopically in the 25 mg FB1:kg treated group
and to a lesser extent in the 10 mg FB1:kg treated rats. The most prominent toxic lesions by FB1 (10 and 25 mg
FB1:kg dietary groups) in the kidneys were restricted to the tubular epithelium manifesting as granular cast, necrosis,
apoptosis, calcification and the presence of regenerative foci in the proximal convoluted tubules. The existence of a
cytotoxic:proliferative threshold with respect to cancer induction by FB1 in rat liver became apparent, with a dietary
level of B10-mg FB1:kg diet as a no effect threshold for the induction of hepatocyte nodules. © 2001 Elsevier
Science Ireland Ltd. All rights reserved.
Keywords: Toxicity of fumonisin B1 in rats
www.elsevier.com:locate:toxicol
1. Introduction
Chronic feeding studies in male BD IX rats
over 26 months showed that 66% of the rats
developed liver cancer at a dietary level of 50 mg
fumonisin B1 (FB1):kg diet (Gelderblom et al.,
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1991). The cancer developed from severely cir-
rhotic livers, while cholangiofibrosis also ap-
peared to be a common lesion in the majority of
the livers of the rats. Very few hepatotoxic effects
were noticed in the liver of male and female
Fischer rats, even upto a dietary level of 150 mg
FB1:kg fed over a period of 2 years (NTP TR 496,
1999). These long-term, as well as short-term feed-
ing studies in rats (Voss et al., 1993, 1995;
Gelderblom et al., 1996a) indicated that the liver
and kidneys are the major target organs affected
by FB1.
Toxicological and carcinogenic studies to assess
the biological effects of FB1 in vivo in rats
(Gelderblom et al., 1992) and in vitro utilising
primary hepatocytes (Gelderblom et al., 1992;
Norred et al., 1992; Gelderblom et al., 1993)
failed to detect any genotoxic effects. In spite of
these findings, it was shown that FB1 closely
mimics the effects of the genotoxic hepatocarcino-
gens with respect to their ability to induce cancer
initiation and promotion in the liver (Gelderblom
et al., 1992, 1994, 1996b). Studies utilising a short-
term, cancer initiation:promotion model in the rat
liver, indicated that, with FB1, a concurrent hepa-
totoxic effect is required for the induction of
cancer initiation (Gelderblom et al., 1994). Cancer
promotion, however, can be induced at dietary
levels of FB1 that were less hepatotoxic
(Gelderblom et al., 1996b). It is not known
whether cancer will develop in the liver of rats in
the absence of chronic hepatotoxic effects.
The present study further investigates the toxi-
cological effects of low dietary levels of FB1 in
male BD IX rats as part of an ongoing process to
establish risk assessment parameters of fumon-
isins for humans.
2. Materials and methods
2.1. FB1 standard
FB1 was purified as described elsewhere (Ca-
wood et al., 1991) to a purity of between 92 and
95% as verified by HPLC (Shephard et al., 1990).
Contaminants consisted of the mono-methyl es-
ters (1–2%) of FB1 and H2O (1–2%). The mono-
methyl esters also exhibited similar biological
activity with respect to cancer initiation in rat
liver (Gelderblom et al., 1993). The stock sample
of the mycotoxin was kept as a dried powder in
an airtight container at 4°C.
2.2. Animals and diets
Inbred BD IX rats, after having reached a body
weight of approximately 100 g, were randomly
divided into three treatment groups of 20 rats
each. They were caged individually in a controlled
environment facility with a 12-h artificial light
cycle, an environmental temperature varying from
23 to 25°C and humidity of 50%.
The rats were fed a semi-synthetic diet (Van
Rensburg et al., 1985) earlier used in long-term
carcinogenesis studies in rats (Gelderblom et al.,
1991). This corn based diet consisted of sifted
corn meal (750 g:kg diet) and a vitamin and
mineral supplement compiled to be marginally
deficient in vitamins and lipotropes (Gelderblom
et al., 1991). Aflatoxin (Thiel et al., 1986) and
fumonisin (Shephard et al., 1990) levels in the
corn meal supplement were analysed on a regular
basis. Depending on the matrices analysed, the
detection limits of these methods were 0.1–0.5
and 10–50 mg:kg for aflatoxin B1 and FB1,
respectively.
The experimental diets were prepared by dis-
solving the calculated amount of FB1 into
methanol (ca 50 ml) and mixing it into a sub-sam-
ple (200 g) of the diet that was then allowed to
dry overnight in a extraction cabinet. Only
methanol was added to the control diet. The
sub-samples were mixed into the corresponding
stock diets (6-kg) and stored under N2 at 4°C for
periods of not longer than 4 weeks.
2.3. Treatments
Water and food were available ad libitum. The
different groups of the experimental rats were fed
diets containing, respectively 1, 10 and 25 mg
FB1:kg. All the rats were weighed once weekly
and feed intake was measured daily over a period
of 14 days after 2, 8 and 14 months, respectively.
The 14 month FB1 intake of the rats fed the
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control, 1, 10 and 25 mg FB1:kg diets were used
as the average FB1 intake to calculate the cumula-
tive FB1 intakes over the 24 month period. From
18 months after commencement of the experi-
ment, rats in poor condition were euthanised for
necropsy purposes. All surviving rats were killed
after 24 months by intraperitoneally administering
an overdose of sodium pentobarbital and sub-
jected to a necropsy.
2.4. Clinical pathological analyses
Serum samples were prepared from blood col-
lected from the abdominal aorta of rats after
euthanisation. These samples were analysed for
alanine aminotransferase (ALT), aspartate amino-
transferase (AST), glutamine aminotransferase
(GLT), alkaline phosphatase (ALP), and total
cholesterol by Technicon autoanalyses. Low- and
high-density lipoproteins (LDL and HDL) and
triacylglycerol (TAG) were determined by meth-
ods described earlier (Fincham et al., 1992).
2.5. Necropsy
Routine necropsies were performed on all the
rats. At necropsy, the body and liver weight of the
rats were determined and the organs observed
macroscopically for the presence of any abnor-
malities. Specimens collected from the major lobes
of the liver were preserved in 10% buffered forma-
lin for histopathology and histochemical staining
to determine the presence of GSTP and gamma
glutamyltranspeptidase (GGT) foci. The remain-
der of the liver was frozen at 80°C in saline,
while the rest of the organs were preserved in 10%
buffered formalin for histological examination.
2.6. Histopathological and histochemical analyses
GSTP staining (Tatematsu et al., 1988) was
performed using the avidin–biotin–peroxidase
complex (ABC) and affinity-purified biotin-la-
belled goat anti-rabbit IgG serum (Vector Labo-
ratories, Burlingame, CA). The paraffin
wax-embedded sections of the acetone-preserved
material were routinely processed through
petroleum benzene and a graded alcohol series
before being stained with the reagents in the ABC
kit. Rabbit GSTP-antiserum (kindly donated by
Dr E Farber, Department of Pathology, Univer-
sity of Toronto) was used at a dilution of 1:800.
The sections were counter-stained with Carazzi’s
haematoxylin to provide blue-stained nuclei, while
the GSTP cells were characterised by the pres-
ence of a reddish-brown pigment. Negative and
positive controls for the stain were also included
to test for the specificity of anti-GSTP antibody
binding. The procedures outlined by Ogawa et al.
(1980) were followed for the GGT staining. The
presence of GGT and GSTP altered lesions
were detected by light microscopy (10–20X mag-
nification). The GSTP foci were further cate-
gorised into lesions containing B5 cells; 5–20
cells and \20 stained cells per focus. Tissue
sections of all the preserved organs were routinely
processed for histopathological evaluation and
stained with haematoxylin and eosin.
2.7. Determination of thiobarbituric acid reacti6e
material (TBARS)
The liver homogenate (1 ml) (0.1–2.0 mg
protein:ml phosphate buffer containing 0.1 M
EDTA) was mixed with 2 ml of a cold 10%
trichloroacetic acid (TCA) solution containing
0.01% butylated hydroxytoluene (BHT). Follow-
ing centrifugation (3000 rpm), 2 ml of the super-
natant was added to 2 ml of a 0.67% TBA
solution in a test tube and immersed in boiling
water for 10 min. The mixture was then allowed
to cool and the absorbance measured at 532 nm
(Esterbauer and Cheeseman, 1990). Lipid peroxi-
dation was expressed as nmole malondialdehyde
(MDA) equivalents per mg protein using a molar
extinction coefficient of 1.56105 M:cm at 532
nm for MDA (Buege and Aust, 1978). Determina-
tion of MDA as described above is known not to
be specific as various substances such as sucrose,
metal ions and whole tissue homogenates may
also react with TBA or influence the assay proce-
dure. The term thiobarbituric acid-reacting sub-
stances (TBARS) are, therefore, used to describe
the reaction product in the assay (Esterbauer and
Cheeseman, 1990). Non-specific lipid peroxidation
was prevented by the incorporation of EDTA in
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the buffers and BHT in the reaction solutions for
the TBARS assay.
2.8. Statistical analyses
Data were subjected to analysis of variance
(ANOVA) using the Statistical Analysis System
(SAS Institute Inc., Cary, NC). Differences be-
tween mean were determined by the Tukey Stu-
dentised Range method. The differences between
the feed intake profiles at months 2, 8 and 14
(Table 1) were analysed by the parametric paired-
difference t-test. The Kruskal-Wallis test was used
to determine whether the median of the lesions in
the different organs, the liver and kidneys differed
significantly between the four treatment groups.
3. Results
3.1. Feed intake and body weight
Fumonisin analyses of commercial corn meal
samples that were used in the diet revealed mean
levels (FB1FB2) of approximately 0.22 mg:kg
(ranging between 0 and 0.6 mg FB:kg). Based on
these data the control diet contained levels of
approximately 0.16 mg FB:kg. No aflatoxin con-
tamination was detected. The survival rate of the
animals, prior to termination that started between
18 and 24 months after commencement was in the
order of 80%. Rats terminated before the end of
the experiment, (prior to 24 months) suffered
from mild to severe interstitial pneumonia.
There were no significant differences between
the body weights of the FB1-treated rats and the
control group at 2, 8 and 14 months (Table 1).
The total body weight gain for the duration (24
months) of the experiment (Table 4) also did not
differ significantly (P\0.05) between the different
treatment groups. However, the relative liver
weight (g:100 g body weight) of the rats fed the
FB1-containing diets was significantly lower
(either PB0.01 or PB0.05) than the control
group at 24 months. The feed intake (g feed:100 g
body weight) profiles were significantly (PB
Table 1
Body weight, intake of feed and FB1, and the cumulative amount of FB1 ingested at 2, 8 and 14 months, respectively, after
commencement of the experimenta
Cumulative (mg FB1:100Treatment (mg FB1 intake (mg:100 g BWFeed intake (g:100 g BWMean body weight
g BW)b(BW) (g) per day)FB1:kg diet) per day)
2 months
0.0008c5.2690.88a217926 0.0590.02Ctrl (n20)
1 (n20) 4.9890.43a223923 0.00590.001 0.290.1
218922 5.0390.84a 0.0690.01 2.890.610 (n20)
25 (n20) 5.4890.70a209918 0.1490.02 7.891.1
8 months
4.1690.67B335938a 0.1790.04Ctrl (n20) 0.0007c
340947a1 (n18) 4.2390.45B 0.00590.001 1.190.3
345938a10 (n20) 10.192.64.0290.82B 0.0490.01
25 (n19) 26.095.20.1090.014.1190.51B347928a
14 months
419933a 3.0190.46CCtrl (n18) 0.0005c 0.2190.05
1 (n16) 437963a 3.0890.47C 0.00390.001 1.490.05
13.790.50.0390.013.3990.37C413935a10 (n17)
387955 3.4790.43D 0.0890.0125 (n18) 36.594.6
a Values are expressed as the mean9S.D. of the various values obtained from the rats remaining in each group at each time
period. The means followed by the same letter do not differ significantly. If the letters and cases differ, then PB0.01; if the letter
differs then PB0.05.
b Values represent the cumulative FB1 intake from the start of the experiment.
c Values calculated from the FB1 content of commercial maize meal used in compiling the diet (see Section 2). BW; body weight.
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Table 2
Clinical pathological data of rats euthanised 24 months after commencement of the experimenta
LDL cholesterol Total cholesterolTreatment (mg Plasma TAG HDL Cholesterol % HDL
(mmol:l)(mmol:l) (mmol:l)(mmol:l)FB1:kg diet)
Plasma lipid profiles:
1.84a (0.40)Control 3.37a (1.46)1.03a (0.07) 0.73a (0.16) 42.18a (4.89)
1 1.76ab (0.34)1.04a (0.08) 3.94a (1.91) 0.63ab (0.22) 40.35a (6.64)
1.45b (0.38) 4.26a (2.13)1.02a (0.05) 0.48b (0.20)10 35.48a (7.52)
1.12a (0.22)25 1.93a (0.28) 3.52a (0.92) 0.76a (0.15) 39.34a (4.06)
Serum parameters:
AST (U:l) ALT (U:l)Creatinine (mmol:l) GLT (U:l) ALP (U:l)
43.67a (5.92)Control 103.13a (21.68) 29.86a (3.76) 3.56a (1.24) 119.63a (18.45)
120.44a (16.18)1 31.00a (17.00)48.36ab (5.70) 4.09a (0.94) 125.50a (26.73)
168.36B (23.42) 43.36a (14.82)52.56b (6.95) 3.63a (0.92)10 120.75a (18.4)
189.00B (14.80)25 42.80a (12.25)54.13b (8.44) 3.25a (1.28) 120.63a (29.11)
a Values are expressed as the mean9S.D. (in parenthesis) of nine or 10 animal per group. Means followed by the same letter do
not differ statistically (P\0.05). If the letters differ, then PB0.05 and when letters and case differ, then PB0.01.
0.001) reduced in the older rats during the time
course of the experiment (Table 1). The cumula-
tive FB1 intake of the different groups was calcu-
lated at 2, 8 and 14 months using the daily FB1
intakes monitored at that specific period. The
14-month FB1 intake profiles of the rats fed the
control, 1, 10 and 25 mg FB1:kg diets were used
as the average FB1 intake to calculate cumulative
FB1 intakes over the 24 month period. The feed
wastage during the 14-day dietary intake experi-
ments was 0.3690.21%.
3.2. Clinical pathological analyses
After 24 months the total cholesterol and the
HDL cholesterol were significantly (PB0.05)
lower in the rats fed the 1 and 10 mg FB1:kg diets
than in the controls and the high dose group
(Table 2). There were no significant difference
(P\0.05) between the control and the 25 mg
FB1:kg diet groups. FB1 treatment did not alter
the levels of TAG, LDL and the % HDL. Serum
GLT and ALP were not altered, while AST was
significantly (PB0.01) and ALT markedly (but
not significantly) increased in a dose response
manner in the 10 and 25 mg:kg FB1-treated
groups. Creatinine levels were significantly ele-
vated above the controls in the rats fed 10 and 25
mg FB1:kg diets (PB0.05) and markedly (but not
significantly, PB0.1) in the 1 mg FB1:kg
treatment.
3.3. Enzyme altered foci and:or nodules
GGT foci, with irregular outlines, were not
readily detected and only a few liver sections from
the highest dose of FB1 with an average (S.D.) of
0.61190.442 foci:cm2. The foci contained more
than 10 cells with a diameter ranging from 435 to
630 mm (data not shown). No foci were detected
in either the controls or the rats receiving 1 and
10 mg FB1:kg diet. The number of GSTP posi-
tive lesions (B5 cells), minifoci (5–20 cells) and
foci and nodules (\20 cells) did not differ signifi-
cantly between the control, 1 and 10 mg FB1:kg
diet groups although more rats contained foci in
their livers in the 10 mg FB1:kg group. The
number of mini foci (5–20 cells:focus) and foci
(\20 cells:focus) were significantly (PB0.01)
higher in the group fed the 25 mg FB1:kg diet
(Fig. 1). All the rats (14:14) treated with the 25
mg FB1:kg diets exhibited foci in their livers while
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Fig. 1. The distribution of GSTP single cells, mini foci and
foci in liver tissue sections of rats treated with three different
dietary levels (1, 10 and 25 mg FB1:kg) over a period of 24
months. Values are the mean with the number of rats with
lesions in the liver given in parenthesis.
3.5. Gross and histopathological changes
The number of lesions and the extent of the
changes observed at necropsy and histopathologi-
cally differed according to the dosage of FB1
consumed in the diet over the duration of the
experiment. The lesions detected in the individual
rats reflected changes of three basic categories —
those associated with exposure to FB1 in the diet,
those associated with secondary acute bacterial
infections (septicaemia and abscessation), and
age-associated changes (Table 3). Except for the
marginally significant (PB0.1) increase in the
lesions in the liver, no differences in the frequency
of lesions could be observed in other organs that
can be ascribed to the FB1-dietary treatment.
Those seen in the other organs were either age-as-
sociated changes or the consequences of acute
bacterial infections. The prevalence of organ
changes caused by secondary bacterial infections
(abscesses in organs such as the lungs, prostate,
and spleen, as well as peritonitis and meningitis)
was noticeably higher in the rats fed the high
dosage (25 mg:kg diet) of FB1. No difference in
the prevalence of these infections was detected
between the lower dosage groups and the control
animals. Interstitial pneumonia occurred in a
large proportion of the rats of all groups and
resulted in the development of chronic bronchitis
that in certain cases progressed to bronchiectasia.
These pneumonic changes also seemed to enhance
the development of secondary bacterial infections.
Age-associated lesions that occurred in rats of the
various treatment groups and in the control rats
included prostatic hyperplasia and prostatitis, cal-
cification and atrophy of the testes, and the occur-
rence of various neoplasms. The neoplasms seen
were a gastric carcinoma and squamous cell car-
cinoma of undetermined location in the 25 mg
FB1:kg dietary group, lymphoma, small intestinal
carcinoma and a sub-cutaneous fibrosarcoma in
the 10 mg FB1:kg dietary group, and a subcuta-
neous fibrosarcoma in the control group. No neo-
plasms were detected in the 1 mg FB1:kg dietary
group.
The lesions seen in the liver and kidneys of the
animals affected reflected the consequence of ex-
posure of these animals to dietary FB1 (Table 4).
only 5:14, 4:12, 8:11 rats had altered hepatocyte
foci in the control 1, 10 mg FB1:kg treated
groups, respectively.
3.4. TBARS generation
The FB1-treated rats showed no significantly
increase in the production of TBARS at
dietary levels of 1 and 10 mg dietary levels. A
significant (PB0.05) increase was noticed in the
liver of the rats fed the 25 mg FB1:kg dietary level
(Fig. 2).
Fig. 2. Dose-response of TBARS generation in vivo in rat liver
homogenates as a function of dietary FB1 levels. Data are the
mean of triplicate determinations. *PB0.05.
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Table 3
Frequency of lesion in the organs of rats in the treatment (FB1) and control groups
a
10 mg FB1:kg diet (n18) 1 mg FB1:kg diet (n14)Organ Control diet (n16)25 mg FB1:kg diet (n17)
10Kidney 1011 10
12 1016(*) 9Liver
11 11Lung 1115
4 48 4Prostate
2Testis 811 8
2 –1 –Thyroid
1 –Lymph node ––
1 13 –Muscle
– –Spleen –1
– 11 –Bladder
– 1Brain –1
– –2 –Heart
2Pancreas – – –
– 11 –Peritoneum
– –Stomach –2
1 –– –Intestine
3 2 1Septicaemia 7*
3 –2 1Neoplasms
a Values differ significantly from the control treatment; (*PB0.05; (*) PB0.1).
3.6. Li6er
The lesions that could be ascribed to fumonisin
treatment were present in all the FB1 treatment
groups. Minor changes were detected in some of
the rats treated with the 10 mg FB1:kg diet, while
only minimal changes were noticed in the 1 mg
FB1:kg when compared with the control groups.
In the rats that received 25 mg FB1:kg diet,
apoptosis, proliferation of duct epithelial cells
(DEC) and mild fibrosis, that in some cases
caused bridging between the portal tracts, were
detected. These changes resulted in a slight distor-
tion in the architecture of the liver in some rats.
One rat in this group showed a large focal area of
adenofibrosis. Of the rats killed at 24 months in
the groups fed 10 and 25 mg FB1:kg, respectively,
12% (2:17) and 55% (10:18) had hepatocyte nod-
ules that were macroscopically visible in their
liver. The number of nodules varied between 1–2
and 1–5 nodules per liver in the rats fed the 10 or
25 mg FB1:kg diets, respectively. The nodules in
the high-dose group were slightly larger (1–6
mm), than those (1–3 mm) in the rats fed 10 mg
FB1:kg. All the nodules exhibited mild to severe
fatty changes and had a ground glass to
basophilic appearance imparted by the staining
reaction of the hepatocytes in the nodules. Other
pathological changes in the liver included mild
peri-acinar fatty changes, mild to prominent an-
isonucleosis, and a few apoptotic bodies that were
scattered throughout the hepatic lobules.
3.7. Kidneys
The most prominent lesions were present in the
rats that received the 25 mg FB1:kg diet (Table 4).
The lesions seen in glomeruli were consistently
present in all the experimental groups and in the
control group. The severity of these glomerular
lesions was apparently enhanced by the presence
of increased levels of FB1 in the diet. The preva-
lence of hyaline casts and cortical cysts was also
associated with the presence of the glomerular
lesions and did not appear to be correlated with
the dosage level of FB1. The lesions that appear to
have been caused by FB1 were restricted to the
tubular epithelium and included the presence of
granular casts, necrosis, apoptosis, calcification,
and the presence of regenerative foci (that may
also be interpreted as hyperplastic foci) of tubular
epithelium in the proximal convoluted tubules.
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Some of the changes associated with septicaemia
(such as degenerative changes in the tubular ep-
ithelium, acute tubular necrosis and the presence
of granular casts) would not differ from those
caused by the toxicological effects of FB1. The
presence of these changes may influence interpre-
tation of the significance of some of the more
acute lesions present in the kidneys.
4. Discussion
The consequences of the intake of low dietary
levels of FB1 in the present study reflected the
ability of the compound to induce discernible
toxic effects at dosages of, as low as, 0.03 mg:kg
body weight per day (1 mg FB1:kg diet) in the
diet over a period of 18–24 months. No hepato-
Table 4
Frequency of histopathology lesions observed in the liver and kidneys of rats in the FB1 treatment and control groups
a
Parameter Treatments (mg FB1:kg diet)
25 10 1 Control
16:20Survival rate 17:20 18:20 14:20
387.4 (41.4)Body weight gain 390.5 (54.0) 399.2 (39.5) 407 (48.1)
2.5 (0.2)2.2 (0.1)**2.2 (0.3)**Liver weight (%) 2.3 (0.3)*
Li6er histology
13* 8*Anisokaryosis 2 –
Ground glass foci –4*3(*)7*
21 12Cell swelling
10649Fatty changes
9* 0 0Hepatocyte nodules 0
Basophilic foci
3 –Bile duct hyperplasia – –
Apoptosis 1232
Portal fibrosis –––5*
– ––2OVC hyperplasia
5* – – –Lobular distortion
–Bridging fibrosis –1 –
–Adenofibrosis 1 – –
Kidney histology
7 – –Granular casts –
36Hyaline casts 5 3
Cortical cysts 6 2 15
89810Periglomerular infiltrate
Capsular cell proliferation 5544
– 113Hyaline droplets in glomerulus
5 1 3 –Peri-glomerular scarring
PCTs
–Fatty changes 5* – –
2* – – 1Apoptosis
3(*) 2(*)Cell swelling – –
DCTs
4* 3(*)Necrosis of epithelium – –
4* – – –Calcinosis
3(*) –Foci of hyperplasia (regeneration) – –
Embolic abscesses 1 – – –
–Acute tubular necrosis 2 ––
14 1Infarction (recent and healed) 3
––1–Pyelonephritis
a Values differ significantly from the control treatment, **PB0.01, *PB0.05; (*)0.05BPB0.1. PCTs, proximal convoluted tubuli;
DCTs, distal convoluted tubuli; OVC, oval cells.
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cellular or cholangiocellular carcinomas devel-
oped at the higher dosage levels used (10 and 25
FB1:kg). The neoplasms detected in the rats in
this study are considered to be incidental age-as-
sociated lesions as they occurred in various organs
and also in the control group of animals. There
was no obvious dose-response relationship be-
tween the neoplasms seen in the various groups
and the level of FB1 ingested. Septicemia was also
significantly increased in highest dosage group.
Whether this effect could be related to the adverse
effects of FB1 on the immune system as described
by Martinova et al. (1995) is not known at
present.
The lesions induced by FB1 in rats in the
present experiment were similar but far less severe
than those seen in short- and long-term experi-
ments in which higher dosages were used
(Gelderblom et al., 1996a). The clinical pathology
data correlated with the presence and extent of
the lesions seen histopathologically in the liver
and kidney. The changes that occurred in the liver
of the FB1-treated rats, such as fibrosis, prolifera-
tion of bile duct (oval) epithelial cells, lipid accu-
mulation and hepatocyte nodules have been
described in detail elsewhere (Gelderblom et al.,
1988, 1991, 1992, 1993, 1994). In this study, the
peri-acinar fatty changes and cell swelling also
occurred in the control rats and these changes
appear to be a consequence of the diet rather than
the ingestion of FB1. The histological lesions
caused by FB1 in the kidneys, also reflected by an
increase in serum creatinine levels were present in
the rats fed the 10 and 25 mg FB1:kg diet. These
findings are in agreement with those reported in
studies, where renal lesions were detected in male
and female Sprague–Dawley rats fed 15 and 50
mg FB1:kg, respectively, for 4 weeks (Voss et al.,
1993, 1995). The changes that can be ascribed to
FB1 in this study are those of chronic, low-grade
renal toxicity in which the lesions are limited to
the proximal and distal tubules. Many of the
lesions seen in the kidneys of the rats in this study
were those of an endemic, age-associated
glomerulopathy. The severity of these age-associ-
ated lesions that appeared in terms of severity, to
reflect a dose-response effect, did appear to be
enhanced by exposure to the FB1 in the diet. A
focal hyperplastic (or regenerative response) was
seen in only three of the rats at a dosage level of
25 mg FB1:kg in the diet. In some instances,
interpretation of induced lesions was hampered by
the changes that could be ascribed as incidental as
they were caused by embolic abscessation, acute
tubular necrosis, pyelonephritis and infarction
due to septicemia and disseminated abscessation
in a number of rats in the advanced stage of the
experiment.
With respect to the lowest observed effects, it
would appear that under the present experimental
conditions, a level of 1 mg FB1:kg diet still
caused minimal toxic changes (histological) in the
liver and kidneys of BD IX rats fed a mar-
ginally deficient diet over a period of 2 years. The
clinical pathology data also reflects sig-
nificant to marginal effects in serum creatinine
and AST. The only significant change obtained in
the liver with 1 mg FB1:kg dietary level
was the induction of ground glass foci.
The low dietary levels of FB1 used in the present
study did not induce significant (P\0.05) feed
refusal and a reduction in body weight
gain as was observed in short-term studies
using high dosage levels of the toxin (Gelderblom
et al., 1994). However, the relative liver weight
was significantly decreased (Table 4), probably
due to the inhibitory effect of FB1 on hepatocyte
cell proliferation (Gelderblom et al., 1994, 1996b)
and the induction of apoptosis (Lemmer et al.,
1999).
The current study further supports the hypothe-
sis that a relationship exists between FB1-induced
hepatotoxicity and hepatocarcinogenicity. In the
short-term cancer initiating promoting assays, di-
etary levels of 100 mg FB1:kg and less, which only
induce mild toxic effects failed to initiate cancer
(Gelderblom et al., 1994). Cancer promotion oc-
curs at lower dietary levels (up to 50 mg FB1:kg
diet) in the absence of marked toxicity
(Gelderblom et al., 1996b). These data suggest
that a threshold exists for cancer initiation and
promotion. This threshold may be a function of
the level of FB1, the severity of the lesions in-
duced and the duration of exposure. The hepato-
cyte nodules noticed in the rats that received 25
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Fig. 3. Diagram illustrates the kinetics of the induction of preneoplastic and neoplastic lesions in the liver of male BD IX rats as
a function of time and different dietary levels of FB1. A dietary level of \50 mg FB1:kg (Gelderblom et al., 1991) induces
hepatocyte nodules after 6 months (T6 months) while HCC are induced between 18 and 24 months (T18–24 months). Dietary
levels B25 mg FB1:kg induces mild toxic effects and hepatocyte nodules between 18 and 24 months (T18–24 months).
mg FB1:kg (9:17) in the present experiment, indi-
cate that the mild hepatotoxic effects induced by
FB1 is associated with their development. It can
be argued that the presence of only mild toxic
effects caused ingestion of low levels of FB1, delay
the progression of these lesions to cancer. This is
also in agreement with the threshold effect with
respect to cancer promoting potential of the fu-
monisins (Gelderblom et al., 1996b). A cytotoxic:
proliferative threshold, therefore, seems to exist
with respect to induction of hepatocyte nodules
and their progression into cancer. This conclusion
is in agreement with the mechanism proposed for
cancer induction by non-genotoxic carcinogens by
Cohen and Ellwein (1990).
The induction of hepatocyte nodules and:or
foci in the present study was similar with respect
to GSTP and GGT staining and the histological
appearance of the changes when compared with
the earlier studies in which these lesions developed
into neoplasms. The chronic hepatotoxicity
caused by the higher levels of FB1 used in the
earlier study (Gelderblom et al., 1991) is likely to
have played a critical role in the induction and
progression of these early lesions into neoplasia.
The mild hepatotoxicity induced in the present
study resulted in less regenerative proliferation
and oxidative stress than would have been the
case at higher dosages. This would suggest that
the kinetics of cancer induction and the subse-
quent development of neoplasms occur at a far
slower rate when only mild hepatotoxic effects are
present (Fig. 3).
Short-term studies in rats showed that the fu-
monisins are slow cancer initiators (Gelderblom et
al., 1994). Cancer promotion, on the other hand,
is effected at relative low dietary levels in the
absence of excessive hepatotoxicity (Gelderblom
et al., 1996b). The role of ‘spontaneously’ initiated
cells has been considered to play a role when
animals are chronically exposed to the non-
genotoxic carcinogens such as nafenopin and phe-
nobarbital (Schulte-Hermann et al., 1981; Ward
and Henneman, 1990; Kraupp-Grasl et al., 1991).
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The association of these pre-existing putative ini-
tiated cells in normal animals and their subse-
quent development into cancer appears to be
unlikely as there is very little association between
enzyme-altered foci and the development of the
ultimate cancer, especially those that occur in
older animals (Ghoshal and Farber, 1993). Recent
studies suggested that the fumonisins (Gelderblom
et al., 1992, 1994) and the peroxisome prolifera-
tors, cipofibrate (Rao and Reddy, 1991) and clofi-
brate (Nagai et al., 1993) exhibit cancer-initiating
potential. This implies that the role of ‘sponta-
neous’ initiated cells in fumonisin-induced hepato-
carcinogenesis or the induction of hepatocyte
nodules in the present study cannot be proven
beyond doubt. This becomes evident in recent
studies, which indicate that oxidative damage in-
duced by FB1 in vitro and in vivo in the liver is
likely to be involved in the cancer initiating activ-
ity of the compound (Abel and Gelderblom, 1998;
Sahu et al., 1998; Yin et al., 1998). The high
dosage FB1-treated rats also exhibited enhanced
lipid peroxidation in the liver in the present study.
The presence of the early preneoplastic lesions
(GSTP foci and:or nodules) needs to be dis-
cussed in relation to the carcinogenic properties of
the fumonisins and the determination of risk as-
sessment parameters. These lesions are generally
considered as the site from which cancer develops
in the liver of rats (Farber, 1992). The ability of
carcinogens to induce these early, ‘potentially’
preneoplastic lesions has been frequently used to
assess the carcinogenic potential of naturally oc-
curring compounds, which are important in risk
determination (Tsuda and Farber, 1980). A model
for estimating the risk of carcinogen exposure in
humans was developed by incorporating informa-
tion on both intermediate lesions, such as altered
hepatocyte foci, as well as malignant tumours
(Moolgavkar and Luebeck, 1995) into the assess-
ment. Such risk assessment parameters have been
calculated (Gelderblom et al., 1996a) for the car-
cinogenic potential of FB1 based on the data
obtained from long-term studies in BD IX rats
(present study, Gelderblom et al., 1991). The di-
etary level of 25 mg FB1:kg was considered to be
the No Observed Effect Level (NOEL) for cancer
induction of the fumonisins as a diet of 50 mg
FB1:kg resulted in 66% of the rats developing
cancer under similar experimental conditions. The
corresponding Tolerable Daily Intake (TDI) value
for cancer induction in humans, using a safety
factor of 1000 was 0.8 mg FB1:kg body weight per
day (Gelderblom et al., 1996a). Based on the
current data, the Lowest Observed Effect Level
(LOEL) in male BD IX rats with respect to the
induction of GSTP:GGT nodules and:or foci, is
between 10 and 25 mg FB1:kg or a FB1 intake of
between 0.3 and 0.8 mg FB1:kg body weight per
day. The NOEL for the induction of hepatocyte
nodules in male BD IX rats is B10 mg FB1:kg
diet (0.3 mg FB1:kg body weight). The NOEL of
FB1 for hepato- and nephrotoxicity in male BD
IX rats appear to be in the region of 1 mg FB1:kg
diet or an intake of 0.03 mg FB1:kg body weight
per day.
The interpretation of these risk assessment
parameters are complicated, as accurate FB in-
take profiles have not been established to deter-
mine Probable Daily Intakes (PDI) in humans. In
addition, FB-intake depends not only on the level
of corn contamination but also on the pattern of
consumption of corn by the population at risk
(Gelderblom et al., 1996a). Other important
parameters include the pharmacokinetics, bio-
chemical mode of action, threshold effects, as well
as the dependence on cell proliferation and di-
etary deficiencies (Butterworth and Goldsworthy,
1991; Gelderblom et al., 1991). These factors have
to be considered against the background that FB1
is carcinogenic to rats only at dosages that cause
overt hepatotoxic lesions that may culminate in
cirrhosis. As the fumonisins co-occur with afla-
toxin B1 (Chamberlain et al., 1993; Chu and Li,
1994), the synergistic interaction between these
carcinogens, as well as other carcinogenic stimuli
such as a chronic hepatitis B virus infection have
to be critically evaluated to assess the risk of the
fumonisins to humans. This is of particular inter-
est as the ingestion of the fumonisins is implicated
as a possible risk factor in the development of
primary liver cancer in endemic high liver cancer
areas in China (Ueno et al., 1997).
Based on the present findings, important
parameters such as the modulation of cell prolif-
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eration and dietary deficiencies, which could en-
hance the progression of early pre-malignant le-
sions into neoplasia need to be considered in
future studies to establish relevant risk assessment
parameters for the fumonisins in humans.
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Abstract
The co-existence of the fumonisin and aflatoxin mycotoxins in corn merited studies to investigate their possible
synergistic toxicological and carcinogenic effects. When utilising a short-term carcinogenesis model in rat liver, both
the compounds exhibited slow cancer initiating potency as monitored by the induction of foci and nodules stained
positively for the placental form of gluthatione-S-transferase (GSTP+). However, when rats were treated in a
sequential manner with AFB1 and FB1 the number and size of GSTP
+ lesions significantly increased as compared to
the separate treatments. Histopathological analyses indicated that the individual treatments showed far less toxic
effects, including occasional hepatocytes with dysplastic nuclei, oval cell proliferation and, in the case of FB1, a few
apoptotic bodies in the central vein regions. The sequential treatment regimen induced numerous foci and dysplastic
hepatocyte nodules, and with oval cells extending from the periportal regions into the centrilobular regions. This
would imply that, in addition to the cancer promoting activity of FB1 of AFB1-initiated hepatocytes, the AFB1
pre-treatment enhanced the FB1 initiating potency, presumably by rendering the liver more susceptible to the toxic
effects of FB1. The co-occurrence of AFB1 and FB1 in corn consumed as a staple diet could pose an increased risk
and should be included in establishing risk assessment parameters in humans. © 2002 Elsevier Science Ireland Ltd.
All rights reserved.
Keywords: Fumonisin B1; Aflatoxin B1; Rat liver
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1. Introduction
The bulk of our knowledge regarding the ad-
verse effects of naturally occurring mutagens and
carcinogens and their possible effects on human
health are obtained by investigating the biological
effects of purified compounds in experimental ani-
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mals. In contrast very little is known about the
interaction of complex mixtures in biological sys-
tems. A single compound may effect different
reactions within one biological system while it may
also exhibit additive, antagonistic or synergistic
interactions with other compounds (Carpenter et
al., 1998). The co-occurrence of mycotoxins to-
gether with various endogenous and exogenous
risk factors such as nutrition, viral infections,
alcohol and tobacco that may modulate cell prolif-
eration and drug metabolism, are known to act
synergistically with respect to the development of
cancer in animals and possibly in humans (Yu et
al., 1996). The multiplicity and complexity of these
interactions need to be elucidated in order to
clarify the adverse health and environmental ef-
fects of a mixture of compounds and their subse-
quent regulation.
Numerous studies have been conducted on the
aflatoxins, secondary metabolites produced by spe-
cies in the genus Aspergillus, that are natural
contaminants of human foods and animal feeds.
They are known to be potent liver carcinogens in
laboratory animals (Wogan, 1973, 1992; Wogan et
al., 1974). Aflatoxin B1 (AFB1) has been implicated
as one of the etiological factors, apart from hepati-
tis B virus, in the development of human liver
cancer (Van Rensburg et al., 1985; Peers et al.,
1987; JECFA, 1998). In transgenic mice it was
shown that the chronic liver damage due to the
over expression of the hepatitis B virus large
peptide envelope acts synergistically with AFB1
with respect to neoplastic development (Sell et al.,
1991). The recently discovered fumonisin B myco-
toxins (Gelderblom et al., 1988) are produced by
Fusarium spp. that contaminate corn worldwide
(Rheeder et al., 1992; Shephard et al., 1996). The
fumonisins are non-mutagenic in different bacte-
rial assays (Gelderblom and Snyman, 1991a; Knas-
muller et al., 1997) and lack genotoxicity in
short-term DNA repair assays in vivo and in vitro
(Gelderblom et al., 1992). However, a recent study
indicated that the fumonisins exhibited clastogenic
effects in primary hepatocytes (Knasmuller et al.,
1997). Long-term studies indicated that fumonisin
B1 (FB1) is hepatocarcinogenic in male BD IX rats
(Gelderblom et al., 1991b, 2001a) while a recent
study reported on the nephrocarcinogenicity and
cancer promoting activity in male Fischer rats and
the liver of female B6C3F1 mice, respectively
(Howard et al., 2001). The occurrence of FB1 in
corn is associated with the incidence of
oesophageal (Rheeder et al., 1992; Chu and Li,
1994) and liver cancer (Ueno et al., 1997) in
humans.
Several studies reported on the co-occurrence of
aflatoxin B1, the fumonisins and the trichothecenes
deoxynivalenol, nivalenol and zearalenone (Gao
and Yoshizawa, 1997; Ueno et al., 1997; Zhang et
al., 1997; Ali et al., 1998). At present little is known
about the interaction between AFB1 and FB1 with
regard to their toxic and carcinogenic properties.
FB1 is known to exhibit different kinetics with
respect to cancer initiation as compared to
genotoxins, presumably due to the inhibitory effect
on hepatocyte proliferation (Gelderblom et al.,
1994, 1996a, 2001b) and induction of apoptosis
(Lemmer et al., 1999). On the other hand the
inhibitory effect on cell proliferation is suggested
to be the major mechanism for the cancer promot-
ing property of the fumonisins (Gelderblom et al.,
1995, 1996b, 2001c). Cancer initiation by AFB1 in
rat liver is similar to that seen with FB1, and is not
readily effected by a single toxic dosage, but rather
by a low-level prolonged feeding regimen (Godoy
et al., 1976; Neal and Cabral, 1980). The cytotox-
icity and inhibitory effect on hepatocyte prolifera-
tion effected by AFB1, prohibited the induction of
a population of ‘resistant’ hepatocytes with a
reduced sensitivity to the cytotoxic effects of AFB1.
In general it would appear that the toxic and/or
carcinogenic response to AFB1 and FB1 in terms of
the induction and rate of progression of hyperplas-
tic lesions depend on the time of exposure, the dose
levels and the rate of cell proliferation.
The present paper reports on the interaction of
AFB1 and FB1 in a short-term cancer model in rat
liver.
2. Materials and methods
2.1. Chemicals
FB1 was purified according to the method
described by Cawood et al. (1991) to a purity of
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90–95%. A major impurity (3–4%) was the mono
methyl ester of FB1, which is known to exhibit
similar properties with respect to cancer initiation
(Gelderblom et al., 1993). Diethylnitrosamine
(DEN) and 2-acetylaminofluorene (2-AAF) were
obtained from Sigma Chemical Company and
dissolved in dimethylsulfoxide (DMSO) while
AFB1 was obtained from Makor Chemicals Ltd
and dissolved in DMSO:H2O (1:1). Glutathione-
S-tranferase placental form (GSTP) and alpha
smooth muscle (SMA) antibodies were obtained
from DAKO and the OV-6 antibody was a
generous gift from Professor S. Sell, Albany, NY.
2.2. Animals and diets
The FB1 diet (250 mg FB1/kg) used was pre-
pared as described previously (Gelderblom et al.,
1994). In short, the FB1 was first dissolved in
methanol and added to a sub sample (200 g) of
the diet and dried overnight. The sub-sample was
diluted with the AIN-76 diet (American Institute
of Nutrition, 1980) to obtain the desired FB1
concentration (250 mg/kg diet) and stored under
nitrogen at −20 °C for the duration of the ex-
periment. Male Fischer rats, weighing approxi-
mately 150 g, were fed a modified AIN-76 diet
when weaned. They were randomised (5–8 ani-
mals/group) and housed separately prior to the
start of the experiment and weighed three times
weekly.
2.3. Treatment models
Two different protocols were used to investigate
the cancer potency of AFB1 and FB1. (Fig. 1) The
first protocol compared the cancer initiation po-
tency of AFB1 and FB1 with that of DEN, utilis-
ing the resistant hepatocyte model with
2-AAF/partial hepatectomy (PH) as the promot-
ing stimuli (Semple-Roberts et al., 1987). Initia-
tion was effected by either a single initiating dose
of DEN (200 mg/kg; i.p.) or a daily per gavage
dose (17 g/kg bw) of AFB1 over a period of 14
days to obtain a total dosage of 0.25 mg AFB1/kg
bw or by feeding FB1 (250 mg FB1/kg) over a
period of 21 days as described previously
(Gelderblom et al., 1994). Promotion commenced
three weeks after initiation. In the case of the
2-AAF/PH promoting regimen the rats received a
gavage dosage of 2-acetylaminofluorene (20 mg/
kg bw) on three consecutive days followed by
partial hepatectomy on day four. Control groups
included 2-AAF/PH and PH groups for cancer
promotion and DMSO and DMSO:H2O (1:1) as
the initiation controls for DEN and AFB1 treat-
ments respectively. In the second protocol, re-
ferred to as the sequential treatment model, the
combined effects of AFB1 and FB1 were moni-
tored. Rats were treated with AFB1 (17 g AFB1/
kg bw/day per gavage) over a period of 14 days
followed by FB1 treatment (250 mg/kg diet) 3
weeks later over a period of 21 days. Control
groups consisted of a 14 day DMSO:H2O (1:1)
treatment (0.2 ml/100g bw), a 3 week FB1 dietary
treatment and the AFB1 gavage treatment over a
14-day period.
2.4. Necropsy and histopathology
Rats were killed 3 weeks following the 2-AAF/
PH promoting treatment and immediately after
the FB1 treatment when using the sequential treat-
ment model (Fig. 1). Rats were killed by decapita-
tion, liver weights recorded and liver slices were
fixed in neutral buffered formalin (pH 7.4) for
routine processing, staining with haematoxylin
and eosin (H&E) and immunohistochemical stain-
ing as described below. The sirius red stain was
used to confirm the presence of fibrous tissue in
livers that appeared to be cirrhotic. For the pur-
pose of histopathological examination a ‘focus’ of
hepatocyte dysplasia was defined as 1 mm
(Wanless et al., 1992).
2.5. Immunohistochemistry
Dewaxed sections were immunostained using a
standard three stage indirect strepavidin–biotin
technique; peroxidase activity was developed us-
ing the chromagen substrate diaminobenzidine
and GSTP+ staining was used to identify initiated
hepatocytes (Ogawa et al. 1980). The number and
size (area) of the ‘enzyme altered’ foci were
quantified microscopically (×10 magnification)
and categorised according to the number of cells
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per focus or ‘minifocus’ (5, 20 and 20
cells per focus) and expressed as GSTP+ lesions
per cm2 of the liver section.
The mouse monoclonal antibody OV-6, origi-
nally raised against the hepatocytes isolated from
nodules from the liver of 2-AAF treated rats also
stains bile ducts (Dunsford and Sell, 1998). In rats
OV-6 recognises a cytokeratin with epitopes
Fig. 1. A schematic diagram illustrating the different experimental and control treatments. The cancer initiating and promoting
treatment with FB1 consisted of the 3 week feeding period (250 mg FB1/kg diet), while with AFB1 a daily gavage dosage over a
period of two weeks was administered. Initiation by diethylnitrosamine (DEN) consisted of a single i.p. dosage. In all the cases a
3 week recovery period was allowed before the promoting regimen commenced.
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shared on both CK 14 and CK 19 (Bisgaard et al.,
1993). The amount of oval cell proliferation was
graded according to how far the cells extended
from the periportal regions into the acini—grade
1, oval cells limited to the periportal region; grade
2, oval cell extending through zone 1 into zone 2;
and, grade 3, oval cells extending through all
zones of the acinus. The -smooth muscle anti-
body (-SMA) antibody (Dako A/S Copenhagen.
Clone 1A4 code M0851) was used to demonstrate
stellate (Ito) cells.
2.6. Statistical analyses
Statistical analyses were performed by the
analyses of variance (ANOVA) using the SAS
program while the Tukey Studentized Range
method was used to test for significant differences
between the means. The interaction between FB1,
AFB1 and 2-AAF/PH treatments was also deter-
mined. The Kolmogorov–Smirnov test was used
to test the data for normality (5% significance
level). As there were only two groups, which
needed to be tested for group differences, and the
data were normally distributed, the Student’s t-
test was used (P0.05). Tests for testing the
equality of variances were done beforehand. De-
pending on whether the variances were equal or
unequal, the Pooled or Satterthwaite methods
were used for the t-test. The three interactive
plots are the mean GSTP values for each of FB1
and AFB1 when comparing it with the YES and
NO groups for each of the 2-AAF/PH and AFB1
variables.
3. Results
The relative liver weight of the AFB1, FB1, and
the sequentially treated (AFB1/FB1) rats was sig-
nificantly (P0.01) reduced (Table 1) compared
to the control treatment. However, the relative
liver weight of the rats receiving AFB1 and the
combined AFB1/FB1 treatments were significantly
(P0.05) higher as compared to the FB1 treat-
ment group. These changes are reflected in the
body weight gain of the rats subjected to the
different treatment regimens. No dietary intake
was conducted but a daily intake of 15 mg FB1/kg
bw was reported from a feeding study using a
dietary level of 250 mg FB1/kg diet over a period
of 21 days carried out under similar experimental
conditions (Gelderblom et al., 1994).
3.1. GSTP+ foci and nodules
When the AFB1 and FB1-treated rats were sub-
jected to the 2-AAF/PH promoting treatment (re-
sistant hepatocyte model, Fig. 1), a significant
(P0.001) increase in the number of the larger
GSTP+ lesions was noticed with no significant
differences between the two regimens (Table 1).
The total AFB1 intake during the 14 day period
was 0.25 mg/kg body weight while dietary studies
showed that the FB1 intake of the rats over the 21
day treatment period is in the order of 308 mg/kg
body weight/day (Gelderblom et al., 1994). The
induction of GSTP+ lesions was also significantly
enhanced in rats treated either with AFB1 or FB1
without the 2-AAF/PH promoting stimuli. The
sequential treatment (sequential treatment model,
Fig. 1) of the rats with AFB1 and FB1 was more
effective in the induction of GSTP+ lesions into
foci and/or nodules than the 2-AAF/PH promot-
ing treatment of the individual treatments. The
AFB1/FB1 treatment not only increased the size of
the foci but also the number by a factor of at least
fivefold indicating that the sequential treatment
exceeded the additive effect of the separate treat-
ments even after 2-AAF/PH selection (Table 1).
The different interactions of FB1 and AFB1, with
each other, or with the 2-AAF/PH promoting
treatment are illustrated in Fig. 2. A highly signifi-
cant interaction (P=0.001) is noticed between
AFB1 and FB1 in the sequential treatment model.
Under the present experimental conditions a
higher interaction (P=0.03) was obtained be-
tween FB1 and the 2-AAF/PH promoting regimen
than with the AFB1 initiating treatment (P=0.07)
using the resistant hepatocyte model.
3.2. Histopathology
The livers from some control rats showed an
occasional mitotic figure but no abnormal
changes were seen in any of the livers. The livers
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Table 1
Induction of GSTP+ foci by single and combined treatment of AFB1 and FB1 utilising different carcinogenesis models in rat liver
Initiation Promotion Liver weight (% ofGroup GSTP+ foci and/or nodules
bwb)
5 cells/cm2 20 cells/cm2 20 cells/cm2 Total (5
cells/cm2)
Resistant hepatocyte model
0.2 ml/100 g bw PHControl (DMSO) ND – – – –
0.2 ml/100 g bw 2-AAF/PHControl (DMSO) ND 1.180.65a – – 0.040.13a
250 mg/kg 4.161.55A2-AAF/PH NDFB1 0.730.25a 0.180.19a 3.971.65a
diet/21 days
1.8 g/100g 12.038.20AAFB1a 2-AAF/PH ND 2.862.46a 9.178.00a
bw/day
200 mg/kg bw 2-AAF/PH NDDEN 2.601.30A 8.994.25b 29.6114.34B 38.6017.86B
Sequential treatment model
0.2 ml/100 g bw – 4.00.26a 0.040.13aControl(DMSO) 0.140.36a 0.040.13a –
(29.55.8)
1.8 g/100g – 3.320.19Ab 5.022.95b– 1.400.94aAFB1a 3.623.00a
bw/day (19.77.6)
1.8 g/100g 4.151.84AFB1 (250 mg/kg diet/21 67.6132.28AAFB1a 3.010.21Ab(20.3 71.7632.69B–
bw/day days)
8.6)
DMSO/Salinea 0.2 ml/100g 1.651.47bFB1 (250 mg/kg diet/21 0.730.92a2.500.31Ac 0.920.79a0.100.23a
days) (8.57.5)bw/day
Data represent the meansSD. Means followed by the same letter do not differ significantly, if the letter differ then P0.05, if the cases differ then P0.001.
a Dosed on a daily basis for a period of 14 days.
b Values in brackets indicate the body weight gain. ND, not determined.
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Fig. 2. Statistical box plots representation of the interaction
between FB1 (Fig. 2a), AFB1 (Fig. 2b) and the cancer promot-
ing 2-AAF/PH treatment with respect of the induction of
GSTP+ foci in the liver. The interaction between FB1 and
AFB1 is illustrated in Fig. 2c. Date represents the median, 75
percentile (upper limit) and 25 percentile (lower limit). N, No
and Y, Yes and reflects the absence or presence of the variable.
bers of mitotic figures, some of which were abnor-
mal. Four rats showed occasional single
dysplastic-appearing hepatocytes. All of the livers
showed oval cell proliferation, which ranged from
grade 1 to grade 2, i.e. the oval cells extended
from the periportal zone 1 region, or through
zone 1 into zone 2, respectively. The oval cells
formed cords that intermingled with individual
hepatocytes in a ‘lace-like’ pattern. No nodules
were identified. However, no oval cell prolifera-
tion, foci or nodule formation were noted in any
of the control groups of animals. FB1 treatment
resulted in liver cell death mainly through apopto-
sis. Hepatocyte regeneration was seen as increased
numbers of mitoses. The apoptotic cells were pre-
dominantly found in zone 3 around the central
veins and there was an impression of a minor
degree of zone 3 collapse. Four livers showed an
occasional single dysplastic hepatocyte, while the
liver from one rat showed grade 1 oval cell prolif-
eration confined to the periportal (zone I) region.
Treatment with AFB1 alone did not cause an
increase in the number of apoptotic cells or mi-
toses. In 3/8 animals occasional dysplastic hepato-
cyte nuclei were observed. These nuclei were
enlarged, hyperchromatic and pleomorphic with a
coarse chromatin pattern (Fig. 3). Oval cell prolif-
eration, extending through zones 1 and 2 of the
acinus (grade 2), was seen in the livers of 5/8
animals. Although no nodules were identified, a
focus of small hepatocytes was seen in one rat.
The sequential AFB1/FB1 administration re-
sulted in increased numbers of both apoptotic
cells and mitoses. The livers of all animals were
cirrhotic with the majority of the regenerative
nodules being less than 1 mm in diameter (Fig. 4).
In each animal some lobes showed more architec-
tural disturbance than others. Thin bands of
fibrous tissue, confirmed by staining with sirius
red, were seen encircling the nodules of hepato-
cytes and large numbers of oval cells were seen
within the fibrous tissue (Fig. 5a, 5b). Sheets of
OV-6 positive oval cells also surrounded single
hepatocytes. Scattered hepatic stellate cells, im-
munoreactive for -SMA and OV-6 negative,
were also demonstrated in the bands of fibrous
tissue amongst the sheets of oval cells. In the
cirrhotic livers the distinction between regenera-
of rats that had a partial hepatectomy showed
increased numbers of mitoses indicating regenera-
tion. Rats that received the DMSO showed
slightly increased numbers of mitoses suggesting
regeneration after minor liver injury. Rats that
received the combined DMSO and 2-AAF/PH
promoting treatment showed occasional apoptotic
cells, and 6/7 of the livers showed increased num-
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tive nodules and dysplastic hepatocyte nodules
was difficult. The presence of mitoses, abnormal
nuclei and cytoplasmic eosinophilic changes in the
hepatocytes in the nodules, which measured over
1mm in size, favoured the interpretation that most
of the nodules were dysplastic. The largest dys-
plastic nodule identified measured 3 mm in diame-
ter. In addition, multiple foci that showed
eosinophilic cell and large cell change, were seen
in all animals. Occasional single cells with dys-
plastic nuclei were also identified in these foci.
Occasional dysplastic nuclei were also seen in the
proliferating oval cell-derived ductular structures.
No hepatocellular carcinomas were identified but
several dysplastic hepatocyte nodules showed a
focal spindle cell pattern, the significance of which
was not known.
In the AFB1 treated group subjected to the
2-AAF/PH promoting regimen apoptotic cells
were not prominent, but again increased numbers
of mitoses were identified. The liver of one rat
showed a cirrhotic appearance. All livers showed
oval cell proliferation although there was some
variation in the number and distribution of the
Fig. 3. Hepatocellular dysplasia in an AFB1 treated rat. The hepatocyte nucleus (centre) displays hyperchromatic and pleomorphic
features with a coarse chromatin pattern H&E ×400.
Fig. 4. Cirrhotic liver of a rat that received sequential AFB1/FB1 treatment. The features are those of a micronodular cirrhosis, many
regenerative nodules being less than 1 mm in diameter. H&E ×25.
Fig. 5. (a) Proliferating oval cells surrounding regenerative nodules in a rat that received the sequential AFB1/FB1 treatment. H&E
×100. (b) Proliferating oval cells between parts of two regenerative nodules in a rat that received the sequential AFB1/FB1
treatment. Immunostained for OV-6 ×200.
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cells ranging from grade 1 to grade 3. The oval
cells formed cords, intermingling between individ-
ual hepatocytes in a lace-like pattern. Some cells
with the morphology of hepatocytes were noted
within ductule walls. In addition occasional small
groups of small basophilic cells with a morpho-
logical appearance of cells in transition from bil-
iary cells to hepatocytes, so called transitional
hepatocytes, were identified. Single dysplastic hep-
atocytes were identified in the livers of six ani-
mals. In five animals foci and dysplastic
hepatocyte nodules were identified, the largest of
which was 3.1 mm in size. Some basophilic foci
were seen and the dysplastic hepatocyte nodules
showed mixed eosinophilic and large cell dys-
plasia and clear cell change. Oval cells were ob-
served forming a rim around and penetrating the
nodules and penetrating small foci of eosinophilic
hepatocytes. In addition a small cholangiofibroma
was observed in one rat. In the rats that received
FB1 and subjected to the 2-AAF/PH-stimulus,
apoptotic cells were not prominent but increased
numbers of mitoses were identified. All animals
showed oval cell proliferation extending from the
periportal to the central areas, i.e. grade 1- grade
3. The oval cells formed cords, intermingling be-
tween individual hepatocytes in a lace-like pat-
tern. Single dysplastic hepatocytes were identified
in the livers of 6/6 animals. In 3/6 animals foci
were seen and in 4/6 animals dysplastic hepato-
cyte nodules were identified, the largest of which
was 3.4 mm in size. The dysplastic nodules
showed mixed large cell dysplasia, eosinophilic
and clear cell change.
4. Discussion
Information regarding the potential synergistic
interaction between AFB1 and FB1 could be im-
portant for risk assessment analyses for liver can-
cer development in humans. A recent study in
growing barrows showed that diets containing
both AFB1 and FB1 induce liver disease more
effectively than the individual toxins (Harvey et
al., 1995). In a similar study, FB1 and deoxyniva-
lenol (DON) induced a more toxic response re-
garding clinical performances, serum biochemical,
hematologic and immunologic values than that
induced by either toxin separately (Harvey et al.,
1996). Therefore, sequential or combined adminis-
tration of mycotoxins may give additive and
sometimes synergistic results. Induction of
metabolic enzymes related to aflatoxin
metabolism (Eaton and Gallagher, 1994) as well
as changes in the rate of cell proliferation in the
liver are known to alter carcinogenesis induced by
AFB1 (Neal and Cabral, 1980; Hiruma et al.,
1996).
The present study investigated the interaction
of FB1 and AFB1 by comparing their separate
and combined effects on the cancer initiating and
promoting phases of hepatocarcinogenesis in rats.
The effective dosage level (EDL) for cancer initia-
tion by FB1 treatment (per gavage) over a period
of 14 and a feeding study over 21 days in male
Fischer rats is 0.39EDL0.83 and 0.7
EDL1.5 mg FB1/100g bw per day, respectively
(Gelderblom et al., 1994). When compared to the
gavage treatment over 14 days using AFB1
(present study), FB1 is between 200 and 400 times
less potent as a cancer initiator, further emphasiz-
ing the weak cancer initiating potential of FB1.
The differences in the cancer initiating potencies
could be related to the mechanisms involved dur-
ing the initiating phase of cancer induction. FB1
lacks genotoxicity and mutagenic effects although
one study indicates that FB1 induces clastogenic
effects in primary hepatocytes (Knasmuller et al.,
1997). Oxidative damage, secondary to the hepa-
totoxicity of FB1, was proposed as a possible
mechanism for cancer initiation in rat liver
(Gelderblom et al., 1996b; Abel and Gelderblom,
1998; Abado-Becongnee et al., 1998). The hepato-
toxicity and subsequent lipid peroxidation could
explain the delayed response and dose-dependent
threshold effect associated with FB1-induced can-
cer initiation as compared to the genotoxic car-
cinogens that interact directly with the DNA. In
this regard, AFB1 exhibits potent mutagenic and
genotoxic properties in different in vitro and in
vivo test systems (Eaton and Gallagher, 1994).
Similar to FB1, AFB1 also effects oxidative dam-
age in primary rat hepatocytes and in rat liver in
vivo (Shen et al., 1995a,b), which has been sug-
gested to be involved during cancer initiation of
the latter mycotoxin.
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FB1 significantly reduced the relative liver
weight similar to that reported previously
(Gelderblom et al., 1995, 1996a; Lemmer et al.,
1999), indicating that the resultant hepatotoxicity,
apoptosis and inhibitory effect on cell prolifera-
tion, interferes with normal growth related pro-
cesses and hence the disruption of normal liver
homeostasis. The reduction in the relative liver
weight by the AFB1 treatment is possibly due to
the high cytotoxicity and inhibition of hepatocyte
cell proliferation (Neal and Cabral, 1980). How-
ever, the marked increase in the sizes and num-
bers of hepatocyte nodules in the liver of the rats
receiving the sequential treatment resulted in a
significant increased liver weight as compared to
the separate treatments. Treatment of the rats
with either AFB1 or FB1 only shows mild toxico-
logical effects including mitoses, apoptosis and
occasional hepatocytes with dysplastic nuclei and
oval cell proliferation. However, the sequential
treatment resulted in cirrhotic livers with numer-
ous regenerative and dysplastic nodules encircled
extensively by oval cells. Therefore, the sequential
treatment of AFB1 and FB1 extensively enhance
the susceptibility of the liver to the toxicity and
the induction of dysplastic nodules as compared
to the separate treatments. However, mechanisti-
cally this interaction is extremely complex and
appears to involve different biological parameters
regarding toxicity, cancer initiation and promo-
tion that facilitate the induction and subsequent
development of early pre-neoplastic lesions. The
effect of a simultaneous treatment regimen of
AFB1 and FB1 on the induction of hepatocyte
nodules was not monitored under the present
experimental design. The inhibitory effect on cell
proliferation and induction of apoptosis (Lemmer
et al., 1999) by FB1 is likely to reduce the capacity
of AFB1-induced initiation as was reported for
initiation effected by DEN (Lebepe-Mazur et al.,
1995). However, other experimental designs need
to be developed to investigate such a treatment
regimen.
FB1 increased GSTP+ lesions to a similar ex-
tent as AFB1, even though the AFB1-treated rats
were killed 5 weeks after the initiating treatment
as compared to the FB1 rats that were terminated
immediately after the 3 week treatment. When
utilising 2-AAF/PH promoting treatment the
number of large foci (20 cells/foci) increased
markedly or significantly in the AFB1 and FB1
groups, respectively. However, when compared to
the rats that received the DEN treatment (single
gavage dose), both AFB1 and FB1 were weak or
slow cancer initiators under the present experi-
mental conditions. As cell proliferation is a pre-
requisite for initiation (Columbano et al., 1981),
the inhibitory effect on hepatocyte cell prolifera-
tion and apoptotic effects induced by AFB1 and
FB1 has been suggested to be responsible for the
slow cancer initiating potential of these com-
pounds (Gelderblom et al., 1996b; Neal and
Cabral, 1980). Pre-treatment of Sprague-Dawley
male rats with dietary FB1 decreases the persis-
tence of GSTP+ lesions induced by DEN suggest-
ing that the inhibitory effect of cell proliferation
and/or apoptosis could counteract the efficacy of
initiation (Lebepe-Mazur et al., 1995). It is evi-
dent that, in studies of the synergistic interaction
of different compounds with respect to certain
biological effects, the time of administration of
one compound relative to the other will have an
important impact on the outcome of the study. As
different parameters appear to be involved in
determining the outcome of cancer initiation by
FB1 and AFB1, the sequential treatment protocol
seems to favour this process in the present study.
Despite the fact that AFB1 and FB1 were ad-
ministered three weeks apart when utilising the
sequential model, they seem to act synergistically
with respect to cancer initiation as the number of
hepatocyte nodules and foci was significantly in-
creased. It seems likely that the marked toxicity
induced by AFB1, still evident at 5 weeks follow-
ing the exposure, could render the liver more
susceptible to the cancer initiating potency of FB1
when treated after three weeks (sequential model).
In this regard it is known that treatment with
hepatotoxins, such as CCl4, that effect regenera-
tive cell proliferation, markedly enhanced the can-
cer initiating potential of carcinogens such as
AFB1 (Hiruma et al., 1996) and FB1 (Gelderblom
et al., 2001b). The underlying mechanism that
resulted in the significant (P0.001) increase in
the size of GSTP+ foci and nodules during the
successive AFB1/FB1 treatment regimen could be
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ascribed to the potent cancer promoting potential
of FB, a property used in its original isolation and
purification (Gelderblom et al., 1988). A study in
rainbow trout failed to indicated any cancer ini-
tiating activity by FB1, while it enhances tumor
formation following AFB1 initiation presumably
solely through a cancer promoting mechanism
(Carlson et al., 2001)
Of interest is the effectiveness of the FB1 pro-
moting regimen as compared to the 2-AAF/PH,
which is regarded as a very strong selection stimu-
lus (Semple-Roberts et al., 1987) as indicated
when using DEN as a cancer initiator. The reason
why FB1 exhibited a far stronger promoting stim-
ulus, under the present conditions, could be due
to (i) as stated above, the additional cancer ini-
tiating potency of FB1; and (ii) the selection of a
broader spectrum of initiated cells induced by
AFB1 when compared to 2-AAF/PH. AFB1 has
long been known to induce different types of
hepatic lesions of which the growth of subsets of
the lesions could be stimulated by different
growth promoting and/or inhibitory signals
(Kalengayi and Desmet, 1975; Kalengayi et al.,
1975). The interaction between FB1 and 2-AAF/
PH was also significantly higher than the AFB1/2-
AAF/PH interaction in the resistant hepatocyte
model suggesting the 2-AAF/PH promoting pro-
tocol is not very effective in stimulating the
growth of AFB1-initiated hepatocytes.
A threshold exists with respect to the cancer
initiating and promoting activity of FB1
(Gelderblom et al., 1994, 1996a,b). As a result, it
has been postulated that due to the relatively low
levels in naturally contaminated corn, FB1 could
be regarded solely as a cancer promoter
(Gelderblom et al., 1996b). However, the present
study indicated that the co-occurrence of AFB1
and FB1 could pose a threat when consumers,
particularly in Southern Africa, are exposed to
both toxins. Under specified conditions that
mimic cancer initiation and promotion, the two
mycotoxins can interact synergistically with re-
spect to the induction of enzyme altered foci and
nodules. Future studies need to explore the inter-
action of low dosage levels as well as other expo-
sure regimens involving these carcinogens in
different model systems. As stated above, the
synergistic interactions between different natural
occurring toxins and carcinogens are very com-
plex as a recent study indicated that the tri-
chothecene mycotoxin, nivalenol, also promotes
the development of GSTP+ foci induced by AFB1
(Ueno et al., 1992). As AFB1 was shown to occur
in the endemic areas for liver cancer it was sug-
gested that the fumonisins could modulate the
incidence of liver cancer together with hepatitis B
virus. Studies in southern Africa also reported on
the natural occurrence of AFB1 in maize and
groundnuts in regions of a high incidence of
primary liver cancer (Van Rensburg et al., 1985).
In the Transkei region of the Eastern Cape
Province the incidence of esophageal cancer is
very high when compared to liver cancer and it is
not known whether any association exists between
FB1 and liver cancer development (Rheeder et al.,
1992). Other mycotoxins such as nivalenol and
deoxynivalenol also occur naturally in home-
grown in this endemic regions for oesophageal
cancer (Sydenham et al., 1990). The co-occurrence
of FB1 with other natural occurring cancer pro-
moting and initiating food contaminants such as
AFB1, the trichothecenes and HBV could there-
fore be of relevance in the development of liver
cancer in high incidence regions. The present
study indicates that more emphasis should be
placed on the synergistic interaction between car-
cinogenic principles rather than investigating sin-
gle biological effects representing only certain
phases of cancer development.
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Abstract
A corn sample associated with a ﬁeld outbreak of equine leukoencephalomalacia in Pennsylvania, USA, during 1983/1984 and
induced hepatotoxic and hepatocarcinogenic eﬀects when fed to male Fischer rats was analyzed mycologically and chemically for the
presence of fumonisins (FB), hydrolysed FB derivatives and aﬂatoxins (AFB). Fusarium verticillioideswas found to be the predominant
fungal contaminant in the corn sample but Aspergillus ﬂavus was also present. Trace amounts (0.1 mg/kg) of AFB1 and AFB2 and a
total FB level of 33.5 mg/kg (FB1:FB2:FB3 ratio of 9:2.3:1) were found. No hydrolysed FB derivatives or AFG1 and AFG2 were
detected. Based on the chemical stability of the fumonisins in diﬀerent corn cultures of F. verticillioides kept at 4 C over a period of
13–20 years, a level of approximately 55 mg/kg of total FB is estimated in the original corn sample. A possible role of certain
dietary constituents such as the high protein content and deﬁciencies in certain micronutrients is evaluated to address diﬀerences in
the organ-speciﬁc toxicity of FB1 in rats using commercial, semi-puriﬁed, puriﬁed and corn-only diets.
# 2004 Elsevier Ltd. All rights reserved.
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1. Introduction
Fungal contaminated corn (Zea mays) obtained from
households in areas with a high incidence of oesopha-
geal cancer (OC) in the Transkei region of the Eastern
Cape Province, South Africa, was shown to cause toxic
and preneoplastic lesions in the liver of male BD IX rats
when fed for a prolonged period of time (Purchase et
al., 1975). The carcinogenic potential of corn cultures
of Fusarium verticillioides (previously known as F.
moniliforme), a major fungal contaminant identiﬁed in the
home-grown corn, was ﬁrst described experimentally by
Marasas et al. (1984) when fed at levels ranging from 2 to
4% in the diet to male BD IX rats over a period of
approximately 15 months. The majority (80%) of rats
developed hepatocellular carcinoma while 63% developed
cholangiocarcinoma and/or cholangioﬁbrosis. These
cancers developed in livers that were severely cirrhotic and
contained lesions such as nodular hyperplasia and bile
duct proliferation. A commercial rat diet (EPOL Ltd,
South Africa) that sustains breeding and general main-
tenance of the rats was used as the experimental diet. In
a follow-up long-term experiment, using the same fun-
gal culture material but at a much lower dietary level
(0.5%), the carcinogenicity was monitored in the male
BD IX rat using a semi-puriﬁed corn-based diet,
marginally deﬁcient in certain vitamins and lipotropes
(Jaskiewicz et al., 1987a). Much lower incidences of
hepatocellular (2/21) and cholangiocarcinomas (8/21)
were noticed after a feeding period of 23 to 27 months.
Wilson et al. (1985) showed that corn screenings, known
to cause leukoencephalomalacia (LEM) in horses in the
USA, also caused severe hepatotoxic and hepatocarci-
nogenic lesions in male Fischer 344 rats when fed over a
period of 6 months. The major lesions reported after
feeding the corn-only diet, which included hepatic nodules
and large areas of adenoﬁbrosis and cholangiocarci-
noma, were remarkably similar to those obtained in BD
IX rats fed the fungal cultures irrespective of the diet
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used. Studies in male BD IX and Fischer 344 rats, using
naturally contaminated corn (Purchase et al., 1975;
Wilson et al., 1985) suggest that nutritional imbalances
and speciﬁcally the low methionine/choline levels in the
corn-only diet may have promoted the formation of the
liver tumors observed in these experiments. Studies with
puriﬁed fumonisin B1 (FB1) in male BD IX rats fed a
dietary level of 50 mg/kg using the semi-puriﬁed diet
described by Jaskiewicz et al. (1987a), prove that this
mycotoxin is responsible for the hepatocarcinogenic
eﬀects of the fungal culture material (Gelderblom et al.,
1991, 2001a). A long-term (2 years) study of FB1 in
male Fischer 344 rats fed dietary levels of 50 and 150 mg
FB1/kg, using a NIH 33 commercial diet, however,
failed to show any toxic and/or carcinogenic eﬀects in
the liver but rather produced nephrotoxic and nephro-
carcinogenic eﬀects (NTP, 2000; Howard et al., 2001).
Some aspects regarding certain dietary deﬁciencies and
dose response eﬀects as possible confounders in FB1-
induced hepatocarcinogenesis in male Fischer 344 and
BD IX rats need to be considered to address diﬀerences
in the target organ aﬀected.
The present study reports on the fumonisin levels in
the corn sample from the USA which was implicated in a
ﬁeld outbreak of LEM and which caused hepatocarci-
nogenic eﬀects in male Fischer 344 rats when fed over a
period of 6 months (Wilson et al., 1985). In addition, the
nutritional constituents of some diets used in the long-
term fumonisin carcinogenesis studies in diﬀerent rat
species are compared and discussed to provide some
new perspectives regarding their possible modulating
role in FB1-induced toxic and carcinogenic eﬀects in
rats.
2. Materials and methods
2.1. Fungal cultures
Corn cultures of F. verticillioides strain MRC 826
(Marasas et al., 1984) were prepared by inoculating
autoclaved, moistened whole yellow kernels with
lyophilised conidia, incubated at 25 C for 21 days,
freeze dried and ground to a ﬁne meal. Diﬀerent corn
culture batches of F. verticilioides MRC 826 were
prepared, batch B during 1981 and batches 55 and 57
during 1987. Batch B was used in long-term rat experi-
ments (Marasas et al., 1984; Jaskiewicz et al., 1987a)
while batches 55 and 57 were used in long-term vervet
monkey experiments (Jaskiewicz et al., 1987b; Fincham
et al., 1992; Gelderblom et al., 2001b). The diﬀerent
cultured batches were kept in airtight containers at 4 C
until analysed for the fumonisins in 1990 and again in
2000. The culture material of F. verticilioides MRC 826
batch B was prepared at approximately the same time as
the outbreaks of LEM in the USA (see below).
2.2. Corn sample
A sample of corn screenings that caused LEM in
horses on a farm in southeastern Pennsylvania during
1983–1984 and caused hepatotoxic and carcinogenic
eﬀects in male Fischer 344 rats (Wilson et al., 1985;
Thiel et al., 1986a) was obtained from the late Prof PE
Nelson, Pennsylvania State University, Pennsylvania,
USA. The sample, consisting of broken kernels, pieces
of cobs and stalks was ﬁnely ground and stored in an
airtight container at 4 C until analysed for fumonisins
in 2000, i.e. approximately 17 years after it was
naturally infected.
2.3. Mycological analyses
Fungal counts of the corn sample were performed by
weighing out 1 g of the ﬁnely ground sample into the
ﬁrst tube of each of two dilution series of 1:101 to 1:106
in sterile distilled water. Aliquots (1 ml) of each dilution
were dispensed into individual sterile 9-mm-diameter
Petri dishes, mixed with molten sterilised malt extract
agar (15 ml), allowed to cool and incubated at 25 C in
the dark for 7 days. The developing fungal colonies
were microscopically identiﬁed and the number of
colonies expressed as colony forming units per gram of
the ground sample (cfu g1).
2.4. Chemical analyses
2.4.1. Fumonisins
The corn sample (20 g) or fungal culture material (5 g)
were extracted by homogenisation with 100 ml of a
mixture (3:1) of methanol (MeOH) and distilled water
(H2O) in duplicate. Aliquots (10 ml) were adjusted to
pH 2.5 with the addition of 0.1 M HCl and fractionated
on Bond Elute C18 solid phase extraction (SPE)
cartridges, which had been preconditioned with MeOH
(5 ml) and H2O) (5 ml). After the sample was applied
the cartidge was washed with H2O/MeOH mixture (3:1)
and the fumonisins and aminopolyols eluted in MeOH
(15 ml). The eluates were evaporated to dryness and
reconstituted in MeOH (200 ml) and retained for
chromatographic analyses. Aliquots (50 ml) of the
reconstituted residues were derivatised with o-phthal-
dialdehyde (OPA) as previously described (Shephard et
al., 1990). The derivatised sample was injected via a
Reodyne injector (Cotati, CA) onto a Phenomex
(Torrance, CA) column (1504.6 mm i.d.) packed with
5 mm Ultracarb ODS 20 material. A mobile phase of
MeOH:0.1 M sodium dihydrogen phosphate (77:23)
was adjusted to pH 3.35 with phosphoric acid and used
at a ﬂow rate of 1 ml/min. The fumonisins and amino-
polyols were monitored by ﬂuorescence at an excitation
wavelength of 335 nm and an emission wavelength of
440 nm. Detection limit of the method is 50 mg/kg.
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2.4.2. Aﬂatoxins
The corn sample (20 g) was extracted by homo-
genization with 100 ml MeOH/H2O (7:3). Extract was
diluted (4) with distilled water and applied (25 ml) to
an AﬂaTest (Vicam, Watertown, MA) immuno-aﬃnity
column. The column was washed with distilled water
(210 ml) and allowed to run dry for 15 minutes. The
aﬂatoxins were eluted with HPLC grade MeOH (1 ml)
and the eluates evaporated to dryness under nitrogen
and dissolved in MeOH (200 ml). Samples (20 ml) were
injected by means of a Waters U6K injector onto a
reversed-phase column (Phenomenex Ultracarb 3 m
ODS (20) 4.6 mm i.d.75 mm) using a mobile phase
of 0.01 M KH2PO4/acetonitrile/MeOH (690:130:75)
delivered by a Waters Model 510 pump at a ﬂow rate of
1 ml/min. Post-column derivatisation for the enhance-
ment of ﬂuorescence was achieved with aqueous iodine
delivered by a Waters Model 510 pump via a T-junction
at a ﬂow rate of 0.4 ml/min (Thiel et al., 1986b). The
combined ﬂow was passed through a Teﬂon reaction
coil (0.3 mmID20 m). The temperature of the
chromatographic column, T-junction and reaction coil
was maintained at 65 C by means of an oven (Milli-
pore, South Africa). The aﬂatoxins were detected using
a Perkin Elmer (Norwalk, CT) Fluorescence Detector
(Model 650S) at an excitation wavelength of 365 nm
and an emission wavelength of 440 nm. The presence of
aﬂatoxin B1 (AFB1) was conﬁrmed by making sequen-
tial injections with and without post-column reagent
addition. The limit of detection was 0.05 mg/kg (0.05
ppb) based on a signal to noise ratio of 3:1.
2.5. Stability of FB1 standard and fumonisins in fungal
cultures
The corn cultures of F. verticillioides MRC 826
batches B, 55 and 57 were analysed for the fumonisin B
mycotoxins in 1990 and 2000 in order to assess their
stability. Two batches of FB1 standards (0.5 mg solid),
stored in closed glass vials at 4 C during 1990, were
also included and analysed in 2000.
2.6. Nutritional constituents of diﬀerent diets used in
FB1-carcinogenesis studies
Dietary constituents of the semi-puriﬁed diets used in
carcinogenicity studies of FB1 in male BD IX rats were
calculated using the MRC Food Composition
Table (Langenhoven et al., 1991). The nutritional values
of yellow corn were obtained from the United States
Department of Agriculture (USDA) Nutrient Database
for Standard Reference (USDA, 2001). The dietary
formulation of the NIH-31 diet used in the long-term
carcinogenicity study of FB1 in Fischer rats was
obtained from the National Toxicology Program (NTP)
Technical Report, NTP TR 496 (NTP, 2000). The dif-
ferent dietary constituents were compared to the
minimal requirements for normal rat growth (Keenan et
al., 2000).
3. Results
3.1. Mycological analyses
Fusarium verticillioides was the predominant fungal
species in the sample of corn screenings while Aspergil-
lus ﬂavus and Penicillium spp. were also found to be
present (Table 1).
3.2. Chemical analyses
The major fumonisins (FB1, FB2 and FB3) were
detected in the corn screenings with trace amounts of
AFB1 and AFB2 (Table 1). Low levels (1–1.5% of total
FB) of the hydrolysed FB1 (aminopentol) were also
detected in the diﬀerent fungal cultures of F. verti-
cillioides strain MRC 826 (data not shown) while no
hydrolysed FB derivatives were detected in the corn
sample.
3.3. Stability of fumonisins
The analytical standards of FB1 remained stable
during a 10-year storage period at 4 C with a recovery
of 94% (Table 2). The original fumonisin levels in the
fungal cultures prepared in 1981 and 1987 are unknown,
but during the last 10 years in storage (1990–2000) the
mean recovery of the total FB was 69%.
Table 1
Mycological and chemical analyses of the corn sample associated with
LEM in horses and hepatocarcinogenicity in rats
Fungi Mycological
analyses (cfu/g)
Fusarium verticillioides 2300
Aspergillus ﬂavus 400
Penicillium spp 100
Mycotoxin Chemical
analyses (mg/kg)a
Fumonisins
FB1 24.3
FB2 6.4
FB3 2.8
Total FB 33.5
Aﬂatoxins (mg/kg)b
AFB1 0.1
AFB2 0.1
No hydrolysed FB derivatives, AFG1 and AFG2 detected.
a Detection limit: 50 mg/kg.
b Detection limit 0.05 mg/kg.
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3.4. Dietary constituents of various diets used in FB1
short- and long-term studies
Diﬀerent diets have been used in long-term toxicological
studies of the fungal cultures and the puriﬁed fumonisins
in various rat species. These included a corn-only diet
(Purchase et al., 1975; Wilson et al., 1985), a commercial
diet (Masasas et al., 1984), semi-puriﬁed basal diet
(Jaskiewicz et al., 1987a, b; Gelderblom et al., 1991,
2001a) and the NIH-31 (NTP, 2000). The dietary
constituents of these diets are summarised (Table 3) and
compared to the minimum dietary requirements
(Keenan et al., 2000) and a standard puriﬁed diet (AIN-
76) developed by the American Institute of Nutrition
(AIN, 1980) in order to meet the growth requirements of
adult rats. In spite of diﬀerences in the constituents of the
semi-puriﬁed and corn-only diets used, the protein, fat
and carbohydrate content, provide a similar energy
content (KJ) to that proposed by the AIN-76 diet (AIN,
1980). The protein content (g/100 g diet) of the AIN 76,
NIH-31 and commercial diets varied between 21, 20, and
18%, respectively. The semi-puriﬁed and corn-only diet
contained 10 and 9% protein, respectively.
When considering the choline level, the corn-only and
the semi-puriﬁed diets are similar to the estimated
requirements for rats (Keenan et al., 2000) as compared
to the level in the NIH-31 diet, which is 4.5 times higher
than the estimated requirements. The methionine levels
of the corn-only and the semi-puriﬁed diets are between
40 and 60% of that of the standard AIN 76, NIH-31
and commercial diets (Table 3). Biotin, vitamins B12, D
and K were absent in the corn while riboﬂavin and
vitamin E were approximately 50 and 30% lower
respectively, than the estimated requirements. In the
semi-puriﬁed diet used in the BD IX studies, vitamins
B6, B12 and D constituted 20, 15 and 25%, respectively
while thiamine and riboﬂavin about 75% and folate and
biotin about 60% of the estimated requirements. The
NIH-31 diet used in the long-term FB1 study (NTP,
2000), contained most of the vitamins in excess of the
estimated requirements and to some extent to that of
the levels in the AIN-76 diet (AIN, 1980). These
increased levels include thiamine (10 times), nicotinic
acid (8 times), vitamins A (7 times), vitamin D (4 times),
vitamin E (2 times), vitamin B6 (2 times), riboﬂavin (2
times), folate (2.5 times) and pantothenate (2 times).
Relative to the estimated nutritional requirements of
rats, the semi-puriﬁed and corn-only diets contained
approximately 12 and 2% calcium, 13 and 25%
magnesium and 40 and 60% phosphate, respectively. In
contrast the NIH-31 and the commercial Epol diet
contained approximately three times more calcium and
phosphate than the minimum requirements while the
magnesium level was about 50% of the required
amount. The semi-puriﬁed diet contained about 23% of
the required amount while the NIH-31 and the
commercial diet contained about seven times and
three times, respectively, more dietary iron. Of the
micronutrients, manganese constituted about 5% when
using the corn-only diet while the zinc level was
approximately two times higher than the required level.
Both the NIH-31 and the commercial diet contained
excess zinc (5–8 times) and similar manganese levels
with respect to the minimal requirements.
4. Discussion
The present study conﬁrmed that F. verticillioides was
the predominant fungus present in the corn sample
associated with the ﬁeld outbreak of LEM ﬁeld
outbreak in the USA as well as causing hepatotoxic and
hepatocarcinogenic eﬀects in male Fischer rats (Wilson
et al., 1985). However, other fungal species, A. ﬂavus
and some Penicillium spp are reported, for the ﬁrst time,
to be present as fungal contaminants of the corn sample.
Of the mycotoxins analysed, the presence of fusarin C
and moniliformin was reported previously by Thiel et al.
(1986b) while no aﬂatoxins were detected (Wilson et al.,
1985). Thiel et al (1986b) suggested that it was highly
unlikely that either moniliformin or fusarin C was
involved in the aetiology of either LEM or the hepato-
carcinogenicity in rats. They further emphasized the
importance of identifying the active compound(s) in
corn culture material of F. verticillioides MRC 826
which was shown to cause LEM in horses (Kriek et al.,
1981) as well as liver cancer in rats (Marasas et al.,
1984). This goal was achieved in 1988 with the isolation
and characterization of the fumonisins from corn
cultures of the fungus (Gelderblom et al., 1988).
The trace amounts (two times above the detection
limit) of AFB1 and AFB2 detected in the corn sample
may be ascribed to the high sensitivity (approximately
20 times) of the method used in the present study as
Table 2
Stability of fumonisin B1 analytical standard and total fumonisins in
culture material of Fusarium verticillioides MRC 826 stored at 4 C
Sample 1990 2000 Stability
(% recovered)
FB1 standard (mg)
Batch A 0.53 0.49 93
Batch D 0.63 0.59 95
Mean=94
F. verticilioides culturesa (g total FB/kg)
MRC 826-Ba 4.90.5 3.61.0 73.5
MRC 826-55b 2.60.1 1.70.5 65.4
MRC 826-57b 3.70.3 2.50.8 67.6
Mean=68.9
a Fungal cultures were prepared during 1981 and kept at 4 C in
airtight containers.
b Fungal cultures were prepared during 1987 and kept at 4 C in
airtight containers.
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compared to the method used byWilson et al. (1985). It is
highly unlikely, however, that these trace amounts of AFB
could have played a role in the hepatocarcinogenic eﬀect
of the corn sample despite the fact that a recent study
indicated a synergistic eﬀect between AFB1 and FB1 in a
short-term liver carcinogenesis model (Gelderblom et al.,
2002). The presence of the fumonisins (33.5 mg FB/kg)
in the corn sample is the ﬁrst report on the natural
Table 3
Comparison of dietary composition of AIN, NIH-31, semi-puriﬁed, commercial and corn only diets used in fumonisin B1 feeding studies
ER AIN-
76
NIH-
31a
Comm.
diet
Semi-
puriﬁed
Yellow Corn
Protein (g/kg) 50–100 214.3 201 180 102 94
Soy protein – – – – 15 –
Casein – 200 – – 10 –
Egg albumin – – – – 10 –
Corn meal – – – – 66.7 –
Methionine – 3 3.7 3.9 1.5 2
CHO (g/kg) NR 605.1 – – 785.4 740.3
Corn meal – 150 – – 612 –
Sucrose – 500 – – – –
Glucose – – – – 111.3 –
Dextrin – – – – 54.3 –
Fat (g/kg) 40–60 46.4 35.5 40 49.2 47.4
Saturated – 5.9 – – 6.3 6.67
MUFA – 9.0 – – 11.4 12.51
PUFA – 29.3 – – 26.4 21.63
Sunﬂower oil – 44 – – 30 –
Energy
KJ NR 15 235 18 125 10 892 14 426 15 270
Fibre (g/kg) NR 54.8 – 70.2 26.7 34
Vitaminsa
Thiamine (mg) 4 6 40 3.94 3.0 3.9
Riboﬂavin (mg) 4 6 8.54 4.95 3.18 2.0
Nicotinic acid (mg) 15 30 122.3 50 30.5 36.27
Vitamin B6 (mg) 6 7 11.4 6 1.1 6.2
Folate (mg) 1 2 2.48 9.5 0.62 0.19
Vitamin B12 (mg) 50 10 43 11 8 –
Panto. (mg) 8.8 16 33.6 12 6 4.24
Biotin (mg) 0.2 0.2 – – 0.13 –
Vitamin A (IU) 2300 4005 17 000 11 000 16 672 4690
Vitamin D (IU) 1000 1000 3881 2750 250 –
Vitamin E (mg) 27 80 53.5 60 34.6 7.5
Vitamin K (mg) 1 5 – 2.86 2.95 –
Choline (g) 0.75 2 3.38 – 0.7 0.89
Mineralsb
Calcium 5000 5123 14 300 9000 590 70
Iron 35 50.6 260 100 8 27.1
Magnesium 5000 514.5 2470 75 643.5 1270
Phosphate 3600 4059 9370 7400 1467# 2100
Potassium 3600 3707 6900 8768 3343 2870
Sodium 50 1083 2470 2156 990 350
Zinc 12 44.9 92.2 64 10.4 22.1
Copper 5 5.7 11.7 10 1.9 3.14
Manganese 100 54 131.3 75 – 4.85
Selenium 0.15 0.1 0.5 – – 0.16
Abbreviations: CHO=carbohydrate, MUFA=monounsaturated fatty acids,PUFA=polyunsaturated fatty acids. AIN-76 (AIN, 1980); Semi-
puriﬁed diet (Marasas, et al., 1984; Jaskiewicz et al., 1987a). ER=estimated requirements (Keenan et al., 2000), Comm.=commercial; NR=not
reported. ‘‘–‘‘ No data.
a mg/kg or units/kg.
b mg/kg.
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occurrence in a naturally infected US corn sample
involved in the development of LEM in horses and to
exhibit hepatocarcinogenic eﬀects in male Fischer 344.
When considering the stability of the total FB in the
corn cultures, the retrospective estimation of the total
FB in the corn sample (Wilson et al., 1985) fed to the
male Fischer rats was likely to be in the order of
between 47.8 and 55.8 mg FB/kg corn. This calculation
is based on the fact that almost 70% of FB was recov-
ered in corn cultures kept for 13–20 years and analysed
over a 10 year period (1990–2000) and an assumption
that at least between 60 and 70% of the total FB (33.5
mg FB/kg) is likely to be recovered in the corn sample
after 17 years. This dietary level closely simulates
the level of puriﬁed FB1 fed to male BD IX rats
(Gelderblom et al., 1991) when remarkably similar
hepatic lesions were reproduced. These include hepato-
cyte nodules, adenoﬁbrosis and cholangiocarcinoma
that developed in the liver after a period of 5–6 months.
Similar hepatic lesions were reported in long-term
studies conducted by Marasas et al. (1984) and
Jaskiewicz et al. (1987a) in male BD IX rats fed low
dietary levels of corn culture material of F. verticillioides
MRC 826 over a period of 24 months. The mean daily
FB intake (mg/kg bw) of the rats was between 6.9 (288
days) and 3.2 (606 days) in the study of Marasas et al.
(1984) and varied between 0.4 (211 days), 0.9 (311 days),
1.3 (81 days) and 0.9 (266 days) mg/kg bw/day in the
study of Jaskiewicz et al. (1987a) (JECFA, 2001). These
calculations were based on an average daily feed intake
of BD IX rats over this period of between 30 and 35 g/
kg bw. If a similar assumption is made for the male
Fischer rats fed the corn screenings (Wilson et al., 1985),
a daily FB intake of between 2.3 and 3.2 mg FB/kg bw is
estimated (JECFA, 2001). These FB intake values are in
the same order (1.6 mg FB1/kg bw) to those of male BD
IX rats using puriﬁed FB1 at a dietary level of 50 mg/kg
diet (Gelderblom et al., 1991). A daily FB1 intake of 1.6
mg/kg diet and 0.8 mg FB1/kg resulted in liver cancer or
the induction of hepatocyte nodules in male BD IX rats,
respectively (Gelderblom et al., 2001a). In contrast,
studies in male Fischer rats fed puriﬁed FB1 for 2 years,
at dietary levels of 50 and 150 mg FB1/kg, representing
a daily intake of 2.2 and 6.6 mg FB1/kg bw, respectively,
did not cause any marked pathological lesions in the
liver (NTP, 2000; JECFA, 2001).
Short-term studies in male Fischer rats indicated that
a daily intake of 3.5 mg FB1/kg bw using the AIN-76
diet showed mild changes in the liver after 21 days
(Gelderblom et al., 1996). However, other studies in
male Fischer rats showed that FB1 intakes up to 12 and
20 mg FB1/kg bw/day over a period of 28 days (NTP,
2000; JECFA, 2001) using the NIH-31 diet, or a daily
intake up to 5.7 FB1/kg bw over a period of 90 days
using the NIH 07 diet (Voss et al., 1995a) did not show
any liver lesions. With respect to the kidneys, dietary
levels 0.7 mg FB1/kg bw/day over 21 days (JECFA,
2001, Gelderblom et al., 1996) and 2 years (NTP, 2000;
JECFA, 2001) were shown to eﬀect degenerative
changes. A study by Voss et al. (1995b) also showed
kidney lesions in male Fischer rats at a dietary level of
0.6 mg FB1/kg bw/day over a period of 90 days. When
considering the long-term study when feeding naturally
contaminated corn sample to male Fischer rats for 6
months (Wilson et al., 1985) with an estimated daily
exposure of between 2.3 and 3.2 mg FB/kg bw (NTP,
2000; JECFA, 2001), liver damage was eﬀected while no
kidney damage was reported (Wilson et al., 1985). It
would appear that major diﬀerences exist with respect
to dose response toxic eﬀects in the liver of male Fischer
rats while these diﬀerences do not exist with respect to
the induction of degenerative changes in the kidneys.
The outcome of the 2-year study performed in male
Fischer rats also provides the ﬁrst evidence that the
fumonisins induced kidney tumours in the absence of
liver damage (NTP, 2000). This must be considered
against the background that long-term feeding studies
using naturally infected corn (Purchase et al., 1975,
Wilson et al., 1985), corn cultures of F. verticillioides
(Marasas et al., 1984; Jaskiewicz et al., 1987a) and
puriﬁed FB1 (Gelderblom et al., 1991, 2001a) induced
liver damage in both BD IX and Fischer 344 rats in the
absence of any prominent kidney lesions.
Feeding of two samples of maize screenings
associated with ﬁeld cases of LEM in horses in the USA
during 1986 to male Sprague–Dawley rats over a period
of 4 weeks induced similar pathological changes in the
liver as described above for the fungal culture material
in BD IX and Fischer rats, which included single cells
necrosis, mild ﬁbrosis, bile duct hyperplasia, adenoﬁ-
brosis and apoptosis (Voss et al., 1989). Based on the
FB levels and the daily feed intake, a FB intake of
between 10.2–13.5 and 1.2–1.4 mg FB/100g bw/day
could be calculated (Plattner et al., 1990; JECFA, 2001).
Only mild changes were observed in the liver of the rats
exposed to the low FB1-containing latter sample while
both samples induced lesions in the kidneys. When
fungal culture material was fed in the diet over a period
of 21 days, mild liver changes were noticed at a dietary
level of 2.7–4.5 mg/ FB/kg bw in male Sprague–Dawley
rats (JECFA, 2001; Voss et al., 1998). Studies in male
Sprague–Dawley rats using puriﬁed FB1 showed mild
liver changes when fed daily levels of 4.1 mg FB1/kg bw
over a period of 28 days (JECFA, 2001; Voss et al.,
1993, 1995b).
In view of the above toxicological studies, it would
appear that diﬀerences exist with respect to the induction
of toxicological eﬀects by FB1 in the liver and kidney of
rats that cannot be ascribed to strain diﬀerences because
both male BD IX, Sprague–Dawley and Fischer rats, fed
similar dietary levels of FB1 using diﬀerent experimental
diets, developed mild hepatic changes. Interestingly
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comparative toxicity experiments have shown that
Fischer 344 are more sensitive than Sprague–Dawley
rats to 1,2 dichlorobenzene-mediated hepatocellular
oxidative stress when fed the same diet (Younis et al.,
2000). As diet could play a major role in the suscept-
ibility of rats to toxins, an evaluation of the diﬀerent
diets used to investigate the toxicological eﬀects of FB1
is required. It is not known at present whether diﬀer-
ences in the nutritional status of the diﬀerent diets could
have modulated the sensitivity of the target organ to the
eﬀects of FB1. Dietary analyses could therefore provide
important information on the diﬀerential eﬀects of FB1
with respect to its carcinogenicity in the kidney and liver
of rats.
Detailed comparison of the corn-only and the
semi-puriﬁed diets used in the studies in male BD IX
and Fischer rats showed that the protein content is well
within the minimal requirements for rats and approxi-
mately 50% lower when compared to the AIN-76 and
the NIH 31 diets. Recently the NIH-07 diet, containing
22% protein and used in the National Toxicology
Program’s (NTP) toxicological and carcinogenesis
studies was replaced by the NTP 2000 diet containing
much lower protein levels (14.5%) due to chronic diet
and age related changes such as nephropathy (Rao et
al., 2001). In male Fischer 344 rats the severity of
nephropathy, of which the presence of focal to multi-
focal regenerative renal tubule is an indicator, was
reduced markedly. In the long-term study of FB1 in
Fischer rats, using the NIH-31 diet with a protein
content of 20.1%, nephropathy up to 80–90% was
reported in the male and female Fischer rats (NTP,
2000). Renal tubular hyperplasia was reported to be
signiﬁcantly higher in the high dose groups (50 and 150
mg FB1/kg diet) with non-typical dose response eﬀects.
The high protein diet could have predisposed the kidney
to the carcinogenic eﬀects of FB1 in male Fischer rats
while the low protein semi-puriﬁed diet protects against
nephrocarcinogenic eﬀects in the male BD IX rats
(Gelderblom et al., 1991, 2001a). In this regard no
kidney pathology was reported in the male Fischer rats
fed the corn sample that caused major hepatic lesions
(Wilson et al., 1985). However, high protein diets
enhance the susceptibility of the liver for the induction
of preneoplastic lesions (Youngman and Campbell,
1991). The ﬁnding in the NTP study (NTP, 2000) that
the high protein content of the NIH-31 diet and FB1
levels 3X higher than that used in the studies in male
BD IX (Gelderblom et al., 1991, 2001a) and Fischer 344
rats (Wilson et al., 1985) did not markedly aﬀect the
liver is, therefore, diﬃcult to explain.
The corn-only (Purchase et al., 1975; Wilson et al.,
1985) and semi-puriﬁed diets used (Jaskiewicz et al., 1987a
and b, Gelderblom et al., 1991, 2001a) were proposed to
be marginally deﬁcient in vitamins and micronutrients,
such as choline, methionine and certain vitamins (Wilson
et al., 1985). However, when considering the minimal
nutritional requirements for rats (Keenan et al., 2000)
both the semi-puriﬁed and corn-only diets contained
suﬃcient quantities of choline and 50–70% of the
methionine levels when compared to the AIN-76 diet.
Both the AIN-76 and the NIH-31 diets contained choline
levels far in excess (2–4) of the required amount. As
suﬃcient levels of these feed constituents were present an
increased the sensitivity of the liver to FB1-induced
pathological eﬀects in the liver seems unlikely. However,
with respect to certain vitamins, both the corn only and
the semi-puriﬁed diets contained far less than the
required levels. Of interest is the absence of vitamins B12
and D and low levels of vitamins E in the corn-only diet.
The semi-puriﬁed diet also contained low levels of
vitamins B6 and B12. The low levels of folate in both
these diets appear not to be a factor as the intestinal
bacteria serves as a source (Keenan et al., 2000). In
contrast the NIH-31 diet contained folate levels far in
excess of the required levels. However, recent studies
showed that FB1 disrupts folate transport (Stevens and
Tang, 1997) and induces developmental abnormalities
in mice embryos in culture, which are partially counter-
acted by the addition of folate (Sadler et al., 2002). It is
not known at present whether the uptake of dietary
folate is impaired in rats. As oxidative damage has been
implicated in FB1-induced liver carcinogenesis (Abel
and Gelderblom, 1998) the low levels of dietary vitamin
E and selenium in the corn-only diet could have played
an enhancing role in the induction of hepatotoxic eﬀects
by the fungal contaminated corn (Purchase et al., 1975;
Wilson et al., 1985).
With respect to the minerals both the corn-only and
the semi-puriﬁed diets contained extremely low calcium
levels resulting in incorrect calcium to phosphorus ratio
which is very important in the maintenance of rat
growth (Keenan et al., 2000). The phosphorus in plant
products is present as phytate which is largely unavailable
to the animal due to a lack of absorbance from the gut. In
both the semi-synthetic and corn-only diets the calcium
level is lower than the phosphate and therefore below the
1:3 molar ratio of calcium-to-phosphorus, suggested to
prevent nephrocalcinosis (Keenan et al., 2000). In a
chronic feeding study in male BD IX rats, nephrocalci-
nosis has been reported to occur, but it was only noticed
in the rats fed the high dose of FB1 (Gelderblom et al.,
2001a).
The dietary modulation of FB1-induced carcinogenesis
in rats is likely to play an important role in the sensi-
tivity of rats within and between diﬀerent strains. When
considering the long-term carcinogenesis experiments of
fumonisins in rats and the nutritional content of the
diets used, certain dietary components most likely
aﬀected the dose–response eﬀects monitored. Future
studies need to be conducted focusing on the eﬀect of
diﬀerent dietary components as possible modulators of
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fumonisin-induced carcinogenesis in diﬀerent rat strains
and/or diﬀerent target organs in the same rat strain.
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Abstract
The present study was performed to determine whether excess hepatic iron modulates the cancer-initiating and promoting
properties of FB1. Thirty-eight male F344 rats were divided into four dietary treatment groups: (i) control diet (AIN, n  8); (ii)
FB1 250 mg/kg diet (FB1, n  10); (iii) 1±2% carbonyl iron (CI, n  10); or (iv) FB1 plus iron loading (FB1/CI, n  10) for 5
weeks (2 £ 2 factorial design). Hepatic iron concentrations in iron-loaded animals at 5 weeks were 444 ^ 56 (CI) and 479 ^ 80
mmol/g dry weight (FB1/CI) (mean ^ SEM). All the FB1-fed rats, in the presence or absence of CI, developed a toxic hepatitis
with a 4-fold rise in serum alanine transaminase (ALT) levels. FB1 appeared to augment iron-induced hepatic lipid peroxida-
tion, as measured by the generation of thiobarbituric acid reacting substances (TBARS) in liver homogenates (P , 0:0001).
Morphometric analysis showed that FB1 caused a signi®cantly greater mean ^ SEM number of `enzyme-altered' foci and
nodules per cm2 (5:34 ^ 1:42 vs. 1:50 ^ 0:52, P , 0:05), as well as a greater area (%) of liver occupied by foci and nodules
(0:33 ^ 0:12% vs. 0:05 ^ 0:03%, P , 0:001), compared with FB1/CI. The addition of FB1 to dietary iron loading caused a shift
in distribution of iron from hepatocytes to Kupffer cells, probably due to phagocytosis of necrotic iron-loaded hepatocytes. In
conclusion, (i) FB1 appears to cause toxicity in the liver independently from effects on lipid peroxidation; (ii) FB1 has a
potentiating effect on iron-induced lipid peroxidation; and (iii) dietary iron loading appears to protect against the cancer
promoting properties of FB1, possibly due to a stimulatory effect of iron on hepatocyte regeneration. q 1999 Elsevier Science
Ireland Ltd. All rights reserved.
Keywords: Fumonisin B1; Iron overload; Rat liver; Hepatic lipid peroxidation; Cancer initiation and promotion
1. Introduction
Fumonisin B1 (FB1), a food-borne mycotoxin
produced by the fungus Fusarium moniliforme [1],
causes a variety of naturally occurring toxicoses in
animals, including fatal illnesses in horses and pigs
[2,3]. Human dietary consumption of Fusarium-
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contaminated corn products has been linked epide-
miologically to increased rates of esophageal cancer
[4,5] and, perhaps, hepatocellular carcinoma (HCC)
[6], in regions of the world in which corn is the staple
grain, such as South Africa and China.
FB1 is hepatotoxic and hepatocarcinogenic in rats.
Short-term feeding with FB1 causes zone 3 liver
injury, marked apoptosis, oval cell proliferation,
and hepatic ®brosis [7]. Chronic feeding with FB1
leads to chronic toxic hepatitis, cirrhosis, and HCC
[8]. FB1 acts as a strong promoter (and possibly
weak initiator) of `enzyme-altered' hepatic foci
and nodules in short-term cancer studies [9,10].
The mechanisms of FB1-induced toxicity and cancer
induction in the liver are unclear, but there is some
evidence that peroxidation of lipid membranes
[11,12] and oxidative DNA damage [13] might
play a role.
Dietary iron overload is common in sub-Saharan
Africa, and hepatic iron concentrations rival those
occurring in genetic hemochromatosis. Recent
studies suggest that dietary iron overload may be a
risk factor for HCC in black Africans [14,15]. The
development of HCC in humans with iron overload
(genetic or dietary) usually occurs in the setting of
iron- or alcohol-induced cirrhosis [16], and it is not
clear whether iron plays a direct role in the induc-
tion of liver tumors or whether the increased cancer
risk arises solely from the cirrhotic process.
Although mechanisms of iron-induced hepatotoxi-
city are incompletely understood, free radical-
mediated peroxidative damage to cellular lipids,
proteins, and DNA is likely [17,18]. Experimentally,
the potentiation of cancer induction due to polyha-
logenated hydrocarbons by iron overload in rodents
[19] would suggest that iron may act as a promoter
of initiated hepatocytes. Studies carried out to
test this hypothesis have, however, shown con¯ict-
ing results, with both promoting and inhibiting
effects on cancer induction by excess hepatic iron
[20,21].
Both FB1 and excess hepatic iron may thus cause
peroxidation of membrane lipids and oxidative liver
injury [11,17]. Furthermore, both agents may, either
directly or indirectly, affect the induction of liver
tumors. The aims of this study were to determine
whether dietary iron loading modulates the cancer
initiating and promoting properties of FB1.
2. Materials and methods
2.1. Chemicals
FB1 was puri®ed from corn cultures of Fusarium
moniliforme strain MRC 826 according to the method
described by Cawood et al. [22] to a purity of 92±
95%. Carbonyl iron (CI), an extremely pure form of
elemental iron (.98% iron with , 0.8% carbon, ,
0.3% oxygen and , 0.9% nitrogen), was purchased
from Sigma Chemical Company (St. Louis, MO).
2.2. Animals and diet
The study was approved by the Ethics and Research
Committee of the University of Cape Town, and the
experiments were conducted in accordance with the
laws and regulations controlling experiments on live
animals in South Africa. Thirty-eight male Fischer
344 rats were fed a modi®ed AIN diet [23], which
has an iron content of 50 mg/kg feed [24]. The diets
containing FB1 250 mg/kg were prepared as described
previously [23] and stored under nitrogen at 2208C
for the duration of the study. Animals that were rando-
mized to receive dietary iron loading, were initially
fed 2% (w/w) CI when weaned, but this had to be
temporarily discontinued after 1 week (for 1 week)
due to growth retardation, whereafter iron supplemen-
tation was resumed with 1% (w/w) carbonyl iron until
the completion of the study.
2.3. Experimental design
The 5-week FB1-feeding experiment (250 mg/kg
diet) was commenced when the rats weighed approxi-
mately 155±165 g (group 1, 160:9 ^ 5:0 g; group 2,
165:2 ^ 1:9 g; group 3, 153:2 ^ 4:6 g; group 4,
155:7 ^ 4:8 g). The 38 animals were divided into
four treatment groups according to a 2 £ 2 factorial
design, i.e. controls (group 1, n  8); FB1 250 mg/kg
diet (group 2, n  10); dietary CI 1±2% (group 3,
n  10); and FB1 plus CI (group 4, n  10). The
quantities of feeds in the different groups were
adjusted to match the average intake of animals in
group 4 (FB1/CI). Two animals from each treatment
group and one animal from the control group were
sacri®ced at weeks 3 and 4 for analysis of hepatic
histopathology, and the remainder of the animals
(n  6, each group) were sacri®ced at week 5. The
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rats were weighed daily and feed intake and wastage
were carefully determined. At sacri®ce, animals were
anaesthetized by the intraperitoneal injection of a
sodium pentobarbitone solution (6% m/v). Blood
was drawn by cardiac puncture for measurement of
alanine transaminase (ALT) levels for biochemical
assessment of liver injury, and animals were termi-
nated by exanguination. The livers were harvested
and weighed. A slice of liver was taken from the
left, right, and median lobes of each animal, and
these were ®xed in 10% neutral buffered formalin,
routinely processed, and embedded in paraf®n for
light microscopy. The remaining liver was snap
frozen in liquid nitrogen and stored at 2 708C.
2.4. Light microscopy and immunohistochemistry
Liver sections (5 mm) were stained with hematox-
ylin and eosin (HE) for routine light microscopy, and
with sirius red for collagen. Perls' Prussian blue stain
for trivalent iron was used to assess hepatic iron
content [25]. Stainable iron in hepatocytes was graded
0±4, using a modi®cation of the scale devised by
Scheuer et al. [26]. Staining with rabbit polyclonal
GST pi (Novacastra, Newcastle-Upon-Tyne, UK)
was performed for `enzyme-altered' hepatic foci and
nodules. After sequential layering with swine anti-
rabbit, (Dako, Copenhagen, Denmark) link antibody
(1:250 dilution), peroxidase-conjugated with strepta-
vidin-biotin (Dako, Copenhagen, Denmark) 1:500,
was applied for 30 min at room temperature.
2.5. Morphometric analysis of hepatic foci and
nodules
A total of 18 liver sections (three sections per rat in
six rats sacri®ced at week 5) each from rats in group 2
(FB1) and group 4 (FB1/CI) were stained with GST pi
for determination of the number and size of `enzyme-
altered' foci and `premalignant' nodules. One section
from each of the left, right, and median lobes was
examined for each rat. The number of GST pi-positive
hepatic lesions (foci and nodules) per cm2 were
counted, and were considered an estimate of the
cancer initiating effects of FB1 with or without iron
loading [27,28]. For the purposes of this study, a
group of GST pi-positive cells was classi®ed as a
`focus' if it had an area of less than 100 mm2, and a
`nodule' if it had an area of 100 mm2 or greater. The
percentage area of liver occupied by GST pi-positive
foci and nodules was determined using video image
analysis (Optimas, Bothell, WA), and was considered
a measurement of the cancer promoting effects of FB1
with or without iron loading [27,28].
2.6. Hepatic iron concentration
Liver tissue for determination of iron content was
dried for 24 h at 1058C, weighed, digested in 50%
nitric acid at 708C for 1 h, and diluted in 0.2 M sodium
acetate buffer (pH 4.5) [29]. All glassware was
rendered iron-free and rinsed with iron-free water
[29]. Iron concentration was determined using a
Roche Unimate 5 Iron Kit (Roche Diagnostic
Systems, Basel, Switzerland), on a Roche Cobas
Fara II Centrifugal Analyser.
2.7. Assessment of oxidative damage
Malondialdehyde (MDA) is formed when polyun-
saturated fatty acids of membrane phospholipids
undergo peroxidation. Lipid peroxidation was
measured by the thiobarbituric acid (TBA) assay for
MDA concentration on samples of liver homogenate,
as described by Esterbauer and Cheeseman [30].
Related substances such as sucrose, non-ferrous
metal ions and whole tissue homogenates may also
react with TBA or in¯uence the assay procedure,
and the term thiobarbituric acid reacting substances
(TBARS) more accurately describes the product of
this assay [30]. Addition of EDTA to the liver homo-
genate and butylated hydroxytoluene (BHT) to the
TBA reagent prevent further oxidative changes during
the assay procedure. Lipid peroxidation was
expressed as nmol MDA equivalents per mg protein,
using a molar extinction coef®cient of 1:56 £ 105
M21cm21 at 532 nm for MDA [31].
2.8. Statistics
The data are presented as the mean ^ SEM.
Outcome measurements between the treatment groups
were compared by one way analysis of variance
(ANOVA). Individual comparisons were made using
ScheffeÂ's test. FB1-induced GST pi-positive hepatic
lesions in groups 2 and 4 were compared using the
Mann±Whitney U-test for non-parametric data.
Signi®cance was set at a P-value of 0.05.
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3. Results
3.1. Body weight gain and liver weight/body weight
ratio
Total feed intake was 222:35 ^ 14:26 g/100 g body
wt., and equivalent total FB1 intake was calculated as
55:59 ^ 3:56 mg/100 g body wt. Daily feed intake
was 6:57 ^ 0:40 g/100 body wt. and daily FB1 intake
was 1:64 ^ 0:10 mg/100 g body wt. Despite control of
feed intake there were signi®cant differences in
weight gain in the treatment groups, presumably
re¯ecting differential toxic effects (Fig. 1). The liver
weight/body weight ratio was reduced only in rats
from group 2 (FB1; P , 0:0001) (Fig. 2).
3.2. Liver injury analysis
Serum levels of ALT in animals that received
control AIN diet was 42 ^ 2 units/l at 5 weeks.
There was a marked increase in week 5 ALT levels
in rats fed FB1 (group 2, 200 ^ 28 units/l) and FB1/CI
(group 4, 191 ^ 10 units/l), re¯ecting signi®cant
hepatotoxicity of FB1-containing regimens. Serum
ALT levels in animals given CI (group 3) were mildly
raised (66 ^ 7 units/l) at 5 weeks, indicating minimal
hepatocellular injury caused by dietary iron loading
alone.
3.3. Liver histopathology
Pathological changes in rat liver caused by feeding
of FB1 250 mg/kg diet for 5 weeks have been
described elsewhere [7], and include severe zone 3
injury with collapse of the reticulin framework,
frequent hepatocyte mitoses, and apoptotic bodies,
seen after 1 week. These initial changes are followed
by the development of `enzyme-altered' foci and
nodules, marked oval cell proliferation, and hepatic
®brosis by week 3. Sequential liver sections from
weeks 3±5 in group 2 animals (FB1) from the present
study showed milder liver injury, with cell loss and
collapse in zone 3, mitoses, minimal ®brosis, and
multiple small GST pi-positive foci and nodules.
Even though the FB1 content of the diet was the
same compared with the earlier study [7], total intake
of FB1 in the present study was reduced because of
averaged feeding. Similarly, liver sections of group 4
rats (FB1/CI) showed evidence of mild liver injury
histologically, and there appeared to be fewer hepatic
GST pi-positive foci in these animals. Liver sections
from control animals and group 3 rats (CI) showed no
evidence of liver injury.
Perls' Prussian blue staining of sequential liver
sections showed progressive hepatic iron loading
from weeks 3±5 in animals that received iron supple-
mentation (groups 3 and 4). There was a striking
difference in the pattern of iron distribution between
animals in group 3 (CI) and group 4 (FB1/CI). At week
5, livers from group 3 rats (CI) showed grade 3±4
parenchymal iron loading and a zonal gradient of
iron deposition, with maximum deposition in zone
1. Lesser amounts of iron was detected in Kupffer
cells (Fig. 3A). Livers from group 4 rats (FB1/CI)
showed evidence of marked iron deposition mainly
in the Kupffer cells in zone 3, occurring in association
with hepatocyte death in this region. (Fig. 3B).
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Fig. 1. Body weight gain (g) of rats over 35 days according to
treatment group.
Fig. 2. Liver weight to body weight (LW/BW) ratio of rats accord-
ing to treatment group.
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Fig. 3. Stainable iron in livers from rats in groups 3 and 4. (A) Liver section from a rat in group 3 (CI), showing grade 3 parenchymal iron
deposition with maximal deposition in zone 1. (B) Liver section from a rat in group 4 (FB1/CI), showing loss of hepatocytes in zone 3 and
abundant iron in Kupffer cells, with lesser amounts of parenchymal iron deposition. Perls' stain for iron, objective £ 10. Straight arrows indicate
central veins; curved arrows indicate portal tracts.
3.4. Morphometric analysis of GST pi-positive foci
and nodules
Rats given dietary iron loading alone (CI) did not
develop any GST pi-positive hepatic foci or nodules.
At 5 weeks, 4/6 rats treated with FB1 (group 2) had
developed hepatic foci and 6/6 rats from this group
had developed hepatic nodules. In contrast, 3/6 rats
treated with FB1/CI (group 4) had developed foci by 5
weeks, and 4/6 rats from this group had developed
nodules. At week 5, corresponding liver sections (3
sections/rat from 6 rats in each group) from rats in
group 2 contained an average of 5:34 ^ 1:42 GST
pi-positive lesions per cm2, as compared with 1:50 ^
0:52 GST pi-positive lesions per cm2 in livers of rats
from group 4 (P , 0:05; Table 1). Furthermore, the
area (%) of liver sections occupied by GST pi-positive
lesions in rats from group 2 was 0:33 ^ 0:12%, as
compared with 0:05 ^ 0:03% in sections of rats
from group 4 (P , 0:05; Table 1). These data indicate
that there were more, and larger, lesions in the livers
of rats that received FB1 only (group 2).
3.5. Hepatic iron concentration
Hepatic iron concentration (mmol/g dry weight of
liver) in the livers of rats treated with CI (group 3) and
FB1/CI (group 4) was 444 ^ 56 and 479 ^ 80 mmol/g
dry weight, respectively. In contrast, liver iron
concentration in control animals (group 1) and rats
treated FB1 was 48 ^ 4 and 48 ^ 5 mmol/g dry
weight, respectively.
3.6. Hepatic lipid peroxidation
Generation of TBARS in liver homogenates
differed between the treatment groups (Fig. 4), and
these differences persisted when using differences in
weight gain as the covariant (F ratio  5:24,
P , 0:01). Although treatment with FB1 (group 2)
slightly increased TBARS generation above control
levels, these changes were not signi®cant (P , 0:3).
Treatment with CI (group 3), however, caused a
signi®cant increase in TBARS generation
(P , 0:001). Contrast coef®cient analysis revealed
that hepatic TBARS generation due to FB1/CI
(group 4) was signi®cantly more than the sum of
TBARS generation by CI (group 3) plus FB1 (group
2) (P , 0:0001), indicating a potentiating effect of
FB1 on iron-induced lipid peroxidation (Fig. 4).
4. Discussion
FB1-induced hepatotoxicity may be caused, at least
in part, by lipid peroxidation and oxidative damage to
hepatocytes [11±13]. Abel and Gelderblom [11]
recently showed that FB1 caused a dose-dependent
increase in the level of TBARS in rat liver in vivo
and in primary rat hepatocytes in vitro. The in vitro
effect was further potentiated by the addition of
cumene hydroperoxide (CMHP), a potent oxidizing
agent. The authors suggested that lipid peroxidation
with generation of TBARS appeared to be an end
result rather than a cause of FB1-induced hepatic
injury [11]. Sahu et al. [13] found no effect of metals
(iron or copper) on FB1-induced peroxidation of lipid
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Table 1
Glutathione S-transferase (GST) pi-positive hepatic lesions found at
week 5 in rats treated with FB1 (group 2) and FB1/CI (group 4)
(n 6, each)
FB1 (group 2) FB1/CI (group 4)
No. of rats with focia 4/6 3/6
No. of rats with nodules 6/6 4/6
No. of lesions per cm2b 5.34 ^ 1.42c 1.50 ^ 0.52
Area (%) of lesionsb 0.33 ^ 0.12c 0.05 ^ 0.03
a A GST pi-positive lesion was classi®ed as a `focus' if it had an
area of less than 100 mm2, and as a `nodule' if it had an area of 100
mm2 or greater.
b Data presented as mean ^ SEM.
c P , 0:05.
Fig. 4. Generation of thiobarbituric acid reacting substances
(TBARS) from liver homogenates according to treatment group
(n  6, each).
membranes and oxidative DNA damage of isolated rat
nuclei. The present in vivo study, however, shows that
excess liver iron (mean content 479 mmol/g dry
weight) has a signi®cant potentiating effect on FB1-
induced lipid peroxidation, measured as generation of
TBARS, in liver homogenates. In contrast to the study
by Abel and Gelderblom [11], FB1 250 mg/kg diet
alone did not cause a signi®cant increase in hepatic
TBARS generation, although the level appeared to be
slightly higher than in controls. This might have been
due to the lower total dose of FB1 administered in the
present study due to averaged feeding of the animals.
FB1-induced hepatotoxicity was re¯ected by a reduc-
tion in the liver/body weight ratio and a four-fold rise
in serum ALT levels, and was con®rmed histologi-
cally.
Agents may increase the risk of cancer by causing
DNA damage (genotoxicity) and/or by causing
increased proliferation (increased DNA replications)
in a pluripotential cell population of the tissue [32].
To increase the number of DNA replications, an agent
can either increase cell births (direct mitogenesis or
toxicity and regenerative proliferation) and/or
decrease cells deaths (inhibition of apoptosis) [33].
FB1 appears to be a unique carcinogen which causes
marked TGF-b1-induced apoptosis accompanied by
regeneration of hepatocytes and proliferation of oval
cells [7], putative precursor cells for liver tumors [34].
Although FB1 was found to be non-genotoxic in the
Ames mutagenicity test [35,36], recent studies have
reported the DNA damaging potential of FB1
[13,37,38]. FB1-induced lipid peroxidation might
result in oxidative damage to DNA and errors in repli-
cation. These effects might be enhanced by oxidative
injury due to iron loading. However, in the present
study, iron overload signi®cantly enhanced lipid
peroxidation in the absence of hepatotoxic injury,
whereas FB1-induced hepatocyte injury was only
associated with mild changes in lipid peroxidation.
These ®ndings are in accordance with the hypothesis
of Abel and Gelderblom [11] that lipid peroxidation is
secondary to FB1-induced liver injury. With respect to
cancer induction, this study showed that moderately
severe hepatic iron overload (9-fold increase in liver
iron content) decreased the number and size of GST
pi-positive foci and nodules in FB1-fed rats. A similar
protective effect of hepatic iron loading (6- to 13-fold
increase) was reported by StaÊl et al. [20], who added
or substituted dietary iron loading for the initiating
and promoting events in the Solt Faber model of
chemical hepatocarcinogenesis. They showed a mild
mitostimulatory effect of iron on normal hepatocytes,
which may have protected against the promotion of
resistant hepatocytes. Although hepatocyte prolifera-
tion was not measured in this study (e.g. BrdU label-
ing, PCNA), the liver weight/body weight ratio was
maintained in animals treated with FB1/CI, suggesting
that iron may augment the hepatic regenerative
response to FB1-induced loss of hepatocytes and
hence may counteract the selection process (mitoinhi-
bition of normal hepatocytes) that effects the
outgrowth of initiated cells into GST pi-positive foci
and nodules. Under the present conditions, where
cancer promotion was apparently impaired, the effect
of excess hepatic iron on FB1-induced cancer initia-
tion could not be determined.
There was a striking difference in the pattern of
distribution of liver storage iron between group 3
(CI) and group 4 (FB1/CI). Dietary supplementation
with CI is known to cause predominantly parenchy-
mal (zone 1) hepatic iron deposition, with a zonal
gradient, similar to that seen in genetic hemochroma-
tosis [39,40]. Addition of FB1 feeding to iron loading
resulted in a shift of liver iron from parenchymal cells
to Kupffer cells, presumably due to ingestion of dead
hepatocytes by liver macrophages. A similar shift in
the distribution of iron from hepatocytes to reticuloen-
dothelial cells is seen in alcohol±iron±CCl4-treated
rats [41], and also occurs in genetic hemochromatosis
with episodes of alcoholic hepatitis [42]. Although
African dietary iron overload is also characterized
by massive deposition of reticuloendothelial iron
[43], the pathogenesis of the hepatic siderosis is
different, and appears to relate to associated ascorbic
acid de®ciency with impaired release of iron from
Kupffer cells [44,45].
In conclusion, FB1 had a potentiating effect on iron-
induced lipid peroxidation in the liver. However, the
effects on cancer induction by the fumonisin myco-
toxins still need to be elucidated, particularly as diet-
ary iron overload appears to protect against the
promotion of GST pi-positive hepatic lesions by
FB1, probably due to a stimulatory effect on hepato-
cyte regeneration. These exciting ®ndings provide
new avenues of research regarding the mechanisms
involved in FB1-induced carcinogenesis and the
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modulating role of environmental factors, such as iron
overload.
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Fumonisin B1 (FB1) is a naturally occurring mycotoxin
produced by Fusarium verticillioides. Dietary exposure to
FB1 has been linked to human cancer in certain parts of the
world, and treatment with FB1 causes oval cell prolifera-
tion and liver tumors in rats. To study the potential role of
oval (liver progenitor) cells in the cellular pathogenesis of
FB1-induced liver tumors, we gave male F344 rats pro-
longed treatment with FB1 for 25 weeks, followed by return
to control diet until 50 weeks (`stop study'). The time
course of FB1-induced liver lesions was followed by exam-
ination of serial liver biopsies at set time intervals and post-
mortem liver tissue at the end of the study. The effects of
different FB1 treatment regimens (5 versus 25 weeks), as
well as the modulating effect of 2-acetylaminofluorene
(2-AAF), on the kinetics of oval cell proliferation and
development of liver tumors were compared. Prolonged
treatment with FB1 in normal diet caused persistent oval
cell proliferation and generation of both hepatic adenomas
and cholangiofibromas (CFs). These liver lesions occurred
in the setting of chronic toxic hepatitis and liver fibrosis/
cirrhosis, similar to that seen in human hepatocarcinogen-
esis. Some adenomas and CFs were dysplastic, and one
post-mortem liver contained a hepatocellular carcinoma.
OV-6 oval cells were noted in close relation to prolifera-
tive neoplastic liver lesions, and some of these lesions
expressed OV-6, suggesting that all these cell types were
derived from a common progenitor cell. 2-AAF enhanced
the size of FB1-induced glutathione S-transferase pi
 hepa-
tocellular lesions and the incidence of CFs in post-mortem
liver specimens, but this was not statistically significant. In
conclusion, this study supports the involvement of dietary
FB1 in liver carcinogenesis in male F344 rats. Oval cells
may be the source of both the hepatocellular and cholangio-
cellular tumors induced by prolonged treatment with FB1.
2-AAF appears to have an enhancing effect on FB1-induced
liver tumors, presumably due to its potent inhibitory
effects on hepatocyte regeneration.
Introduction
Fumonisin B1 (FB1) is a food-borne mycotoxin produced
by the fungus Fusarium verticillioides (previously Fusarium
moniliforme) (1) that occurs worldwide and causes a variety
of naturally occurring toxicoses in animals, including fatal
illnesses in horses (2) and pigs (3). Human dietary consump-
tion of Fusarium-contaminated corn products has been linked
epidemiologically to increased rates of esophageal cancer
(4,5), and perhaps hepatocellular carcinoma (HCC) (6), in
regions of the world in which corn is the staple grain, such as
South Africa and China. FB1 is hepatotoxic and hepatocarci-
nogenic in rats. Short-term feeding with FB1 causes severe
toxic hepatitis (1), while continued FB1 administration leads to
a chronic toxic hepatitis and fibrosis, which progresses to
cirrhosis, and sometimes terminates in HCC or cholangiocar-
cinoma (7). FB1 appears to be a unique carcinogen that causes
regenerative hyperplasia of hepatocytes and promotion of
tumors despite striking pro-apoptotic effects (8,9). The mole-
cular mechanisms underlying FB1-induced hepatocarcinogen-
esis are not known, but recent data implicate the activation
of specific apoptotic and oncogenic pathways, including the
TGF-b pathway (10) and the Akt/cyclinD1 pathway (11).
The cellular origin of HCCs induced by FB1 is unclear, and
most studies have focused on the role of the mature hepatocyte
(9). However, we recently showed that short-term treatment of
rats with FB1 resulted in early proliferation of `oval cells',
which coincided with the appearance of foci of altered hepa-
tocytes (FAH) (10). Microscopically, oval cells are small cells
with elongated nuclei and scanty cytoplasm (12), which appear
to arise from cells in the terminal bile ductules (canals of
Hering) or from periductular cells (13). Proliferating oval
cells have been noted to appear early in several experimental
carcinogenesis protocols, and these cells may represent the
progeny of a liver stem cell (14). Oval cells are bipotential
and can differentiate into either hepatocytes or bile duct
epithelial cells, and they have been shown to have clonogenic
potential in vivo and in vitro. Oval cells are not normally
involved in liver regeneration, due to the enormous replicative
capacity of hepatocytes, but are induced to proliferate under
conditions of severe liver injury when mature hepatocytes are
overwhelmed or prevented from proliferating (14). There is
now good evidence that bipotential ductular progenitor cells
(oval cells) may give rise to HCCs under certain experimental
conditions (15).
In order to study the potential role of oval cell proliferation
in the generation of FB1-induced proliferative and neoplastic
Abbreviations: 2-AAF, 2-acetylaminofluorene; CF, cholangiofibroma;
FAH, foci of altered hepatocytes; FB1, fumonisin B1; GSTP, glutathione
S-transferase pi; HA, hepatocellular adenoma; HCC, hepatocellular carcinoma;
H&E, hematoxylin--eosin; LTFB, long-term fumonisin B1 treatment; LTFB/
AAF, long-term fumonisin B1 treatment plus 2-AAF; STFB, short-term
fumonisin B1 treatment; STFB/AAF, short-term fumonisin B1 treatment plus
2-AAF.
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liver lesions, male F344 rats were treated with FB1 for 25 weeks,
followed by return to control diet (`stop study'). Different FB1-
containing treatment regimens (5 versus 25 weeks) were com-
pared, and the modulating effect of 2-acetylaminofluorene
(2-AAF) on FB1-induced oval cell proliferation and tumori-
genesis was also assessed. The sequential development of
hepatic histopathologic lesions in the different treatment
groups was monitored by examination of serial liver biopsies
as well as post-mortem liver tissue.
Materials and methods
Chemicals
FB1 was purified from corn cultures of F.verticillioides strain MRC 826
according to a method described previously (16). The purity as compared
with an analytical standard by high-performance liquid chromatography was
in the order of 92--95% (24). The monomethylester derivatives of FB1, which
are artifacts of the purification procedure, constituted the remainder of the
FB1 preparation. 2-AAF stock powder was purchased from Sigma-Aldrich
(St Louis, MO).
Animals and diets
The study was approved by the Animal Ethics and Research Committee of the
Faculty of Health Sciences, University of Cape Town and the experiments were
conducted in accordance with the laws and regulations controlling experiments
on live animals in South Africa. Fifty-four male Fischer 344 rats weighing
between 150 and 200 g were used for the experiments. The animals were caged
individually in a controlled environment at 23--24C and 50% humidity with a
12 h artificial light cycle. Food and water were available ad libitum, and rats
were weighed weekly. All the animals received American Institute of Nutrition
(AIN)-76 diet (17) with the following modifications: the corn starch was
replaced with glucose/sucrose/corn starch (1:1:1) while sunflower oil was
used instead of corn oil as a fat source. Corn products were excluded from
the control diet in order to prevent any possibility of contamination by
F.verticillioides.
Treatments
The FB1-containing treatments were prepared as described previously (18).
The 2-AAF containing treatments were prepared by mixing 2-AAF stock
powder into AIN-76 diet to give a concentration of 0.02% (w/w), a dose
known to cause effective mitoinhibition of hepatocytes (19,20).
Experimental
The different FB1-containing treatment regimens are shown in Figure 1, and
the details of the individual treatment groups (in order of decreasing intensi-
ties) are as follows: group I rats (long-term FB1 plus 2-AAF, LTFB/AAF, n 
12) initially received FB1 250 mg/kg diet for 5 weeks, a dose shown previously
to induce oval cell proliferation and appearance of FAH (10). The animals then
received a 2-week course of 2-AAF 0.02% in the diet (weeks 5--7), and were
then continued on FB1 100 mg/kg until 25 weeks. The maintenance dose of
FB1 was reduced from the initial dose in order to avoid fulminant hepatotoxi-
city while maintaining a pro-carcinogenic effect (21); group II rats (long-term
FB1, LTFB, n  12) initially received FB1 250 mg/kg diet for 5 weeks, and
were then continued on FB1 100 mg/kg until 25 weeks; group III rats (short-
term FB1 plus 2-AAF, STFB/AAF, n  12) received FB1 250 mg/kg diet for
5 weeks only, followed by 2-AAF 0.02% from weeks 5--7; group IV rats (short-
term FB1, STFB, n  12) received FB1 250 mg/kg diet for 5 weeks only; and
group V rats (controls, n  6) received control (modified AIN-76) diet. A
treatment group of rats given only a 2-week course of 2-AAF was not included
in this study, but this regimen is reported to produce little cellular change (22).
Following treatment with the different active (FB1-containing) treatment regi-
mens in groups I--IV, all animals were returned to control diet until week 50, in
order to assess the reversibility of FB1-induced proliferative and neoplastic
liver lesions.
Serial liver biopsies
The sequential development of histopathologic liver lesions was followed by
histologic examination of liver tissue obtained by repeated open wedge liver
Fig. 1. Schema of FB1-containing treatment regimens (see text for details of individual treatment groups). Dashed arrow indicate open liver biopsies and
solid arrow indicate post-mortem liver tissue.
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biopsies (Figure 1), which were performed under ether anesthesia (to reduce
the potential for hepatotoxicity) according to the method described by
Cmielewski et al. (23). Biopsies were performed via a small (2--3 cm) midline
incision, and bleeding from the biopsy site was controlled by diathermy. A
different lobe was biopsied each time, commencing with the posteriorly
situated left lobe, and rotating to the more accessible median lobe for repeat
biopsy. Biopsies were performed at weeks 5 and 7, and then 4-weekly. At each
session, two rats from each of the active treatment groups and one control
animal were biopsied. Rats receiving biopsies were rotated at each session until
all the animals in the different groups had undergone a liver biopsy, thereafter
repeat biopsies were performed in the same order. As a result of the high
surgical mortality rate (see Results), serial liver biopsies were discontinued at
39 weeks.
Post-mortem liver examinations
Post-mortem liver tissue was obtained upon the death of surviving rats at
50 weeks (Figure 1), or following deaths at any time during the course of the
study period. The livers were weighed and sectioned. Macroscopic tumor
nodules near the peritoneal surface or on the cut surface were recorded. Slices
from each of the four liver lobes were processed for histological examination
(see below).
Light microscopy and immunohistochemistry
Four to five millimeter-thick slices of liver were fixed in 10% neutral buffered
formalin, embedded in paraffin, and sectioned at 4 mm for staining with
hematoxylin--eosin (H&E) for routine light microscopy and Sirius red stain
for collagen (10). Immunohistochemical staining for desmin (stellate cells),
OV-6 (oval cells) and glutathione S-transferase pi (GSTP) was performed as
described previously (10). Diagnoses of proliferative and neoplastic liver
lesions were made according to the criteria of Bannasch and Zerban (24).
Oval cells were identified by characteristic light microscopic features (12), and
confirmed by staining with OV-6 monoclonal antibody.
Scoring of hepatic histopathological lesions
In order to enable semi-quantitative assessments and comparisons between
treatment groups, numerical scoring systems were devised for hepatic fibrosis,
oval cell proliferation and area (%) occupied by GSTP lesions (Table I). In
this study, only GSTP lesions 41 mm were included in the measurements.
The liver pathologist examined coded liver sections, and was unaware of the
treatment given in each case.
Statistical analysis
For comparison of liver biopsy histopathological parameters (scores) amongst
the different treatment groups, statistical analysis was performed on the
unweighted means of the treatment-time combinations of the groups, using the
general linear model of analysis of variance (ANOVA). Histopathological data
from post-mortem livers for the different treatment groups were compared
using two-way ANOVA. The level of statistical significance was set at P5 0.05.
Results
Surgical mortality
The 54 rats underwent 84 open liver biopsies at 10 time points
during the study period. All 54 rats had one liver biopsy, and
30 rats underwent a second biopsy. The numbers of biopsies
performed in the different groups were as follows: group I
(LTFB/AAF), 19; group II (LTFB), 18; group III (STFB/
AAF), 19; group IV (STFB), 17; and group V (controls), 11.
The surgical mortality rates by treatment group were as fol-
lows: group I, 5.0% (1/20); group II, 19.0% (4/21); group III,
10.5% (2/19); group IV, 23.3% (5/19); and group V, 11.1%
(1/9). Most deaths appeared to be related to general anesthesia
and liver surgery in animals with severe chronic liver toxicity,
and the single operative death in the control group was an
unexpected event related to anesthesia overdose. Because of
the high surgical mortality rate encountered, serial liver biop-
sies were not extended beyond week 39 of the study.
Hepatic histopathological lesions caused by treatment of male
F344 rats with FB1-containing feeding regimens
Group I rats (LTFB/AAF). The early hepatic histopathological
lesions induced by treatment with FB1 (at 5 weeks) were
similar to those described previously (10), although the degree
of toxic liver injury and oval cell proliferation appeared to be
less severe. Proliferation of hepatic stellate cells was maximal
at weeks 5--7 (during treatment with 2-AAF), and desmin-
positive stellate cells and portal fibroblasts were seen to radiate
out from portal tracts into the surrounding hepatic parenchyma
(data not shown). By week 7, there was established hepatic
fibrosis, resulting in portal--portal linkage and architectural
distortion. Thereafter, liver fibrosis progressed more gradu-
ally, eventuating in septal fibrosis or (less commonly) cirrhosis
(Figure 2A) during the study period. Many of the larger
nodules in cirrhotic livers were GSTP, indicating that these
nodules were in fact hepatic adenomas (HAs) (Figure 2A,
inset). Proliferation of OV-6 oval cells and ductules was
maximal at 7 weeks and declined thereafter, despite continued
treatment with FB1. The size of HAs appeared to enlarge
progressively, attaining maximal size after completion of
FB1 treatment (~27 weeks). However, several HAs persisted
and even enlarged from weeks 25--50, following discontinua-
tion of FB1. Histologically, basophilic and clear cell types
predominated in the HAs (Figure 2B). Some HA hepatocytes
showed features of nuclear atypia (Figure 2B). Proliferating
oval cells and ductules were seen within several GSTP (ade-
nomatous) lesions. In addition, several HAs contained curious
cystic lesions lined by cuboidal cells. These lining cells had the
morphology of hepatocytes, but they expressed OV-6 antigen
(Figure 2C). The intimate spatial relationships and common
phenotypic markers of these different epithelial cell types
suggested that they might have all originated from proliferat-
ing oval cells and ductules. Most livers contained typical
cholangiofibromas (CFs) (often multiple) by the end of the
study, characterized by proliferating bile ducts embedded in
dense connective tissue (Figure 3A), presumably laid down by
proliferating stellate cells (Figure 3A, inset). Some CFs
showed cytologic features of dysplasia (Figure 3B), but no
unequivocal cholangiocarcinomas were seen. In post-mortem
livers, some GSTP lesions were noted to be located directly
Table I. Scoring systems for hepatic fibrosis, oval cell proliferation and
GSTP lesions
Score Fibrosisa
0 None
1 Enlarged, fibrotic portal tracts
2 Periportal or portalÐportal septa
3 Fibrosis with disturbed architecture,
but no cirrhosis
4 Probable or definite cirrhosis
Score Oval cell proliferation
0 None
1 Confined to portal tracts
2 Radiating out from portal tracts into
fibrous septa
3 Infiltrating liver parenchyma
4 Diffuse proliferation
Score GSTP lesionsb
0 None
1 525% of liver section
2 25--50% of liver section
3 450% but 575% of liver section
4 75--100% of liver section
aModified from Scheuer (35).
bPercentage area of liver section occupied by GSTP lesions was a
simple visual assessment by the histopathologist.
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adjacent to CFs (Figure 3C), and proliferating oval cells were
intertwined with both of these lesions (Figure 3C). Further-
more, some HAs contained hepatocytes that appeared to form
ductular structures, and these cells showed expression of OV-6
in a peripheral pattern (Figure 3D). Multilocular cystic cho-
langiomas were seen in some livers, and the lining epithelial
cells of these biliary lesions also expressed OV-6 (Figure 3D).
Taken together, these close spatial and immunophenotypic
relationships raised the possibility that proliferating oval
and ductular cells might be involved in the generation of
both the hepatocellular and cholangiocellular lesions seen in
these animals.
Fig. 2. Hepatic histopathological changes in F344 rats treated with FB1-containing regimens. (A) Sirius red stain of a liver biopsy from group I rat (LTFB/AAF) at
week 23 showing loss of the normal acinar architecture due to the presence of regenerative nodules of hepatocytes, which are partially or completely surrounded by
bands of fibrous tissue, indicating established cirrhosis. Sirius red, 40. (Inset) Low power view of liver biopsy from another group I rat at week 23 showing
cirrhotic liver with regenerative nodules of different sizes. Several of the larger nodules are composed of GSTP hepatocytes, indicating altered enzyme
phenotype and suggesting that these are HAs. GSTP; 40. (B) Post-mortem liver from group I (LTFB/AAF) rat at week 50 death showing a HA with features of
dysplasia. The HA contains both basophilic and clear hepatocytes, and these cells show evidence of cytological atypia. A mitotic figure (arrow) is seen in a
basophilic hepatocyte. H&E, 200. (C) OV-6 immunostaining of liver from a group I (LTFB/AAF) rat at week 50 death showing large cystic lesions that are lined
by cuboidal cells, and which have the morphology of hepatocytes but express OV-6 antigen (arrows). These cystic lesions are located within a HA, and
some of the surrounding hepatocytes also express OV-6 (arrowheads). OV-6, 200. (D) Liver biopsy specimen from group II rat (LTFB) at week 19 showing cells
with the morphology of oval cells (arrowheads) which are proliferating inside a lesion composed of GSTP hepatocytes. The oval cells do not stain with GSTP,
which aids their identification within the GSTP lesion. GSTP, 200. (E) Post-mortem liver from a group II rat (LTFB) at week 50 death showing an unequivocal
HCC. The malignant tumor is moderately differentiated and has a predominantly trabecular pattern, but in areas the formation of pseudoglands can be seen
(arrows). H&E, 200. (F) Liver biopsy from group III animal (STFB/AAF) at week 7 showing extensive proliferation of OV-6-positive oval cells and ductules,
which are radiating out from a portal tract (PT) as ribbons and cords into the hepatic parenchyma. OV-6, 200.
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Group II rats (LTFB). The histopathological changes were
similar to those described for group I animals (LTFB/AAF)
above. Once again, proliferating oval cells were noted within
and around GSTP (Figure 2D) lesions, suggesting a common
cell of origin. One post-mortem liver contained a trabecular
HCC (Figure 2E), and this was the only animal in the study that
had developed an unequivocal HCC.
Group III rats (STFB/AAF). 2-AAF appeared to enhance FB1-
induced proliferation of OV-6 oval cells and ductules seen at
7 weeks (Figure 2F), but oval cell proliferation declined
rapidly following discontinuation of treatment. HAs were
small and no HCCs were found. However, 2-AAF appeared
to have a potentiating effect on the incidence and number of
CFs induced by short-term treatment with FB1.
Group IV rats (STFB). Minimal long-term effects, e.g. fibrosis,
HAs and CFs were noted in livers from animals that received
short-term treatment with FB1 only.
Group V (controls). Livers from control rats all showed normal
histology, apart from occasional single cell GSTP foci by the
end of the study.
Kinetics of oval cell proliferation and development of liver
tumors in rats from the different FB1-containing treatment
groups
Liver biopsy data. As shown in Figure 4A, mean oval cell
scores (treatment-time combinations) were significantly
increased in all active (FB1-containing) treatment groups com-
pared with controls. There was no clear increase in oval cell
score by either 2-AAF [group I (LTFB/AAF) versus II (LTFB)
and III (STFB/AAF) versus IV (STFB)] or prolonged FB1
treatment [group I (LTFB/AAF) versus III (STFB/AAF) and
II (LTFB) versus IV (STFB)]. However, the combination of
2-AAF and prolonged FB1 (LTFB/AAF) resulted in a signifi-
cant increase in mean oval cell score when compared with
brief FB1 treatment (STFB) alone (Figure 4A), suggesting an
enhancing effect. Despite marked variability at individual time
points, there appeared to be a decline in oval cell scores over
time in all active treatment groups (data not shown). Biopsy
GSTP scores were significantly increased in all treatment
groups compared with controls, but there were no differences
between the different active treatment groups (Figure 4B).
Unlike the sequential biopsy oval cell scores, GSTP scores
appeared to remain stable or increase over time in all active
treatment groups (data not shown). Scores for fibrosis were
increased in all active treatment groups compared with con-
trols, but there were no differences between treatment groups,
and no significant increases over time (data not shown).
Post-mortem liver data. Scores for oval cell proliferation
were increased in all active (FB1-containing) treatment groups
compared with controls, despite return to control diet after
completion of the FB1-containing regimens (Table II). Similar
to the biopsy findings (see above), there is evidence of
Fig. 3. Hepatic histopathological changes in F344 rats treated with FB1-containing regimens. (A) Post-mortem liver from a group I rat (LTFB/AAF) at week 50
death showing a CF with dense fibrosis surrounding proliferative bile duct lesions. Strands of fibrotic tissue extend into the surrounding liver, which shows
disturbance of the normal acinar architecture and early regenerative nodules. Sirius red, 100. (Inset) Staining of the same liver specimen with desmin showed the
presence of proliferating vessels and hepatic stellate cells within the fibrous tissue surrounding the bile duct lesions in a CF. Desmin, 100. (B) Liver biopsy
specimen from a group I rat (LTFB/AAF) at week 15 showing a CF containing irregular tapered bile ducts, which show features of cytological atypia, e.g.
crowding of cells, nuclear hyperchromasia, and a mitotic figure (arrow). H&E, 400. (C) Post-mortem liver from group I rat (LTFB/AAF) at week 50 death
showing a HA containing of GSTP hepatocytes (upper right), and which is directly adjacent to proliferative bile duct lesions of a CF. Furthermore, cells with the
morphology of oval cells and ductules are proliferating in close relationship to the GSTP hepatocytes (arrowheads) and proliferative bile duct lesions. Of note
is that the proliferating oval cells, ductules, and bile duct lesions do not stain with GSTP. A mitotic figure (arrow) is seen within one of the GSTP hepatocytes.
GSTP, 200. (D) OV-6 immunostaining of a post-mortem liver from a group I rat (LTFB/AAF) at week 50 death showing HA-containing hepatocytes that are
expressing OV-6 antigen in a peripheral (membranous) pattern. Many of the OV-6-positive hepatocytes within the nodule appear to be forming ductules
(arrowheads). A multilobular cholangioma () is seen adjacent to the adenoma, and the flattened epithelial lining cells also express OV-6. OV-6, 200.
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enhancement of oval cell scores by either 2-AAF or prolonged
FB1 treatment alone, but in combination (LTFB/AAF) the two
treatments had an augmented effect compared with brief FB1
treatment (STFB) alone. The scores for GSTP lesions were
increased in all active treatment groups compared with
controls. GSTP scores were increased by 15% for group I
(LTFB/AAF) versus group II (LTFB) and by 50% for group III
(STFB/AAF) versus group IV (STFB) (data not shown), but
these differences were not statistically significant. However,
the ranges of GSTP lesion sizes (percentage liver area occu-
pied) that were chosen for the different scoring levels were
quite broad (Table I), and could hide marked differences in
sizes of lesions. Examination of the raw data for percentage
area occupied by GSTP lesions showed that there was clear
evidence of considerable enhancement of GSTP lesions
caused by both 2-AAF (group I versus II and III versus IV)
and prolonged FB1 treatment (group I versus III and II versus
IV) (Table II), which was of borderline statistical significance.
Furthermore, the effects of 2-AAF and prolonged FB1 treat-
ment on GSTP lesions appeared to be augmented, as
evidenced by a significant increase in percentage area of GSTP
lesions in group I (LTFB/AAF) compared with group IV
(STFB). Scores for fibrosis were increased in all treatment
groups compared with controls, but there were no significant
differences in fibrosis scores (or the development of cirrhosis)
between the different active treatment groups. Interestingly,
there appeared to be an enhancing effect of 2-AAF (but not
prolonged FB1) on the development of CFs, as evidenced by a
non-significant increase in the number of post-mortem livers
that contained CF in groups I (LTFB/AAF) and III (STFB/
AAF) compared with groups II (LTFB) and IV (STFB),
respectively. Only one post-mortem liver was found to contain
unequivocal HCC, and this liver came from a group II (LTFB)
animal.
Discussion
The present study shows that prolonged treatment with FB1 in
normal diet causes liver tumors (both hepatocellular and cho-
langiocellular) in rats. Male F344 rats given FB1 (250 mg/kg
diet for 5 weeks followed by 100 mg/kg diet until 25 weeks)
developed GSTP hepatic foci (FAH) and adenomas (HA),
and these lesions persisted following discontinuation of FB1,
indicating autonomous (neoplastic) growth. The FB1-induced
hepatocellular tumors developed in a setting of chronic (toxic)
hepatitis and marked hepatic fibrosis, sometimes progressing
to cirrhosis. These findings are reminiscent of human HCC,
which typically develops in the setting of chronic necroinflam-
matory liver disease and cirrhosis (25). The FB1-fed rat may
thus be a useful model to study the histopathogenesis of tumor
development in human HCC. Prolonged FB1 treatment also
resulted in the appearance of CFs, and some hepatocellular and
cholangiocellular tumors showed cytological features of dys-
plasia. However, only one post-mortem liver (from a rat that
received prolonged FB1 without 2-AAF) showed a trabecular
Table II. Comparisons of hepatic histopathological lesions caused by different FB1-containing treatment regimens (post-mortem liver data)
a
Group (n) Treatment Oval cell score % GSTP lesions area Fibrosis score Livers (%) with cirrhosis Livers (%) with CF Livers (%) with HCC
I (8) LTFB/AAF 2.6  0.4 49.0  6.9b 2.3  0.3 2 (25) 7 (88) 0 (0)
II (6) LTFB 2.0  0.5 22.9  8.8 2.0  0.4 2 (33) 2 (33) 1 (17)
III (9) STFB/AAF 1.6  0.3 22.2  6.9 1.8  0.3 0 (0) 5 (56) 0 (0)
IV (7) STFB 1.3  0.5 6.3  9.8 2.0  0.4 1 (20) 1 (14) 0 (0)
V (5) Controls 0.0  0.0c 0.5  9.8d 0.0  0.0b 0 (0) 0 (0) 0 (0)
aSee Table I for details of histological scoring systems and Figure 1 for outline of FB1 treatment groups.
bP 5 0.05 compared with group IV (STFB).
cP 5 0.01 versus active treatment groups (I--IV).
dP 5 0.05 versus active treatment groups.
Fig. 4. Histopathological scores for liver lesions caused by different FB1-containing treatment regimens (liver biopsy data). The combined (treatment-time)
mean histological score for each treatment group is shown. (A) Oval cell proliferation. (B) GSTP lesions. The numbers of animals per group are indicated in
brackets and vertical bars represent the standard error (SE). P 5 0.01, active treatment groups (groups I--IV) versus controls; yP(0.05), group I (LTFB/AAF)
versus IV (STFB). See Table I for numerical histologic scoring systems and Figure 1 for details of treatment protocols.
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HCC, and no unequivocal cholangiocarcinomas were found. It
is likely that a longer period of FB1 treatment is required
to cause HCC and cholangiocarcinomas in these animals. In
this regard, Gelderblom et al. (7) showed previously that treat-
ment of BD IX rats with FB1 (50 mg/kg diet) for 26 months
resulted in the development of HCCs (in 60% of rats) and
cholangiocarcinomas. However, the basal diet used in the
study was deficient in multiple vitamins and lipotropes, and
such dietary deficiencies could modulate FB1-induced hepato-
carcinogenesis (26). More recently, Howard et al. (27) found that
male F344/N rats fed diets containing FB1 (up to 150 mg/kg
diet) for 2 years developed renal tubular neoplasms but no liver
tumors, and there was no evidence of carcinogenic activity of
FB1 in females. The reason for the lack of hepatocarcinogenic
effects of FB1 in this long-term feeding study is unclear.
To date, in vivo studies on cellular carcinogenesis by FB1
have focused on the role of initiated hepatocytes and the foci-
nodule-carcinoma sequence (9), according to the resistant
hepatocyte model of Solt and Farber (28,29). Here we provide
evidence of a potential role for oval cells in FB1-induced
hepatocarcinogenesis. Prolonged treatment of rats with FB1
caused both hepatocellular and cholangiocellular tumors (fre-
quently in the same animal). This propensity of FB1 to cause
both hepatocellular and bile duct tumors is shared by only a
few other experimental carcinogens, e.g. 2-AAF (30) and furan
(31), and suggests that both the hepatocelluar and cholangio-
cellular tumors induced by FB1 may originate from a common
bipotential progenitor cell capable of differentiating along
both the hepatocytic and biliary lineages. OV-6 is a mouse
monoclonal antibody directed at cytokeratin 14/19 (32), which
normally stains oval cells and also may stain some bile duct
cells, adenomatous hepatocytes (within HAs) and HCCs in rat
liver (33,34). We noted an intimate spatial relationship
between proliferating OV-6 oval cells and ductules, GSTP
hepatocellular lesions (foci and adenomas) and bile duct
lesions (CFs). Furthermore, several cell types besides oval
cells and ductular cells were found to express OV-6 antigen,
including some adenomatous hepatocytes and also cells within
HAs that resembled hepatocytes, but which lined curious
cystic structures or appeared to form ductules. While these
observations do not provide direct proof that oval cells are
the source of the hepatocellular and cholangiocellular tumors
in the FB1-fed rat, they add to the growing weight of evidence
from other carcinogenesis models of such a concept (15,22).
From the biopsy and post-mortem liver data, it appears that
2-AAF and prolonged FB1 treatment have transient effects
only on oval cell proliferation, but they exert sustained and
enhancing effects on the growth of GSTP hepatocellular
lesions. Although not specifically monitored in this study, it
is unlikely that the liver biopsy procedures themselves resulted
in any significant enhancing effects on the development of
liver lesions. The enhancing effects of 2-AAF and FB1 on
GSTP lesions were particularly evident in post-mortem
liver specimens, especially when using the raw data for percen-
tage area occupied by GSTP lesions rather than the GSTP
score. Examination of whole liver specimens avoids the poten-
tial problem of sampling error, which is inherent in liver
biopsy specimens, and is thus the most accurate method for
assessing focal liver lesions in the rat. Although there appeared
to be discordance in the kinetics of oval cell proliferation and
GSTP lesion growth during the course of the study, it is quite
possible that some oval cells may have differentiated into
adenomatous hepatocytes at an early time point. These
findings thus do not militate against the possibility of an oval
cell origin for the hepatocellular tumors caused by FB1. Inter-
estingly, 2-AAF (but not prolonged FB1 treatment) had a
marked enhancing effect on the incidence of CFs in post-
mortem livers. Although not specifically measured in this
study, 2-AAF is known for marked inhibition of proliferation
of normal hepatocytes (19,20), and this property was thought
to underlie its potent promoting effects on FB1-induced
GSTP lesions and CFs, possibly through resultant activation
of a facultative stem cell compartment (oval cells) in the liver.
In conclusion, this study supports the involvement of dietary
FB1 in liver carcinogenesis in male F344 rats. Oval cells may
be the source of both the hepatocellular and cholangiocellular
tumors induced by prolonged treatment with FB1. 2-AAF
appears to have an enhancing effect on FB1-induced liver
tumors, presumably due to its potent inhibitory effects on
hepatocyte regeneration.
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a b s t r a c t
The chemoprotective properties of unfermented and fermented rooibos (Aspalathus linearis) and hon-
eybush (Cyclopia intermedia) herbal teas, and green and black teas (Camellia sinensis) were investi-
gated against fumonisin B1 (FB1) promotion in rat liver utilizing diethylnitrosamine (DEN) as cancer
initiator. The various teas differently affected the clinical chemical parameters associated with liver
and kidney damage associated with FB1 suggesting speciﬁc FB1/iron/polyphenolic interactions. Green
tea enhanced (P < 0.05) the FB1-induced reduction of the oxygen radical absorbance capacity, while
fermented herbal teas and unfermented honeybush signiﬁcantly (P < 0.05) decreased FB1-induced lipid
peroxidation in the liver. The teas exhibited varying effects on FB1-induced changes in the activities of
catalase, glutathione peroxidase (GPx) glutathione reductase (GR) as well as the glutathione (GSH)
status. Unfermented rooibos and honeybush signiﬁcantly (P < 0.05) to marginally (P < 0.1) reduced
the total number of foci (>10 lm), respectively, while all the teas reduced the relative amount of
the larger foci. Fermentation seems to reduce the protective effect of the herbal teas. Differences in
the major polyphenolic components and certain FB1/polyphenolic/tissue interactions may explain
the varying effects of the different teas on the oxidative parameters, hepatotoxic effects and cancer
promotion in rat liver.
 2008 Elsevier Ltd. All rights reserved.
1. Introduction
The popularity of the two South African indigenous herbal teas,
rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia),
is increasing as health beverages worldwide. This is mainly due
to the absence of caffeine (Morton, 1983), as well as antioxidant
(Von Gadow et al., 1997; Yoshikawa et al., 1990; Hubbe and Jou-
bert, 2000a,b; Joubert et al., 2004, 2008), anticlastogenic (Sasaki
et al., 1993; Shimoi et al., 1994) and antimutagenic properties
(Marnewick et al., 2000; Van der Merwe et al., 2006; Snijman
et al., 2007). Although the antioxidant and antimutagenic proper-
ties of rooibos and honeybush herbal teas have been investigated,
little information is available about their potential cancer modulat-
ing properties in vivo.
A recent study indicated that the consumption of rooibos and
honeybush herbal teas enhanced the activity of phase II detoxifying
enzymes, as well as altering the oxidative status in the liver of rats
(Marnewick et al., 2003). Cytosolic liver fractions of the herbal tea
treated rats protected against the mutagenesis of aﬂatoxin B1
(AFB1) and 2-acetylaminoﬂuorene (2-AAF). Themicrosomal bioacti-
vation of AFB1 was reduced, indicating the potential of the herbal
tea components to modulate their metabolic fate ex vivo (Marne-
wick et al., 2004). These ﬁndings suggest that aqueous extracts of
rooibos and honeybush are likely to alter the carcinogenic potency
of hepatocarcinogens in vivo. A study inmouse skin showed that ex-
tracts of the herbal teas disrupt cancer promotion subsequently re-
duces the development of papillomas (Marnewick et al., 2005).
0278-6915/$ - see front matter  2008 Elsevier Ltd. All rights reserved.
doi:10.1016/j.fct.2008.11.004
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Based on studies with green and black teas (Camellia sinen-
sis), polyphenolic components have been considered as potential
chemopreventive agents (Fujiki et al., 2002; Yang et al., 2000a).
Tea polyphenols are known to modulate the metabolic fate of
carcinogens in several ways to render them less active, thus
protecting the target tissue against their adverse effects (Yang
et al., 2000b). Several studies in animals showed that black
and green teas modulate cancer development in vivo (Mukhtar
et al., 1994; Steele et al., 1999). The consumption of tea poly-
phenols and tea pigments, comprising of the oxidized ﬂavanol
products, theaﬂavins and thearubigins, signiﬁcantly reduced
the number as well as the average area of glutathione-S-trans-
ferase placental form positive (GSTP+) foci in the liver (Gong
et al., 2000; Jia et al., 2002). An aqueous extract of green tea
inhibited both cancer initiation and promotion of AFB1- and car-
bon tetrachloride-induced hepatocarcinogenesis in male Fischer
rats (Qin et al., 2000).
Whereas the major polyphenolic constituents of green and
black tea are ﬂavanols and oxidation products of ﬂavanols, the
main monomeric phenolic constituents of rooibos are the ﬂavonoid
aspalathin, a dihydrochalcone, and its ﬂavone analogues (Joubert,
1996; Bramati et al., 2002). The major monomeric phenolic constit-
uents of honeybush are the xanthone, mangiferin and the ﬂava-
none, hesperidin (Ferreira et al., 1998; Joubert et al., 2003;
Kamara et al., 2003). Differences in the polyphenolic constituents
could explain variations in the biological properties, e.g. when
comparing the antioxidant and antimutagenic properties of the dif-
ferent teas (Van der Merwe et al., 2006; Joubert et al., 2008).
The fumonisin B (FB) mycotoxins, which are natural contami-
nants produced by Fusarium verticillioides on maize, are potent li-
ver cancer promoters (Gelderblom et al., 1988) and were recently
shown to synergistically interact with AFB1 in the induction of liver
nodules in a short-term carcinogenesis model (Gelderblom et al.,
2002). As these mycotoxins co-occur naturally, the modulation of
their carcinogenic characteristics is of importance (Zhang et al.,
1997; Ali et al., 1998). Numerous studies reported on the modula-
tion of the carcinogenicity of AFB1 by natural occurring dietary
constituents (Qin et al., 1997; Maxuitenko et al., 1998) whereas
the modulation of the carcinogenic properties of the fumonisins
has not been investigated. Carcinogenesis by FB1, the main fumon-
isin produced, is associated with a chronic hepatotoxic effect and
the induction of oxidative damage (Abel and Gelderblom, 1998;
Sahu et al., 1998; Lemmer et al., 1999). The role of reactive oxygen
species in carcinogenesis is well established as it regulates critical
events regarding cell proliferation and apoptosis (Klaunig and
Kamendulis, 2004). The modulating role of antioxidants in the
ROS-induced effects on the different cell survival parameters is
therefore of interest with respect to fumonisin-induced hepatocar-
cinogensis. The present study investigated the modulating proper-
ties of aqueous extracts of fermented and unfermented South
African herbal teas, as well as green and black teas, against differ-
ent oxidative parameters and cancer promoting activity induced by
FB1 in rat liver.
2. Materials and methods
2.1. Chemicals and diets
Diethylnitrosamine (DEN) was purchased from Sigma (Sigma–Aldrich, Cape
Town, South Africa) and prepared in dimethylsulfoxide (DMSO). FB1 was puriﬁed
according to the method of Cawood et al. (1991) at the PROMEC Unit, Medical
Research Council, Tygerberg, South Africa to a purity of 93–95%. The FB1-contain-
ing diet for the rats was prepared by evaporating FB1, dissolved in methanol
(Gelderblom et al., 1994), on a sub sample (200 g) of Epol (Epol Ltd., Johannes-
burg, South Africa) rat mash diet and mixing it with the control diet to obtain
the desired dietary level of 250 mg/kg diet. The diet was stored under nitrogen
at 4 C. Glutathione-S-transferase placental form (GSTP) antibody was obtained
from Novacastra, Newcastle, UK. Reduced (GSH) and oxidized (GSSG) glutathione
were purchased from Roche (Cape Town, South Africa). Glutathione reductase,
perchloric acid (PCA), trichloro acetic acid (TCA), 1-methyl-2-vinyl-pyridinium
triﬂuoromethane sulfonate (M2VP), 5,50-dithiobis-2-nitrobenzoic acid (DTNB),
NADPH, EDTA, gallic acid, (+)-catechin, quercetin, mangiferin and rutin were pur-
chased from Sigma (Sigma–Aldrich). Phycoerytherin (B-PE) was purchased from
ProZyme and 2,20-azobis (2-amidinopropane) dihydrochloride (AAPH), Trolox,
hesperidin and hesperetin were obtained from Aldrich Chemical Company (Cape
Town, South Africa). Aspalathin and nothofagin, with >95% purity were isolated at
the PROMEC Unit, while isovitexin, vitexin, isoquercitrin, orientin, iso-orientin
were purchased from Extrasynthese (Genay, France). All other chemicals used
were of analytical grade.
2.1.1. Plant material and tea preparation
Black tea (C. sinensis var assamica), a blend of locally produced African and Sri
Lankan teas, was bought from a retail outlet in Cape Town, while green tea
(C. sinensis var sinensis), imported from China, was a gift from Vital Health Foods
(Kuilsriver, South Africa). Fermented (‘‘oxidized”) and unfermented (‘‘green” or
‘‘unoxidized”) rooibos (A. linearis) and honeybush (C. intermedia) herbal teas were
obtained from Rooibos Ltd. (Clanwilliam, South Africa) and the Agriculture Re-
search Council, Infruitec-Nietvoorbij (Stellenbosch, South Africa), respectively.
Green and black tea and rooibos herbal tea were prepared at concentrations
customarily used for tea making purposes, while for honeybush a higher ratio
of plant material to water was used, to compensate for its relatively high stem
content that lowers its extractable polyphenol content. Aqueous extracts of hon-
eybush is known to exhibit lower antioxidant and antimutagenic properties than
the other teas (Van der Merwe et al., 2006; Joubert et al., 2008). Freshly boiled tap
water was added to the plant material at concentrations of 2 g/100 ml for fer-
mented and unfermented rooibos herbal, green and black teas and at 4 g/
100 mL for fermented and unfermented honeybush herbal tea. The aqueous ex-
tracts were allowed to cool to room temperature and fed to rats ad libitum. Fresh
tea was prepared every second day.
2.2. HPLC quantiﬁcation of the major ﬂavonoids in herbal tea aqueous extracts
Freeze-dried samples of rooibos and honeybush aqueous extracts were recon-
stituted in puriﬁed water (Modulab Water Puriﬁcation System from Continental
Water System Corporation), ﬁltered (Magna Nylon, 0.45 lm) and separated on a
LiChrospher 100 RP-18 (5 lm, 250  4.6 mm) column (Joubert, 1996) and a
Phenomenex Synergy Max-RP C12 column with TMS end capping (4 lm,
150  4.6 mm) (Joubert et al., 2003), respectively. A C18 guard column was used
in both cases and the HPLC system consisted of a Merck/Hitachi LaChrom system
comprising of both a L-7400 UV and a L-7450 DAD detector, L-7100 pump,
L-7200 autosampler, D-7000 HPLC system manager and interface module. The
UV detector output was used for quantiﬁcation, while the DAD detector was
used to conﬁrm peak identity, based on the spectra of the standards. Column
temperature was maintained at 30 C. The polyphenols were detected at
280 nm and quantiﬁed using calibration curves constructed for each ﬂavonoid.
Rutin co-eluted with isoquercitrin and the peak area was quantiﬁed in terms
of quercetin equivalents.
2.2.1. Treatment of animals
Ninety male Fischer rats (150–170 g), obtained from the Primate Unit, MRC
(Tygerberg, South Africa), had free access to Epol rat mash. They were housed in
wired top and bottom cages, ﬁtted with PerspexTM houses and kept in a controlled
environment of 23–24 C, 50% humidity and a 12 h light/dark cycle. Rats were ran-
domly divided into nine groups of ten rats each and caged individually. Initiation
was effected by a single dose of diethylnitrosamine (DEN; 200 mg/kg body weight,
i.p.). Tea or herbal teas were offered as the sole source of drinking ﬂuid and com-
menced one week after initiation until the end of the experiment, while promotion
commenced three weeks after initiation by giving the FB1-diet (250 mg/kg) for 21
days (Fig. 1). The DEN-initiated positive control group received the FB1 promotion
treatment (FB1) and tap water. The negative control groups either received DEN ini-
tiation or DMSO (carrier solvent) with the mash diet and tap water. All the rats were
averaged fed during the FB1 promotion treatment period, i.e., all the FB1 treated rats
received an equal amount of feed than the rats of the DEN-FB1 positive control
group. Their body weights were monitored on a weekly basis. The FB1 and tea in-
take proﬁles over the 3 week period were calculated as a function of the body
weight and expressed as mg FB1 or ml tea per 100 g body weight. At termination,
fasted (16 h) animals were euthanized by i.p. injection of sodium pentobarbital
(0.15 mL/100 g bw) and blood collected from the abdominal aorta. Livers were ex-
cised, weighed and sections processed in buffered formalin for histological exami-
nation. The remaining liver tissue were immediately frozen in liquid nitrogen and
stored at 80 C for biochemical analyses.
2.2.2. Clinical chemistry
The clinical biochemical parameters including serum creatinine, total choles-
terol, total iron, aspartate transaminase (AST), alanine transaminase (ALT), and
alkaline phosphatase (ALP) were measured on a Technicon RA 1000 automated
analyzer.
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2.2.3. Oxidative parameters
2.2.3.1. Lipid peroxidation. The thiobarbituric acid reacting substances (TBARS) were
determined according to a modiﬁed method described by Esterbauer and Cheese-
man (1990). Sub samples of the excised livers were homogenized on ice in 19 vol-
umes of 0.01 M phosphate buffer (pH 7.4) and incubated with 15 lM FeSO4 for one
hour at 37 C. The incubated homogenate (1 mL) was mixed with 2 mL of cold TCA
reagent (10% TCA, 0.01% BHT). The samples were centrifuged (3000 rpm) and 2 mL
of the resultant supernatant was combined with 2 mL of 0.67% TBA solution and
incubated at 90 C for 20 min. The mixture was allowed to cool to room tempera-
ture and the absorbance was measured at 532 nm. Lipid peroxidation was ex-
pressed as nmole malondialdehyde (MDA) per mg protein using a mmolar
extinction coefﬁcient of 156 (Esterbauer and Cheeseman (1990)). Non speciﬁc lipid
peroxidation was prevented by the incorporation of EDTA in the phosphate buffer
and BHT in the reaction solution for the TBARS assay.
2.2.3.2. Oxygen radical absorbance capacity (ORAC). Sub samples of the stored livers
were homogenized in 4 volumes of sodium phosphate buffer (75 mM, pH 7.0) in a
Thomas homogenizer (10 strokes) and centrifuged at 12,000g for 10 min at 4 C. The
supernatant was deproteinised using 0.25 M perchloric acid (PCA), centrifuged at
16,000g for 15 min and the resulting supernatants stored at 80 C prior to analy-
sis. The ORAC assay was conducted according to the method of Cao and Prior, 1998
on a 96 well microtiter plate using a BioTEK Fluorescence plate reader (FL-600). The
reaction consisted of 10 ll of diluted sample (1:1) and ﬂuorescein (56 nM), which
was used as a target for free radical attack. The reaction was initiated by the addi-
tion of 20 ll AAPH (240 mM) and the ﬂuorescence (emission 590 nm, excitation
530 nm) recorded every 5 min until the reading had declined to less than 5% of
the initial reading. The ORAC values were calculated and expressed as lM Trolox
equivalents/g wet liver weight.
2.2.3.3. Glutathione analysis. The total glutathione (GSH and GSSG) was measured
according to a modiﬁed method of Tietze (1969). Liver samples were homogenized
(1:10) in 15% (w/v) TCA containing 1 mM EDTA for GSH determination and in 6% (v/
v) PCA containing freshly prepared 3 mM M2VP and 1 mM EDTA for GSSG determi-
nation on ice. After centrifugation at 10,000g for 10 min, 50 ll of supernatant was
added to glutathione reductase (1U) and 75 lM DTNB. The reaction was initiated
by addition of 0.25 mM NADPH to a ﬁnal volume of 200 ll. The change in absor-
bance was monitored at 410 nm for 5 min and levels calculated using pure GSH
and GSSG as standards.
2.2.3.4. Activity of antioxidant enzymes. Liver homogenates (10% m/v) were prepared
in a phosphate buffer, centrifuged for 10 min at 15,000g at 4 C and the supernatant
preserved for enzyme analyses. Catalase (CAT) activity was determined spectropho-
tometrically at 240 nm by monitoring the decomposition of H2O2 and expressed as
lmoles H2O2/min/lg protein while superoxide dismutase (SOD) activity was deter-
mined by the method of Ellerby and Bredesden (2000), modiﬁed for a microplate
reader and expressed as the amount of protein (ng) required to produce a 50% inhi-
bition of auto-oxidation of 6-hydroxydopamine. Glutathione peroxidase (GPx)
activity was measured spectrophotometrically (340 nm) by the method of Flohe
and Gunzler (1984), expressing activity as nmoles NADPH/min/lg protein using
the mmolar extinction coefﬁcient of 6.22. Glutathione reductase (GR) activity was
measured spectrophotometrically (340 nm) by the method of Ellerby and Bredes-
den (2000), expressing activity as nmoles of NADPH utilised per min per lg protein
using the mmolar extinction coefﬁcient of 6.22.
2.2.4. GST-Pi immunohistochemical assay
Histochemical staining for the placental form of glutathione-S-transferase
(GSTP) was conducted on dewaxed liver sections using a three-stage indirect strep-
avidin–biotin technique to identify GSTP+ stained hepatocytes (Ogawa et al., 1980).
The enzyme altered foci were quantiﬁed microscopically (10 magniﬁcation),
according to their number and size (internal diameter) and categorized according
to the following sizes, 5–10 (mini foci), 11–20, 21–30, >30 lm. Foci were expressed
as number of foci/cm2 of the liver section, the area of which was determined by im-
age analyses. The relative amount of each focal size category was expressed as a % of
the total GSTP+ foci (P5 lm). The total GSTP+ foci (P10 lm) excluding the mini foci
were also determined.
2.2.5. Statistical analysis
Data were tested for normality using the Kolmogorov–Smirnof Test and Le-
vene’s Test for Equality of variances. One-way ANOVA’s (two-tailed) was used to
test for signiﬁcant group differences followed by the Tukey–Cramér multiple com-
parison tests in order to establish which groups differed signiﬁcantly. The Kruskal–
Wallis Test, a non-parametric analogue to the one-way ANOVA, was used to test for
group differences when the data was not normally distributed. Statistical signiﬁ-
cance was at the 5% level (P < 0.05). Statistical comparisons were conducted be-
tween (1) the DEN-FB1 treated rats with the DEN and DMSO control as well as
the tea treated groups and (2) among the different tea treated groups in so-called
inter tea comparisons.
Fig. 1. Schematic diagram illustrating the experimental regimens utilized to investigate the modulating properties of the different teas on cancer promotion by FB1 in rat
liver. DEN = diethylnitrosamine (200 mg/kg body weight; i.p., single dose); FB1 (250 mg/kg) = rat mash containing FB1 (250 mg/kg diet for 3 weeks) as promotion regimen;
s = sacriﬁce animals; ctrl = control.
222 J.L. Marnewick et al. / Food and Chemical Toxicology 47 (2009) 220–229
3. Results
3.1. Intake of selected herbal tea ﬂavonoids
The dihydrochalcone, aspalathin, was the major ﬂavonoid con-
sumed by the rats that received unfermented rooibos. Substan-
tially lower quantities of its structural ﬂavone analogues, orientin
and iso-orientin, the ﬂavonol glycosides, rutin/isoquercitrin and
the dihydrochalcone, nothofagin and its ﬂavone analogues, vitexin
and isovitexin, were consumed (Table 1). In the aqueous extract of
fermented rooibos, aspalathin and nothofagin were present at
much lower concentrations, resulting in an increased intake of
iso-orientin, orientin, vitexin and isovitexin relatively to aspalathin
and nothofagin. The xanthone mangiferin and the ﬂavanone hes-
peridin were the major monomeric polyphenols in both the unfer-
mented and fermented honeybush. The intake of mangiferin and
hesperidin was reduced substantially when consuming fermented
honeybush. Only trace amounts of hesperetin, the aglycone of
hesperidin were detected.
3.2. FB1 and tea intake proﬁles
The average tea intake and feed intake were signiﬁcantly
(P < 0.05) reduced during the second week due to FB1-induced tox-
icity. After the third week the tea intake proﬁles returned back to
the levels monitored during the ﬁrst three weeks (data not shown).
During the second week, the black tea intake was signiﬁcantly de-
creased (6.2 ml/100 g bw) when compared to the other teas which
ranged between 8.6 and 10.2 ml/100 g bw. As a result the averaged
black tea consumption was signiﬁcantly (P < 0.05) lowered during
the FB1 treatment (Table 2). The average intake of fermented hon-
eybush was signiﬁcantly higher when compared to the other teas.
There was no signiﬁcant difference between the FB1 intake proﬁles
between the different groups.
3.3. Effect of FB1 and tea treatments on body weight parameters
The total body weight gain (BWG) during the experimental per-
iod was signiﬁcantly (P < 0.05) reduced in the FB1 treated rats com-
pared to the DMSO and DEN control groups consuming water,
while the different tea treatments showed no additional effect
(Table 2). However, inter tea comparisons indicated that unfer-
mented rooibos signiﬁcantly (P < 0.05) lowered the total BWG
compared to fermented rooibos and green tea. Compared to the
DMSO control treated rats, DEN and the DEN-FB1 treatments sig-
niﬁcantly (P < 0.05) increased and decreased the relative liver
weight, respectively. Fermented honeybush counteracted
(P < 0.05) the FB1-induced reduction, while unfermented rooibos
marginally (P < 0.1) further enhanced the reduction in the relative
liver weight. Inter tea comparisons showed that fermented and
unfermented rooibos signiﬁcantly (P < 0.05) reduced the relative li-
ver weights compared to the other teas.
3.4. Clinical chemical parameters
Serum levels of AST, ALT, ALP, creatinine and cholesterol were
signiﬁcantly (P < 0.05) increased by FB1 as compared to the DMSO
control group (Table 3). The DEN treatment signiﬁcantly increased
the ALT and ALP serum parameters as compared to the DMSO con-
trol. Unfermented rooibos signiﬁcantly (P < 0.05) enhanced the
FB1-induced increase of serum AST and ALT levels while unfer-
mented honeybush signiﬁcantly (P < 0.05) increased the ALT level.
No signiﬁcant reduction of the FB1-induced increase in serum ALP
levels was observed for any of the teas. Inter tea comparisons
showed that both rooibos herbal teas signiﬁcantly (P < 0.05) in-
creased AST compared to black and green teas. Unfermented rooi-
bos signiﬁcantly (P < 0.05) increased ALT when compared to
fermented honeybush, black and green teas. Fermented honeybush
signiﬁcantly (P < 0.05) increased the ALP level compared to black
tea.
Black tea and fermented honeybush signiﬁcantly (P < 0.05) and
unfermented honeybush marginally (P < 0.1) counteracted the FB1-
induced increase in serum creatinine levels. A similar trend was
noticed with the inter tea group comparison. With respect to
FB1-induced increase of serum cholesterol both fermented and
unfermented honeybush as well as green tea signiﬁcantly
(P < 0.05) decreased the level. A marginal (P < 0.1) reduction was
also noticed with black tea. A similar trend was noticed for the in-
ter tea comparison. The total iron levels were not signiﬁcantly al-
tered by the FB1 treatment while the teas appeared not to have
any additional effect. However, inter tea comparisons showed that
fermented and unfermented honeybush and green tea signiﬁcantly
(P < 0.05) increased the total iron levels compared to the rooibos
herbal and black teas.
Table 1
Quantiﬁcation of the major ﬂavonoids in aqueous extracts of rooibos and honeybush teas consumed by rats during FB1 promotion.
Soluble solids (mg/ml)* Fermented Unfermented
2.59 ± 0.44 5.36 ± 0.81
Phenolic compounds (%) of soluble solids Daily intake (mg/100 g BW)** (%) of soluble solids (%) Daily intake (mg/100 g BW)
Rooibos tea
Aspalathin 0.53 ± 0.02 0.15 ± 0.01 8.4 ± 1.38 4.96 ± 0.41
Nothofagin 0.05 ± 0.02 0.02 ± 0.01 0.36 ± 0.13 0.21 ± 0.02
Orientin 0.46 ± 0.01 0.13 ± 0.01 0.65 ± 0.18 0.38 ± 0.03
Iso-orientin 0.66 ± 0.04 0.19 ± 0.01 0.80 ± 0.18 0.47 ± 0.04
Vitexin 0.19 ± 0.01 0.05 ± 0.01 0.13 ± 0.02 0.08 ± 0.01
Isovitexin 0.18 ± 0.03 0.05 ± 0.01 0.29 ± 0.07 0.14 ± 0.01
Rutin/iso-quercitrin 0.45 ± 0.03 0.13 ± 0.01 0.60 ± 0.10 0.35 ± 0.03
5.96 ± 0.78b 11.78 ± 1.18c
(%) of soluble solids Daily intake (mg/100 g BW)** (%) of soluble solids Daily intake (mg/100 g BW)
Honeybush tea
Mangiferin 1.11 ± 0.15 0.82 ± 0.06 6.68 ± 0.84 8.90 ± 0.79
Hesperidin 0.37 ± 0.08 0.27 ± 0.02 2.63 ± 0.16 3.49 ± 0.31
Hesperetin Trace Trace
All samples used were aqueous extracts prepared as described in the methods. The values in columns represent the mean ± standard deviation of 2–3 repeats of each sample.
* Data from Marnewick et al., 2003. BW = body weight.
** Mean daily tea intake during the 3 week FB1 period (Table 2) was used.
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3.5. Effect on hepatic oxidative status (Table 4)
3.5.1. Oxygen radical absorbance capacity (ORAC)
The DEN treatment signiﬁcantly (P < 0.05) lowered the hepatic
ORAC status compared to the DMSO control group. Of the teas, only
green tea further decreased (P < 0.05) the hepatic ORAC values
while unfermented rooibos marginally (P < 0.1) increased the
ORAC status when compared to the DEN treatment group.
3.5.2. Hepatic glutathione
Rats receiving the FB1-dietary treatment showed signiﬁcantly
(P < 0.05) elevated GSH levels in the liver when compared to the
DMSO and DEN treated control groups. Consumption of the rooibos
herbal teas resulted in a signiﬁcant (P < 0.05) reduction in hepatic
GSH concentration when compared to the DEN-FB1 treatment
group. A similar effect on the GSH concentration was noticed for
the inter tea comparison. The GSSG levels were not affected by
FB1 resulting in a signiﬁcantly (P < 0.05) increased GSH:GSSG ratio
in the liver when compared to the DMSO and DEN treated control
groups. The GSSG level was signiﬁcantly (P < 0.05) elevated with
the consumption of green, black, unfermented rooibos and honey-
bush herbal teas, resulting in a signiﬁcantly (P < 0.05) decreased
GSH:GSSG ratio, while a marginal (P < 0.1) decrease was noticed
with fermented rooibos.
3.5.3. Antioxidant enzyme activity
FB1 treatment signiﬁcantly (P < 0.05) increased the activity of
GPx (Table 3) while CAT activity was signiﬁcantly (P < 0.05) re-
duced. No effect was observed on the activity of SOD. Treatment
with green, black and herbal teas did not alter the FB1-induced ef-
fect on GPx. Treatment with both honeybush herbal, green and
black teas resulted in a signiﬁcant (P < 0.05) recovery in the FB1-in-
duced decrease in the activity of CAT. FB1 signiﬁcantly increased
the GR activity while none of the teas showed any modulating
effect.
3.6. Lipid peroxidation
The TBARS levels were signiﬁcantly (P < 0.05) increased in the
liver of the FB1 treated rats (Table 4) when compared to the DMSO
and DEN treated groups. The rats consuming fermented rooibos,
and fermented and unfermented honeybush showed a signiﬁcant
(P < 0.05) decrease in the TBARS levels. Consumption of unfer-
mented rooibos, black and green teas showed no effect on the
FB1-induced lipid peroxidation. Among the different teas, fer-
mented rooibos and honeybush signiﬁcantly (P < 0.05) decreased
lipid peroxidation compared to their unfermented counterparts,
and unfermented honeybush signiﬁcantly (P < 0.05) reduced lipid
peroxidation compared to black tea.
3.7. Effect of various tea treatments on FB1-induced promotion
FB1 signiﬁcantly (P < 0.05) promoted the growth of GSTP+ foci
by increasing the number and relative number [(expressed as a %
of the total foci (>5 lm)] of GSTP+ foci in all size categories as
well as the total number (>10 lm) when compared to the DEN
treated control rats (Table 5). No GSTP+ foci were detected in
the liver of the DMSO control rats. When considering the posi-
tive control treatment (DEN-FB1), all the tea preparations signif-
icantly (P < 0.05) to marginally (P < 0.1) increased the number of
Table 2
Effect of DEN-FB1 and various tea treatments on the rat body weight parameters.
Groups Ave tea intake (ml/100 g BW/day) Ave FB1 intake (mg/100 g BW/day) Body weight gain (g)B Relative liver weight (%)A
DMSO – – 86.9 ± 8.2a 2.9 ± 0.35a
DEN – – 77.7 ± 25.1a 3.51 ± 0.27c
DEN-FB1 – 1.5 ± 0.3a 39.8 ± 13.8b 2.50 ± 0.16b
DEN-FB1-Rf 11.0 ± 0.9a 1.6 ± 0.3a 44.0 ± 6.8bc 2.36 ± 0.12(b)d
DEN-FB1-Ru 10.8 ± 0.7a 1.5 ± 0.4a 29.6 ± 9.6bd 2.44 ± 0.09bd
DEN-FB1-Hf 12.4 ± 0.8b 1.3 ± 0.3a 37.9 ± 12.7b 2.79 ± 0.05ae
DEN-FB1-Hu 11.3 ± 1.0a 1.5 ± 0.3a 36.1 ± 16.4b 2.58 ± 0.19be
DEN-FB1-Bl 9.0 ± 0.9c 1.5 ± 0.3a 40.2 ± 19.8b 2.58 ± 0.13be
Values in columns represent the mean ± STD. Abbreviations: Rp = fermented rooibos, Rg = unfermented/‘‘green” rooibos, Hp = fermented honeybush and Hg = unfermented/
‘‘green” honeybush tea extracts, Bl = black and Gr = green tea. Values followed by the same letters do not differ signiﬁcantly. When letters differ then P < 0.05. Letters in
parenthesis then P < 0.1. Inter tea comparison are indicated in bold.
A Relative liver weights equal liver weight/body weight 100.
B Including DEN, Pre-FB1 tea treatment and FB1 treatment regimens. N = 7–10 rats per group.
Table 3
Effect of DEN-FB1 and various tea treatments on the serum clinical chemistry.
Groups AST (U/L) ALT (U/L) ALP (U/L) Creatinine (umol/L) Cholesterol (mmol/L) Total iron (lmol/L)
DMSO 88.1 ± 16.8a 53.7 ± 7.3a 168.9 ± 32.8a 69.0 ± 6.0a 1.6 ± 0.2a 23.1 ± 5.8a
DEN 102.8 ± 15.4a 96.7 ± 11.5c 272.4 ± 69.1c 67.3 ± 3.7a 1.4 ± 0.3a 25.9 ± 2.6a
DEN-FB1 258.7 ± 60.2b 211.6 ± 48.0b 282.4 ± 82.0b 85.8 ± 4.7b 3.5 ± 0.4b 24.4 ± 7.4a
DEN-FB1-Rf 296.8 ± 52.3bd 256.62 ± 68.9b 283.4 ± 61.3b 85.3 ± 4.4bd 3.3 ± 0.4bc 21.9 ± 2.3ab
DEN-FB1-Ru 341.1 ± 50.0cd 321.3 ± 75.4de 325.3 ± 86.8b 83.5 ± 5.8bd 2.9 ± 1.0bc 22.6 ± 4.4ab
DEN-FB1-Hf 242.9 ± 54.3b 236.3 ± 63.9bf 355.3 ± 77.8bd 77.2 ± 3.8ce 2.3 ± 0.8ad 27.5 ± 2.2ac
DEN-FB1-Hu 283.2 ± 52.1b 280.9 ± 71.7d 314.3 ± 57.9b 80.8 ± 5.8(b)d 2.1 ± 0.3ad 28.3 ± 4.9ac
DEN-FB1-Bl 207.1 ± 56.3be 216.0 ± 90.5bf 245.0 ± 58.4be 78.4 ± 2.2(c)d 3.0 ± 0.6(b)c 24.1 ± 6.3ab
DEN-FB1-Gr 226.4 ± 22.5be 229.3 ± 41.4bf 296.8 ± 62.1bd 83.6 ± 3.0bd 2.4 ± 0.5ad 27.1 ± 4.4ac
Values in columns represent the mean ± STD. Abbreviations: Rp = fermented rooibos, Rg = unfermented/‘‘green” rooibos, Hp = fermented honeybush and Hg = unfermented/
‘‘green” honeybush tea extracts, Bl = black and Gr = green tea. Values followed by the same letters do not differ signiﬁcantly. When letters differ then P < 0.05. Letters in
parenthesis then P < 0.1. Inter tea comparison are indicated in bold. n = 7–10 rats per group.
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mini foci (5–10 lm) as well as the relative number. A similar
effect was noticed when considering the relative amount of lar-
ger foci (11–20 lm) constituting 50% of the number of foci. The
number of foci was signiﬁcantly decreased by unfermented
rooibos (P < 0.05) and marginally by honeybush (P < 0.1). The
unfermented herbal teas signiﬁcantly (P < 0.05) decreased the
number of foci (size 21–30 lm) constituting approximately 20%
of the total number of foci in the positive control group. The
unfermented herbal teas and black tea signiﬁcantly (P < 0.05)
and marginally (P < 0.1) decreased the relative amount of foci
in this size category, respectively. When considering the focal
size >30 lm, which constituted approximately 6% of the total
amount of foci unfermented rooibos signiﬁcantly (P < 0.05) and
unfermented honeybush marginally (P < 0.1) decreased the num-
ber and relative amount. The total number of foci (>10 lm),
excluding the mini foci, was signiﬁcantly (P < 0.05) and margin-
ally (P < 0.1) reduced by unfermented rooibos and honeybush,
respectively.
Interactive plots showed that the herbal teas (combined ef-
fect) signiﬁcantly (P < 0.05) decreased the total amount of foci
(>5 lm) as compared to the black and green teas (Fig. 2A). The
separate effects of the different teas indicated that the unfer-
mented rooibos and honeybush signiﬁcantly (P < 0.05) decreased
the total number of foci when compared to the green and black
teas (Fig. 2B). A similar effect was noticed with the fermented
herbal teas, although differences were not signiﬁcant, implying
that fermentation reduced the protective effects of the herbal
teas.
4. Discussion
FB1 was characterized as a non-genotoxic liver cancer promoter
(Gelderblom et al., 1996) and shown to be hepato- and nephrocar-
cinogenic in rats (Gelderblom et al., 1991; Howard et al., 2001). In
mice, FB1 signiﬁcantly increased the incidence of adenomas and
carcinomas that developed spontaneously in the liver (Howard
et al., 2001). The mechanism of cancer induction is not known at
present but studies in rats indicate that FB1 could effect both can-
cer initiation and promotion in the liver (Gelderblom et al., 1992,
1994, 1996, 2008). The disruption of growth-stimulatory responses
in normal and genetically altered initiated cells is suggested to be
important in establishing a growth differential whereby the prene-
oplastic cell populations are clonally expanded, subsequently lead-
ing to carcinogenesis by FB1 in the liver. At a cellular level, FB1
disrupts sphingolipid, phospholipid and fatty acid metabolism,
which have been suggested to be the underlying mediators respon-
sible for cancer promotion in the liver (Riley et al., 2001; Gelderb-
lom et al., 2001; Burger et al., 2007).
The present study conﬁrmed the FB1-induced hepatotoxic and
nephrotoxic effects (Gelderblom et al., 1991; Voss et al., 1995),
which were manifested by a signiﬁcant (P < 0.05) increase in
the clinical chemical parameters associated with liver and kidney
function, decreased body weight gain and relative liver weight.
Black tea and fermented honeybush counteracted the reduction
in serum creatinine suggesting a protective effect against FB1-in-
duced nephrotoxicity. Honeybush and green tea also protected
against FB1-induced accumulation of serum cholesterol. Both hes-
Table 4
Effect of unfermented and fermented herbal, green and black teas on reduced glutathione (GSH), oxidized glutathione (GSSG), the ratio GSH:GSSG, oxidative enzyme parameters
and lipid peroxidation in livers of rats.
Groups ORAC
(umole Trolox
eq/g wet liver)
GSH GSSG GSH: GSSG GR
(nmoleNADPH/
min/lg protein)
GPx
(nmoleNADPH/
min/ lg protein)
CAT (lmole H2O2/
min/lg protein)
SOD* TBARS
(nmol MDA /mg
protein)
(umole/g wet liver) Ratio
DMSO 15.5 ± 2.4a 5.3 ± 1.3a 0. 41 ± 0.06a 12.8 ± 1.5a 0.025 ± 0.001a 0.024 ± 0.001a 0.21 ± 0.04a 413.6 ± 30.9a 0.08 ± 0.01a
DEN 12.8 ± 2.2b 5.3 ± 1.1a 0.50 ± 0.12a 11.1 ± 2.9a Nd Nd Nd Nd 0.07 ± 0.01a
DEN-FB1 13.6 ± 0.7b 8.8 ± 1.5b 0.41 ± 0.05a 21.6 ± 3.1b 0.032 ± 0.002b 0.032 ± 0.003b 0.14 ± 0.02b 450.2 ± 89.5a 0.32 ± 0.08b
DENFB1-Rf 14.5 ± 1.5b 6.0 ± 1.8a 0.40 ± 0.11a 15.9 ± 4.7(b) 0.031 ± 0.001b 0.033 ± 0.002b 0.17 ± 0.03b 454.0 ± 65.6a 0.21 ± 0.07a
DEN-FB1-Ru 14.7 ± 1.3(b) 5.2 ± 1.3a 0.54 ± 0.08b 9.9 ± 2.8a 0.032 ± 0.003b 0.035 ± 0.003b 0.15 ± 0.03b 418.5 ± 53.2a 0.30 ± 0.04b
DEN-FB1-Hf 14.4 ± 1.1b 8.5 ± 0.7b 0.46 ± 0.14a 20.5 ± 8.5b 0.029 ± 0.002b 0.033 ± 0.003b 0.20 ± 0.02a 381.4 ± 59.9a 0.16 ± 0.04ac
DEN-FB1-Hu 13.2 ± 1.1b 7.0 ± 0.9b 0.57 ± 0.13b 12.7 ± 2.4a 0.030 ± 0.002b 0.034 ± 0.004b 0.22 ± 0.03a 425.3 ± 67.3a 0.26 ± 0.06ad
DEN-FB1-Bl 13.6 ± 1.1b 7.8 ± 2.8b 0.6 ± 0.12b 13.1 ± 4.6a 0.030 ± 0.003b 0.036 ± 0.004b 0.22 ± 0.03a 400.3 ± 69.4a 0.35 ± 0.07be
DEN-FB1-Gr 10.0 ± 0.88c 7.4 ± 2.3b 0.71 ± 0.17b 11.1 ± 4.9a 0.030 ± 0.003b 0.038 ± 0.006b 0.20 ± 0.04a 420.9 ± 39.5a 0.31 ± 0.09bd
Values in columns represent average of 5–8 values per group ± STD. Means followed by the same letter do not differ signiﬁcantly, when letters differ then P < 0.05. Letters in
parenthesis indicated P < 0.1. Abbreviations: Rf = fermented rooibos, Ru = unfermented/”green” rooibos, Hp = fermented honeybush and Hg = unfermented/”green” honey-
bush tea extracts, Bl = black and Gr = green tea. *Amount of protein (ng) required to produce a 50% inhibition of auto-oxidation of 6-hydroxydopamine. GR = glutathione
reductase; GPx = glutahione peroxidase; CAT = catalase; SOD = superoxide dismutase.
Table 5
Effect of various tea treatments on the induction of GSTP+ foci by combined treatment of DEN and FB1.
Treatment
groups
GSTP+ Liver Foci
No foci/cm2
(5-10 lm)
% of the total
no of foci
No foci/cm2
(11-20 lm)
% of the total
no of foci
No foci/cm2
(21–30 lm)
% of the total
no of foci
No foci/cm2
(>30 lm/cm2)
% of the total
no of foci
Total no of foci
(>10 lm)
DMSO Nd nd nd nd nd nd nd nd nd
DEN 4.7 ± 1.7a 58.7 ± 13.4a 1.9 ± 0.8a 32.9 ± 7.6a 0.5 ± 0.8a 6.5 ± 8.7a 0.14 ± 0.34a 2.0 ± 4.0a 2.6 ± 1.8a
DEN-FB1 8.0 ± 2.8b 23.7 ± 7.5b 18.2 ± 5.6b 50.2 ± 8.4b 6.5 ± 1.4b 19.6 ± 5.0b 2.3 ± 1.4b 6.5 ± 3.9b 27.0 ± 11.1b
DEN-FB1-Rf 15.9 ± 8.7(b) 39.2 ± 14.3c 15.5 ± 5.7b 39.1 ± 4.3a 6.5 ± 2.9b 16.1 ± 3.6b 2.3 ± 1.1b 6.0 ± 3.2b 24.2 ± 8.8b
DEN-FB1-Ru 12.6 ± 4.9c 53.9 ± 17.1a 10.4 ± 5.3c 36.0 ± 9.0a 3.1 ± 2.4c 10.3 ± 6.6a 0.7 ± 1.1a 1.9 ± 2.8a 14.2 ± 7.8c
DEN-FB1-Hf 17.9 ± 5.4c 42.3 ± 7.9a 15.1 ± 6.3b 33.9 ± 4.6a 7.6 ± 4.8b 16.4 ± 7.0b 3.5 ± 2.7b 7.5 ± 4.1b 26.3 ± 12.3b
DEN-FB1-Hu 19.7 ± 8.5c 52.7 ± 14.7a 11.9 ± 5.9(b) 31.8 ± 6.2a 4.0 ± 2.7c 10.6 ± 5.1a 0.9 ± 1.7(b) 2.3 ± 4.1(b) 17.1 ± 14.2(b)
DEN-FB1-Bl 30.0 ± 3.5c 54.0 ± 12.3a 17.3 ± 9.9b 27.9 ± 15.8a 7.7 ± 3.0b 13.8 ± 6.1(b) 2.5 ± 1.4b 4.3 ± 2.1b 27.5 ± 10.9b
DEN-FB1-Gr 23.9 ± 11.3c 37.8 ± 13.3a 18.2 ± 6.2bd 33.3 ± 4.6a 10.4 ± 6.6b 17.5 ± 8.8b 5.9 ± 5.2b 9.7 ± 7.2b 33.7 ± 4.7b
Values represent the average of ten rats per group ± STD. Means (column) followed by the same letter do not differ signiﬁcantly. When letters differ then P < 0.05. Letters in
parenthesis indicated P < 0.1. Abbreviations: Rf = fermented rooibos, Ru = unfermented rooibos, Hf = fermented honeybush and Hu = unfermented honeybush tea extracts,
Bl = black and Gr = green tea, nd = not detected. Shaded areas; foci number expressed as a % of the total GSTP* foci (5 lm).
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peridin and mangiferin, present in large quantities in unfer-
mented honeybush, is of interest as the aglycone of hesperidin,
hesperetin and mangiferin reduce the level of rat plasma choles-
terol (Kim et al., 2003; Nair and Devi, 2006). FB1 and the different
tea treatments did not alter the total serum iron levels when
compare to the control. However, fermented and unfermented
rooibos and black teas signiﬁcantly (P < 0.05) decreased the levels
when compared to green tea and fermented and unfermented
honeybush. As rooibos did not affect serum iron after a 10 week
feeding study (Marnewick et al., 2003) speciﬁc iron/polyphenolic
interactions, the decreased feed intake proﬁles and associated
hepatotoxic effects during the 3 week FB1 feeding regimen seems
to be involved in the reduction of serum iron levels as compared
to the other teas.
Unfermented rooibos further enhanced the FB1-induced hepa-
totoxic effect when considering the increased liver function en-
zymes, reduced body weight gain and relative liver weight.
Unfermented honeybush also increased the ALT levels but the body
and liver weight parameters were not altered. Speciﬁc interactions
between the tea polyphenolic constituents and FB1-induced toxic
effects are likely to be involved as the tea consumption proﬁles, ex-
cept for the lower black tea intake, and total FB1 intake proﬁles
were similar. One possibility could be the induction of a pro-oxida-
tive effect by the unfermented herbal tea polyphenols in the pres-
ence of iron. Aspalathin-enriched extracts of unfermented rooibos
exhibit pro-oxidative effects in a Fenton-type reaction in vitro, a
property that was signiﬁcantly reduced by fermentation (Joubert
et al., 2005). It has been suggested that high levels of mangiferin,
the major antioxidant of unfermented honeybush, could also result
in pro-oxidant activity (Joubert et al., 2008). The rat intake proﬁles
of mangiferin given unfermented honeybush were almost double
that of aspalathin receiving the unfermented rooibos, suggesting
that under these conditions mangiferin could act as a pro-oxidant.
However, studies regarding the bioavailability of these polypheno-
lic constituents in the herbal extracts that are currently under
investigation will provide more information on their in vivo antiox-
idant potencies. FB1-induced hepatotoxcity was associated with an
increased oxidative damage (Abel and Gelderblom, 1998) and the
mobilization of iron (Lemmer et al., 1999) that create an ideal envi-
ronment for the induction of pro-oxidant effects by aspalathin and
mangiferin. In this regard, the antioxidant potency of speciﬁc tea
polyphenols is likely to determine whether antioxidant and/or
pro-oxidant effects prevail. Fermented rooibos and honeybush,
exhibiting weaker antioxidant properties (Von Gadow et al.,
1997; Hubbe and Joubert, 2000a,b) and containing far lower levels
of aspalathin and mangiferin, reduced the FB1-induced lipid perox-
idation. Similar to the major unfermented herbal tea polyphenols,
the potent green and black tea antioxidants, epigallocatechingal-
late (EGCG) and theaﬂavins, are known to act as pro-oxidants in
the presence of copper and/or iron (Azam et al., 2004; Schuck
et al., 2008). It would appear that under the current conditions,
the tea ﬂavonoids with the highest antioxidant potency are likely
to enhance free radical production via a Fenton-type reaction
thereby potentiating the FB1-induced hepatotoxicity effects. The
reason why green and black teas did not affect the FB1-induced
hepatotoxicity could be related to the iron binding capacity of
the tannins (Andrade et al., 2006) as well as the differential induc-
tion of antioxidant enzymes discussed below.
Protection against lipid peroxidation, proposed to be a second-
ary event to FB1-induced hepatotoxicity (Lemmer et al., 1999),
will not necessarily reduce FB1-induced hepatotoxicity. The sug-
gested pro-oxidative effect of unfermented rooibos and the poten-
tiating effects on FB1-induced hepatoxic effects vs the protection
against the resultant lipid peroxidation appear to be two separate
events. The FB1/polyphenolic interactions are further complicated
when considering different oxidative parameters in the liver. FB1
signiﬁcantly (P < 0.05) reduced the ORAC as a result of the in-
creased oxidative stress which is in agreement with a recent study
in glioblastoma cells showing that the FB1-induced lipid peroxida-
tion and oxidative stress which was associated with a reduced
GSH level (Stockmann-Juvala et al., 2008). In the present study,
the herbal and black teas did not altered the reduction in ORAC,
while green tea signiﬁcantly (P < 0.05) further reduced the level,
implying that the antioxidant capacity is further depleted, which
may lead to a depletion of GSH. This is in agreement with the
ﬁndings of a previous study where green tea reduces ORAC in
the liver although the GSH level was not altered (Marnewick
et al., 2003). In contrast, FB1 signiﬁcantly increased the GSH level
which was associated with the development of preneoplastic le-
sions known to stain positively for gamma glutamyl transpepti-
dase positive (GGT+) foci (Gelderblom et al., 1991). This is in
agreement with the ﬁndings that these preneoplastic lesions had
an increased level of GSH (Marinho et al., 1997; Abel and Gelderb-
lom, 1998). The increased levels of GSH in preneoplastic lesions
provide these lesions with a selective growth advantage when
compared to the surrounding tissue (Hanigan and Pitot, 1985)
and will therefore be more resistant to the oxidative stress in-
duced by FB1. The reduction of the GSH level by unfermented
rooibos and to some extend unfermented honeybush was associ-
ated with a decrease in the number of the preneoplastic foci.
When considering the GSH:GSSG ratio unfermented rooibos, hon-
eybush, black and green teas signiﬁcantly (P < 0.05) decreased the
ratio mainly due to an increased GSSG level while GSH was re-
duced as a result of the decreased number and size of the GSTP+
foci. It is known that, under stressed conditions, the GSH:GSSG
ratio decreases either due to increased GSSG or decreased GSH
Fig. 2. (A) Interactive plots illustrating the combined effects (n = 20) of the various
tea treatments on the induction of total number of hepatic GSTP+ foci >5 lm) by FB1
and (B) separate effects (n = 10) illustrating the affect of tea processing on the
induction of GSTP+ foci. Values are the means ± STD. *Signiﬁcantly different
(P < 0.05) from black and green tea.
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levels (Dickinson and Forman, 2002). The teas exhibiting the high-
est protective effect against FB1-induced lipid peroxidation, fer-
mented rooibos and honeybush did not alter the GSSG level and
the GSH:GSSG ratio although fermented rooibos marginally
(P < 0.1) reduced the ratio due to the reduction in the GSH level.
The development of the preneoplastic lesion therefore compli-
cated interpretations regarding the effect of the herbal teas on
the GSH level and hence the oxidative status in the liver. How-
ever, unfermented rooibos and honeybush have been reported
to signiﬁcantly increase the GSH level in the liver after a 10 week
feeding study (Marnewick et al., 2003), an aspect that is masked
in the present study by the development of preneoplastic lesions.
None of the teas affected the FB1-induced activity of GR, imply-
ing that the increased GSH levels in the liver, as stated above, are
more related to the induction of GSTP+ foci. FB1 increased and de-
creased the activities of GPx and CAT, respectively, implying that
the production of hydrogen peroxide is involved in the FB1-induced
oxidative stress. None of the teas affected the increased activity of
the GPx while honeybush, green and black teas effectively counter-
acted the FB1-induced decrease in CAT. This could explain the
above arguments that green tea, black tea and fermented honey-
bush did not enhance the FB1-induced hepatoxic effects. The activ-
ity of SOD was not affected suggesting that the formation of
superoxide is not a prominent feature during FB1-induced hepato-
toxic effects as was suggested previously (Sahu et al., 1998).
Herbal tea consumption signiﬁcantly (P < 0.05) arrested the
proliferation of GSTP+ altered cells in the presence of the cancer
promoter FB1 as the relative number of foci (11–20 lm), constitut-
ing approximately 50% of the total amount of foci, were signiﬁ-
cantly (P < 0.05) decreased, while the relative number of mini
foci (5–10 lm) was signiﬁcantly (P < 0.05) increased. The reduction
of the total number of foci (>10 lm) by unfermented rooibos and
to a certain extent with unfermented honeybush, could be related
to the increased oxidative stress, which could further enhance
apoptosis know to be effected by FB1 in the liver (Lemmer et al.,
1999). It was reported that apoptosis, induced by FB1, delayed can-
cer induction by removing initiated cells from the liver (Gelderb-
lom et al., 1992, 1994). Similar to the herbal teas, green and
black teas signiﬁcantly decreased and increased the relative num-
ber of foci (11–20 um) and minifoci (5–10 um), respectively. Inhi-
bition of cell proliferation by green tea polyphenols during
cancer promotion has been associated with a reduction of the
number and size of enzyme altered foci (Gong et al., 2000). Green
and black teas signiﬁcantly enhanced the total number of foci
(>5 lm) as compared to the herbal teas and the DEN-FB1 treat-
ments, mainly due to an increase in the number of mini foci, which
could be related to the reduction in liver ORAC, in the case of green
tea, and GSH:GSSG ratio suggestive of an increased oxidative
stress. It is known that a dual role for oxidative stress exists that
could either stimulate cell proliferation or inhibit cell proliferation
thereby increasing cell depletion via the induction of apoptosis
(Klaunig and Kamendulis, 2004). In this regard the green tea ﬂav-
anol, ()-epigallocatechin-3-galate was shown to inhibit the pro-
liferation of cancer cells through the induction of apoptosis (Yang
et al., 1998; Kuo and Lin, 2003). However, the present study indi-
cated that the polyphenolic constituents that differ between the
teas selectively modulate oxidative stress and the cancer promot-
ing potency of FB1 in rat liver.
Fermentation of the herbal teas tended to reduce the inhibition
of cancer promotion effected by FB1 implying that the chemopre-
ventive properties of the unfermented herbal teas should be fur-
ther evaluated. Fermentation signiﬁcantly reduced the soluble
solid content which was associated with a decrease in the major
antioxidants constituents resulting in a reduction in the rat antiox-
idants intake proﬁles. It is known that the antioxidant potency of
plant polyphenolic components may play a determining role in
maintaining the balance between cell growth and cell death in pre-
neoplastic lesions (Lee et al., 2002). In the present study the
involvement of antioxidant properties of the different teas modu-
lates the oxidative stress during FB1-induced cancer promotion
by selectively affecting the ORAC and GSH levels, antioxidant en-
zymes and the level of lipid peroxidation presumably due to differ-
ences in their polyphenolic constituents. The reduced protective
effect of honeybush against FB1-induced cancer promotion further
emphasized the role of antioxidants as rooibos extracts exhibit
higher antioxidant properties than honeybush (Joubert et al.,
2008). It would appear that at similar concentrations, honeybush
would have exhibited a far weaker protection. However, the pro-
tection against FB1-induced cancer promotion by the different teas
may not be entirely related to their antioxidative activities and
other features, e.g. their pro-oxidant activity due to speciﬁc poly-
phenol/FB1/iron interactions, affecting cell regulatory processes re-
lated to cell survival need to be further investigated.
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FUMONISIN-INDUCED HEPATOCARCINOGENESIS: MECHANISMS OF CANCER 
INITIATION AND PROMOTION  
 
4.1 Cancer initiation by fumonisin B1 
 
4.1.1 Studies in rat liver 
Several studies have been carried out to investigate the mechanism of cancer 
initiation by FB1 in an in vivo rat liver cancer initiation/promotion model. The cancer 
initiating potential of the apparent non-genotoxic FB1 was therefore of interest as it is 
normally accepted that this stage of cancer induction is associated with a mutation-
like event (Farber, 1984). At present very little is known about the nature of the 
initiating step of either genotoxic or non-genotoxic carcinogens although many other 
cell parameters such as protein and RNA can be altered independently from changes 
to the DNA. Apoptosis is also known to play a determining role in the outcome of the 
initiating event, as initiated cells are more prone to undergo apoptosis (Bursch et al., 
1992). It is known that FB1 induces necrosis as well as apoptosis in the liver that 
could determine the outcome of cancer initiation by the mycotoxin (Lemmer et al., 
1999a; Gelderblom et al., 2008). A biphasic effect of FB1 on cell proliferation is 
proposed in the liver that results in the genesis of altered hepatic lesions ultimately 
leading to cancer (Figure 1). FB1 either stimulates compensatory/regenerative cell 
proliferation as a result of cell death induced in the liver or inhibits cell proliferation, 
which will result in the induction of apoptosis. These processes are controlled by the 
induction of specific growth regulatory factors. The balance between these processes 
will determine the level of cell proliferation that prevails and the extent of cancer 
initiation achieved which will depend on the dose and duration of exposure. 
 
When utilising the classical model for cancer initiation generally used for genotoxic 
carcinogens, i.e. a single dosage of a carcinogen 18-20 hr after partial hepatectomy, 
the fumonisins failed to effect initiation after a single or multiple dosages (Gelderblom 
et al., 1992). One possible explanation for the lack of cancer initiation was ascribed to 
the inhibitory effect of the fumonisins on cell proliferation. Cancer initiation by FB1 
was only effected after prolonged feeding in the diet, and depending on the dosage, 
could be induced over a 14-day period (Gelderblom et al., 1994).   
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 Fig 1. The effect of the biphasic response of FB1 on cell proliferation in relation to cancer 
initiation. The overexpression of several growth stimulating and inhibitory factors 
are effected which are likely to play a determining role in the induction of the altered 
resistant hepatocytes (Gelderblom et al., 1994; Lemmer et al., 1999b). 
 
 
The “Effective Dosage Level” for cancer initiation in male Fisher rats fed the AIN 76 
diet was determined and interesting aspects regarding exposure levels and initiation 
were noticed. In this regard a total dosage of 30 mg FB1/100 g body weight failed to 
initiate cancer over a 7-day period whilst the same dosage effected initiation over a 
period of 21 days. A critical balance between compensatory or regenerative cell 
proliferation resulted from the hepatotoxicity and the inhibitory effect on cell 
proliferation thereof seems to exist, which will eventually determine initiation by FB1 
(Fig 1). A dose dependent effect on FB1-induced cancer initiation was also observed 
during a gavage dosage regimen over a period of 14 days, although it was more 
effective than the dietary treatment.  
 
A gavage FB1 treatment protocol was utilized to investigate the effect of cell 
proliferation on the cancer initiating properties of FB1 over 14 days (Gelderblom et al., 
2001a). The role of regenerative cell proliferation and mitogen-induced hyperplasia, 
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induced by partial hepatectomy and lead nitrate, respectively, were monitored as a 
single insult after 7 days. Similar to genotoxic carcinogens, lead nitrate failed to, while 
partial hepatectomy supported cancer initiation when using the induction of placental 
glutathione S-transferase positive (PGST+) foci as the endpoint. This study supports 
the initial studies utilizing FB1 that a non-toxic threshold exists for cancer initiation 
and that regenerative cell proliferation plays an important role which in turn will 
depend on the FB1 dose and duration of exposure. In this regard a low dose 
exposure for an extended period of time will initiate cancer in the absence of a 
hepatotoxic effect (Gelderblom et al., 2001b), which provides additional information 
regarding threshold effects and the complex nature of the cancer initiating step. 
 
Additional studies of the cancer initiating potential of fumonisin B1 (FB1) were 
conducted in rat liver to (i) monitor the effect of another cancer promoter, such as 
phenobarbital (PB) and (ii) to evaluate the involvement of spontaneously initiated 
cells (Gelderblom et al., 2008). The PB promoting regimen was found to stimulate the 
outgrowth of FB1-induced PGST
+ positive initiated hepatocytes. A specific role for 
spontaneously initiated cells and promotion by FB1 into the development of 
eosinophilic clear cell foci could not be established. The ability of different stimuli to 
selectively promote the outgrowth of FB1-induced initiated cells and the lack of 
selectively promoting eosinophilic clear cell subtype foci in older rats, excluding the 
role of spontaneous initiated cells, verifying the cancer initiating potency of this 
apparent non-genotoxic mycotoxin.  
 
4.1.2 Genotoxicity 
FB1 has been shown to be non-genotoxic in in vitro mutagenic and genotoxic assays 
and in in vivo unscheduled DNA repair assays in rat liver. Fumonisins B1, B2 and B3 
lack mutagenicity in the Salmonella mutagenicity test against TA97a, TA98, TA 100 
and TA 102, both in the absence and presence of metabolic activation (Gelderblom & 
Snyman, 1991). In contrast fusarin C exhibited a mutagenic response against TA 
97a, TA 98 and TA 100 in the presence of metabolic activation. The lack of 
mutagenicity by FB1 was confirmed against TA 98 and TA 100 while it was also 
negative when conducting the SOS chromotest assay with E coli PQ37 and the 
induction of reparable DNA damage with E coli K-12 strains (Knasmuller et al., 1997). 
In vitro and in vivo unscheduled DNA repair assays in primary hepatocytes related to 
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genotoxic cell damage showed FB1 to lack genotoxic effects (Gelderblom et al., 
1992).  Clastogenic effects, however, were noticed when utilizing primary cultures of 
hepatocytes. The induction of micronuclei were less clear as FB1 only induces 
significant effects at certain doses although no clear dose response effects could be 
established. Induction of chromosomal aberrations was dose dependent with a 7-fold 
increase above the background (Knasmuller et al., 1997). 
 
4.1.3  Role of oxidative damage. 
As cancer initiation by FB1 is associated with the induction of a hepatoxic effect a role 
of oxidative damage in the induction of the altered genetic events has been 
suggested. Oxidative damage was closely associated to FB1-induced cancer initiation 
in vivo while the plasma and microsomal membranes and to some extent the 
mitochondria and the nuclei, appear to be significantly affected by lipid peroxidation 
(Abel & Gelderblom, 1998). In vitro studies in primary hepatocytes revealed a similar 
association between cytotoxicity and lipid peroxidation, measured as the induction of 
thiobarbituric acid reactive substances (TBARS). FB1-induced lipid peroxidation in 
primary hepatocytes was potentiated in the presence of cumol hydroperoxide, a 
potent oxidising agent, while it was reduced by the addition of vitamin E. The 
protection of vitamin E was only partly effective suggesting that the induction of lipid 
peroxidation is a result and not necessarily a cause of the FB1-induced hepatoxic 
effects. Many cell processes, including cellular membranes, proteins, DNA and 
carbohydrates could be altered as a result of oxidative damage and these processes 
appear to occur as a result of cell injury induced by FB1. These changes could result 
from the over production of free radicals and/or reduced cellular defense 
mechanisms which could eventually effect cellular damage and altered biological 
responses within the cell. As it is known that oxidative damage could effect cancer 
initiation (Rushmore et al., 1984), the slow cancer initiating potency of FB1 as well as 
the close association of hepatotoxicity and oxidative damage suggests that it is likely 
to be an important determinant during cancer induction by this non-genotoxic 
mycotoxin. Potentiation of FB1-induced lipid peroxidation was also effected by dietary 
iron (Lemmer et al., 1999a). As dietary iron caused lipid peroxidation in the absence 
of hepatic injury while FB1 only induces mild lipid peroxidation as a result of the 
hepatoxicity further provide evidence that lipid peroxidation is secondary to FB1-
induced hepatic injury. Although Fe potentiates lipid peroxidation the effect on cancer 
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initiation could not be determined, as iron overload tends to protect against cancer 
promotion due to the stimulatory effect on cell proliferation. 
 
4.2 Structure activity relationships 
 
The toxicological and/or biochemical effects of structural related compounds provide 
important information about the underlying mechanism involved as well as possible 
targets for strategising deactivation procedures. The occurrence of different 
structurally related fumonisins, eg the N-acetyl derivatives, the hydrolised products 
(aminopolyols) and the mono methyl esters, which are purification artifacts, provided 
a unique opportunity to conduct comparative cytotoxicity and in vivo cancer induction 
assays (Gelderblom et al., 1993; Van der Westhuizen et al., 1998).   
 
4.2.1 Studies using primary hepatocyte cultures 
Comparative cytotoxicity studies showed that FB2 exhibited the highest cytotoxic 
effect followed by FB3 and FB1. The respective hydrolised products of FB1 and FB2 
showed a higher cytotoxic effect than the parent molecules, with AP2 exhibiting a 
significantly higher effect than AP1. It became evident that the polarity of the specific 
analogue is of importance as the less polar compound exhibiting a higher cytotoxicity. 
FA1 and FA2 exhibited significant weaker cytotoxic effects, emphasizing the role of 
the free amino group in the biological properties of the fumonisins (Van der 
Westhuizen et al., 1998).  
 
The disruption of sphingolipid biosynthesis was also monitored in primary 
hepatocytes using the different structural analogues as well as the Alternaria 
alternata toxins, TA and TB (Van der Westhuizen et al., 1998). FB1 (1 uM) maximally 
disrupt sphingolipid biosynthesis after 24 hrs in an irreversible manner (section 
4.4.1). FB1 was shown to be more cytotoxic than TA and TB, although the latter two 
toxins were more effective in disrupting sphingolipid biosynthesis in the order 
TB>TA>FB1. FA1 was more, and AP1 was far less effective in disrupting sphingolipd 
metabolism than FB1. It was suggested that the structural requirements for the 
cytotoxic effect differs from that required for ceramide synthase inhibition, especially 
when considering the activities of the hydrolised structural analogues vs the parent 
fumonisin compounds. It would appear that additional effects, apart from the 
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disruption of sphingolipid biosynthesis, are required to explain the cytotoxic effects in 
primary hepatocytes. 
 
4.2.2 In vivo studies in rat liver  
The cancer initiating properties of FB1, FB2, FB3 and the structural analogues, FA1, 
AP1, AP2, the momomethylesters of FB1 (MME) and tricarbalylic acid moiety of the 
fumonisins (TCA) were monitored in a 21-day feeding study in two separate 
experiments (Gelderblom et al., 1993). The cancer promoting regimen 2-AAF/PH was 
used two weeks following the initiating treatment to select the outgrowth of initiated 
cells with the induction of GGT positive foci as the endpoint for cancer initiation. The 
FB series were fed at dietary levels of 0.1% for 7 days and 0.05% for 14 days in the 
first experiment and 0.05% for 21 days during the second experiment. FA1 was fed at 
a dietary level of 0.1% for 21 days in both experiments. MME was only used in one 
experiment and fed at a dietary level of 0.1% for 1 week followed by 0.05% for two 
weeks. AP1 and AP2 were fed at 0.05% for three weeks in the first experiment while 
AP1 was fed at a dietary level of 0.1 for three weeks. Only the compounds with an 
intact fumonisin structure and a free amino group initiated cancer, which was 
associated with a significant reduction in body weight gain over the 21 days feeding 
period. It was of interest that AP1, which exhibited a higher cytotoxic effect than FB1 
in primary hepatocytes, lacks any cancer initiating properties even when fed at 
double the concentration. 
 
4.3 Mechanisms related to cancer promotion.  
The purification of FB1 was based on the cancer promoting characteristics of maize 
culture material of F. verticillioides in a short-term liver cancer initiating promoting 
model using diethylnitrosamine as cancer initiator. Although two mechanisms for 
cancer promotion exist, FB1 seems to select the outgrowth of initiated cells by the 
process of differential inhibition. During this selection process the growth of normal 
hepatocytes is inhibited while the initiated cells, resistant to the growth inhibitory 
effects of FB1, proliferate. This model of cancer promotion was based on the resistant 
hepatocyte model originally developed in rat liver by Solt et al., (1977). Additional 
models for cancer induction by FB1 have been proposed in rat kidney (Riley et al., 
2001; Dragan et al., 2001). 
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4.3.1 Studies in rat liver 
The inhibitory effect of FB1 on hepatocyte cell proliferation formed the basis of the 
bioassay during the isolation of the compound from the culture material of the fungus 
(Gelderblom et al., 1988). It would appear that, with respect to the inhibition of cell 
proliferation, the fumonisins exhibit a dual response on cancer induction, i.e. on the 
one hand it delays cancer initiation via the induction of apoptosis while on the other 
hand it promotes the growth of genetically altered cells resistant to the adverse 
biological properties (Fig 1). Consequently fumonisin B1 is a far better cancer 
promoter than cancer initiator, an aspect that should be considered when 
establishing risk assessment parameters (see section V). 
 
The first evidence that FB1 altered growth responses in the liver came from the initial 
study on the isolation of FB1 and FB2 indicating that the fumonisins caused numerous 
toxic lesions leading to a toxic hepatitis (Gelderblom et al., 1988a). Short-term 
studies in rats showed that FB1 significantly inhibited hepatocyte cell proliferation 
induced by partial hepatectomy, either by a single gavage dosage or by feeding in a 
diet over a period of 21 days (Gelderblom et al., 1994). Hepatocyte proliferation was 
effectively delayed and 3 days after removal of FB1 from the diet, the FB1-treated rats 
exhibited a higher level of cell proliferation than the controls suggesting that the 
inhibitory effect of FB1 is reversible. Dose-response studies indicated that a dietary 
level up to 50 mg FB1/kg significantly reduced hepatocyte cell proliferation induced by 
partial hepatectomy (Gelderblom et al., 1996b). Of interest was the fact that this 
inhibitory effect was closely associated with the cancer promoting activity of 
diethylnitrosamine (DEN)-induced GSTP positive foci. Cancer promotion by FB1 was 
induced in the absence of any adverse hepatotoxic effects at dietary levels that lack 
cancer initiation activity over a 21-day feeding period. It would appear that in contrast 
to cancer initiation, cancer promotion is effected in the absence of hepatotoxicity, 
which was originally thought not to be the case (Gelderblom et al., 1988a; 1988b; 
1994). Although other mechanisms also exist to explain cancer promotion the 
inhibitory effect of the fumonisins on hepatocyte proliferation and several cell culture 
systems strongly suggest that cancer promotion in the liver results form the induction 
of differential growth inhibition of normal hepatocytes allowing the “resistant” initiated 
hepatocytes to proliferate.  
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In order to correlate the histopathological alterations with changes in gene expression 
in rat liver during short-term treatment with FB1, male Fisher rats were fed either a 
diet containing FB1 at 250 mg/kg or a control diet for 5 weeks (Lemmer et al., 1999b). 
FB1 caused a predominantly zone 3 ‘toxic’ liver injury, with hepatocyte death due to 
necrosis and apoptosis. Hepatocyte injury and death were mirrored by desmin-
positive hepatic stellate cell proliferation and marked fibrosis, with progressive 
disturbance of architecture and formation of regenerative nodules. Despite the 
inhibition of hepatocyte regenerative activity, OV-6 positive oval cell proliferation was 
noted from week 2, PGST+ hepatic foci and nodules developed and, at later time 
points, oval cells were noted inside some of the ‘atypical’ nodules. Northern blot 
(mRNA) analysis of liver specimens from weeks 3 to 5 showed a progressive 
increase in gene expression for α-fetoprotein (AFP), hepatocyte growth factor (HGF), 
TGF-α  and especially TGF-β1 and c-myc. Immunostaining with LC (1-30) antibody 
demonstrated a progressive increase in expression of mature TGF-β1 protein by 
zone 1 and 2 hepatocytes over the 5 week feeding period. FB1 thus appears to be a 
unique liver carcinogen, which causes the rapid induction of oval cell proliferation and 
preneoplastic lesions despite marked apoptosis. The overexpression of TGF-β1 by 
hepatocytes may be causally related to the prominent apoptosis and fibrosis seen 
with liver injury due to FB1. Increased expression of c-myc and TGF-β1 may 
cooperate in the promotion of liver tumour development in the FB1-fed rat, possibly 
by providing an environment that stimulates the outgrowth of TGF-β1-resistant 
transformed hepatocytes and/or oval cells via the regulation of cyclin D1, cyclin D 
kinases, retinoblastoma protein (Rb) phosphorilation and  E2F (Fig 2). The interaction 
of cyclin D1 and c-myc expression with the subsequent inactivation of Rb may alter 
the expression of E2F and the deregulation of cell cycle control.  
 
A study in male Fischer 344 and BD IX rats showed that FB1 increased the levels of 
cyclin D1 in preneoplastic and neoplastic liver lesions (Ramljak et al., 2000). FB1 was 
shown to activate protein kinase B (Akt), which stimulates the phosphorylation of 
cyclin D1 via glucacon synthase kinase 3β (GSK-3β), thereby inhibiting its 
proteosomal breakdown. Subsequent events include an increase in the cyclin 
dependent kinase 4 (CdK4) complex with cyclin D1 resulting in the elevation of CdK4  
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Fig 2.  Alteration of cell cycle control genes in regulating cell proliferation and apoptosis. 
Differential effects of FB1 on c-myc, TGF-α and TGF-β1 in normal and altered hepatocytes 
forms the basis of cancer promotion via the regulation of cyclin D1 and E2F (Lemmer et al., 
1999b). 
 
 
activity and phosporylation of retinoblastoma, which will provide a selective growth 
advantage to the altered preneoplastic and neoplastic liver cells. Akt is also known to 
inhibit apoptosis in the resistant preneoplastic cells resulting from cancer initiation 
while normal cells will undergo apoptosis in the absence of cyclin D1 stabilisation. 
The disruption of sphingolipid, phospholipid and fatty acid metabolism and the 
subsequent effects on cyclin D1 stabilisation are illustrated in below (Fig 3). 
 
Upstream membranal events are likely to be involved in the FB1-induced effects on 
lipid biosynthesis, especially the regulatory roles of arachidonic acid (AA; C20:4n-6) 
and ceramide on cell cycle parameters, such as MAPK and PI3K pathways 
determining cell survival. The differential effects of these lipid-associated changes on 
normal and preneoplastic lesions in the liver could provide a plausible explanation for 
the cancer promoting properties of the fumonisins. The disruption of sphingolipid 
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metabolism in hepatocyte nodules, induced by either FB1 or DEN, followed by 2-
acetylaminofluorene/partial hepatectomy (AAF/PH) promotion was investigated by 
monitoring the effect of a secondary FB1 treatment on the levels of sphinganine (Sa) 
and sphingosine (So) in the nodules and surrounding tissue (Van der Westhuizen et 
al., 2004). The initiating treatment of FB1 (250 mg FB1/kg diet for 21 days) 
significantly increased the Sa, So and Sa/So ratio in the liver which returned to 
baseline levels after the 2-AAF/PH promoting treatment except for So in the nodules.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3. Membrane effects of FB1 disrupting lipid biosynthesis at different levels, affecting 
membrane integrity and key cell survival regulatory molecules related to cell 
proliferation and apoptosis (Ramljak et al., 2000; Gelderblom et al., 2001, 2008) 
 
The secondary treatment increased the Sa levels to a similar extent in the nodules 
and surrounding tissue while So was further increased in the FB1- and DEN-induced 
hepatocyte nodules.  DEN initiation sensitized the nodules and surrounding tissue to 
the accumulation of Sa when compared to FB1 initiation, resulting in a higher Sa/So 
ratio. The nodules resulted from FB1-initiation are sensitized to accumulate So which 
could selectively support proliferation, presumably via the production of So-1-P.  
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4.3.2 Studies in primary hepatocytes 
A common property of many cancer promoters is their mitoinhibitory effect in primary 
rat hepatocytes when using epidermal growth factor (EGF) as a mitogen. In a 
comparative study 2-AAF, a known cancer promoter, exhibited the highest inhibitory 
effect followed by FB1 and phenobarbital (PB), on the EGF-induced mitogenic 
response (Gelderblom et al., 1996b). PB is generally regarded as a mitogen that 
selectively stimulates the development of preneoplastic lesions in the liver via the 
disruption of apoptosis (Schulte-Herman et al., 1990). From these studies it would 
appear that the inhibition of cell proliferation by FB1 is a key event in creating the 
differential growth response in the liver during cancer promotion. At present very little 
is known about the mechanisms involved in the mitoinhibitory effect and/or the 
inhibition of cell proliferation by FB1. Studies in primary hepatocytes indicated that 
mitoinhibition was reversible and that the pretreatment of cells has very little effect on 
the EGF response (Gelderblom et al., 1995). It would appear that hepatocytes have 
very little “memory” and that the continued presence of FB1 is required for maximal 
inhibition. The mitoinhibition by FB1 was not associated with cytotoxicity as it was 
effected well below (10x) the cytotoxic levels. When compared to cancer promotion in 
vivo similarities exist with respect to the reversibility and the lack of an association 
with hepatotoxicity. Due to these similarities the mitoinhibitory effect in primary 
hepatocytes was used as a tool to investigate the possible mechanism(s) involved. 
 
The EGF response in primary hepatocytes was associated with changes in the n-6 
fatty acid (FA) metabolism as C20:4n-6 and C18:2n-6 was significantly decreased 
and increased, respectively (Gelderblom et al., 1999). Addition of C20:4n-6 increased 
the EGF response while C20-5n-3 decreased not only the levels of C20:4n-6, but 
also the EGF mitogenic response. The inhibition of the EGF mitogenic response by 
C20:5n-3 was associated with a decrease in the total n-6 FA, PUFA and an increase 
in the saturated (SATS) and mono unsaturated FA (MONO-UNSATS) resulting in a 
decrease in the polyunsaturated/saturated (P/S) FA ratio. The underlying 
mechanisms are not known, but the inhibition of the EGF response was associated 
with changes in the membrane environment, specifically the FA content of PC. The 
stimulation of the EGF response was directly associated with the increased level of 
C20:4n-6 in the membranal PC phospholipid fraction. The role of C20:4n-6 was 
further emphasized as the addition of PGE2, derived from C20:4n-6, stimulated, while 
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ibuprofen, a non steroidal anti-inflammatory drug known to inhibit PGE2 formation, 
decreased the EGF mitogenic response, respectively. PGE2 also counteracted the 
FB1-induced mitoinhibitory effect suggesting that this biosynthetic pathway is 
disrupted in primary hepatocytes. The disruption of C20:4n-6 levels and subsequent 
prostanoid metabolism are likely to be one of the underlying mechanisms responsible 
for the modulation of the growth regulatory effects in primary hepatocytes and rat 
liver in vivo.  
 
4.4 Metabolism and disruption of lipid biosynthesis  
 
4.4.1  In vitro studies using primary hepatocytes 
FB1 and FB2 were found not to be highly toxic to primary hepatocytes when 
compared to AFB1 (Gelderblom et al., 1993). Of the fumonisins, FB2 exhibited the 
highest cytotoxic effects with FB1 and FB3 having similar potencies. In comparative 
studies using 14C radiolabelled fumonisins a higher specific binding was noticed with 
FB2, presumably due to a lower polarity (Cawood et al., 1994). The effective dose 
level, i.e. the lowest levels to elicit a cytotoxic effect, was similar. About 10% of the 
fumonisins are bound irreversibly to the hepatocytes indicating that the mycotoxins 
are associated with both the soluble and insoluble (membranal) compartments of the 
cell. Some of the radiolabelled fumonisins were tightly bound to the microsomes and 
plasma membranes. FB1 was not metabolized by the primary hepatocytes as no 
radiolabelled metabolites could be detected after the fractionation of the culture 
media. Enzymatic incubation assays also provide evidence that FB1 was not 
metabolised by cytochrome P450, the hepatic esterases, the trygliceride hepatic 
endothelial lipase or the porcine pancreatic lipase. The study provides evidence that 
the intact molecule is responsible for the toxicological effects in the liver and 
hydrolisation to the aminopolyols does not occur. 
 
A study using [14C] leucine provided evidence that FB1 did not affect the incorporation 
in primary hepatocytes at both cytotoxic and non-cytotoxic doses (Gelderblom et al., 
1996a). In contrast the incorporation of [14C] labeled palmitic acid was significantly 
reduced in triacylglycerol (TAG) and sphingomyelin (SM) while it was increased in 
phosphatidylcholine (PC) and phosphatidylethanolamine (PE). The increased 
accumulation in the phospholipids closely mimics the increased concentration of the 
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respective phospholipids in the treated cells. The relative levels of C18:2n-6 and 
C20:4n6 was significantly increased in the hepatocytes resulting in an increase in the 
total PUFA. Cholesterol, free cholesterol and SM levels were significantly lowered 
while sphinganine was increased. The increased PC/free cholesterol ratio was 
indicative of a more rigid membrane structure while the decreased C20:3n-6/C18:2n-
6 ratio implies the impairment of the delta-6 desaturase, the rate limiting enzyme in 
fatty acid metabolism. Changes in the conversion of C18:2n-6 to C20:4n-6 also 
regulates TAG synthesis.  
 
The kinetics of sphingolipid metabolism inhibition was investigated in primary 
hepatocytes (Van der Westhuizen et al., 1998). The accumulation of sphinganine 
(Sa) and sphingosine (So) was maximally increased by FB1 (1µM) after 40 hr 
resulting in a significant increase in the Sa/So ratio in the absence of any cytotoxic 
effects. Removal of FB1 after 12 or 24 hrs did not effect the accumulation of Sa 
although the level of So was significant reduced. This would imply that the 
accumulation of Sa is irreversible in primary hepatocytes and the accumulation of Sa 
was not associated with a cytotoxic effect. 
 
4.4.2 In vivo studies in rat liver 
Lipid alterations in the livers of male Fischer and BD IX rats were monitored in a 
short-term, high dose and a long-term, low dose feeding treatment regimens, 
respectively (Gelderblom et al., 1997). Phospholipid changes noticed involved an 
increase in PE and decrease in SM at the highest dose (250 mg FB1/kg) while PE 
was markedly increased at the 50 and 100mg FB1/kg diet groups. Total serum and 
liver cholesterol was significantly increased at the highest dose level. Sa was 
markedly to significantly increased at all the dietary treatments while the Sa/So ratio 
was significantly increased at 100 mg FB1 dietary level. When considering the 
relative fatty acid (FA) levels, C18:2n-6 and C22:5n-6 were significantly increased 
and decreased respectively, in PE and markedly in PC suggesting an impairment of 
the delta 6-desaturase enzyme. This resulted in a decrease in the total n-6 FA and 
PUFA at the highest dose. In the long-term study PE was significantly increased in 
the liver at 1, 10 and 25 mg FB1/kg diet, while Sa and So were markedly increased at 
the highest dose level. Total FA analyses showed that C18:2n-6 was significantly 
increased at all the dose levels while C22:5n-6 was markedly decreased again 
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suggesting an impaired delta 6-desturase. In the long-term experiment the n-6/n-3 
ratio was significantly decreased in PC due to an increase in the total n-3 FA. 
Retrospective analyses of the C20:4n-6 PC/PE ratio in both the short-term and long-
term experiments showed that FB1 decreased the ratio implying that the level was 
increased in PE relatively to PC (See section 4.5 for additional comments). 
 
Table 1. The modulating effect of FB1 on the arachidonic acid (C20:4n-6) distribution 
in phosphatidylcholine (PC) and phosphatydyl-ethanolamine (PE) in rat 
liver of short-term and long-term feedings studies. 
Dietary FB1 
(21 days)* 
C20:4n-6 
(PC/PE ratio)  
Dietary FB1 
(2 yr)** 
C20:4n-6 
(PC/PE ratio) 
Crtl 1.15 Ctrl 1.05 
50 1.17 1 0.91 
100 1.10 10 0.93 
250 1.02 25 0.76 
*Male Fischer 344 rats; **Male BD IX rats (Data derived from Gelderblom et al., 1997) 
 
A study in liver microsomal preparations of rats receiving different dietary levels of 
FB1 (10, 50, 100 and 250 mg/kg) over 21 days showed a dose dependent increase in 
PC, PE, PI and cholesterol (Chol) resulting in changes in the membrane lipid 
parameters (Gelderblom et al., 2002). This resulted in a decrease in the PC/PE and 
an increase in the total phospholipid/Chol ratios suggesting an increase in the rigidity 
of the microsomal membrane. The absolute FA levels, including SATS, MONO-
UNSATS and polyunsaturated (PUFA), increased as a function of the elevated 
phospholipid levels and were already altered at the lowest FB1 dietary level. The 
relative levels of the monounsaturated (C16:1n-7, C18:1n-9) as well as C18:2n-6 
increased in the liver of the rats receiving the 100 mg FB1/kg/kg diet and higher. 
Similarly, the relative levels of the long chained PUFA’s, C20:4n-6 and C22:5n-6 
decreased implying an impairment of the delta 6–desaturase enzyme. Enzyme 
analyses showed that FB1 inhibited the activity of the enzyme in a dose dependent 
manner and coincided with the changes of the relative FA levels. The significant 
increase in the C18:3n-6/20:4n-6 and the C20:3n6/C20:4n-6 ratios also imply the 
impairment of the delta 5- desaturase enzyme. The mechanism of inhibition is not 
known at present, although the disruption of the integrity of the microsomal 
membrane is likely to affect the activity of the enzyme, especially at higher dietary 
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levels. The increase of PE relative to PC implies that certain FA, especially the 
C20:4n-6 PC/PE ratio is enhanced (Table 2) which has been suggested to be an 
important growth stimulus in hepatocyte nodules (Abel et al., 2001). A specific role of 
C20:4n-6 has been proposed for the development of liver cancer induced by FB1 
(see section 4.5).   
 
 
Table 2. The modulating effect of FB1 on the arachidonic acid (C20:4n-6) distribution 
in phosphatidylcholine (PC) and phosphatydyl-ethanolamine (PE) in rat 
liver after a 21 day feedings study. 
Dietary FB1 
(21 days)* 
Ctrl  10 50 100 250 
C20:4n6 
(PC/PE ratio) 
2.7 2.4 2.6 1.8 1.9 
* male Fischer rats (Adapted from Gelderblom et al., 2002) 
 
Changes in the lipid composition by FB1 was further expanded by including different 
subcellular fractions of the liver of rats exposed to the highest dietary level of 250 mg 
FB1/kg for 21 days (Burger et al., 2007). This dietary level effects both cancer 
initiation and promotion (Gelderblom et al., 1994, 1996b). Similar changes related to 
cholesterol, phospholipid and FA metabolism as described above were noticed in the 
subcellular fraction although it differs between the subcellular membrane fractions. 
PE was increased in the microsomal, mitochondrial and plasma membrane fractions 
while PC was increased in the microsomes but decreased in the mitochondria. SM 
was decreased and increased in the mitochondria and nuclear fractions, respectively. 
Cholesterol was increased in both the microsomal and nuclear fractions. It would 
appear that most of the changes in these lipid parameters are located in the 
microsomes, mitochondria and plasma membrane. SATS increased in PE in the 
microsomes and mitochondria due to an increase in both C16:0 and C18:0 and 
decreased in the mitochondrial PC due to a decrease in C18:0. The MONO-UNSATS 
were increased in PC and PE in the microsomes and mitochondria mainly due to an 
increase in C18:1n-9. The PUFA were decreased in PE in the microsomes, PC in the 
mitochondria and plasma membrane mainly due to a decrease in the long chain 
PUFAs (C20:4n-6, C22:4n-6 and C22:5n-6). The reduction in the levels of PUFA and 
increased in the MONO-UNSATS, C16:1n-7 and C18:1n-9, were indicative of an 
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impaired FA desaturase enzymes. Changes in the different lipid parameters in the 
various cellular compartments regarding the PC/PE and P/S ratios suggest a more 
rigid membrane structure. Changes in the n-6/n-3 ratio and the decreased C20:4n-6 
PC/PE ratio due to a relative increase of C20:4n-6 in PE, suggest a shift in the 
prostanoid synthesis of the E2 series. Changes in the PE and C20:4n-6 in the plasma 
membrane could also impact on the key growth regulatory cell receptors specifically 
those located in lipid rafts known to be altered by FB1. An interaction between 
C20:4n-6 and ceramide was suggested to play a critical role in the mitochondria to 
regulate the balance between cell proliferation and apoptosis which could be 
important during cancer promotion of the resistant hepatocytes induced in the liver 
(Fig 4). Changes in the level of oxidative stress in the normal and the preneoplastic 
lesions (section 4.1.3) will also contribute to the balance that exists between the 
proliferative and apoptotic status prevailing in the liver. 
 
4.5 Perspectives 
 
The genotoxicity of the fumonisins has been debated although it is generally 
accepted that it lacks DNA interactive reactivity in different short-term genotoxicity 
assays utilising bacteria (Knasmuller et al., 1997: Aranda et al., 2000; Ehrlich et al., 
2002) and in vivo and in vitro DNA repair assays in primary hepatocytes (Gelderblom 
and Snyman, 1991). No direct interaction of FB1 with oligonucleotides could be 
detected (Pocsfalvi et al., 2000). However, recent studies showed that FB1 exhibited 
clastogenic and apoptotic effects in different human cells including human fibroblasts 
(Galvano et al., 2002), HepG2 cells (Ehrlich et al., 2002), lymphocytes (Lerda et al., 
2005; De Lorenzi et al., 2005), monkey and, rabbit kidney cells (Abado-Becognee et 
al., 1998; Rumora et al., 2002). DNA damage of the apoptotic type was induced in 
the fibroblast in the absence of cytotoxic effects. A study in C6 gliomal cells with 
normal p-53 status underwent apoptosis after incubation with FB1 associated with a 
dose-related increased in oxidative DNA adduct formation via the formation of 8-
hydroxy deoxyguanine (8-OH-dG) and fragmentation (Mobio et al., 2003). 
 
The loss in the suppression of cell cycle progression and absence of apoptosis in p-
53-null mouse embryonic fibroblasts cells suggest that p53 gene governed DNA 
lesions induced by FB1 further supported DNA reactivity. In the HepG2 cells 
 57 
chromosomal aberrations and DNA migration patterns as monitored by the comet 
assay were detected at very low concentrations in the absence of any cytotoxic 
effects.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4. Interactive pathways of FB1-induced lipid and oxidative changes in the regulation of 
cell proliferation and apoptosis in the liver (Burger et al., 2007; Gelderblom et al., 
2008) 
 
 
Oxidative DNA damage appears to be one of the major mechanisms proposed for 
disrupting membrane structures associated with an increased lipid peroxidation (Yin 
et al., 1998; Sahu et al., 1998; Atroshi et al., 1999), which could explain the genotoxic 
effects of the fumonisins via the formation of hydroxyl and peroxyl radicals. An in vivo 
study in rats suggested that the disruption of sphingolipid biosynthesis played an 
important role in DNA damage in the kidney caused by FB1 as it occurs in the 
absence of different markers associated with oxidative damage (Domijan et al., 
2007). In the liver, however, oxidative markers and changes to the sphingolipid levels 
coincided with DNA damage. The study confirms the notion that oxidative damage 
appears to be a secondary event following the FB1-induced cytotoxic effects, which 
was associated with DNA alterations in the liver.  
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The in vitro and in vivo studies confirmed that FB1-induced DNA damage, 
presumably by indirect means associated with cell toxicity and resultant oxidative 
damage. The implications of these genetic alterations in cancer development have 
been evaluated by utilising the rat liver cancer initiating/promotion model. These 
studies provided sufficient evidence that FB1 possesses cancer initiating activity as 
defined below: 
 
• Studies using male BD IX, Fischer 344 and Sprague Dawley rats showed that FB1 
exhibits cancer-initiating properties (Gelderblom et al., 1988a, 1992, 1994, 2001a, 
2008; Metha et al., 1998). 
 
• The induction of a hepatotoxic effect, as discussed for the induction of 
hepatocarcinogenesis, is a prerequisite for cancer initiation. An apparent no-effect 
threshold related to hepatotoxicity and hepatocyte regeneration exists for cancer 
initiation, which in turn is determined by the dosage and the duration of exposure.  
In this regard a low non-toxic dose effect initiation in the absence of a heptotoxic 
effect (Gelderblom et al, 2001b). The inhibition of hepatocyte proliferation and the 
induction of apoptosis seem to play a critical role in the genesis and/or the 
threshold of the initiating event (Gelderblom et al., 1994; Lemmer et al., 1999b). 
 
• FB1 initiates cancer in rat liver similarly to the genotoxic carcinogens, by inducing 
“resistant” hepatocytes with a dependence on cell proliferation, although the 
kinetics differ. Phenotypically these initiated cells develop into eosinophilic clear 
cell foci and nodules that stained positively PGST and γ-glutamyl-transferase 
(GGT). The absolute level of events (DNA mutations, etc), resulting in initiation, 
occurs at a far slower rate when compared to genotoxic carcinogens (Gelderblom 
et al., 1991; 1992, 1994).  
 
• Similarly to genotoxins, cell proliferation associated with hyperplasia failed to 
enhance, while stimulation of regenerative cell proliferation enhanced the cancer 
initiating potency of FB1 (Gelderblom et al., 2001a). 
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• Irreversibility of cancer initiation by FB1 was demonstrated as a five-week 
exposure resulted in liver adenomas after 1 year in male Fischer 344 rats 
(Lemmer et al., 2004).  
 
• Different cancer promoting stimuli, 2-AAF/PH, 2-AAF/CCl4 and PB promote the 
development of altered preneoplastic hepatic lesions (Gelderblom et al., 1991, 
2008). 
 
• FB1 lacks peroxisome proliferative activity (Gelderblom et al., 1996b) while the 
role of promoting spontaneous initiated cells in older rats (Gelderblom et al., 
2008) seems not to play a role in FB1-induced carcinogenesis.  
 
The intact fumonisin structure is a prerequisite for the toxicological effects in the liver 
while the hydrolysation to the aminopolyols does not occur in the liver.  Studies in 
vervet monkeys indicated the presence of the aminopentol and -tetrol and partial 
hydrolised forms of FB1 and FB2 in the faeces is only a minor metabolic pathway, 
presumably related to the breakdown by the gut microflora (Shephard et al., 1995, 
1999). However, the aminopentol (AP1 of HFB1) has been implicated in the 
toxicological effects in rats (Hendrich et al., 1993; Voss et al., 1996). These studies 
showed that nixtamalised culture material containing HFB1, but no FB1, exhibited 
cancer promoting and toxic effects in the liver and nephrotoxic effects in kidneys of 
rats. It was suggested that HFB1 still retains hepatotoxic and nephrotoxic effects in 
rats when fed at dietary levels between 7-10 and 39 mg/kg diet, although it was less 
potent than the parent FB1. Culture material containing 58 mg HFB1/kg diet and fed 
to rats for 4 weeks significantly increased the So level and Sa/So ratio and toxic 
effects in the liver and kidneys (Voss et al., 1998). Studies in rats using purified HFB1 
(AP1) and HFB2 (AP2), however, showed contrasting results in that levels up to 500 
and 1000 mg/kg over a period of 21 days lack any toxic and/or cancer initiating 
potency (Gelderblom et al., 1993). A study in mice also indicated that HFB1, fed at a 
dietary level of up to 140 ppm for 27 days lacks any histopathological effects and 
changes in sphingolipid biosynthesis (Howard et al., 2002) suggesting that the 
hydrolised products lack any biological activity in vivo. These studies showed that the 
free amino group is a prerequisite for biological activity in vivo. 
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Studies utilising primary hepatocytes showed that HFB1 and HFB2 were less effective 
in disrupting sphingolipid metabolism while it was more cytotoxic than the parent 
molecule (Gelderblom et al., 1993; Van der Westhuizen et al., 1998). Cytotoxic 
effects of FA1 and FA2 were similar to those of FB1 and FB2, respectively although it 
tended to be less toxic at higher dose levels (Gelderblom et al., 1993). At a low dose 
(1 µM) FA1 was more effective in disruption of Sa and So levels in primary 
hepatocytes than FB1. However, studies with liver slices showed that purified FA1 
lacks any inhibition of ceramide synthase (Norred et al., 2001). It was reported that 
FA1 is converted to 3-O-acetyl and 5- acetyl FB1 thereby liberating the free amino 
group in solution, especially under acidic conditions, which could explain the lack of 
effect on sphingolipid biosynthesis. Irrespective whether FA1 underwent 
rearrangement in the study of Van der Westhuizen et al (1998) the conversion under 
neutral conditions in saline at 4 °C is not known and highly unlikely to be complete 
yielding the free amino derivatives as suggested by Norred et al., (2001). This must 
be considered against the background that a high conversion is noticed under acid 
conditions. Norred et al. (2001) also directly linked the disruption of sphingolipid 
metabolism in liver slices in which no cytotoxic assessment was conducted to the 
study in primary hepatocytes where the disruption of sphingolipid metabolism was 
associated with cytotoxic effects. It would appear that both the hydrolised FB’s and 
the N-acetyl derivatives lack activity in vivo while they either exhibited similar or 
increased effects on sphingolipid metabolism and cytotoxicity in primary hepatocytes. 
However, the role of the hydrolised FB’s in the toxicological effects of the fumonisins 
in vivo is therefore controversial and should be re-evaluated.  
 
In contrast to the cancer initiating properties of FB1 several studies have been 
conducted to investigate the cancer promoting properties and including in vitro 
studies in primary hepatocytes and cancer cell lines as well as in rats and mice in 
vivo. Studies in rat liver have been described in detail above (Section 4.3) which was 
based on the resistant hepatocyte model (Solt et al., 1977; Farber, 1990). An 
additional hypothesis has been developed in the liver and kidney of rats, which was 
based on a compensatory cell proliferative model for non genotoxic carcinogens 
(Dragan et al., 2001; Howard et al., 2001a; Riley et al., 2001). Introducing concepts 
such as oncotic necrosis and apoptotic necrosis further developed the model, both 
leading to a sustained cell proliferation which will lead to an increased incidence of 
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tumors in the target tissue. This theoretical model was based on the cell death and 
compensatory regeneration hypothesis formulated for a variety of non-genotoxic 
chemical carcinogens in different tissues (Cohen, 1998; Cohen and Ellwein, 1990; 
Butterworth and Goldsworthy, 1991). The development of a different subset of cells, 
resistant to the apoptotic necrosis has also been considered to be involved in the 
genesis of renal tumors induced by FB1 (Riley et al., 2001). The induction of renal 
tumors in rats by FB1 was argued to be an example of apoptotic necrosis 
regenerative cell proliferation carcinogenesis model. In the liver, however, apoptotic 
necrosis and oncotic necrosis occur at the same time, which complicates the 
apoptotic cancer model. However, the high incidence of nephropathy in the kidneys 
and the resultant formation of many proliferative lesions including atypical tubule 
hyperplasia (Hard et al., 2004) suggest a possible FB1/high protein diet interaction 
(Chapter III). The study on the carcinogenic effects of FB1 in female B6C3F1 mice 
was also complicated by the spontaneous development of hepatocellular adenomas 
and carcinomas (Howard et al., 2001b). Although no carcinomas developed in the 
mice due to feed restriction it is not clear whether the increased development of 
adenomas and carcinomas could be ascribed to the cancer promoting properties of 
FB1 rather than being considered as a carcinogen.  
 
The role of sphingolipids in the development of kidney cancer has been reviewed in 
detail (Merrill et al., 2001; Dragan et al., 2001; Riley et al., 2001) and will not form 
part of the current discussions. The role of cell proliferation in the development of 
cancer has also been debated in the past after the questioning of the role of cell 
proliferation as a risk factor per se in the long process of cancer development (Perera 
et al., 1991; Farber, 1995). During a follow up debate (Letters to Editor) by 
Butterworth, Cohen, Ames and Ellwein regarding the role of cell proliferation in 
carcinogenesis it was concluded that, due to the complexity of cancer development, 
there is no scientific evidence that a sustained proliferation is a risk factor for cancer 
(Ward et al., 1993; Tomatis, 1993; Weistein, 1993; Farber 1996). As carcinogenesis 
in rat kidney by FB1 has not been well characterised regarding the different phases 
as compared to the liver, the oncotic apoptotic cell proliferative model is debatable, 
especially against the background of the numerous proliferative tubular lesions due to 
the development of CPN (Chapter III). This is of particular importance when the 
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underlying principles of such a model impact on setting risk assessment parameters 
for the fumonisins, an aspect that will be further debated in Chapter V. 
 
The role of the disruption of lipid metabolism by FB1, involving phospholipid and fatty 
acids in rat liver cancer promotion, has been reviewed extensively (Gelderblom et al., 
1996; 2001a, b; 2008). The model was based on studies regarding the role of lipid 
metabolism in liver cancer development (Abel et al., 2001; 2004 – see addenda 1, 2) 
during which different lipid parameters were monitored in hepatocyte nodules over a 
period of 9 months. In short the decrease in the PC/PE phospholipid ratio, 
impairment of the delta 6-desaturase and a decrease in the oxidative status in 
hepatocyte nodules were identified as the key components responsible for the altered 
growth characteristics in these lesions. These changes closely mimiced regenerating 
liver, which further provides proof that they are associated with cell proliferation. 
Persistent changes in the nodules include an increase in cholesterol and PE which 
were associated with an increase in C18:1n-9 and C18:2n-6 while C20:4n-6 
decreased in PC and increased in PE resulting in an increase C20:4n-6 PC/PE ratio. 
The end products of both the n-6 and n-3 FA pathways, C20:5n-6 and C22:6n-3 also 
decreased in PC resulting in a reduction in the total PUFA and long chain PUFA 
levels in the nodules. The specific role of these altered FA parameters in the growth 
of nodules can be summarised as follow: 
 
• The increased and decreased levels of C18:1n-9 and long chained PUFA levels, 
respectively, render the nodules less susceptible to oxidative stress and hence to 
undergo apoptosis. C18:1n-9 has been proposed to act as a membranal 
antioxidant known to be enhanced in many cancer cells (Horrobin, 1994). These 
lesions were shown to exhibit a low level of lipid peroxidation, the latter, which 
was increased due to an increased level of PUFA using a diet high in long chain 
(LC) n-3 PUFA (Abel et al., 2004). The increased level of lipid peroxidation was 
associated with a decrease in the incidence and sizes of hepatocyte nodules, 
presumably due to increases their susceptibility to undergo apoptosis.  
 
• The increased C20:4n-6 PE/PC ratio has been implicated in the altered 
proliferation of hepatocyte nodules due to the role of C20:4n-6 and the 
prostaglandin E2 series products via the activation of protein kinase C and the 
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mitogen activation protein kinases. It has been proposed to be involved in the 
development of preneoplastic foci via its effect on different growth factors and the 
deregulation of c-myc involving ceramide (Jayadev, et al., 1994).   
 
FB1-induced effects in the liver closely mimic the lipid changes in hepatocyte nodules 
and are therefore likely to selectively stimulate the growth in hepatocyte nodules, 
suggesting that similar changes in the normal surrounding tissue resulted in an 
adverse effect on cell viability. Altered lipid changes induced by FB1: 
 
• Impaired delta 6-desaturase, leading to the accumulation of C18:1n-6, C18:2n-6 
and a reduction in LC PUFA levels in the cell (Gelderblom et al., 2002).  
 
• Increase PE resulting in an increased C20:4n-6 PE/PC ratio. Inhibition of 
ceramide synthase with accumulation of sphinganine and decrease in 
sphingomyelin. Changes in these parameters differ in the subcellular fractions 
with the increased PE noticed in the plasma membrane, mitochondria and 
microsomes while SM was decreased in mitochondria. The C20:4n-6 PE/PC ratio 
was altered in all the membranal fractions (Burger et al., 2007). 
 
• Differential effects of these lipid associated changes on the viability of normal and 
preneoplastic cells provide the basis for cancer promotion. The association of the 
lipid changes and the selective induction of growth factors and signaling 
molecules are likely to inhibit cell proliferation and induce apoptosis in normal 
cells whilst inducing cell proliferation in preneoplastic cells (Lemmer et al., 1999a; 
Ramljak 2000). This inhibitory effect on cell proliferation was demonstrated by FB1 
in proliferating hepatocytes in normal liver following partial hepatectomy 
(Gelderblom et al., 1994). 
 
• Effect of FB1 on cellular oxidative status played an important differential role in the 
regulation of apoptosis and cell proliferation between normal and neoplastic cells. 
A recent study showed that FB1 modulated the cellular redox balance in the liver 
by altering oxidative enzymes and redox sensitive signaling molecules including 
the GSH levels, MAPK activation, heat shock proteins, ERK and p38 (Rumora et 
al., 2007; Marnewick et al., 2009)  
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Interaction of the fumonisins with cellular membranes has become a major focus 
point of research to explain the toxicological and carcinogenic effects in experimental 
animals. A study in model membranes showed that FB1 interacted with the polar 
head group region effecting the membrane organization and dynamics, which will 
impact on the permeability and integral proteins such as the ion channels and 
lypolytic enzymes (Theumer et al., 2008). Subsequent disruption of sphingolipid, 
phospholipid and fatty acid metabolism and their underlying interaction are likely to 
play a determining role in the selection of altered hepatocytes and the development 
of hepatocellular carcinoma in rat liver. These interactions may occur at several 
levels that could affect the growth signaling and apoptotic pathways determining cell 
survival and hence cancer promotion in the liver.  
 
In vitro studies utilising oesophageal cancer cells (WHC03) showed that FB1 
interfered with the effects of C20:4n-6 on cell cycle progression, apoptosis and 
tyrosine- and cyclin D dependent kinase 2 (CDC2-kinase) activity (Seegers et al., 
2000). FB1 inhibited apoptosis induction by C20:4n-6 and PGE2, which was 
associated with a reduction in tyrosine kinase, increase in CDC2-kinase and a 
reduction in the p53 levels. C20:4n-6-induced apoptosis has been shown to be 
effected via the modulation of the ceramide levels by increasing the 
sphingomyelinase activity (Jayadev et al., 1994). Ceramide-induced apoptosis is also 
dependent on an increased tyrosine kinase activity (Stewart et al., 1995) which was 
markedly enhanced by C20:4n-6. The latter also enhanced the p53 level, which in 
turn reduced the level of cyclin B1 and the activity of CDC2-kinase via the expression 
of p21. The disruption of ceramide synthase by FB1 will therefore abrogate the anti-
mitotic and apoptotic-inducing effects of C20:4n-6. Additional evidence for the role of 
C20:4n-6 in the FB1-induced effects was obtained from a study in human bronchial 
epithelial cells (Pinelli et al., 1999). FB1 increased protein kinase C translocation and 
mitogen-activated protein kinase (MAPK) resulting in the down regulation of 
phospolipase A2 (PLA2) and C20:4n-6 metabolism. Activation of PLA2 was related to 
the phosphorylation by MAPK and the increase in sphingosine due to the disruption 
of ceramide synthase. The activation of MAPK by FB1 was also demonstrated in 
Swiss 3T3 fibroblasts, which were related to the stimulation of mitogenesis in these 
cells (Wattenberg et al., 1996).  Apart from the PUFA, the levels of SATS and 
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MONO-UNSATS, both disrupted by the fumonisins, also plays a determining role in 
cell survival. Of interest is the study in breast cancer cells indicating that C16:0 and 
C18:1n-9, increased and decreased phosphatidylinositol 3-kinase (PI3-K), an 
important modulator of cell proliferation and apoptosis (Hardy et al., 2000). As 
reported previously, FB1 activated AKt the activity of which is also regulated by PI3-K 
(Ramljak et al., 2000). The disruption of these cell cycle dependent pathways and 
bioactive fatty acids and sphingolipids in cells could play an important role in the 
selective outgrowth of pre-neoplastic cells in vivo and during cancer promotion. A 
study in Sprague-Dawley rats showed that menhaden oil, high in n-3 fatty acids 
(C20:5n-3, C22:6n-3), inhibited cancer promotion by FB1 following DEN initiation (Lee 
et al., 2000). The protection against cancer promotion was also assossciated with a 
decrease in hepatic PGE2 and PGF2α providing further proof for the involvement of 
these lipid parameters.  
 
The FA/sphingolipid interactive pathways (Figs 3, 4) represent alterations related to 
membranal changes affecting subsequent resultant signal transduction pathways 
involved in cell survival. However, these pathways are proposed to exist in the liver, 
the outcome of which will differ when considering the differential effects on normal 
and pre-neoplastic cells. 
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